0001045309FALSE--12-312020FYus-gaap:OtherAssetsus-gaap:OtherAssetsus-gaap:OtherAssetsus-gaap:OtherLiabilitiesCurrentus-gaap:OtherLiabilitiesCurrentus-gaap:OtherLiabilitiesCurrentus-gaap:OtherLiabilitiesus-gaap:OtherLiabilitiesus-gaap:OtherLiabilities2017 2018 20192017 2018 20191111600010453092020-01-012020-12-31iso4217:USD00010453092020-06-30xbrli:shares00010453092021-01-3100010453092019-01-012019-12-3100010453092018-01-012018-12-31iso4217:USDxbrli:shares00010453092019-12-3100010453092018-12-3100010453092017-12-3100010453092020-12-310001045309us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2017-12-310001045309us-gaap:RetainedEarningsMember2017-12-310001045309us-gaap:TreasuryStockMember2017-12-310001045309us-gaap:AccumulatedOtherComprehensiveIncomeMember2017-12-310001045309us-gaap:NoncontrollingInterestMember2017-12-310001045309us-gaap:RetainedEarningsMember2018-01-012018-12-310001045309us-gaap:NoncontrollingInterestMember2018-01-012018-12-310001045309us-gaap:TreasuryStockMember2018-01-012018-12-310001045309us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2018-01-012018-12-310001045309us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-01-012018-12-310001045309srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMemberus-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member2018-12-310001045309srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member2018-12-310001045309srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMemberus-gaap:AccountingStandardsUpdate201812Member2018-12-310001045309srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMemberus-gaap:AccountingStandardsUpdate201812Member2018-12-310001045309srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201812Member2018-12-310001045309us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2018-12-310001045309us-gaap:RetainedEarningsMember2018-12-310001045309us-gaap:TreasuryStockMember2018-12-310001045309us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001045309us-gaap:NoncontrollingInterestMember2018-12-310001045309us-gaap:RetainedEarningsMember2019-01-012019-12-310001045309us-gaap:NoncontrollingInterestMember2019-01-012019-12-310001045309us-gaap:TreasuryStockMember2019-01-012019-12-310001045309us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2019-01-012019-12-310001045309us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001045309us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2019-12-310001045309us-gaap:RetainedEarningsMember2019-12-310001045309us-gaap:TreasuryStockMember2019-12-310001045309us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001045309us-gaap:NoncontrollingInterestMember2019-12-310001045309us-gaap:RetainedEarningsMember2020-01-012020-12-310001045309us-gaap:NoncontrollingInterestMember2020-01-012020-12-310001045309us-gaap:TreasuryStockMember2020-01-012020-12-310001045309us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2020-01-012020-12-310001045309us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001045309us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2020-12-310001045309us-gaap:RetainedEarningsMember2020-12-310001045309us-gaap:TreasuryStockMember2020-12-310001045309us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001045309us-gaap:NoncontrollingInterestMember2020-12-31gra:segment0001045309srt:MaximumMember2020-01-012020-12-310001045309us-gaap:BuildingMembersrt:MinimumMember2020-01-012020-12-310001045309us-gaap:BuildingMembersrt:MaximumMember2020-01-012020-12-310001045309us-gaap:TechnologyEquipmentMembersrt:MinimumMember2020-01-012020-12-310001045309srt:MaximumMemberus-gaap:TechnologyEquipmentMember2020-01-012020-12-310001045309us-gaap:MachineryAndEquipmentMembersrt:MinimumMember2020-01-012020-12-310001045309us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2020-01-012020-12-310001045309us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2020-01-012020-12-310001045309srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2020-01-012020-12-310001045309srt:MinimumMember2020-01-012020-12-31xbrli:pure00010453092020-04-012020-06-300001045309us-gaap:LandMember2020-12-310001045309us-gaap:LandMember2019-12-310001045309us-gaap:BuildingMember2020-12-310001045309us-gaap:BuildingMember2019-12-310001045309us-gaap:TechnologyEquipmentMember2020-12-310001045309us-gaap:TechnologyEquipmentMember2019-12-310001045309us-gaap:MachineryAndEquipmentMember2020-12-310001045309us-gaap:MachineryAndEquipmentMember2019-12-310001045309us-gaap:ConstructionInProgressMember2020-12-310001045309us-gaap:ConstructionInProgressMember2019-12-310001045309us-gaap:PropertyPlantAndEquipmentMember2020-01-012020-12-310001045309us-gaap:PropertyPlantAndEquipmentMember2019-01-012019-12-310001045309us-gaap:PropertyPlantAndEquipmentMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMember2018-12-310001045309gra:GraceMaterialsTechnologiesMember2018-12-310001045309gra:GraceCatalystsTechnologiesMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMember2019-12-310001045309gra:GraceMaterialsTechnologiesMember2019-12-310001045309gra:GraceCatalystsTechnologiesMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMember2020-12-310001045309gra:GraceMaterialsTechnologiesMember2020-12-310001045309us-gaap:DevelopedTechnologyRightsMember2020-12-310001045309us-gaap:DevelopedTechnologyRightsMember2019-12-310001045309us-gaap:CustomerListsMember2020-12-310001045309us-gaap:CustomerListsMember2019-12-310001045309us-gaap:TrademarksMember2020-12-310001045309us-gaap:TrademarksMember2019-12-310001045309us-gaap:OtherIntangibleAssetsMember2020-12-310001045309us-gaap:OtherIntangibleAssetsMember2019-12-310001045309gra:A2025TermLoanMember2020-12-310001045309gra:A2025TermLoanMember2019-12-310001045309gra:SeniorNotesDue2027Member2020-12-310001045309gra:SeniorNotesDue2027Member2019-12-310001045309gra:SeniorNotesDue2024Member2019-12-310001045309gra:SeniorNotesDue2024Member2020-12-310001045309gra:SeniorNotesDue2021Member2020-12-310001045309gra:SeniorNotesDue2021Member2019-12-310001045309gra:OtherborrowingsMember2020-12-310001045309gra:OtherborrowingsMember2019-12-310001045309gra:SeniorNotesDue2027Member2020-06-260001045309gra:SeniorNotesDue2027Member2020-06-262020-06-260001045309gra:SeniorNotesDue2021Member2020-07-132020-07-1300010453092020-07-012020-09-300001045309gra:A2025TermLoanMember2018-04-030001045309gra:A2025TermLoanMember2018-04-032018-04-030001045309us-gaap:RevolvingCreditFacilityMember2018-04-030001045309us-gaap:RevolvingCreditFacilityMember2018-04-032018-04-030001045309gra:A2018CreditAgreementMember2018-04-032018-04-030001045309us-gaap:RevolvingCreditFacilityMember2020-12-310001045309us-gaap:SeniorNotesMember2014-09-160001045309gra:SeniorNotesDue2021Member2014-09-160001045309gra:SeniorNotesDue2024Member2014-09-1600010453092014-09-162014-09-160001045309us-gaap:SeniorNotesMember2014-09-162014-09-160001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:A2018CreditAgreementMember2020-12-310001045309gra:A2018CreditAgreementMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:A2018CreditAgreementMember2019-12-310001045309gra:A2018CreditAgreementMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:SeniorNotesDue2027Member2020-12-310001045309gra:SeniorNotesDue2027Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:SeniorNotesDue2027Member2019-12-310001045309gra:SeniorNotesDue2027Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:SeniorNotesDue2024Member2020-12-310001045309us-gaap:EstimateOfFairValueFairValueDisclosureMembergra:SeniorNotesDue2024Member2020-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:SeniorNotesDue2024Member2019-12-310001045309us-gaap:EstimateOfFairValueFairValueDisclosureMembergra:SeniorNotesDue2024Member2019-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:SeniorNotesDue2021Member2020-12-310001045309us-gaap:EstimateOfFairValueFairValueDisclosureMembergra:SeniorNotesDue2021Member2020-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:SeniorNotesDue2021Member2019-12-310001045309us-gaap:EstimateOfFairValueFairValueDisclosureMembergra:SeniorNotesDue2021Member2019-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:OtherborrowingsMember2020-12-310001045309us-gaap:EstimateOfFairValueFairValueDisclosureMembergra:OtherborrowingsMember2020-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMembergra:OtherborrowingsMember2019-12-310001045309us-gaap:EstimateOfFairValueFairValueDisclosureMembergra:OtherborrowingsMember2019-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310001045309us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001045309us-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001045309us-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-31gra:country0001045309us-gaap:ForeignExchangeContractMember2020-12-310001045309gra:A2018CreditAgreementMemberus-gaap:CrossCurrencyInterestRateContractMember2018-04-03iso4217:EUR0001045309gra:A2018CreditAgreementMemberus-gaap:CrossCurrencyInterestRateContractMember2018-11-050001045309gra:A2018CreditAgreementMemberus-gaap:CrossCurrencyInterestRateContractMember2019-01-012019-12-310001045309us-gaap:InterestRateSwapMember2018-04-030001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2020-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2020-12-310001045309us-gaap:FairValueMeasurementsRecurringMember2020-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CrossCurrencyInterestRateContractMember2020-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CrossCurrencyInterestRateContractMember2020-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2020-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateContractMember2020-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2019-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2019-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CrossCurrencyInterestRateContractMember2019-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CrossCurrencyInterestRateContractMember2019-12-310001045309us-gaap:FairValueMeasurementsRecurringMember2019-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2019-12-310001045309us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateContractMember2019-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-310001045309us-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:InterestRateContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:InterestRateContractMember2020-12-310001045309us-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMemberus-gaap:InterestRateContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CrossCurrencyInterestRateContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:CrossCurrencyInterestRateContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMemberus-gaap:CrossCurrencyInterestRateContractMember2020-12-310001045309us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310001045309us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2019-12-310001045309us-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2019-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMemberus-gaap:ForeignExchangeContractMember2019-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:InterestRateContractMember2019-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:InterestRateContractMember2019-12-310001045309us-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateContractMember2019-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMemberus-gaap:InterestRateContractMember2019-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CrossCurrencyInterestRateContractMember2019-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:CrossCurrencyInterestRateContractMember2019-12-310001045309us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMemberus-gaap:CrossCurrencyInterestRateContractMember2019-12-310001045309us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2019-12-310001045309us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2019-12-310001045309us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2020-01-012020-12-310001045309us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2020-01-012020-12-310001045309us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-01-012020-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-01-012020-12-310001045309us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2020-01-012020-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2020-01-012020-12-310001045309us-gaap:CashFlowHedgingMember2020-01-012020-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310001045309us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-01-012020-12-310001045309us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2019-01-012019-12-310001045309us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2019-01-012019-12-310001045309us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2019-01-012019-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2019-01-012019-12-310001045309us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2019-01-012019-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2019-01-012019-12-310001045309us-gaap:CashFlowHedgingMember2019-01-012019-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2019-01-012019-12-310001045309us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2019-01-012019-12-310001045309us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2018-01-012018-12-310001045309us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2018-01-012018-12-310001045309us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2018-01-012018-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2018-01-012018-12-310001045309us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2018-01-012018-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2018-01-012018-12-310001045309us-gaap:CashFlowHedgingMember2018-01-012018-12-310001045309us-gaap:NonoperatingIncomeExpenseMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2018-01-012018-12-310001045309us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2018-01-012018-12-310001045309us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2020-01-012020-12-310001045309us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2019-01-012019-12-310001045309us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2018-01-012018-12-310001045309us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2020-12-310001045309us-gaap:NetInvestmentHedgingMember2019-01-012019-12-310001045309us-gaap:NetInvestmentHedgingMember2020-01-012020-12-310001045309us-gaap:NetInvestmentHedgingMember2018-01-012018-12-310001045309us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2020-01-012020-12-310001045309us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2019-01-012019-12-310001045309us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2018-01-012018-12-310001045309us-gaap:NetInvestmentHedgingMembergra:ForeigncurrencydenominateddebtMember2020-01-012020-12-310001045309us-gaap:NetInvestmentHedgingMembergra:ForeigncurrencydenominateddebtMember2019-01-012019-12-310001045309us-gaap:NetInvestmentHedgingMembergra:ForeigncurrencydenominateddebtMember2018-01-012018-12-310001045309us-gaap:NetInvestmentHedgingMembergra:ForeigncurrencydenominateddeferredintercompanyroyaltiesMember2020-01-012020-12-310001045309us-gaap:NetInvestmentHedgingMembergra:ForeigncurrencydenominateddeferredintercompanyroyaltiesMember2019-01-012019-12-310001045309us-gaap:NetInvestmentHedgingMembergra:ForeigncurrencydenominateddeferredintercompanyroyaltiesMember2018-01-012018-12-310001045309us-gaap:DomesticCountryMember2020-01-012020-12-310001045309us-gaap:DomesticCountryMembergra:TaxCreditCarryforwardMember2020-01-012020-12-310001045309us-gaap:StateAndLocalJurisdictionMembergra:NetOperatingLossAndTaxCreditsMember2020-01-012020-12-310001045309us-gaap:StateAndLocalJurisdictionMember2020-12-310001045309us-gaap:StateAndLocalJurisdictionMember2019-12-310001045309us-gaap:ForeignCountryMember2020-12-310001045309us-gaap:ForeignCountryMember2019-12-310001045309country:DE2020-01-012020-12-310001045309us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001045309us-gaap:UnderfundedPlanMember2020-12-310001045309us-gaap:UnderfundedPlanMember2019-12-310001045309us-gaap:UnfundedPlanMember2020-12-310001045309us-gaap:UnfundedPlanMember2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMember2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMember2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-12-310001045309country:US2020-01-012020-12-310001045309gra:StandardDefinedContributionPlanMembercountry:US2020-01-012020-12-310001045309gra:StandardDefinedContributionPlanMembercountry:US2019-01-012019-12-310001045309gra:StandardDefinedContributionPlanMembercountry:US2018-01-012018-12-310001045309gra:EnhancedDefinedContributionPlansMembercountry:US2020-01-012020-12-310001045309gra:EnhancedDefinedContributionPlansMember2020-01-012020-12-310001045309gra:EnhancedDefinedContributionPlansMember2019-01-012019-12-310001045309gra:EnhancedDefinedContributionPlansMember2018-01-012018-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:US2018-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2018-12-310001045309us-gaap:PensionPlansDefinedBenefitMember2018-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:US2019-01-012019-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-01-012020-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2019-01-012019-12-310001045309us-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:US2018-01-012018-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2018-01-012018-12-310001045309us-gaap:OverfundedPlanMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001045309us-gaap:OverfundedPlanMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:UnderfundedPlanMembercountry:US2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:UnderfundedPlanMembercountry:US2019-12-310001045309us-gaap:UnfundedPlanMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001045309us-gaap:UnfundedPlanMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:UnderfundedPlanMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:UnderfundedPlanMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:UnfundedPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:UnfundedPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:DE2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:DE2019-12-310001045309us-gaap:QualifiedPlanMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-12-310001045309us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001045309us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:USgra:MultiassetcreditMember2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:USgra:MultiassetcreditMember2019-12-310001045309gra:LiabilityhedgingassetsMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001045309gra:LiabilityhedgingassetsMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001045309us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Membercountry:US2020-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMembergra:AnnuityAndImmediateParticipationContractsMembercountry:US2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMembergra:AnnuityAndImmediateParticipationContractsMemberus-gaap:FairValueInputsLevel2Membercountry:US2020-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Membercountry:US2020-12-310001045309gra:InvestmentsMeasuredAtNetAssetValueMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercountry:US2020-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001045309us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Membercountry:US2019-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMembergra:AnnuityAndImmediateParticipationContractsMembercountry:US2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembergra:AnnuityAndImmediateParticipationContractsMemberus-gaap:FairValueInputsLevel2Membercountry:US2019-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Membercountry:US2019-12-310001045309gra:InvestmentsMeasuredAtNetAssetValueMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercountry:US2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:CA2020-01-012020-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:CA2019-01-012019-12-310001045309us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMembercountry:CA2020-12-310001045309us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMembercountry:CA2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:BondsMembercountry:CA2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:BondsMembercountry:CA2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembergra:OtherInvestmentMembercountry:CA2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMembergra:OtherInvestmentMembercountry:CA2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:CA2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMembercountry:CA2019-12-310001045309gra:OtherForeignMemberMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001045309gra:OtherForeignMemberMemberus-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:CorporateDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMembergra:InsuranceContractsAndOtherInvestmentsMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Membergra:InsuranceContractsAndOtherInvestmentsMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CashMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CashMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignPlanMember2020-12-310001045309gra:InvestmentsMeasuredAtNetAssetValueMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:ForeignPlanMember2020-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:CorporateDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMembergra:InsuranceContractsAndOtherInvestmentsMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Membergra:InsuranceContractsAndOtherInvestmentsMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CashMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CashMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2019-12-310001045309us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignPlanMember2019-12-310001045309gra:InvestmentsMeasuredAtNetAssetValueMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:ForeignPlanMember2019-12-3100010453092014-02-032017-02-0300010453092014-02-032019-12-310001045309srt:MinimumMembergra:ZAIPDTrustMember2020-12-310001045309srt:MaximumMembergra:ZAIPDTrustMember2020-12-3100010453092019-10-012019-12-310001045309gra:OperableUnit3Member2018-07-012018-09-300001045309gra:OperableUnit3Membersrt:MinimumMember2020-12-310001045309srt:MaximumMembergra:OperableUnit3Member2020-12-310001045309gra:VermiculiteRelatedMattersMember2020-01-012020-12-310001045309gra:VermiculiteRelatedMattersMember2019-01-012019-12-310001045309gra:VermiculiteRelatedMattersMember2018-01-012018-12-310001045309gra:VermiculiteRelatedMattersMember2020-12-310001045309gra:VermiculiteRelatedMattersMember2019-12-310001045309gra:NonVermiculiteRelatedMattersMember2020-01-012020-12-310001045309gra:NonVermiculiteRelatedMattersMember2019-01-012019-12-310001045309gra:NonVermiculiteRelatedMattersMember2018-01-012018-12-310001045309gra:NonVermiculiteRelatedMattersMember2020-12-310001045309gra:NonVermiculiteRelatedMattersMember2019-12-310001045309gra:SpillwayMember2019-01-012019-12-310001045309gra:SpillwayMember2020-07-012020-09-300001045309gra:SpillwayMember2020-12-310001045309gra:SpillwayMembersrt:MinimumMember2020-12-310001045309gra:SpillwayMembersrt:MaximumMember2020-12-310001045309gra:SpillwayMembersrt:MinimumMember2020-01-012020-12-310001045309gra:SpillwayMembersrt:MaximumMember2020-01-012020-12-310001045309us-gaap:FinancialGuaranteeMember2020-12-310001045309us-gaap:SuretyBondMember2020-12-310001045309us-gaap:FinancialStandbyLetterOfCreditMember2020-12-310001045309gra:GraceCatalystsTechnologiesMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMember2018-01-012018-12-310001045309us-gaap:CorporateMember2020-01-012020-12-310001045309us-gaap:CorporateMember2019-01-012019-12-310001045309us-gaap:CorporateMember2018-01-012018-12-310001045309gra:WriteOffEngineeringAndSiteCostsMember2020-01-012020-12-310001045309gra:CostsRelatedToReviewOfStrategicAlternativesMember2020-01-012020-12-310001045309gra:SeveranceandstockcompensationcostsrelatedtoemployeeseparationsMember2018-01-012018-12-310001045309gra:WriteOffEngineeringAndSiteCostsMember2018-01-012018-12-3100010453092020-07-012020-12-3100010453092020-01-012020-06-3000010453092019-10-012020-06-300001045309us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001045309us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001045309us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-12-310001045309us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-12-310001045309us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310001045309us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-01-012019-12-310001045309us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-01-012018-12-310001045309us-gaap:AccumulatedTranslationAdjustmentMember2018-01-012018-12-310001045309us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-01-012018-12-310001045309us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2017-12-310001045309us-gaap:AccumulatedTranslationAdjustmentMember2017-12-310001045309us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2017-12-310001045309us-gaap:AccountingStandardsUpdate201802Memberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001045309us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:AccountingStandardsUpdate201802Member2018-12-310001045309us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:AccountingStandardsUpdate201802Member2018-12-310001045309us-gaap:AccumulatedOtherComprehensiveIncomeMemberus-gaap:AccountingStandardsUpdate201802Member2018-12-310001045309us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001045309us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001045309us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-12-310001045309us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001045309us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001045309us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310001045309us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001045309us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001045309us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310001045309gra:SharebasedPaymentArrangementBoardofDirectorsMember2020-01-012020-12-310001045309us-gaap:ShareBasedPaymentArrangementEmployeeMember2020-01-012020-12-3100010453092018-05-092020-12-3100010453092017-01-012018-05-080001045309us-gaap:EmployeeStockOptionMember2017-12-310001045309us-gaap:EmployeeStockOptionMember2018-01-012018-12-310001045309us-gaap:EmployeeStockOptionMember2018-12-310001045309us-gaap:EmployeeStockOptionMember2019-01-012019-12-310001045309us-gaap:EmployeeStockOptionMember2019-12-310001045309us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001045309us-gaap:EmployeeStockOptionMember2020-12-310001045309us-gaap:EmployeeStockOptionMembergra:ExercisePriceRangeFiveMember2020-01-012020-12-310001045309us-gaap:EmployeeStockOptionMembergra:ExercisePriceRangeFiveMember2020-12-310001045309us-gaap:EmployeeStockOptionMembergra:ExercisePriceRangeSixMember2020-01-012020-12-310001045309us-gaap:EmployeeStockOptionMembergra:ExercisePriceRangeSixMember2020-12-310001045309gra:ExercisePriceRangeSevenMemberus-gaap:EmployeeStockOptionMember2020-01-012020-12-310001045309gra:ExercisePriceRangeSevenMemberus-gaap:EmployeeStockOptionMember2020-12-310001045309us-gaap:EmployeeStockOptionMembergra:ExercisePriceRangeEightMemberMember2020-01-012020-12-310001045309us-gaap:EmployeeStockOptionMembergra:ExercisePriceRangeEightMemberMember2020-12-310001045309us-gaap:EmployeeStockOptionMembersrt:MinimumMember2020-01-012020-12-310001045309us-gaap:EmployeeStockOptionMembersrt:MaximumMember2020-01-012020-12-310001045309us-gaap:EmployeeStockOptionMembersrt:MinimumMember2019-01-012019-12-310001045309us-gaap:EmployeeStockOptionMembersrt:MaximumMember2019-01-012019-12-310001045309us-gaap:EmployeeStockOptionMembersrt:MinimumMember2018-01-012018-12-310001045309us-gaap:EmployeeStockOptionMembersrt:MaximumMember2018-01-012018-12-310001045309gra:PerformanceBasedUnitsMember2020-01-012020-12-310001045309gra:PerformanceBasedUnitsMember2019-01-012019-12-310001045309gra:PerformanceBasedUnitsMember2018-01-012018-12-310001045309us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001045309us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-12-310001045309us-gaap:RestrictedStockUnitsRSUMember2018-01-012018-12-310001045309gra:RestrictedStockUnitsRSUsandPerformanceBasedUnitsPBUsMember2020-01-012020-12-310001045309gra:RestrictedStockUnitsRSUsandPerformanceBasedUnitsPBUsMember2019-01-012019-12-310001045309gra:RestrictedStockUnitsRSUsandPerformanceBasedUnitsPBUsMember2018-01-012018-12-310001045309gra:RestrictedStockUnitsRSUsandPerformanceBasedUnitsPBUsMember2020-12-3100010453092017-02-0800010453092020-02-280001045309gra:A282017ShareRepurchaseProgramMember2020-02-280001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMembergra:PolyolefinandChemicalCatalystsMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMemberus-gaap:EMEAMembergra:PolyolefinandChemicalCatalystsMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMembergra:PolyolefinandChemicalCatalystsMember2020-01-012020-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMembergra:PolyolefinandChemicalCatalystsMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembergra:PolyolefinandChemicalCatalystsMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMembergra:RefiningCatalystsMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMemberus-gaap:EMEAMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMembergra:RefiningCatalystsMember2020-01-012020-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMemberus-gaap:EMEAMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMember2020-01-012020-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:PharmaConsumerMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMemberus-gaap:EMEAMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:PharmaConsumerMember2020-01-012020-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:CoatingsMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMembergra:CoatingsMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:CoatingsMember2020-01-012020-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:CoatingsMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembergra:CoatingsMember2020-01-012020-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMember2020-01-012020-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMember2020-01-012020-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMember2020-01-012020-12-310001045309gra:ChemicalprocessMembersrt:LatinAmericaMembergra:GraceMaterialsTechnologiesMember2020-01-012020-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:OthermaterialsMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMembergra:OthermaterialsMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:OthermaterialsMember2020-01-012020-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:OthermaterialsMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembergra:OthermaterialsMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMember2020-01-012020-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMember2020-01-012020-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMember2020-01-012020-12-310001045309srt:NorthAmericaMember2020-01-012020-12-310001045309us-gaap:EMEAMember2020-01-012020-12-310001045309srt:AsiaPacificMember2020-01-012020-12-310001045309srt:LatinAmericaMember2020-01-012020-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMembergra:PolyolefinandChemicalCatalystsMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMemberus-gaap:EMEAMembergra:PolyolefinandChemicalCatalystsMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMembergra:PolyolefinandChemicalCatalystsMember2019-01-012019-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMembergra:PolyolefinandChemicalCatalystsMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembergra:PolyolefinandChemicalCatalystsMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMembergra:RefiningCatalystsMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMemberus-gaap:EMEAMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMembergra:RefiningCatalystsMember2019-01-012019-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMemberus-gaap:EMEAMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMember2019-01-012019-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:PharmaConsumerMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMemberus-gaap:EMEAMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:PharmaConsumerMember2019-01-012019-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:CoatingsMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMembergra:CoatingsMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:CoatingsMember2019-01-012019-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:CoatingsMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembergra:CoatingsMember2019-01-012019-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMember2019-01-012019-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMember2019-01-012019-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMember2019-01-012019-12-310001045309gra:ChemicalprocessMembersrt:LatinAmericaMembergra:GraceMaterialsTechnologiesMember2019-01-012019-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:OthermaterialsMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMembergra:OthermaterialsMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:OthermaterialsMember2019-01-012019-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:OthermaterialsMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembergra:OthermaterialsMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMember2019-01-012019-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMember2019-01-012019-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMember2019-01-012019-12-310001045309srt:NorthAmericaMember2019-01-012019-12-310001045309us-gaap:EMEAMember2019-01-012019-12-310001045309srt:AsiaPacificMember2019-01-012019-12-310001045309srt:LatinAmericaMember2019-01-012019-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMembergra:PolyolefinandChemicalCatalystsMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMemberus-gaap:EMEAMembergra:PolyolefinandChemicalCatalystsMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMembergra:PolyolefinandChemicalCatalystsMember2018-01-012018-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMembergra:PolyolefinandChemicalCatalystsMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMembergra:PolyolefinandChemicalCatalystsMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMembergra:RefiningCatalystsMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMemberus-gaap:EMEAMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMembergra:RefiningCatalystsMember2018-01-012018-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMembergra:RefiningCatalystsMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:NorthAmericaMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMemberus-gaap:EMEAMember2018-01-012018-12-310001045309gra:GraceCatalystsTechnologiesMembersrt:AsiaPacificMember2018-01-012018-12-310001045309srt:LatinAmericaMembergra:GraceCatalystsTechnologiesMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:PharmaConsumerMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMemberus-gaap:EMEAMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:PharmaConsumerMember2018-01-012018-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembergra:PharmaConsumerMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:CoatingsMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMembergra:CoatingsMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:CoatingsMember2018-01-012018-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:CoatingsMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembergra:CoatingsMember2018-01-012018-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMember2018-01-012018-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMember2018-01-012018-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMember2018-01-012018-12-310001045309gra:ChemicalprocessMembersrt:LatinAmericaMembergra:GraceMaterialsTechnologiesMember2018-01-012018-12-310001045309gra:ChemicalprocessMembergra:GraceMaterialsTechnologiesMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMembergra:OthermaterialsMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMembergra:OthermaterialsMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMembergra:OthermaterialsMember2018-01-012018-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMembergra:OthermaterialsMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembergra:OthermaterialsMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:NorthAmericaMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMemberus-gaap:EMEAMember2018-01-012018-12-310001045309gra:GraceMaterialsTechnologiesMembersrt:AsiaPacificMember2018-01-012018-12-310001045309srt:LatinAmericaMembergra:GraceMaterialsTechnologiesMember2018-01-012018-12-310001045309srt:NorthAmericaMember2018-01-012018-12-310001045309us-gaap:EMEAMember2018-01-012018-12-310001045309srt:AsiaPacificMember2018-01-012018-12-310001045309srt:LatinAmericaMember2018-01-012018-12-3100010453092021-01-012020-12-3100010453092022-01-012020-12-3100010453092023-01-012020-12-3100010453092024-01-012020-12-3100010453092025-01-012020-12-310001045309us-gaap:CorporateMember2020-12-310001045309us-gaap:CorporateMember2019-12-310001045309us-gaap:CorporateMember2018-12-310001045309country:US2020-01-012020-12-310001045309country:US2019-01-012019-12-310001045309country:US2018-01-012018-12-310001045309country:CA2020-01-012020-12-310001045309country:CA2019-01-012019-12-310001045309country:CA2018-01-012018-12-310001045309country:US2020-12-310001045309country:US2019-12-310001045309country:US2018-12-310001045309country:CA2020-12-310001045309country:CA2019-12-310001045309country:CA2018-12-310001045309srt:NorthAmericaMember2020-12-310001045309srt:NorthAmericaMember2019-12-310001045309srt:NorthAmericaMember2018-12-310001045309country:DE2020-12-310001045309country:DE2019-12-310001045309country:DE2018-12-310001045309gra:EMEAexcludingGermanyMember2020-12-310001045309gra:EMEAexcludingGermanyMember2019-12-310001045309gra:EMEAexcludingGermanyMember2018-12-310001045309us-gaap:EMEAMember2020-12-310001045309us-gaap:EMEAMember2019-12-310001045309us-gaap:EMEAMember2018-12-310001045309srt:AsiaPacificMember2020-12-310001045309srt:AsiaPacificMember2019-12-310001045309srt:AsiaPacificMember2018-12-310001045309srt:LatinAmericaMember2020-12-310001045309srt:LatinAmericaMember2019-12-310001045309srt:LatinAmericaMember2018-12-310001045309gra:ARTMember2020-12-310001045309gra:ARTMember2019-12-310001045309gra:ARTMember2020-01-012020-12-310001045309gra:ARTMember2019-01-012019-12-310001045309gra:ARTMember2018-01-012018-12-310001045309gra:ARTMember2020-12-310001045309gra:ARTMember2019-12-310001045309gra:ARTMember2020-01-012020-12-310001045309gra:GraceLOCtoARTMember2020-12-310001045309gra:ChevronLOCtoARTMember2020-12-310001045309gra:GraceLOCtoARTMember2020-01-012020-12-310001045309gra:ChevronLOCtoARTMember2020-01-012020-12-310001045309gra:GraceLOCtoARTMember2020-12-310001045309gra:GraceLOCtoARTMember2019-12-310001045309gra:JointVentureMember2019-12-310001045309gra:JointVentureMember2020-12-310001045309srt:AffiliatedEntityMember2020-12-310001045309srt:AffiliatedEntityMember2019-12-310001045309srt:AffiliatedEntityMember2020-01-012020-12-310001045309srt:AffiliatedEntityMember2019-01-012019-12-310001045309srt:AffiliatedEntityMember2018-01-012018-12-310001045309gra:RiveTechnologyIncMember2019-01-012019-12-310001045309gra:RiveTechnologyIncMember2020-07-012020-09-300001045309gra:PolyolefinCatalystsBusinessofAlbemarleCorporationMember2018-01-012018-12-3100010453092020-01-012020-03-3100010453092020-10-012020-12-3100010453092019-01-012019-03-3100010453092019-04-012019-06-3000010453092019-07-012019-09-300001045309gra:SpillwayMember2019-01-012019-03-310001045309us-gaap:SubsequentEventMembergra:FineChemistryServicesBusinessOfAlbemarleCorporationMember2021-02-252021-02-250001045309us-gaap:SubsequentEventMembergra:FineChemistryServicesBusinessOfAlbemarleCorporationMember2021-02-250001045309gra:AllowancesfornotesandaccountsreceivableMember2019-12-310001045309gra:AllowancesfornotesandaccountsreceivableMember2020-01-012020-12-310001045309gra:AllowancesfornotesandaccountsreceivableMember2020-12-310001045309us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-310001045309us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-01-012020-12-310001045309us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310001045309gra:AllowancesfornotesandaccountsreceivableMember2018-12-310001045309gra:AllowancesfornotesandaccountsreceivableMember2019-01-012019-12-310001045309us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-12-310001045309us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-01-012019-12-310001045309gra:AllowancesfornotesandaccountsreceivableMember2017-12-310001045309gra:AllowancesfornotesandaccountsreceivableMember2018-01-012018-12-310001045309us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2017-12-310001045309us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-01-012018-12-31
Table of Contents
TOC—Financial Statements
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________________________________________________
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission file number 1-13953
W. R. GRACE & CO.
(Exact name of registrant as specified in its charter)
Delaware   65-0773649
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
7500 Grace Drive, Columbia, Maryland 21044-4098
(Address of principal executive offices) (Zip Code)
(410) 531-4000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value per share GRA New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes     No 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes     No 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes     No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report  Yes  No 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes     No 
The aggregate market value of W. R. Grace & Co. voting and non-voting common equity held by non-affiliates as of June 30, 2020 (the last business day of the registrant’s most recently completed second fiscal quarter) was $2,844,898,340.
At January 31, 2021, 66,191,426 shares of W. R. Grace & Co. Common Stock, $0.01 par value per share, were outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive Proxy Statement to be delivered to our shareholders in connection with the registrant’s
2021 Annual Meeting of Shareholders, are incorporated by reference into Part III.



Table of Contents
TOC—Financial Statements
TABLE OF CONTENTS
PART I
1
14
24
24
25
26
27
PART II
28
30
31
56
58
116
116
116
PART III
117
117
117
117
117
PART IV
118
121
122





Table of Contents
TOC—Financial Statements
Notes on references that we use in this Report. Unless the context indicates otherwise, the terms “Grace,” the “Company,” “we,” “us,” or “our” mean (i) W. R. Grace & Co. itself, or (ii) W. R. Grace & Co. and/or one or more of its consolidated subsidiaries and affiliates and, in certain cases, their respective predecessors. Unless otherwise indicated, the contents of websites that we mention are not incorporated by reference or otherwise made a part of this Report.
We refer to the Financial Accounting Standards Board as the “FASB.” The FASB issues, among other things, Accounting Standards Codifications (which we refer to as “ASC”) and Accounting Standards Updates (which we refer to as “ASU”). We refer to the U.S. Internal Revenue Service as the “IRS.”
Trademarks and other intellectual property that we discuss in this Report. GRACE®, the GRACE® logo (and any other use of the term “Grace” as a tradename) as well as the other trademarks, service marks, or trade names used in this Report are trademarks, service marks, or trade names, registered in the United States and/or other countries, of Grace or its operating units, except as otherwise indicated. UNIPOL® and UNIPOL UNIPPAC® are trademarks of The Dow Chemical Company or an affiliated company of Dow. Grace and/or its affiliates are licensed to use the UNIPOL® and UNIPOL UNIPPAC® trademarks in the area of polypropylene. ART® and ADVANCED REFINING TECHNOLOGIES® are trademarks, registered in the United States and/or other countries, of Advanced Refining Technologies LLC. RESPONSIBLE CARE® and RESPONSIBLE CARE MANAGEMENT SYSTEM® are trademarks, registered in the United States and/or other countries, of the American Chemistry Council. Sustainalytics, a leading independent provider of ESG and corporate governance ratings, research and analysis, has provided the ESG Risk Rating as set forth in the ESG Risk Rating Summary Report issued December 31, 2020.
FORWARD-LOOKING STATEMENTS
This Report contains, and our other public communications may contain, forward-looking statements, that is, information related to future, not past, events. Such statements generally include the words “believes,” “plans,” “intends,” “targets,” “will,” “expects,” “suggests,” “anticipates,” “outlook,” “continues,” or similar expressions. Forward-looking statements include, without limitation, statements regarding future: financial positions; results of operations; cash flows; financing plans; business strategy; operating plans; capital and other expenditures; impact of COVID-19 on our business; competitive positions; growth opportunities for existing products; benefits from new technology; benefits from cost reduction initiatives; succession planning; and markets for securities. For these statements, we claim the protections of the safe harbor for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. We are subject to risks and uncertainties that could cause actual results or events to differ materially from our projections or that could cause other forward-looking statements to prove incorrect. Factors that could cause actual results or events to differ materially from those contained in the forward-looking statements include, without limitation: risks related to foreign operations, especially in areas of active conflicts and in emerging regions; the costs and availability of raw materials, energy and transportation; the effectiveness of our research and development and growth investments; acquisitions and divestitures of assets and businesses; developments affecting our outstanding indebtedness; developments affecting our pension obligations; legacy matters (including product, environmental, and other legacy liabilities) relating to past activities of Grace; our legal and environmental proceedings; environmental compliance costs (including existing and potential laws and regulations pertaining to climate change); the inability to establish or maintain certain business relationships; the inability to hire or retain key personnel; natural disasters such as storms and floods; fires and force majeure events; the economics of our customers’ industries, including the petroleum refining, petrochemicals, and plastics industries, and shifting consumer preferences; public health and safety concerns, including pandemics and quarantines; changes in tax laws and regulations; international trade disputes, tariffs, and sanctions; the potential effects of cyberattacks; and those additional factors set forth under Item 1A. “Risk Factors” and elsewhere in this Annual Report on Form 10-K. Our reported results should not be considered as an indication of our future performance. Readers are cautioned not to place undue reliance on our projections and forward-looking statements, which speak only as of the dates those projections and statements are made. We undertake no obligation to release publicly any revisions to our projections and forward-looking statements, or to update them to reflect events or circumstances occurring after the dates those projections and statements are made.



Table of Contents
TOC—Financial Statements
PART I

Item 1.    BUSINESS
BUSINESS OVERVIEW
W. R. Grace & Co., through its subsidiaries, is engaged in the production and sale of specialty chemicals and specialty materials on a global basis through two reportable business segments: Grace Catalysts Technologies (“Catalysts Technologies”), which includes catalysts and related products and technologies used in petrochemical, refining, and other chemical manufacturing applications; and Grace Materials Technologies (“Materials Technologies”), which includes specialty materials, including silica-based and silica-alumina-based materials, used in pharma/consumer, coatings, and chemical process applications.
Historical Perspective
Grace is the successor to a company that began in 1854 and originally became a public company in 1953. We entered the specialty chemicals and specialty materials industries in 1954, the year in which we acquired the Davison Chemical Company. W. R. Grace & Co. is a Delaware corporation.
W. R. Grace & Co. conducts all of its business through a single wholly owned subsidiary, W. R. Grace & Co.–Conn. (“Grace–Conn.”), a Connecticut corporation formed in 1899. Grace–Conn. owns all of the assets, properties and rights of W. R. Grace & Co. on a consolidated basis, either directly or through subsidiaries.
Recent Developments
Acquisitions
We discuss our approach to Mergers and Acquisitions below, under “Profitable Growth Strategy.” In line with that strategy, in recent years we have completed the following transactions:
We completed the acquisition of the business and assets of Rive Technology, Inc. (“Rive”) on June 17, 2019, for $22.8 million, with an additional $2.0 million holdback payment remitted in the three months ended September 30, 2020. The business is included in the Refining Technologies operating segment of our Catalysts Technologies reportable segment. The acquisition included Rive’s MOLECULAR HIGHWAY® zeolite technology for catalytic processes, which allows us to offer a broader spectrum of products for converting crude oil to petrochemical feedstocks.
On April 3, 2018, we acquired the assets of the polyolefin catalysts business of Albemarle Corporation for $418.0 million, net of cash acquired and including customary post-closing adjustments. The acquisition included production plants in Baton Rouge, Louisiana, and Yeosu, South Korea; research and development and pilot plant capabilities; and an extensive portfolio of intellectual property. The business is included in the Specialty Catalysts operating segment of our Catalysts Technologies reportable segment. The acquisition was complementary to our existing Specialty Catalysts business and has strengthened our commercial relationships, catalysts technology portfolio, and manufacturing network.
On June 30, 2016, we completed the acquisition of the assets of the BASF Polyolefin Catalysts business for a purchase price of $250.6 million. The acquisition included technologies, patents, trademarks, and production plants in Pasadena, Texas, and Tarragona, Spain. The acquisition added the following technologies to our catalysts portfolio: (1) LYNX® high-activity polyethylene (“PE”) catalyst technologies used commercially in slurry processes for the production of high-density PE resins such as bimodal film and pipe; and (2) LYNX® polypropylene (“PP”) catalyst technologies used commercially in all major PP process technologies including slurry, bulk loop, stirred gas, fluid gas, and stirred bulk. The acquisition also provided us with significant additional flexibility and capacity for our global polyolefin catalysts manufacturing network. These products became part of the Specialty Catalysts operating segment of our Catalysts Technologies reportable segment.
We completed the acquisition of the assets of the Polypropylene Licensing and Catalysts business of The Dow Chemical Company on December 2, 2013, for a cash purchase price of $510.4 million (which included post-closing adjustments). The acquisition included UNIPOL® Polypropylene Process Technology as well as CONSISTA® and SHAC® catalysts. The technology and products complemented our polyolefin catalyst
1


businesses as part of the Specialty Catalysts operating segment of our Catalysts Technologies reportable segment. The acquisition also included our production plant in Norco, Louisiana.
Other Notable Developments
In 2016, Grace completed a separation transaction with respect to GCP Applied Technologies Inc., then a wholly-owned subsidiary of Grace (“GCP”), which included Grace’s former Construction Products operating segment and the packaging technologies business of its Materials Technologies operating segment (the “Separation”). The Separation was effected by means of a pro rata distribution to the Company’s stockholders of all of the outstanding shares of GCP common stock. As a result of the transaction, GCP became an independent public company.
On February 3, 2014, Grace concluded a voluntary reorganization under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware, when the joint plan of reorganization (the “Joint Plan”) filed by Grace and certain other parties became effective.
Global Scope
We operate our business on a global scale with approximately 73% of our 2020 consolidated sales outside the United States. We operate and/or sell to customers in over 60 countries and in over 30 currencies. We manage our operating segments on a global basis, to serve global markets. Currency fluctuations affect our reported results of operations, cash flows, and financial position.
Profitable Growth Strategy
We create value for customers and investors by profitably growing our specialty chemicals and specialty materials businesses and achieving high levels of efficiency and cash flow. To meet these objectives, we:
Invest to accelerate growth and extend our competitive advantages;
Invest in great people to strengthen our high-performance culture;
Execute the Grace Value Model to drive operating excellence; and
Acquire to build our technology and manufacturing capabilities for our customers.
Our businesses are well-positioned to grow through our customer-driven innovation, commercial and operating excellence and thoughtful, disciplined merger and acquisition approach. Our businesses are interconnected through shared materials science and our highly integrated global manufacturing and supply chain operations.
Our organic growth drivers include: global demand for plastics and petrochemical feedstocks; global demand for cleaner fuels and heavy oil upgrading; rising living standards and growing middle class incomes; stricter environmental standards; and increased focus on health and wellness.
2


The Grace Value Model (“GVM”)
The Grace Value Model is our framework for creating and delivering value to customers, investors and employees. At the company level, we create value through our focused portfolio, strong strategic position, and disciplined capital allocation. At the business level, we create value through customer-driven innovation, commercial excellence, and operating excellence. Linking and enabling all of these elements are great talent, high-performance culture, and integrated business management processes. Our ability to rigorously execute the Grace Value Model is a principal source of our competitive advantage in the global marketplace and our financial performance. The Grace Value Model is illustrated as follows:
GRA-20201231_G1.JPG
Human Capital Management
Our great talent and high-performance culture are the most important sources of our competitive advantage and long-term ability to deliver value to customers and investors. We have invested heavily in our global talent and talent management system, which includes aligned goal setting, ongoing feedback and coaching, effective performance reviews, and a continuous cycle of professional development. We have also invested significantly in talent development and effectiveness, including over $6 million and 50,000 hours of commercial excellence investment and training for our commercial teams since 2016. In 2019 and 2020, we refreshed more than 10% of our global workforce, including upgrading talent where needed and adding key leadership roles throughout the organization. Our voluntary workforce turnover rate was 5.4% in 2020.
Our high-performance culture is based on our commitment to performance and our five Grace Leadership Behaviors: Deliver Results; Think Critically; Be Authentic; Communicate; and Engage and Include. We expect our colleagues to model these behaviors and our values in their daily business conduct and include behavior as a core element of our performance reviews.
We aspire to continually strengthen our talent and high-performance culture by welcoming and valuing the unique backgrounds, cultures, ethnicities, genders, experiences, perspectives, and contributions of our employees around the globe. We have a well-developed Diversity and Inclusion strategy and a multi-year action plan to improve the diversity of our global team and ensure every employee feels included and valued.
Our diversity and inclusion strategy starts at the top: on the Grace Board of Directors, 29% of our independent directors are women, and on the Grace Leadership Team, 50% of our executives are women or people of color, including three of four business unit leaders. Increasing the diversity of our global team, including greater representation of women and under-represented minorities, is a focus. Through diversity and inclusion, we strengthen our people and our business.
The COVID-19 pandemic had a significant impact on our human capital management strategies and priorities in 2020. Aligned with our strong safety culture, we developed clear and effective worksite safety protocols, updated policies to add flexibility, and provided personal protective equipment to protect our essential employees working onsite in our manufacturing plants, research laboratories, and quality control laboratories. In addition, we paid for COVID-19 testing globally and covered treatment in the U.S. Approximately 45% of our workforce worked from home for most of 2020, following a seamless transition to remote work in March, including implementation of new communication and collaboration technology. We reduced operating costs during the year,
3


but were careful to protect our growth investments, maintain our focus on technology leadership, and continue our commercial excellence and operating excellence initiatives. We made no layoffs or salary reductions and continued employee development and hiring of critical talent. We experienced very high levels of engagement and productivity throughout the year.
As of December 31, 2020, we employed approximately 4,000 employees with 2,200 employed in the United States and 1,000 employed in Germany.
Approximately 2,300 employees are salaried, and 1,700 employees are hourly. Approximately 700 of our manufacturing employees at 5 manufacturing sites in the United States are represented by unions. We have operated without a labor work stoppage for more than 20 years. Outside the United States, we have works councils and unions serving approximately 1,400 employees, the majority of whom are located at our European sites.
Our Approach to Mergers & Acquisitions (“M&A”)
Our approach to M&A prioritizes strategic fit and financial returns. We seek investments that improve our technology, research and development and/or commercial capabilities; enhance and/or leverage our manufacturing capabilities; and include attractive growth and profitability opportunities. Our recent acquisitions have been very synergistic, with strong growth and returns driven by significant cost and capital synergies. We establish minimum return requirements for acquisitions, based on specific risk-adjusted hurdle rates, and expect all acquisitions to be accretive to earnings per share (“EPS”).
Our Reportable Business Segments
GRACE CATALYSTS TECHNOLOGIES
Catalysts Technologies uses our significant catalysts knowledge and applications expertise to design and manufacture products to create significant value for our customers. Our customers include plastics and chemicals manufacturers as well as oil refiners. We believe that our technological expertise and broad technology platform provide a competitive advantage, allowing us to quickly design products that help our customers create value in their operations and their end markets.
The following table sets forth Catalysts Technologies sales of similar products as a percentage of Grace total revenue.
Year Ended December 31,
2020 2019 2018
(In millions) Sales % of Grace Revenue Sales % of Grace Revenue Sales % of Grace Revenue
Polyolefin and chemical catalysts
$ 621.6  35.9  % $ 705.3  36.0  % $ 661.5  34.2  %
Refining catalysts 649.8  37.6  % 791.4  40.4  % 802.0  41.5  %
Total
$ 1,271.4  73.5  % $ 1,496.7  76.4  % $ 1,463.5  75.7  %
4


A description of our Catalysts Technologies products and services and their applications follows:
Products and Services Overview/Use Key Brands
Polyolefin and Chemical Catalysts (also referred to as Specialty Catalysts)
Polyethylene Catalysts/Polypropylene Catalysts/Catalyst Supports Used in the production of polyethylene (PE) and polypropylene (PP) thermoplastic resins, which can be customized to enhance the performance of a wide range of industrial and consumer end-use applications including high pressure pipe, geomembranes, food packaging, automotive parts, medical devices, and textiles; non-phthalate catalysts allow customers to produce phthalate-free PP products and cleaner, clearer PP products; includes catalysts that allow for the lightweighting of automobiles by replacing steel parts with PP while meeting demanding performance standards of automakers
PE Brands -
MAGNAPORE® • SYLOPOL® • LYNX®
PP Brands -
CONSISTA® • SHAC® • LYNX® • POLYTRAK® • HYAMPP®
Gas-Phase Polypropylene Process Technology Licensing Provides licensees with a cost-effective, flexible, and reliable capability to manufacture polypropylene products having a wide spectrum of performance attributes, enabling customers to manufacture products for a broad array of end-use applications
UNIPOL® Polypropylene Process Technology • UNIPOL UNIPPAC® Process Control Software
Chemical Catalysts Include hydrogenation and dehydrogenation catalyst products used in a variety of petrochemical chain conversions and fine chemical production
RANEY® • DAVICAT®
Refining Technologies
FCC Catalysts Crack the hydrocarbon chains in distilled crude oil to produce transportation fuels, such as gasoline and diesel fuels, and feeds for production of petrochemicals
MIDAS® • IMPACT® • NEKTOR™ • GENESIS® • ACHIEVE® • FUSION® VIP‑R™ RIVE TECHNOLOGY® • MOLECULAR HIGHWAY®
FCC Additives Used to reduce sulfur in gasoline, maximize propylene production from refinery FCC units, and reduce emissions of sulfur oxides, nitrogen oxides, and carbon monoxide from refinery FCC units
D-PRISM® • GSR® • SURCA® • ZAVANTI™ • OLEFINSULTRA® • DESOX® • DENOX® • CP® • OXYBURN®
Hydroprocessing Catalysts (HPC) Marketed through the ART joint venture with Chevron (discussed below), these catalysts are used in process reactors to upgrade heavy oils into lighter, more useful products, enabling less expensive feedstock usage in the petroleum refining process, and to produce products that meet more stringent environmental regulations; our catalysts and solutions allow our customers to improve their profitability in the production of cleaner petroleum-based fuels to meet regulatory and fuel quality standards
ICR® • HOP® • SmART Catalyst System® • APART® • LS™ Catalyst Platform • HSLS® Catalyst Platform • HCRC™ Catalyst Platform • DCS™ Catalyst Platform • ECAD™ Catalyst Platform • GR® • ENRICH®
Polyolefin and Chemical Catalysts (also referred to as Specialty Catalysts)
Grace Specialty Catalysts provides process technology for polypropylene and a broad range of high-performance catalysts and supports for specialized processes in the chemical value chain, from plastics to petrochemicals.
We are the only fully integrated supplier of polyolefin catalyst solutions across all process and catalyst technologies. Our strong strategic position is particularly evident in our worldwide polyolefin catalysts and process technology licensing business. After investing $1.2 billion in accretive, synergistic acquisitions over the past seven years, including five new plants on three continents, we offer customers the broadest and most technically advanced portfolio of polyolefin catalysts technologies that enable the production of high performance and differentiated resins. Polyolefin catalysts are used to produce plastics including HDPE (high density polyethylene), LLDPE (linear low density polyethylene) and PP (polypropylene). Applications include packaging, consumer/housewares, food packaging, construction, and automotive segments providing recyclable, lightweight, durable and versatile materials.
The business comprises four major segments, including UNIPOL® PP Process Licensing, PP Catalysts, PE Catalysts, and Chemical Catalysts.
5


The UNIPOL® PP Process Licensing provides plant design and operational technology to polymer producers. We are the largest independent technology licensor, offering the advantages of a gas-phase process with low capital cost, mechanical simplicity, energy efficiency, and the demonstrated capability to produce differentiated resins. The UNIPOL® Polypropylene Process Technology provides polypropylene producers with the capability to innovate and succeed faster, as their business evolves to meet more sophisticated market needs. UNIPOL® PP licensees also have access to our tailored services, experienced technical team, and our Advanced Process Control software to improve their overall plant lifetime performance.
Our PP Catalysts serve multiple process technologies, including UNIPOL® PP, with optimized sizes, shapes, and composition tailored for each process requirement. We also offer unique external donor technologies that are combined with our catalysts, providing customers with resin product differentiation and production operability advantages.
Our PE Catalysts portfolio, with supporting R&D and technical service, offers existing producers the best choice of resin properties, operability and economics utilizing the three main types of Metallocene, Chromium, and Ziegler catalysts. Products include catalyst components and finished catalysts across all three systems and are offered as merchant products or custom developments.
Chemical Catalysts has two product lines: RANEY® and DAVICAT®. RANEY® catalyst products are used in a broad range of niche hydrogenation applications such as butanediol, sorbitol, and amines. DAVICAT® catalysts and catalyst carriers extend Grace-wide material science expertise in silicas, aluminas, and zeolites into a number of petrochemicals and fine chemicals applications.
Refining Technologies
FCC Catalysts and Additives
We are a global leader in developing and manufacturing fluid catalytic cracking, or FCC, catalysts and additives that are designed to enable petroleum refiners to increase profits by improving product yields, value and quality. Our FCC products also enable refiners to reduce emissions from their FCC units and reduce sulfur content in the transportation fuels they produce. Oil refining is a highly specialized discipline, and FCC catalysts must be tailored to meet local variations in crude oil feedstocks and a refinery’s desired product mix. We work regularly with our customers to identify the most appropriate catalyst and additive formulations for their changing needs.
FCC units are designed to produce a broad spectrum of refined product yields, including gasoline, middle distillates, and liquefied petroleum gas, or LPG. Traditionally, many FCC operators have focused on maximizing yields of transportation fuels. However, as demand for petrochemicals increases, a growing segment of refiners have transitioned their FCC operations with the primary objective of maximizing yields of petrochemical feedstocks, such as propylene. We maintain multiple industry leading technologies, including ZAVANTI™ and VIP-R™, that allow our customers to capture unique value from petrochemical feedstock driven operations.
Many countries and regions, including the U.S., European Union, Japan, Russia, India and China have imposed regulatory limitations on the sulfur content of gasoline and diesel fuel. We have developed a portfolio of products designed to assist refiners in meeting their gasoline sulfur-reduction targets, including our D-PRISM® and GSR® additives and our SURCA® catalyst family.
Also, many U.S. petroleum refiners have entered into consent decrees with the U.S. Environmental Protection Agency (the “EPA”) under which the refiners have agreed to reduce emissions of nitrogen oxides and sulfur oxides. The European Union has also imposed requirements on refineries with respect to nitrogen oxides and sulfur oxides emissions. Our additives are designed to assist refineries in meeting their obligations to reduce these pollutants. Our Super DESOX® additive reduces sulfur oxides emissions from commercial FCC units. Our DENOX® additives are designed to achieve reductions in nitrogen oxides emissions comparable to those obtained from capital intensive alternatives available to a refinery, while our non-platinum-based combustion promoter CP® P is designed to enable refiners to control carbon monoxide emissions without increasing nitrogen oxides. Our newly developed OXYBURN® additives are used in the reduction of oxygenates which are often a problem when co-processing renewable feedstocks in FCC units.
6


Hydroprocessing Catalysts
We market most of our hydroprocessing catalysts through our Advanced Refining Technologies LLC (“ART”) joint venture with Chevron Products Company (“Chevron”). We hold a 50% economic interest in ART, which is not consolidated in our financial statements so ART’s sales are excluded from our sales. We established ART to combine our technology with that of Chevron and to develop, market, and sell hydroprocessing catalysts to customers in the petroleum refining industry worldwide.
We are a leading supplier of hydroprocessing catalysts designed for processing high resid content feedstocks. We offer products for fixed-bed resid hydrotreating, on-stream catalyst replacement, and ebullating-bed resid hydrocracking processes.
We also offer a full line of catalysts, customized for individual refiners, used in distillate hydrotreating to produce ultra-low sulfur content gasoline and diesel fuel, including our SmART CATALYST SYSTEM® and APART® Catalyst Systems. As discussed above, regulatory limitations on the sulfur content of gasoline and diesel fuel are becoming more common. These products are designed to help refiners to reduce the sulfur content of their products.
Our ENRICH® catalysts, which are marketed by Grace rather than ART, enable the coprocessing of bio-based feedstocks at refineries.
We have rights to sell hydrocracking and lubes hydroprocessing catalysts to licensees of Chevron Lummus Global (“CLG”) and other petroleum refiners for unit refills. These rights allow us to streamline hydroprocessing catalyst supply and improve technical service for refining customers by establishing ART as their single point of contact for all their hydroprocessing catalyst needs.
Manufacturing, Marketing and Raw Materials
Our Catalysts Technologies products are manufactured by a network of globally coordinated plants. Our integrated supply chain organization is responsible for the effective utilization of our manufacturing capabilities. For a discussion of our manufacturing plants for Catalysts Technologies, see Item 2, “Properties,” below.
We use a global organization of direct sales professionals to market our polyolefin catalysts, polypropylene process technology, and chemical catalysts, that seeks to maintain close working relationships with our customers. Our global direct sales force is complemented by a network of distributors and agents in Asia Pacific and, to a lesser extent, the Americas and Middle East. These relationships enable us to cooperate with major polymer and chemical producers to develop catalyst technologies that complement their process or application developments. We have geographically distributed our sales and technical service professionals to make them responsive to the needs of our geographically diverse customers. We typically operate under long-term contracts with our customers.
We use a global organization of technical professionals, including a direct sales force, with extensive experience in refining processes, catalyst development, and catalyst applications to market our refining catalysts and additives. These professionals work to tailor our technology to the needs of each specific customer. We generally negotiate prices for our refining catalysts because our formulations are specific to the needs of each customer and each customer receives individual attention and technical service. We sell a significant portion of our hydroprocessing catalysts through multiple-year supply agreements with our geographically diverse customer base.
The principal raw materials for Catalysts Technologies products include molybdenum oxide, specialty inorganics, caustic soda, alumina and derivatives, sodium silicate, nickel, rare earths, solvents, and titanium tetrachloride. Multiple suppliers are generally available for each of these materials; however, some of our raw materials may be provided by single sources of supply. We seek to mitigate the risk of using single source suppliers by identifying and qualifying alternative suppliers or, for unique materials, by using alternative formulations from other suppliers. In some instances, we produce our own raw materials and intermediates.
Prices for many of our raw materials, including metals, and energy can be volatile. In response to increases in raw materials and energy costs, we generally take actions to mitigate the effects of higher costs including developing alternative formulations for our products, increasing productivity, hedging purchases of certain raw materials, and increasing prices.
7


As in many chemical businesses, we consume significant quantities of natural gas in the production of Catalysts Technologies products. World events and other economic factors cause volatility in the price of natural gas. Increases or decreases in the cost of natural gas and raw materials can have a significant impact on our operating margins. We have implemented a risk management program under which we hedge natural gas in a way that is designed to mitigate the effects of price volatility.
Seasonality
Seasonality does not have a significant overall effect on our Catalysts Technologies reportable segment. However, under traditional patterns, sales of FCC catalysts have tended to be lower in the first calendar quarter due to maintenance outages taken prior to the shift in production by refineries from home heating oil for the winter season to gasoline production for the summer season. FCC catalysts and ebullating-bed hydroprocessing catalysts are consumed at a relatively steady rate and are replaced regularly. Fixed-bed hydroprocessing catalysts are consumed over a period of years and are replaced in bulk in an irregular pattern. Since our customers periodically shut down their refining processes to replace fixed-bed hydroprocessing catalysts in bulk, our hydroprocessing catalyst sales to any customer can vary substantially over the course of a year and between years based on that customer’s catalyst replacement schedule.
Backlog of Orders; Working Capital
While at any given time there may be some backlog of orders, this backlog is not material in respect to our total annual sales for Catalysts Technologies, nor are the changes, from time to time, significant. Our working capital consists of inventory, accounts receivable, accounts payable, and deferred revenue. We closely manage these working capital accounts. We value inventory balances under the first-in, first-out (“FIFO”) method. Inventories have turned regularly, but balances typically increase during the first half of the year before declining as a result of increased sales in the second half. Accounts receivable and accounts payable are also affected by this business cycle, typically requiring us to have greater working capital needs during the second and third quarters.
Competition
Competition in the polyolefin catalyst, catalyst supports, and polypropylene process licensing industry is technology-intensive. Our competition in this industry includes Univation, LyondellBasell, PQ, and Lummus Novolen Technology. Most competitors sell their products and/or license their technology worldwide.
Competition in FCC catalysts and additives and hydroprocessing catalysts is based on value delivered to refiners, which is based on differentiated technology, catalyst performance, technical and customer service, and price. Our principal global FCC catalyst competitors are Albemarle, BASF, and SINOPEC. Our principal global competitors in FCC additives are Johnson Matthey, Albemarle, and BASF. Our principal global competitors in hydroprocessing catalysts are Shell Catalysts (formerly Criterion), Albemarle, Haldor Topsoe, UOP, and Axens. We also have multiple regional competitors.
GRACE MATERIALS TECHNOLOGIES
Materials Technologies uses our significant specialty silica, zeolite and fine chemical knowledge and applications expertise to design and manufacture products to create significant value for our customers. Our customers include pharmaceutical companies, consumer products manufacturers, coatings manufacturers, emission control system manufacturers, petrochemical and natural gas processors, and plastics manufacturers. We believe that our technological expertise and broad technology platform provide a competitive advantage, allowing us to tailor our products to specific customer requirements and help them create value in their operations and end markets.
8


The following table sets forth Materials Technologies sales of similar products as a percentage of Grace total revenue.
Year Ended December 31,
2020 2019 2018
(In millions) Sales % of Grace Revenue Sales % of Grace Revenue Sales % of Grace Revenue
Pharma/Consumer $ 162.5  9.4  % $ 144.6  7.4  % $ 132.6  6.9  %
Coatings 137.5  8.0  % 139.8  7.1  % 155.4  8.1  %
Chemical process 140.6  8.1  % 156.1  8.0  % 157.3  8.1  %
Other 17.8  1.0  % 20.9  1.1  % 23.3  1.2  %
Total $ 458.4  26.5  % $ 461.4  23.6  % $ 468.6  24.3  %
A description of our Materials Technologies products and services and their applications follows:
Products and Services Overview/Use Key Brands
Pharma/Consumer Specialty materials used as additives, intermediates, and purification aids for pharmaceuticals, nutraceuticals, toothpaste, beer, food, and cosmetic segments, including:
Pharmaceutical and nutraceutical excipients, carrier for oily APIs, and drug delivery
SYLOID® • LUDOX® • SYLOID® XDP • SILSOL®
Fine chemicals, including regulatory starting materials and intermediates, especially peptide building blocks, specialty amino acids, chiral boronic acids, and esters
Toothpaste abrasives and thickening agents
SYLODENT® • SYLOBLANC® • SIDENT®
Free-flow agents; anticaking agents; heating agents;
tableting aids; cosmetic additives and carriers for flavor, fragrance, or other active ingredients; and desiccants for food and pharma packaging
PERKASIL® • SYLOID® • SYLOSIV®
Edible oil and biofuel refining agents, stabilizers and clarification aids for beer, juices and other beverages
TRISYL® • DARACLAR®
Chromatography purification products
DAVISIL® • VYDAC® • VYKING™
Coatings Functional additives for wood, coil, general industrial, and architectural coatings that provide surface effects and corrosion protection for metal substrates, including:
Matting agents, anticorrosion pigments, TiO2 extenders and moisture scavengers for paints and lacquers
SYLOID® • SHIELDEX® • SYLOSIV® • SYLOWHITE™
Additives for matte, semi-glossy and glossy ink receptive coatings on high performance ink jet papers, photo paper, and commercial wide-format print media
SYLOJET® • DURAFILL® • LUDOX®
Paper retention aids, functional fillers, paper frictionizers
DURAFILL® • LUDOX®
Defoamers actives
ZEOFLO® • ZEOFOAM™
Chemical Process Functional materials for use in plastics, rubber, tire, and metal casting, and adsorbent products for petrochemical, natural gas, and more specialized applications, including:
Reinforcing agents for rubber and tires
PERKASIL®
Inorganic binders for precision investment casting and refractory applications and surface modification aids for metal and ceramic substrates
LUDOX®
Static adsorbents for dual pane windows and refrigerant applications, moisture scavengers, and package desiccants
PHONOSORB® • SYLOSIV® • CRYOSIV® • PROTEKSORB®
Chemical metal polishing aids and formulations for chemical mechanical planarization/electronics applications
POLIEDGE® • LUDOX®
Antiblocking additives for plastic films to prevent adhesion of layers in manufacturing
SYLOBLOC®
Process adsorbents used in petrochemical and natural gas processes for such applications as ethylene-cracked-gas-drying, natural gas drying and sulfur removal
SYLOBEAD®
9


Silica-based Products
We globally manufacture functional additives and process aids, such as silica gel, colloidal silica, zeolitic adsorbents, precipitated silica and silica-aluminas, for a wide variety of applications and end-use industries. We also custom manufacture fine chemical intermediates and regulatory starting materials used primarily in the pharmaceutical and nutritional supplements industries.
Our materials are integrated into our customers’ manufacturing processes and when combined with our technical support, can increase the efficiency and performance of their operations and their products. By working closely with our customers, we seek to help them respond quickly to changing consumer demands.
In addition, we focus on developing and manufacturing products that differentiate our customers’ products and help them meet evolving regulatory and environmental requirements. For example, our SYLOID® coatings additives are designed to be used in more sustainable water-based and VOC-compliant coatings, and our SHIELDEX® silicas allow our customers to reformulate their anti-corrosive coating products to eliminate heavy metals. Our pharmaceutical excipients help improve bioavailability, extend shelf-life, and/or make drug manufacturing more efficient. Our dental silicas are engineered to provide high cleaning with gentle abrasivity. Our DARACLAR® and TRISYL® silicas allow our customers to reduce their environmental footprint: our beer stabilization silicas offer greater productivity to breweries while allowing them to use water more efficiently, and our edible oil and biofuel refining aids enable the processing of waste materials in refineries, reducing feedstock losses and solid waste sent to landfills. Our custom manufacturing of advanced intermediates supports pharmaceutical drug development processes, enabling commercialization of life-saving therapies. Our LUDOX® colloidal silicas enable our customers to produce automotive catalytic converters for automakers to meet emissions control regulations.
In 2020 we deepened our collaboration with customers to align some of our Materials Technologies product capabilities to support customers in addressing the global COVID-19 pandemic. Our silica-based technology provides separation capabilities found in the PCR (polymerase chain reaction) test kits. Similarly, our silica-based materials are used in purifying lipids that are required to hold together mRNA used in two of the leading approved COVID-19 vaccines.
Manufacturing, Marketing and Raw Materials
Our Materials Technologies products are manufactured by a network of globally integrated plants that are positioned to service our customers. Our integrated supply chain organization is responsible for the effective utilization of our manufacturing capabilities. Our global footprint allows us to partner effectively with both multinational and regional companies requiring multiple manufacturing facilities complemented by regional technical expertise in local languages. For a discussion of our manufacturing plants for Materials Technologies, see Item 2, “Properties,” below.
We use country-based direct sales forces and further support our customers with application-specific technical customer service teams to market our Materials Technologies products. Our sales force seeks to develop long-term relationships with our customers and focuses on consultative sales, technical support, and key account growth programs. To ensure full geographic coverage, our direct sales organization is further supplemented by a network of distributors.
The principal raw materials for Materials Technologies products include sodium silicate, zeolite, sand, soda ash, sulfuric acid, and caustic soda. Multiple suppliers are generally available for each of these materials; however, some of our raw materials may be provided by single sources of supply. We seek to mitigate the risk of using single source suppliers by identifying and qualifying alternative suppliers or, for unique materials, by using alternative formulations from other suppliers. In some instances, we produce our own raw materials and intermediates.
Prices for some of our raw materials and energy can be volatile. In response to increases in input costs, we generally take actions intended to mitigate the effects of higher costs including developing alternative formulations for our products, increasing productivity, and increasing prices.
As in many chemical businesses, we consume significant quantities of natural gas in the production of Materials Technologies products. World events and other economic factors can cause volatility in the price of natural gas. Increases or decreases in the cost of natural gas and raw materials can have a significant impact on
10


our operating margins. We have implemented a risk management program under which we hedge natural gas in a way that is designed to mitigate the effects of price volatility.
Backlog of Orders; Working Capital
While at any given time there may be some backlog of orders, this backlog is not material in respect to our total annual sales for Materials Technologies, nor are the changes, from time to time, significant. Our working capital consists of inventory, accounts receivable and accounts payable. We closely manage these working capital accounts. We value inventory balances under the FIFO method. Inventories have turned regularly.
Competition
There are many manufacturers of engineered materials that market their products on a global basis including Evonik, PQ, and Nalco. Competition is generally based on product performance, technical service, quality and reliability, price, and other differentiated product features to address the needs of customers, end-users, and brand owners. Our products compete on the basis of distinct technology, product quality, and customer support. Competition for these products is highly fragmented, with a large number of companies that sell their products on a global or regional basis.
INTELLECTUAL PROPERTY; RESEARCH ACTIVITIES
Competition in the specialty chemicals and specialty materials industry is often based on technological superiority and innovation. Our ability to maintain our margins and effectively compete with other suppliers depends on our ability to introduce new products based on innovative technology, as well as our ability to obtain patent or other intellectual property protection. Our research and development programs emphasize development of new products and processes, improvement of existing products and processes, and application of existing products and processes to new industries and uses. We conduct most of our research activity in North America and Europe.
We file patents in order to protect our investments in innovation arising from research and product development in all our businesses, and as a result, numerous patents and patent applications protect our products, formulations, manufacturing processes, equipment, and improvements. For example, we selectively file and obtain patents in our Refining Technologies business, as well as in our chemical catalysts product line in our Specialty Catalysts business, for strategic new products or for significant business opportunities. We routinely file and obtain patents in a number of countries around the world that are significant to our polyolefin catalysts product line in our Specialty Catalysts business.
In our Materials Technologies business, we focus our research on the development and use of specialty materials products and formulations for diverse applications. We file patents and trademarks in various countries to protect our unique products, processes and expertise in strategic areas of our business, and to cover key product innovations in adjacent market segments.
We also benefit from the use of trade secret information, including know-how and other proprietary information relating to many of our products and processing technologies in all of our businesses, including, but not limited to, our business in licensing UNIPOL® Polypropylene Process Technology.
While we seek legal protection for our innovations, there can be no assurance, however, that our patents, patent applications and precautions to protect trade secrets and know-how will provide sufficient protection for our intellectual property. In addition, other companies may independently develop technology that could replicate, and thus diminish the advantage provided by, our trade secrets. Other companies may also develop alternative technology or design-arounds that could circumvent our patents or may acquire patent rights applicable to our business which might interpose a limitation on expansion of our business in the future.
ENVIRONMENT, HEALTH, SAFETY, AND SECURITY (or “EHSS”) MATTERS AND GOVERNMENTAL REGULATIONS
We are subject, along with other manufacturers of specialty chemicals, to stringent regulations under numerous regional, national, provincial, state and local EHSS laws and regulations relating to the manufacture, storage, handling, transportation, disposal and stewardship of chemicals and other materials. In addition to those laws and regulations, as we operate and/or sell to customers in over 60 countries, we must comply with important government regulations around the globe with respect to wide-ranging matters, including business and operating
11


licenses, reporting requirements, registrations of intellectual property rights, human capital management, mine safety, and customs and taxes, among others. Cumulatively, the expenses of compliance with government regulations have a material effect on our earnings; however, as other manufacturers of specialty chemicals face similar regulations (provided they operate under similar regulatory frameworks), we do not see our compliance as creating a material competitive disadvantage to date, and our conscientious adherence to safety and other regulations has positive effects on our overall position as a global company. Nevertheless, changes in, or additions to, governmental regulations may lead to additional expenditures and negative effects on our operations.
Environmental laws require that certain responsible parties, as defined in the relevant statute, fund remediation actions regardless of legality of original disposal or ownership of a disposal site. We are involved in various response actions to address the presence of chemical substances as required by applicable laws.
We have expended substantial funds to comply with environmental laws and regulations and expect to continue to do so in the future. The following table sets forth our expenditures in the past three years, and our estimated expenditures in 2021 and 2022, for (i) the operation and maintenance of manufacturing facilities and the disposal of wastes; (ii) capital expenditures for environmental control facilities; and (iii) site remediation:
(In millions) Operation of
Facilities and
Waste Disposal
Capital
Expenditures
Site
Remediation
2018 $ 56  $ $ 18 
2019 54  14 
2020 56  13 
2021(1) 56  13  18 
2022(1) 58  23  10 
___________________________________________________________________________________________________________________
(1)Amounts are based on environmental response matters for which sufficient information is available to estimate costs. We do not have sufficient information to estimate all of our possible future environmental response costs. As we receive new information, our estimate of such costs may change materially.
The table above does not include estimated expenditures related to the replacement of the dam spillway on the Libby, Montana, mine site. We are legally obligated to operate the dam and construct a new spillway in accordance with the conditions of the latest permit issued by the Montana Department of Natural Resources and Conservation. We have estimated the total cost of the project to be $95.0 million, with the timing of disbursements subject to a number of variables. Construction will begin in 2021 and is expected to take three to four years. Additional information about this matter and our environmental remediation activities is provided in this Report in Item 8 “Financial Statements and Supplementary Data” under Note 10, “Commitments and Contingent Liabilities,” to the Consolidated Financial Statements, which information is incorporated herein by reference.
EHSS Programs
We continuously seek to improve our environmental, health, safety, and security performance. To the extent applicable, we extend the basic elements of the American Chemistry Council’s RESPONSIBLE CARE® program to all our locations worldwide. Our Environment, Health, Safety, and Security Policy and RESPONSIBLE CARE MANAGEMENT SYSTEM® guide the company, our operating segments, and our facilities worldwide in systematically managing the environmental, health, safety, process safety, product safety, security, and sustainability aspects of our operations.
Sustainability
Overview
We succeed when we deliver value to our customers, and that success is increasingly based on how we help them meet their sustainability goals. Many of our products and technical services improve the efficiency of our customers’ products and processes, reduce energy or water use, cut harmful emissions, conserve material inputs, and/or reduce waste. Several of our technologies enable our customers to make products that meet the toughest environmental standards or to reformulate products to address rising consumer and regulatory expectations for sustainability, human health, and safety. As a leading manufacturer of process catalysts, we have become an active participant in the circular economy, with increasing business in assisting our customers with the recycling or
12


reprocessing of spent catalysts. As part of our commitment to RESPONSIBLE CARE®, we systematically track safety and environmental performance through a comprehensive, global EHSS management system covering the environmental, health, safety (including process safety and product safety) and security aspects of our operations, and track progress through pertinent metrics.
In 2019, we began reporting to the Carbon Disclosure Project (“CDP”). This year, we made our CDP Climate and CDP Water disclosures public for the first time. We also published sustainability disclosures aligned with the Sustainability Accounting Standards Board (“SASB”) standard for the chemical industry. In addition, we strengthened the governance of our sustainability and environmental, social, and governance (“ESG”) related activities by naming a Chief Sustainability Officer (“CSO”) reporting directly to the CEO, and established a Sustainability Leadership Council composed of the CSO and leadership from Grace businesses and integrated supply chain. We also established targets to reduce scope 1 and scope 2 greenhouse gas (“GHG”) emissions by 22% from a baseline of 2019 by 2029, as well as 10-year reduction targets for water consumption and waste generation.
Product Portfolio
As part of a strategic review of our product portfolio, in 2019 we identified the products that directly contribute to our customers’ sustainability objectives, including:
Products designed for use-phase efficiency defined by the SASB as products that “through their use—can be shown to improve energy efficiency, eliminate or lower GHG emissions, reduce raw materials consumption, increase product longevity, and/or reduce water consumption,” either through:
Improved products by increasing the efficiency of a product during its use phase, or
Improved processes by increasing the efficiency of the manufacturing processes used to make products;
Meeting the strictest environmental standards products that directly enable customers to meet environmental regulatory/legal requirements applicable to their products or manufacturing processes; and
Cleaner, safer products to meet consumer demands products that enable customers to reformulate their products to avoid or reduce to de minimis levels substances of concern to their customers.
This year, we reviewed the requested disclosures from SASB and CDP as well as other ESG ratings organizations and expanded our product categories to include products that make a significant contribution to the move toward a more circular economy through:
Enabling material recycling and bio-feeds – products that are tailored to enable customers to replace petroleum inputs with bio-based and recycled materials, and FCC catalyst sales (not counted above) where we take back spent FCC catalyst for recycling, or otherwise enable the reuse or recycling of spent catalysts.
Together, the products in our portfolio, including those of our ART joint venture, that address these sustainability endpoints accounted for approximately $1.1 billion, or 49% of our total revenue in 2020. Looking to the future, we estimate that 62% of our R&D projects are linked to at least one of these customer sustainability objectives. We expect to see further opportunities as we continue to develop technologies for advanced plastics recycling and renewable fuels.
ESG Rankings
For 2020, we again earned a Gold Rating from EcoVadis, this year placing us in the 95th percentile of all companies ranked by EcoVadis on their sustainability performance. EcoVadis is a leading third-party entity that evaluates suppliers on a complex scale of sustainability and ESG factors. CDP increased our 2020 Climate Disclosure score to a B-, above the average achieved by our chemical industry peers and above the North American average. Also in 2020, the ESG Risk Rating from Sustainalytics placed us in the top quintile of both chemical and specialty companies. Source Sustainalytics.
13


Further Information
Shareholders and other interested persons can visit our website for additional sustainability information at www.grace.com/sustainability/en-us. That further information is not incorporated herein by reference and is not a part of this Annual Report on Form 10-K.
Security
We have implemented the RESPONSIBLE CARE® Security Code through a company-wide security program focused on the security of our people, processes, and systems. We have reviewed existing security (including cybersecurity) vulnerability and taken actions to enhance security systems where deemed necessary. In addition, we are complying with the Department of Homeland Security’s Chemical Facility Anti-Terrorism Standards, including identifying facilities subject to the standards, conducting security vulnerability assessments and developing and executing site security plans, as necessary.
OTHER INFORMATION, WEBSITE, AND AVAILABILITY OF REPORTS AND OTHER DOCUMENTS
Our principal executive offices are located at: W. R. Grace & Co., 7500 Grace Drive, Columbia, Maryland 21044. We maintain a website at www.grace.com. Our telephone number at our principal executive offices is +1 410.531.4000.
Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports, filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are available, free of charge, on our website as soon as reasonably practicable after such reports are electronically filed with, or furnished to, the Securities and Exchange Commission, or SEC. These reports may be accessed through our website’s investor information page at http://investor.grace.com/. These reports as well as our proxy and information statements may also be accessed through the SEC’s website at www.sec.gov.
In addition, the charters for the Audit, Compensation, Nominating and Governance, and Corporate Responsibility Committees of our Board of Directors, our corporate governance principles and code of ethics are available, free of charge, on our website at www.grace.com/en-us/corporate-leadership/pages/governance.aspx. Printed copies of the charters, governance principles and code of ethics may be obtained free of charge by contacting Grace Shareholder Services at +1 410.531.4167.
The information on our website is not, and shall not be deemed to be, a part of this report or incorporated into any other filings we make with the SEC.
Our Principal Executive Officer and Principal Financial Officer have submitted certifications to the SEC pursuant to the Sarbanes Oxley Act of 2002 as exhibits to this Report.
Important information can be found throughout this Form 10-K and shareholders and potential investors are encouraged in particular to review Item 1A, “Risk Factors.”
EXECUTIVE OFFICERS
See “Information about our Executive Officers” following Part I, Item 4 of this Report for information about our Executive Officers.
Item 1A.    RISK FACTORS
In addition to general economic, business and market conditions, we are subject to other risks and uncertainties, including, without limitation, the risks set forth below. For reference, we have divided the various significant risks to our business, financial condition, and results of operations into the following three categories: (i) key business risks; (ii) risks related to legacy matters; and (iii) risks related to financial matters, as set forth below.
14


Key Business Risks
The global COVID-19 pandemic has had a significant negative effect on certain industries into which we supply products and services, and on our financial results. The pandemic is expected to continue to negatively impact our operations and businesses until successfully controlled.
The COVID-19 pandemic caused an economic slowdown that led to a global recession. If resulting recessionary trends again turn negative or exacerbate, or if there is a resurgence of COVID-19, including variants thereof, such events could have a negative effect on our business, financial condition, and future results. Resulting recessions may impact our share price, as well as our ability to access the capital markets and sources of liquidity on reasonable terms, or at all.
The COVID-19 pandemic has led to significantly lower transportation fuel demand and a reduction in refining activity, which has negatively affected demand for our refining catalysts. Manufacturing activity reduced as a result of the pandemic. Demand for certain manufactured products, including polyolefin resins and products made with our specialty silicas, declined and negatively affected demand for our polyolefin catalysts and specialty silicas.The pandemic continues to present us with significant uncertainty.
The COVID-19 pandemic has also heightened risks associated with our internal operations. An outbreak among our employee population could have a material adverse effect on our overall business and financial condition. Additionally, a large number of our employees are working remotely as a result of restrictions imposed to control the spread of the virus. This could result in increased cybersecurity risk, which could have a material adverse effect on our overall business and financial condition.
The global scope of our operations subjects us to the risks of doing business in foreign countries, which could adversely affect our business, financial condition and results of operations.
We operate our business on a global scale with approximately 73% of our 2020 consolidated sales outside the United States. We operate and/or sell to customers in over 60 countries and in over 30 currencies. We currently have many production facilities, research and development facilities, and administrative and sales offices located outside North America, including facilities and offices located in EMEA (Europe Middle East Africa), Asia Pacific and Latin America. We expect non-U.S. sales to continue to represent a substantial majority of our revenue. Accordingly, our business is subject to risks related to the differing legal, political, social and regulatory requirements and economic conditions of many jurisdictions. Risks inherent in non-U.S. operations include the following:
commercial agreements may be more difficult to enforce and receivables more difficult to collect;
intellectual property rights may be more difficult to enforce;
increased shipping costs, disruptions in shipping or reduced availability of freight transportation;
difficulty transferring our profits or capital from foreign operations to other countries where such funds could be more profitably deployed;
unexpected adverse changes in export duties, quotas and tariffs, and difficulties in obtaining export licenses;
differing regulatory responses to the COVID-19 pandemic in the jurisdictions in which we operate;
additional withholding and other taxes or restrictions on foreign trade or investment, including import, currency exchange and capital controls, charges and limitations;
foreign governments may nationalize private enterprises;
political or economic repercussions on a domestic, country-specific or global level from terrorist activities and the response to such activities;
unexpected adverse changes in foreign laws or regulatory requirements;
the impact of the United Kingdom’s exit from the European Union on January 31, 2020, and the provisional application of the EU-UK Trade and Cooperation Agreement on January 1, 2021;
increased cash taxes in the event of a change in tax laws, regulations or interpretations in one or more foreign jurisdictions, could adversely affect our business, financial condition, results of operations, or liquidity; and
geopolitical risk, where unexpected changes in global, regional, or local political or social conditions could adversely affect our foreign operations.
15


Our success as a global business will depend, in part, upon our ability to succeed in differing legal, regulatory, economic, social and political conditions by developing, implementing and maintaining policies and strategies that are effective in each location where we do business.
In addition to the risks and uncertainties that we discussed above, recent world events have increased the risks posed by international trade disputes, tariffs, and sanctions. We procure a wide spectrum of commodities globally to support our production. For materials sourced from nations that could be impacted by trade disputes, tariffs or sanctions, we could potentially face increased costs, supply disruptions and/or costs associated with securing alternative materials. Additionally, such disputes, tariffs, and sanctions could potentially lead to a reduction in our sales of products, technology, and services. We view geopolitical risk along with other potential supply chain and sales risks, and work actively to diversify and mitigate these potential impacts; however, such events could adversely affect our business, financial condition and results of operations.
As we operate worldwide in a competitive environment, global economic and financial market conditions may adversely affect our business, financial condition and results of operations.
We compete by selling value-added products, technologies and services. Increased levels and numbers of competitors, globally or regionally, could negatively impact our results of operations. Economic conditions around the world can have a direct impact on our revenues. A global or regional economic downturn or market uncertainty could reduce the demand for our products, technologies and services, which could negatively impact our results of operations. Since many of our customers are refiners, our fluid catalytic cracking (FCC) and hydroprocessing catalyst (HPC) businesses are highly dependent on the economics of the petroleum refining industry. Demand for our FCC and HPC products is affected by refinery throughput, the type and quality of refinery feedstocks, and the demand for transportation fuels and other refinery products, such as propylene. Also, disruptions in the financial markets could have an adverse effect on our ability to finance our operations and growth plans, and could negatively impact our suppliers and customers in similar manners.
We are exposed to currency exchange rate changes that impact our profitability.
We are exposed to currency exchange rate risk through our U.S. and non-U.S. operations. Changes in currency exchange rates may materially affect our operating results. For example, changes in currency exchange rates may affect the relative prices at which we and our competitors sell products in the same region and the cost of materials used in our operations. A substantial portion of our net sales and assets are denominated in currencies other than the U.S. dollar, particularly the euro. When the U.S. dollar strengthens against other currencies, at a constant level of business, our reported sales, earnings, assets and liabilities are reduced because the non-U.S. currencies translate into fewer U.S. dollars.
We incur a currency transaction risk whenever one of our operating subsidiaries enters into either a purchase or a sales transaction using a currency different from the operating subsidiary’s functional currency. Given the volatility of exchange rates, we may not be able to manage our currency transaction risks effectively, or volatility in currency exchange rates may expose our financial condition or results of operations to a significant additional risk.
Prices for certain raw materials and energy are volatile and can have a significant effect on our manufacturing and supply chain strategies as we seek to maximize our profitability. If we are unable to successfully adjust our strategies in response to volatile raw materials and energy prices, such volatility could have a negative effect on our earnings in future periods.
We use metals, natural gas, petroleum-based materials, and other materials in the manufacture of our products. We consume substantial amounts of energy in our manufacturing processes. Prices for these materials and energy are volatile and can have a significant effect on our pricing, sales, manufacturing and supply chain strategies as we seek to maximize our profitability. Our ability to adjust strategies successfully in response to volatile raw material and energy prices is a significant factor in maintaining or improving our profitability. If we are unable to successfully adjust our strategies in response to volatile prices, such volatility could have a negative effect on our sales and earnings in future periods.
16


A substantial portion of our raw materials are commodities whose prices fluctuate as market supply and demand fundamentals change.
We attempt to manage exposure to price volatility of major commodities through:
long-term supply contracts;
contracts with customers that permit adjustments for changes in prices of commodity-based materials and energy;
forward buying programs that layer in our expected requirements systematically over time; and
limited use of financial instruments.
Although we regularly assess our exposure to raw material price volatility, we cannot always predict the prospects of volatility and we cannot always cover the risk in a cost effective manner.
Certain of our raw materials may be provided by single sources of supply. We may not be able to obtain sufficient raw materials due to unforeseen developments that would cause an interruption in supply. Even if we have multiple sources of supply for raw materials, these sources may not make up for the loss of a major supplier.
If we are not able to continue our technological innovation and successful introduction of new products, our customers may turn to other suppliers to meet their requirements.
The specialty chemicals and specialty materials industries and the end-use markets into which we sell our products experience ongoing technological change and product improvements. A key element of our business strategy is to invest in research and development activities with the goal of introducing new high-performance, technically-differentiated products. We may not be successful in developing new technology and products that effectively compete with products introduced by our competitors, and our customers may not accept, or may have lower demand for, our new products. If we fail to keep pace with evolving technological innovations or fail to improve our products in response to our customers’ needs, then our business, financial condition and results of operations could be adversely affected as a result of reduced sales of our products.
We may be subject to claims of infringement of the intellectual property rights of others, which could hurt our business.
From time to time, we face infringement claims from our competitors or others alleging that our processes or products infringe on their proprietary technologies. Any claims that our products or processes infringe the intellectual property rights of others, regardless of the merit or resolution of the claims, could cause us to incur significant costs in responding to, defending and resolving the claims, and may divert the efforts and attention of our management and technical personnel from our business. If we are found to be infringing on the proprietary technology of others, we may be liable for damages, and we may be required to change our processes, redesign our products, pay others to use the technology, or stop using the technology or producing the infringing product. Even if we ultimately prevail, the existence of the lawsuit could prompt our customers to switch to products that are not the subject of infringement suits.
Some of our employees are unionized, represented by works councils or employed subject to local laws that are less favorable to employers than the laws in the United States.
As of December 31, 2020, we had approximately 4,000 global employees. Approximately 700 of our approximately 2,200 U.S. employees are unionized at 5 manufacturing sites, and approximately 1,400 of our employees outside the U.S. are represented by works councils and unions. In addition, a large number of our employees are employed in countries in which employment laws provide greater bargaining or other rights to employees than the laws in the United States. Such employment rights require us to work collaboratively with the legal representatives of the employees to effect any changes to labor arrangements. For example, most of our employees in Europe are represented by works councils that have co-determination rights on any changes in conditions of employment, including certain salaries and benefits and staff changes, and may impede efforts to restructure our workforce. A strike, work stoppage or slowdown by our employees or significant dispute with our employees, whether or not related to these negotiations, could result in a significant disruption of our operations or higher ongoing labor costs.
17


We intend to pursue acquisitions, joint ventures and other transactions that complement or expand our businesses. We may not be able to complete proposed transactions and even if completed, the transactions may involve a number of risks that may materially and adversely affect our business, financial condition and results of operations.
We intend to continue to pursue opportunities to buy other businesses or technologies that could complement, enhance or expand our current businesses or product lines or that might otherwise offer us growth opportunities. We may have difficulty identifying appropriate opportunities or, if we do identify opportunities, we may not be successful in completing transactions for a number of reasons. Any transactions that we are able to identify and complete may involve a number of risks, including:
the diversion of management’s attention from our existing businesses to integrate the operations and personnel of the acquired or combined business or joint venture;
possible adverse effects on our operating results during the integration process;
failure of the acquired business to achieve expected financial, operational, and other objectives;
possible assumption of unexpected liabilities; and
inability to obtain indemnification from other parties to transactions.
In addition, we may not be able to successfully or profitably integrate, operate, maintain and manage any newly acquired operations or their employees. We may not be able to maintain uniform standards, controls, procedures and policies, which may lead to operational inefficiencies.
We spend large amounts of money for environmental compliance in connection with our current and former operations.
As a manufacturer of specialty chemicals and specialty materials, we are subject to stringent regulations under numerous U.S. federal, state, local and foreign environmental, health and safety laws and regulations relating to the generation, storage, handling, discharge, disposition and stewardship of chemicals and other materials. We have expended substantial funds to comply with such laws and regulations and have established a policy to minimize our emissions to the environment. Legislative, regulatory and economic uncertainties (including existing and potential laws and regulations pertaining to climate change) make it difficult for us to project future spending for these purposes, and if there is an acceleration in new regulatory requirements, we may be required to expend substantial additional funds to remain in compliance, which may be material.
Evolving energy consumption patterns; investor sentiment regarding fossil fuels and related matters; and risks related to climate change, may negatively affect our business, financial condition, and results of operations, and our stock price.
We are engaged in the production and sale of specialty chemicals and specialty materials used in petrochemical, refining, and other chemical manufacturing applications. These industries are facing challenges from ESG concerns of investors; the economic impacts of climate change developments; and regulation of GHGs, such as carbon dioxide, methane, and nitrous oxide, among others. In addition, the increasing availability of electric vehicles offers an alternative that could lead to reduced demand for liquid transportation fuels. Resulting reductions in refining and related activities could have a negative effect on our revenues and business.
Recently, there have been intensifying efforts directed at various members of the investment community to promote the divestment of shares of energy companies, as well as to pressure lenders and other financial services companies to limit or curtail activities with energy companies. As we provide products and services to energy companies, should these efforts be successful or expanded, there may be a negative impact on our revenues and business, and our stock price.
Potential effects of climate change include increased frequency, severity, and impact of weather-related events. Multiple Grace facilities globally are located in areas that may be at risk from hurricanes and other weather-related events that could cause production interruptions. Key suppliers and associated distribution routes for raw materials and finished goods are similarly at risk of interruptions from severe weather events. Multiple customers are likewise located in areas that could be impacted by extreme weather events. These circumstances present business continuity and related risks.
18


We work with dangerous materials that can injure our employees, damage our facilities, disrupt our operations, and contaminate the environment.
Some of our operations involve the handling of hazardous materials that may pose the risk of fire, explosion, or the release of hazardous substances. Such events could result from natural disasters, operational failures or terrorist attacks, and might cause injury or loss of life to our employees and others, environmental contamination, and property damage. These events might cause a temporary shutdown of an affected plant, or portion thereof, and we could be subject to penalties or claims as a result of any of these events. A disruption of our operations caused by these or other events could have a material adverse effect on our results of operations.
We are subject to business continuity risks that may adversely affect our business, financial condition and results of operations.
We are subject to significant risks from both natural disasters and accidents such as fires, storms, and floods; public health concerns, including pandemics and quarantines; and disruptive events, such as war, insurrection, and terrorist actions; and other force majeure events. These types of occurrences can negatively affect our manufacturing, supply chain, logistics, information technology, and communications functions. Similarly, they can strike major suppliers and customers, thus restricting or delaying our supply of raw materials or energy as well as reducing or deferring demand for our products and services. In the event of a major disruption, we may not be able to replace this business in a timely manner or at similar margins. Also, we have centralized certain administrative functions, primarily in North America, Europe and Asia, to improve efficiency and reduce costs. To the extent that these central locations are disrupted or disabled, key business processes, such as invoicing, payments and general management operations, could be interrupted.
We insure against many of these risks by carrying property, general, liability, and other coverages with highly rated global insurers. Given the current insurance market as well as our recent claims experience, we may experience increased costs to purchase insurance coverage going forward. Our ability to obtain certain coverage, including contingent time element business interruption insurance, for losses related to our suppliers or customers may be limited or more costly in the future.
A failure of our information technology (“IT”) infrastructure could adversely impact our business and operations.
We increasingly rely upon the capacity, reliability and security of our IT infrastructure and our ability to expand and continually update this infrastructure in response to the changing needs of our business. Additionally, a large number of our employees are working remotely as a result of restrictions imposed to control the spread of the COVID-19 virus. If we experience a problem with the functioning of an important IT system, the resulting disruptions could have an adverse effect on our business. Our IT systems affect virtually every aspect of our business, including supply chain, manufacturing, logistics, finance and communications. We and certain of our third-party vendors receive and store personal information in connection with our human resources operations and other aspects of our business. Any IT system failure, natural disaster, accident, or intentional breach could result in disruptions to our operations.
Our ability to operate our businesses and our financial condition could be significantly undermined by cybersecurity breaches.
Our IT systems are subject to cyberattack and other similar disruptions. Breaches by hackers, the introduction of computer viruses, ransomware, and other cybersecurity incidents affecting our IT systems could result in disruptions to our operations. Also, such incidents could include theft of our trade secrets and other intellectual property, as well as confidential customer, employee and business information, which could be used by unauthorized parties and publicly disclosed. This could negatively affect our relationships with customers and our ability to compete effectively, and could ultimately harm our reputation, business, financial condition and results of operations. In addition, we may be required to incur significant costs to protect against damage caused by cybersecurity breaches in the future.
19


Risks Related to Legacy Matters
We are subject to liabilities for Legacy Matters, which include (i) product, (ii) environmental, and (iii) other liabilities, relating to past activities of Grace.
In addition to the legacy product and legacy environmental liabilities discussed below in these Risk Factors, we are subject to other liabilities relating to past activities of Grace. Beginning in 1971, as part of implementing a wet milling process at the Libby, Montana, vermiculite mine, we constructed a dam at the mine property that now prevents vermiculite ore tailings from moving into nearby creeks and rivers. Ongoing operation of the dam is regulated by the Montana Department of Natural Resources and Conservation (“DNRC”). In April 2019, the DNRC renewed the permit necessary for operation of the dam. We are legally obligated to operate the dam and construct a new spillway in accordance with the latest permit conditions.
Construction of the new dam spillway at the former mine site is a key element of our overall remediation strategy. The project includes both an upper spillway and a lower spillway that are being managed as two separate projects with different engineering design and construction timelines. In 2019, we contracted a third-party engineering and consulting firm to develop an initial range of cost estimates for the total project. Based on this work, we recorded a liability of $68.0 million in 2019 for the estimated costs of the project. These costs were preliminary and subject to change as new information becomes available, including defining the final scope of the projects through the contract bidding process. During the three months ended September 30, 2020, we completed a review of contractor bids for the replacement of the upper spillway and increased our cost estimate for this portion of the project by $27.0 million, bringing the estimate for the total project to $95.0 million. Regarding the lower spillway, final engineering will be completed and submitted to the state of Montana for design approval in 2021, after which we will seek contract bids for this portion of the project. We believe it is reasonably possible that the ultimate costs of the two spillway projects could range between $80 million and $120 million. As we receive new information, our estimated liability may change materially. Construction will begin in 2021 and is expected to take three to four years.
We are subject to environmental clean-up costs, fines, penalties and damage claims that have been and continue to be costly.
In the U.S., we are subject to lawsuits and regulatory actions, in connection with current and former operations (including some divested businesses and off-site disposal facilities), that seek clean-up or other remedies. We are also subject to similar risks outside of the U.S.
We purchased a vermiculite mine in Libby, Montana, in 1963 and operated it until 1990. Vermiculite concentrate from the Libby mine was used in the manufacture of attic insulation and other products. Some of the vermiculite ore contained naturally occurring asbestos. We are engaged with the U.S. Environmental Protection Agency (or the “EPA”) and other federal, state and local governmental agencies in a remedial investigation and feasibility study (or the “RI/FS”) of the Libby mine and the surrounding area, known as Operable Unit 3 (or “OU3”). The RI/FS will study the areas within OU3 requiring remediation and will identify possible remedial action alternatives. Possible remedial actions within OU3 are wide-ranging, from institutional controls such as land use restrictions, to more active measures involving soil removal, containment projects, or other protective measures. As part of the RI/FS process, we contracted an engineering and consulting firm to develop a range of possible remedial alternatives and associated cost estimates for OU3. Based on this work, we recorded a pre-tax charge of $70.0 million during the three months ended September 30, 2018, for the estimated costs of remediation of OU3. We believe that this amount should provide for a protective remedy meeting the statutory requirements of the Comprehensive Environmental Response, Compensation, and Liability Act.
The estimated costs of remediation are preliminary and consist of several components, each of which may vary significantly as the remedial alternatives are further developed. It is reasonably possible that the ultimate costs of remediation could range between $30 million and $170 million. We are working closely with the EPA, and the ultimate remedy will be determined by the EPA after the RI/FS is finalized. Such remedy will be set forth in a Record of Decision (or “ROD”) that is currently expected to be issued by the EPA no earlier than 2024. Costs associated with the more active remedial alternatives would be expected to be incurred over a decade or more. We will reevaluate our estimated liability as remedial alternatives evolve based on further work by the engineering and consulting firm and discussions with the EPA as the RI/FS process moves toward a ROD. Technical memoranda expected prior to the issuance of the ROD may provide insight into the likely remedial alternatives ultimately selected, allowing us to update our cost of remediation estimate. Depending on the remedial alternatives that the EPA selects in the ROD, the total cost of remediating OU3 may exceed our current estimate
20


by material amounts. The amounts set forth above do not include possible liability for natural resources damage. Based on ecological studies conducted by the EPA, we do not believe that natural resources damage has occurred. However, if a party were to be successful in asserting a natural resources damage claim, liability related to such obligation could be material.
We have cooperated with the EPA in investigating and remediating a number of formerly owned or operated sites that processed Libby vermiculite into finished products. We have recorded a liability for remaining expected response costs, including costs for EPA oversight and potential future site remediation, where a review has indicated that liability is probable and the cost is estimable. The EPA may commence additional investigations in the future at other sites that processed Libby vermiculite. Liability for unaccrued additional investigation and remediation costs is probable but not yet estimable, and could be material.
We have recorded liabilities for all environmental matters for which a loss is considered to be probable and sufficient information is available to reasonably estimate the loss. We also face legacy environmental liability for response costs at sites not related to our former vermiculite mining and processing activities. This liability relates to our former businesses or operations, including our share of liability at off-site disposal facilities. Our estimated liability is based upon regulatory requirements and environmental conditions at each site. As we receive new information, our estimated liability may increase materially.
We may be required to make one or more contingent deferred payments to the trust for asbestos property damage claims, which we refer to as the “PD Trust,” in respect of claims related to our former Zonolite attic insulation (“ZAI”) product (“ZAI PD Claims”); we may also be obligated to make additional payments to the PD Trust in respect of “Other PD Claims” (those being asbestos property damage claims other than ZAI PD Claims); and our obligations to make payments to the PD Trust in respect of Other PD Claims is not capped.
Grace emerged from bankruptcy effective February 3, 2014 (the “Effective Date”). Under the Joint Plan, the PD Trust was established and funded under Section 524(g) of the Bankruptcy Code. The order of the Bankruptcy Court confirming the Joint Plan contains a channeling injunction, which provides that all pending and future asbestos-related property damage claims and demands (or “PD Claims”) can only be brought against the PD Trust. The PD Trust contains two accounts. One of these accounts is the “ZAI PD Account,” which is funded in respect of claims related to ZAI. The other account is the “PD Account,” which is funded solely in respect of Other PD Claims.
Under the Joint Plan, all pending and future asbestos-related personal injury claims are channeled for resolution to a personal injury trust (the “PI Trust”). We have satisfied all of our financial obligations to the PI Trust. We have contingent financial obligations remaining to the PD Trust. With respect to ZAI PD Claims, the PD Trust was funded with $49.4 million (net of $15 million of attorneys’ fees) to pay claims and expenses. We are also obligated to make up to 10 contingent deferred payments of $8 million per year to the PD Trust during the 20-year period beginning on February 3, 2019, with each such payment due only if the assets of the PD Trust fall below $10 million during the preceding year. As of December 31, 2020, the PD Trust has paid out approximately $38 million in ZAI PD Claims and expenses, leaving a balance of approximately $18 million, including the benefit of realized investment gains.
Due to the limited claims history, the unique nature of this product, and the uncertainty of future claims patterns, an actuarial analysis was completed to estimate the range of possible future payments. The analysis was conducted by a third-party actuarial firm directed by us and using historical claims data provided by the ZAI trustee. Certain key assumptions employed in the analysis were (1) projections of the future number of filed claims, assuming a percentage increase in claims during earlier years and annual decreases in later years; (2) application of historical percentages of claims closed with indemnity payment compared to total closed claims, applied on a regional basis; and (3) application of the average claim payout, which reflects the average indemnity cost per claim closing with payment. As a result of the analysis and taking into account the relative uncertainty of future claims activity, we determined that contingent funding obligations beyond 2025 are not reasonably estimable. We estimate that the reasonable range of payments over the period of 2021 to 2025 is expected to be between $16 million and $24 million and project that the first payment could be due as early as 2022. In the 2019 fourth quarter, we recorded a $24.0 million liability related to probable future obligations to fund the PD Trust for ZAI PD Claims. Our maximum financial obligation over the next 18 years is $80 million, and no single year’s payment can exceed $8 million.
21


With respect to Other PD Claims, claims unresolved as of the Effective Date are to be litigated in the bankruptcy court and any future claims are to be litigated in a federal district court, in each case pursuant to procedures approved by the bankruptcy court. To the extent any such Other PD Claims are determined to be allowed claims, they are to be paid in cash by the PD Trust. We are obligated to make a payment to the PD Trust every six months in the amount of any Other PD Claims allowed during the preceding six months plus interest (if applicable) and the amount of PD Trust expenses for the preceding six months (the “PD Obligation”). We have not paid any Other PD Claims since emergence. Annual expenses have been approximately $0.2 million per year. The aggregate amount to be paid under the PD Obligation is not capped, and we may be obligated to make additional payments to the PD Trust in respect of the PD Obligation. We have accrued for those unresolved Other PD Claims that we believe are probable and estimable. We have not accrued for other unresolved or unasserted Other PD Claims as we do not believe that payment is probable.
All payments to the PD Trust required after the Effective Date are secured by the Company’s obligation to issue 77,372,257 shares of Company common stock to the PD Trust in the event of default, subject to customary anti-dilution provisions.
Risks Related to Financial Matters
Our indebtedness may materially affect our business, including our ability to fulfill our obligations, react to changes in our business and incur additional debt to fund future needs.
We have a substantial amount of debt. As of December 31, 2020, we had $1,063.6 million of unsecured indebtedness outstanding and $926.8 million of secured indebtedness outstanding. Our indebtedness may have material effects on our business, including to:
require us to dedicate a substantial portion of our cash flow to principal and interest payments, thereby reducing funds available for working capital, capital expenditures, acquisitions, research and development, distributions to shareholders (which fall within the discretion of our Board of Directors taking into account financial, liquidity and other considerations), share repurchase programs and other purposes;
restrict us from making strategic acquisitions or taking advantage of favorable business opportunities;
limit our flexibility in planning for, or reacting to, changes in our business and the industries in which we operate;
increase our vulnerability to adverse economic, credit and industry conditions, including recessions;
make it more difficult for us to satisfy our other obligations;
place us at a competitive disadvantage compared to our competitors that have relatively less debt; and
limit our ability to borrow additional funds, or to dispose of assets to raise funds, if needed, for working capital, capital expenditures, acquisitions, research and development and other purposes.
If we incur additional debt, the risks related to our indebtedness may intensify.
Restrictions imposed by agreements governing our indebtedness may limit our ability to operate our business, finance our future operations or capital needs, or engage in other business activities. If we fail to comply with certain restrictions under these agreements, our debt could be accelerated, and we may not have sufficient cash to pay our accelerated debt.
The agreements governing our indebtedness contain various covenants that limit, among other things, our ability, and the ability of certain of our subsidiaries, to:
incur certain liens;
enter into sale and leaseback transactions; and
consolidate, merge or sell all or substantially all of our assets or the assets of our guarantors.
As a result of these covenants, we will be limited in the manner in which we can conduct our business, and may be unable to engage in favorable business activities or finance future operations or capital needs. Accordingly, these restrictions may limit our flexibility to operate our business. A failure to comply with the restrictions contained in these agreements, including maintaining the financial ratios required by our credit facilities, could lead to an event of default which could result in an acceleration of our indebtedness. We cannot guarantee that our future operating results will be sufficient to enable us to comply with the covenants contained in the agreements governing our indebtedness or to remedy any such default. In addition, in the event of an
22


acceleration, we may not have or be able to obtain sufficient funds to make any accelerated payments. Additionally, in the event of a change in control, we will be required to offer to purchase our senior unsecured notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest.
Our indebtedness exposes us to interest expense increases if interest rates increase.
As of December 31, 2020, approximately $268.9 million of our borrowings were at variable interest rates and expose us to interest rate risk, excluding $586.5 million hedged by cross-currency swaps effective in November 2018, and $100.0 million hedged by interest rate swaps effective in April 2018. If interest rates increase, our debt service obligations on the variable rate indebtedness would increase even though the amount borrowed would remain the same, and our net income would decrease. An increase of 100 basis points in the interest rates payable on our variable rate indebtedness would increase our annual estimated debt-service requirements by $2.7 million, assuming our consolidated variable interest rate indebtedness outstanding as of December 31, 2020, remains the same.
The uncertainty regarding the potential phase-out of LIBOR may negatively impact our operating results.
We currently have term loan borrowings, a revolving credit facility and financial derivatives that rely on the London Interbank Offered Rate (“LIBOR”) as a benchmark rate. All of these financial instruments use a three-month U.S. dollar LIBOR for their benchmark rate. The Intercontinental Exchange (“ICE”) Benchmark Administration (“IBA”) announced that it intends to cease publication of three-month U.S. dollar LIBOR on June 30, 2023. No consensus exists as to what rate or rates will become accepted alternatives to LIBOR at this time, although the U.S. Federal Reserve, in connection with the Alternative Reference Rates Committee (“ARRC”), a steering committee composed of large U.S. financial institutions, has identified the Secured Overnight Financing Rate (“SOFR”) as the rate that represents the best practice for replacement of the U.S. dollar LIBOR. SOFR is a more generic measure than LIBOR and considers the cost of borrowing cash overnight, collateralized by U.S. Treasury securities.
Given the inherent differences between LIBOR and SOFR, or any other alternative benchmark rate that may be established, there are uncertainties regarding a transition from LIBOR. These uncertainties include, but are not limited to, the need to amend all contracts with LIBOR as the referenced rate and the impact on our cost of variable rate debt, including the use of certain financial derivatives. Based on guidance issued by the IBA and other regulatory bodies, we do not expect to issue any contracts that reference U.S. dollar LIBOR after 2021. We will need to consider new contracts issued before the end of 2021 to determine if they should reference an alternative benchmark rate and/or include suggested fallback language, as published by the ARRC. The consequences of these developments with respect to LIBOR cannot be entirely predicted and span multiple future periods; however, they could result in a change in the cost of our variable rate debt or derivative financial instruments, which may be detrimental to our financial position or operating results.
We have unfunded and underfunded pension plan liabilities. We will require future operating cash flow to fund these liabilities. We have no assurance that we will generate sufficient cash to satisfy these obligations.
We maintain U.S. and non-U.S. defined benefit pension plans covering current and former employees who meet or met age and service requirements. Our net pension liability and cost is materially affected by the discount rate used to measure pension obligations, the longevity and actuarial profile of our workforce, the level of plan assets available to fund those obligations and the actual and expected long-term rate of return on plan assets. Significant changes in investment performance or a change in the portfolio mix of invested assets can result in corresponding increases and decreases in the valuation of plan assets or in a change in the expected rate of return on plan assets. Assets available to fund the pension benefit obligation of the U.S. advance-funded pension plans at December 31, 2020, were approximately $1,001 million, or approximately 90% of the measured pension projected benefit obligation on a U.S. GAAP basis. In addition, any changes in the discount rate, as well as actual returns on plan assets, could result in a significant increase or decrease in the valuation of pension obligations, affecting the reported funded status of our pension plans as well as the net periodic pension cost in the following years. Similarly, changes in the expected return on plan assets can result in significant changes in the net periodic pension cost in the following years.
23


Our ability to use tax credits and / or net operating losses to reduce future tax payments may be limited if there is a change in ownership of Grace or if Grace does not generate sufficient taxable income or foreign source income for U.S. tax purposes. Our ability to use these attributes is also subject to time limitations. Changes in tax laws and regulations may reduce their value and availability.
Our ability to utilize tax attributes including tax credits, future tax deductions, and net operating losses (“NOLs”), is dependent on our ability to generate sufficient taxable income and foreign source income for U.S. tax purposes. Under U.S. income tax law, federal tax credits may be carried forward for 10 years, and research and development tax credits may be carried forward for 20 years. State NOL carryforwards are generally available for deduction against future taxable income for up to 20 years, subject to state-specific regulations. Also, our ability to realize the benefits of these tax credits and/or NOLs and their value may be adversely affected by changes in tax laws and regulations. In addition, our ability to utilize U.S. federal tax credits as well as U.S. federal and state NOLs may be limited in the event of future changes in the ownership of outstanding Company common stock.
Our business and stock price could be negatively impacted as a result of actions by activist shareholders or others.
We value constructive input from investors and regularly engage in dialogue with our shareholders regarding strategy and performance. Our Board of Directors and management team are committed to acting in the best interests of all of our shareholders. Activist shareholders may from time to time engage in proxy solicitations, advance shareholder proposals, or otherwise attempt to effect changes or acquire control of Grace. Recently, we received a revised proposal from a shareholder to acquire Grace. Our Board of Directors responded that we are willing to discuss a sale of Grace in the context of our ongoing review of strategic alternatives and that any transaction would need to be at a price level that reflects the full value of Grace for its shareholders.

Actions of activist shareholders could affect our business because responding to such actions can be costly and time-consuming and disruptive to our operations, and may divert the attention of our Board of Directors, management and employees. Moreover, such actions may create perceived uncertainties among current and potential customers, suppliers, employees and other constituencies as to our future direction, which could result in lost sales and the loss of business opportunities and make it more difficult to attract and retain qualified directors, personnel, and business partners. In addition, actual or perceived actions of activist shareholders may cause significant fluctuations in our stock price that do not necessarily reflect the underlying fundamentals and value of our business.
Item 1B.    UNRESOLVED STAFF COMMENTS
None.
Item 2.    PROPERTIES
We operate manufacturing plants and other facilities (including offices, warehouses, labs and other service facilities) throughout the world. Some of these plants and facilities are shared by our reportable segments. We consider our operating properties generally to be in good operating condition and suitable for their current use. We believe that the productive capacity of our plants and other facilities, supplemented by tolling arrangements, is
24


generally adequate for current operations. The table below summarizes our manufacturing plants by reportable segment and region as of December 31, 2020:
Number of Facilities(1)
North America Europe Middle East Africa (EMEA) Asia Pacific Latin America Total
Catalysts Technologies 10  3  1    14 
Owned —  10 
Leased —  — 
Materials Technologies 4  2  1  1  8 
Owned
Leased —  — 
___________________________________________________________________________________________________________________
(1)Shared facilities are counted in both reportable segments. The total number of facilities included in the above table, without regard to sharing between reportable segments, is 19, of which we own 13 and lease 6.
Generally, we own the machinery and equipment at our manufacturing plants. We also own the land on which most of our largest manufacturing plants are situated; however, certain manufacturing plants are located on leased land, normally long-term. We own our Corporate Headquarters in Columbia, Maryland. We also lease and operate a shared services facility in Manila, Philippines.
The table below sets forth our manufacturing plants by reportable segment.
Catalysts Technologies Materials Technologies
Aiken, South Carolina Dueren, Germany*
Baton Rouge, Louisiana* East Chicago, Indiana*
Chattanooga, Tennessee Hesperia, California
Chicago, Illinois Kuantan, Malaysia
Lake Charles, Louisiana Sorocaba, Brazil
Norco, Louisiana*
Pasadena, Texas
Stenungsund, Sweden* Shared
Tarragona, Spain* Albany, Oregon
Valleyfield, Quebec, Canada Curtis Bay, Maryland
Yeosu, South Korea Worms, Germany
___________________________________________________________________________________________________________________
*Denotes leased site.
Our three largest manufacturing sites are: Worms, in Germany; and Curtis Bay, Maryland, and Lake Charles, Louisiana, in the United States. The unanticipated loss of any of our manufacturing, headquarters, or shared services facilities could have a material adverse effect upon our business, financial condition or results of operations.
For information on our properties and equipment by region and country, see disclosure set forth in Item 8 (Financial Statements and Supplementary Data) under Note 18 (Segment Information) to our Consolidated Financial Statements, which disclosure is incorporated herein by reference.
Item 3.    LEGAL PROCEEDINGS
CHAPTER 11 PROCEEDINGS AND ASBESTOS CLAIMS
Disclosures provided in this Report in Item 1 (Business) and Item 8 (Financial Statements and Supplementary Data) under Note 10 (Commitments and Contingent Liabilities, under the caption “Legacy Liabilities”) to the Consolidated Financial Statements, are incorporated herein by reference.
25


ENVIRONMENTAL INVESTIGATIONS AND CLAIMS
Disclosures provided in this Report in Item 1 (Business) under the caption “Environment, Health, Safety, and Security Matters” and Item 8 (Financial Statements and Supplementary Data) under Note 10 (Commitments and Contingent Liabilities, under the caption “Legacy Environmental Liabilities”) to the Consolidated Financial Statements, are incorporated herein by reference.
Item 4.    MINE SAFETY DISCLOSURES
Information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K (17 CFR 229.104) is included in Exhibit 95 to this Report.
26


INFORMATION ABOUT OUR EXECUTIVE OFFICERS
Pursuant to General Instruction G(3) of Form 10-K, the following list of executive officers of Grace as of February 15, 2021, is included as an unnumbered Item in Part I of this report in lieu of being included in the Grace Proxy Statement relating to the 2021 Annual Meeting of Shareholders. Our executive officers are elected annually.
Name and Age Office First Elected
Hudson La Force (56) President and Chief Executive Officer
Director
November 8, 2018
November 2, 2017
William C. Dockman (61) Senior Vice President and Chief Financial Officer May 8, 2019
Elizabeth C. Brown (57) Senior Vice President and Chief Human Resources Officer January 21, 2015
Keith N. Cole (62) Senior Vice President, Public Affairs and Environment, Health, Safety, and Chief Sustainability Officer February 10, 2014
Cherée H. Johnson (45) Senior Vice President, General Counsel and Secretary January 11, 2021
Mr. La Force, Ms. Brown, and Mr. Cole have been actively engaged in Grace’s business as executive officers for the past five years. Mr. La Force is Grace’s Principal Executive Officer.
Mr. Dockman joined Grace in 1999. From 2012 until he became an executive officer, Mr. Dockman was Grace’s Vice President—Finance, Controller and Chief Accounting Officer. Mr. Dockman is Grace’s Principal Financial Officer and its Principal Accounting Officer.
Ms. Johnson joined Grace in 2021. From 2015 until Ms. Johnson became an executive officer of Grace, she was Deputy General Counsel and Assistant Corporate Secretary with McCormick & Company, Incorporated.

27


PART II

Item 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Except as provided below, the disclosure required by this Item appears in this Report in: Item 6 (Selected Financial Data) opposite the caption “Other Statistics—Common shareholders of record”; Item 8 (Financial Statements and Supplementary Information) in Note 14 (Shareholders’ Equity) and Note 21 (Quarterly Financial Information (Unaudited)) opposite the caption “Dividends declared per share” to the Consolidated Financial Statements; and Item 12 (Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters), and such disclosure is incorporated herein by reference.
COMPANY COMMON STOCK
The principal market for Company common stock is the New York Stock Exchange, under the symbol GRA.
DIVIDENDS ON COMPANY COMMON STOCK
On February 8, 2021, we announced that our Board of Directors had approved an increase to the annual cash dividend rate, from $1.20 to $1.32 per share of Company common stock. We expect to continue growing our dividend as part of our disciplined capital allocation strategy.
Although our credit agreement and indentures (as described in Item 8 (Financial Statements and Supplementary Data) under Note 5 (Debt) to the Consolidated Financial Statements and filed as an exhibit to this Report) contain certain restrictions on the payment of dividends on, and redemptions of, equity interests and other restricted payments, we believe that such restrictions do not currently materially limit our ability to pay dividends. Any determination to pay cash dividends in the future may be affected by business and market conditions, our views on potential future capital requirements, the restrictions noted above and those that may be imposed by applicable law, covenants contained in any agreements we may enter into in the future and changes in federal income tax law.
SHARE REPURCHASES
On February 8, 2017, we announced that our Board of Directors had authorized a share repurchase program of up to $250 million. On February 28, 2020, we announced that our Board of Directors had increased its share repurchase authorization to $250 million, including approximately $83 million remaining under the previously announced program. Repurchases under the programs may be made through one or more open market transactions at prevailing market prices; unsolicited or solicited privately negotiated transactions; accelerated share repurchase programs; or through any combination of the foregoing, or in such other manner as determined by management. The timing of the repurchases and the actual amount repurchased will depend on a variety of factors, including the market price of the Company’s shares, strategic priorities for the deployment of capital, and general market and economic conditions. We temporarily suspended our share repurchase program in early March 2020 in light of the COVID-19 pandemic. We expect to resume our share repurchase program in 2021.
During the three months ended December 31, 2020, there were no repurchases of Company common stock by or on behalf of Grace or any “affiliated purchaser,” as reflected in the following table:
Total number of shares purchased
(#)
Average price paid per share
($/share)
Total number of shares purchased as part of publicly announced plans or programs
(#)
Approximate dollar value of shares that may yet be purchased under the plans or programs
($ in millions)
10/1/2020 - 10/31/2020 —  —  —  235.0 
11/1/2020 - 11/30/2020 —  —  —  235.0 
12/1/2020 - 12/31/2020 —  —  —  235.0 
Total —  —  — 
28


STOCK PERFORMANCE GRAPH
The following information in Item 5 is not deemed to be “soliciting material” or to be “filed” with the SEC or subject to Regulation 14A or 14C under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or to the liabilities of Section 18 of the Exchange Act, and will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent Grace specifically incorporates it by reference into such a filing.
The line graph and table below compare the cumulative total shareholder return on Company common stock with the cumulative total return of companies on the Standard & Poor’s (“S&P”) 500 Stock Index, the S&P Composite 1500 Specialty Chemicals Index and S&P 1500 Diversified Chemicals Index. This graph and table assume the investment of $100 in Company common stock on December 31, 2015. Cash dividends paid in 2016 through 2020 are assumed reinvested for the graph and table below.
GRA-20201231_G2.JPG
2015 2016 2017 2018 2019 2020
W. R. Grace & Co.(1) $ 100  $ 85  $ 89  $ 84  $ 92  $ 74 
S&P 500 Index 100  112  136  130  171  203 
S&P 1500 Specialty Chemicals 100  112  140  132  156  181 
S&P 1500 Diversified Chemicals 100  115  150  114  101  136 
___________________________________________________________________________________________________________________
(1)W. R. Grace & Co. stock value at December 31, 2015, reflects the adjusted post-Separation market value.
29


Item 6.    SELECTED FINANCIAL DATA
(In millions, except per share amounts and shareholders) 2020 2019 2018 2017 2016
Statement of Operations
Net sales $ 1,729.8  $ 1,958.1  $ 1,932.1  $ 1,716.5  $ 1,598.6 
Income (loss) from continuing operations(1)(2)
(1.7) 126.7  166.8  10.4  107.0 
Financial Position
Total assets 3,765.5  3,932.6  3,565.3  2,907.0  2,911.8 
Debt payable after one year 1,975.1  1,957.3  1,961.0  1,523.8  1,507.6 
Shareholders’ equity 234.5  402.2  337.0  263.3  372.4 
Data Per Common Share
Income (loss) from continuing operations—basic
$ (0.03) $ 1.89  $ 2.49  $ 0.16  $ 1.53 
Income (loss) from continuing operations—diluted
(0.03) 1.89  2.49  0.16  1.52 
Dividends declared
1.20  1.08  0.96  0.84  0.51 
Other Statistics
Common shareholders of record
3,423  3,749  4,369  4,646  4,895 
___________________________________________________________________________________________________________________
(1)Adjustments related to our legacy liabilities and pension mark-to-market accounting are included in and affect the period-to-period comparability of “income (loss) from continuing operations” and the related data per common share. See Note 18 to the Consolidated Financial Statements for a detail of these items.
(2)For 2017, “Income (loss) from continuing operations” includes a charge of $143.0 million related to the estimated impacts of the U.S. Tax Cuts and Jobs Act of 2017.
30


Table of Contents
TOC—Financial Statements
Item 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
See “Analysis of Operations” for a discussion of our non-GAAP performance measures. Our references to “advanced economies” and “emerging regions” refer to classifications established by the International Monetary Fund.
Results of Operations
2020 Performance Summary
Following is a summary of our financial performance for the year ended December 31, 2020, compared with the prior year.
Net sales decreased 11.7% to $1,729.8 million.
Net loss attributable to Grace shareholders was $1.8 million.
Adjusted EBIT1 decreased 34.0% to $312.2 million.
Diluted loss per share was $0.03 per diluted share.
Adjusted EPS1 decreased 39.7% to $2.64 per diluted share.
1 Non-GAAP performance measures further discussed below.
Summary Description of Business
We are engaged in specialty chemicals and specialty materials businesses on a worldwide basis through our two reportable segments, Grace Catalysts Technologies and Grace Materials Technologies. See Item 1 (Business—Business Overview) of this Report for a summary description of our business.
Analysis of Operations
We have set forth in the table below our key operating statistics with percentage changes for the years ended December 31, 2020, 2019, and 2018. Please refer to this Analysis of Operations when reviewing this Management’s Discussion and Analysis of Financial Condition and Results of Operations. In the table we present financial information in accordance with U.S. GAAP, as well as the non-GAAP financial information described below. We believe that the non-GAAP financial information provides useful supplemental information about the performance of our businesses, improves period-to-period comparability, and provides clarity on the information our management uses to evaluate the performance of our businesses. In the table, we have provided reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP. The non-GAAP financial measures should not be considered as a substitute for financial measures calculated in accordance with U.S. GAAP, and the financial results calculated in accordance with U.S. GAAP and reconciliations from those results should be evaluated carefully.
We define Adjusted EBIT (a non-GAAP financial measure) to be net income attributable to W. R. Grace & Co. shareholders adjusted for interest income and expense; income taxes; costs related to legacy matters; restructuring and repositioning expenses and asset impairments; pension costs other than service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits; gains and losses on sales and exits of businesses, product lines, and certain other investments; third-party acquisition-related costs and the amortization of acquired inventory fair value adjustment; gains and losses on modification or extinguishment of debt; the effects of these items on equity in earnings of unconsolidated affiliate; and certain other items that are not representative of underlying trends.
We define Adjusted EBITDA (a non-GAAP financial measure) to be Adjusted EBIT adjusted for depreciation and amortization, and depreciation and amortization included in equity in earnings of unconsolidated affiliate (collectively, Adjusted Depreciation and Amortization).
We define Adjusted EBIT Return on Invested Capital (a non-GAAP financial measure) to be Adjusted EBIT (on a trailing four quarters basis) divided by Adjusted Invested Capital, which is defined as equity adjusted for
31


Table of Contents
TOC—Financial Statements
debt; underfunded and unfunded defined benefit pension plans; liabilities related to legacy matters; cash, cash equivalents, and restricted cash; net income tax assets; and certain other assets and liabilities.
We define Adjusted Gross Margin (a non-GAAP financial measure) to be gross margin adjusted for pension-related costs included in cost of goods sold, the amortization of acquired inventory fair value adjustment, and write-offs of inventory related to exits of businesses and product lines and significant manufacturing process changes.
We define Adjusted Earnings Per Share (EPS) (a non-GAAP financial measure) to be diluted EPS adjusted for costs related to legacy matters; restructuring and repositioning expenses and asset impairments; pension costs other than service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits; gains and losses on sales and exits of businesses, product lines and certain other investments; third-party acquisition-related costs and the amortization of acquired inventory fair value adjustment; gains and losses on modification or extinguishment of debt; certain other items that are not representative of underlying trends; certain discrete tax items; and income tax expense related to historical tax attributes.
We define the change in net sales on a constant currency basis (a non-GAAP financial measure) to be the period-over-period change in net sales calculated using the foreign currency exchange rates that were in effect during the previous comparable period.
“Legacy matters” include legacy (i) product, (ii) environmental, and (iii) other liabilities, relating to past activities of Grace.
In the 2020 first quarter, the definition of Adjusted EBIT was modified to adjust for the effects of interest and taxes on equity in earnings of unconsolidated affiliate. The definition of Adjusted EBITDA was modified to adjust for the effects of depreciation and amortization on equity in earnings of unconsolidated affiliate. We made these changes to provide clarity about the impacts of these items on our equity in earnings of unconsolidated affiliate and to improve consistency in our application of non-GAAP financial measures. Previously reported amounts were revised to conform to the current presentation.
We use Adjusted EBIT as a performance measure in significant business decisions and in determining certain incentive compensation. We use Adjusted EBIT as a performance measure because it provides improved period-to-period comparability for decision making and compensation purposes, and because it better measures the ongoing earnings results of our strategic and operating decisions by excluding the earnings effects of our legacy matters; restructuring and repositioning activities; certain acquisition-related items; and certain other items that are not representative of underlying trends.
We use Adjusted EBITDA, Adjusted EBIT Return on Invested Capital, Adjusted Gross Margin, and Adjusted EPS as performance measures and may use these measures in determining certain incentive compensation. We use Adjusted EBIT Return on Invested Capital in making operating and investment decisions and in balancing the growth and profitability of our operations.
We use the change in net sales on a constant currency basis as a performance measure to compare current period financial performance to historical financial performance by excluding the impact of foreign currency exchange rate fluctuations that are not representative of underlying business trends and are largely outside of our control.
Adjusted EBIT, Adjusted EBITDA, Adjusted EBIT Return on Invested Capital, Adjusted Gross Margin, Adjusted EPS, and the change in net sales on a constant currency basis are non-GAAP financial measures; do not purport to represent income measures as defined under U.S. GAAP; and should not be used as alternatives to such measures as an indicator of our performance. These measures are provided to investors and others to improve the period-to-period comparability and peer-to-peer comparability of our financial results, and to ensure that investors understand the information we use to evaluate the performance of our businesses. They distinguish the operating results of Grace’s current business base from the costs of Grace’s legacy matters; restructuring and repositioning activities; and certain other items. These measures may have material limitations due to the exclusion or inclusion of amounts that are included or excluded, respectively, in the most directly comparable measures calculated and presented in accordance with U.S. GAAP, and thus investors and others should review carefully our financial results calculated in accordance with U.S. GAAP.
32


Table of Contents
TOC—Financial Statements
Adjusted EBIT has material limitations as an operating performance measure because it excludes costs related to legacy matters, and may exclude income and expenses from restructuring, repositioning, and other activities, which historically have been material components of our net income. Adjusted EBITDA also has material limitations as an operating performance measure because it excludes the impact of depreciation and amortization expense. Our business is substantially dependent on the successful deployment of capital, and depreciation and amortization expense is a necessary element of our costs. We compensate for the limitations of these measurements by using these indicators together with net income as measured under U.S. GAAP to present a complete analysis of our results of operations. Adjusted EBIT and Adjusted EBITDA should be evaluated together with net income and net income attributable to Grace shareholders, measured under U.S. GAAP, for a complete understanding of our results of operations.
Analysis of Operations
(In millions, except per share amounts)
Year Ended December 31,
2020 2019 % Change 2018 % Change
Net sales:
Catalysts Technologies $ 1,271.4  $ 1,496.7  (15.1) % $ 1,463.5  2.3  %
Materials Technologies 458.4  461.4  (0.7) % 468.6  (1.5) %
Total Grace net sales $ 1,729.8  $ 1,958.1  (11.7) % $ 1,932.1  1.3  %
Net sales by region:
North America $ 508.4  $ 597.8  (15.0) % $ 581.7  2.8  %
Europe Middle East Africa 721.0  791.6  (8.9) % 752.2  5.2  %
Asia Pacific 413.5  475.4  (13.0) % 481.5  (1.3) %
Latin America 86.9  93.3  (6.9) % 116.7  (20.1) %
Total net sales by region $ 1,729.8  $ 1,958.1  (11.7) % $ 1,932.1  1.3  %
Performance measures:
Adjusted EBIT(A):
Catalysts Technologies segment operating income $ 309.6  $ 466.4  (33.6) % $ 440.9  5.8  %
Materials Technologies segment operating income 85.0  97.8  (13.1) % 105.6  (7.4) %
Corporate costs
(68.0) (72.7) 6.5  % (73.5) 1.1  %
Certain pension costs(B)(C) (14.4) (18.4) 21.7  % (15.9) (15.7) %
Adjusted EBIT 312.2  473.1  (34.0) % 457.1  3.5  %
Pension MTM adjustment and other related costs, net(B)(C)
(94.6) (85.9) 15.2 
Loss on early extinguishment of debt
(39.4) —  (4.8)
Costs related to legacy matters
(39.4) (103.5) (82.3)
Restructuring and repositioning expenses attributable to W. R. Grace & Co. shareholders (36.9) (13.7) (46.4)
Inventory write-offs and disposal costs(D) (20.7) (3.6) — 
Third-party acquisition-related costs
(5.2) (3.6) (7.3)
Taxes and interest included in equity in earnings of unconsolidated affiliate (0.7) 0.1  (0.4)
Benefit plan adjustment   (5.0) — 
Amortization of acquired inventory fair value adjustment   —  (6.9)
Interest expense, net (74.9) (74.8) (0.1) % (78.5) 4.7  %
(Provision for) benefit from income taxes (2.2) (56.8) 96.1  % (78.1) 27.3  %
Net income (loss) attributable to W. R. Grace & Co. shareholders
$ (1.8) $ 126.3  (101.4) % $ 167.6  (24.6) %
Diluted EPS $ (0.03) $ 1.89  (101.6) % $ 2.49  (24.1) %
Adjusted EPS $ 2.64  $ 4.38  (39.7) % $ 4.14  5.8  %
33


Table of Contents
TOC—Financial Statements
Analysis of Operations
(In millions)
Year Ended December 31,
2020 2019 % Change 2018 % Change
Adjusted performance measures:
Gross Margin:
Catalysts Technologies 39.2  % 42.8  % (3.6) pts 41.7  % 1.1 pts
Materials Technologies 33.6  % 36.5  % (2.9) pts 37.8  % (1.3) pts
Adjusted Gross Margin 37.7  % 41.4  % (3.7) pts 40.7  % 0.7 pts
Inventory write-offs(D) (1.2) % (0.2) % (1.0) pts —  % (0.2) pts
Pension in cost of goods sold (0.9) % (0.7) % (0.2) pts (0.7) % — pts
Amortization of acquired inventory fair value adjustment   % —  % — pts (0.3) % 0.3 pts
Total Grace 35.6  % 40.5  % (4.9) pts 39.7  % 0.8 pts
Adjusted EBIT:
Catalysts Technologies $ 309.6  $ 466.4  (33.6) % $ 440.9  5.8  %
Materials Technologies 85.0  97.8  (13.1) % 105.6  (7.4) %
Corporate, pension, and other (82.4) (91.1) 9.5  % (89.4) (1.9) %
Total Grace $ 312.2  $ 473.1  (34.0) % $ 457.1  3.5  %
Depreciation and amortization:
Catalysts Technologies depreciation and amortization $ 85.3  $ 81.9  4.2  % $ 81.7  0.2  %
Depreciation and amortization included in equity in earnings of unconsolidated affiliate 3.3  0.5  NM 0.5  —  %
Catalysts Technologies 88.6  82.4  7.5  % 82.2  0.2  %
Materials Technologies 15.0  14.2  5.6  % 15.5  (8.4) %
Corporate 4.7  4.2  11.9  % 3.6  16.7  %
Adjusted Depreciation and Amortization 108.3  100.8  7.4  % 101.3  (0.5) %
Depreciation and amortization included in equity in earnings of unconsolidated affiliate (3.3) (0.5) NM (0.5) —  %
Total Grace $ 105.0  $ 100.3  4.7  % $ 100.8  (0.5) %
Adjusted EBITDA:
Catalysts Technologies $ 398.2  $ 548.8  (27.4) % $ 523.1  4.9  %
Materials Technologies 100.0  112.0  (10.7) % 121.1  (7.5) %
Corporate, pension, and other (77.7) (86.9) 10.6  % (85.8) (1.3) %
Total Grace $ 420.5  $ 573.9  (26.7) % $ 558.4  2.8  %
Adjusted EBIT margin:
Catalysts Technologies 24.4  % 31.2  % (6.8) pts 30.1  % 1.1 pts
Materials Technologies 18.5  % 21.2  % (2.7) pts 22.5  % (1.3) pts
Total Grace 18.0  % 24.2  % (6.2) pts 23.7  % 0.5 pts
Net income margin (0.1) % 6.5  % (6.6) pts 8.7  % (2.2) pts
Adjusted EBITDA margin:
Catalysts Technologies 31.3  % 36.7  % (5.4) pts 35.7  % 1.0 pts
Materials Technologies 21.8  % 24.3  % (2.5) pts 25.8  % (1.5) pts
Total Grace 24.3  % 29.3  % (5.0) pts 28.9  % 0.4 pts
34


Table of Contents
TOC—Financial Statements
Analysis of Operations
(In millions)
Year Ended December 31,
2020 2019 2018
Calculation of Adjusted EBIT Return On Invested Capital (trailing four quarters):
Net Income $ (1.8) $ 126.3  $ 167.6 
Adjusted EBIT 312.2  473.1  457.1 
Reconciliation to Adjusted Invested Capital:
Total equity 234.5  402.2  337.0 
Debt
1,990.4  1,980.4  1,983.3 
Underfunded and unfunded defined benefit pension plans 649.0  519.8  433.1 
Liabilities related to legacy matters 224.1  206.7  126.9 
Cash, cash equivalents, and restricted cash (306.2) (282.9) (201.0)
Net income tax assets (555.3) (501.6) (517.3)
Other items 13.7  19.7  21.6 
Adjusted Invested Capital $ 2,250.2  $ 2,344.3  $ 2,183.6 
GAAP Return on Equity (0.8) % 31.4  % 49.7  %
Adjusted EBIT ROIC
13.9  % 20.2  % 20.9  %
___________________________________________________________________________________________________________________
Amounts may not add due to rounding.
NM—Not Meaningful
(A)Grace’s segment operating income includes only Grace’s share of income of consolidated and unconsolidated joint ventures.
(B)Certain pension costs include only ongoing costs recognized quarterly, which include service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits. Catalysts Technologies and Materials Technologies segment operating income and corporate costs do not include any amounts for pension expense. Other pension-related costs including annual mark-to-market (MTM) adjustments and actuarial gains and losses are excluded from Adjusted EBIT. These amounts are not used by management to evaluate the performance of Grace’s businesses and significantly affect the peer-to-peer and period-to-period comparability of our financial results. Mark-to-market adjustments and actuarial gains and losses relate primarily to changes in financial market values and actuarial assumptions and are not directly related to the operation of Grace’s businesses.
(C)“Defined benefit pension expense” as measured under U.S. GAAP includes actuarial gains and losses and actual returns on assets. Adjusted EBIT includes expected returns on assets but excludes both actuarial gains and losses and actual returns on assets. The table below presents expected and actual returns on plan assets for U.S. and non-U.S. plans for the years ended December 31, 2020, 2019, and 2018.
2020 2019 2018
(In millions) U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans
Actual return on plan assets $ 115.7  $ 2.3  $ 154.6  $ 4.1  $ (41.9) $ (1.7)
Actual return on plan assets 13.00  % 9.02  % 18.90  % 20.00  % (3.51) % (8.01) %
Expected return on plan assets $ 48.3  $ 1.0  $ 48.2  $ 0.9  $ 57.2  $ 1.0 
Expected return on plan assets 5.25  % 4.17  % 5.75  % 4.43  % 5.25  % 4.69  %
(D)Inventory write-off in 2020 related to the changes in hydroprocessing catalysts manufacturing operations. Inventory      write-off in 2019 related to the idling of Grace’s methanol-to-olefins manufacturing facility.
35


Table of Contents
TOC—Financial Statements
Grace Overview
Following is an overview of our financial performance for the years ended December 31, 2020, 2019, and 2018.
Impact of COVID-19 Pandemic and Recession
The COVID-19 pandemic has led to significantly lower transportation fuel demand and a reduction in refining activity, which has negatively affected demand for our refining catalysts. Demand for manufactured products, including polyolefin resins and products made with our specialty silicas, has also declined and negatively affected demand for our polyolefin catalysts and specialty silicas.
While COVID-19 had a significant negative impact on our financial results for 2020, we are well positioned to meet the operational and financial challenges caused by the pandemic until the economy recovers. Our first priority is the health and safety of our employees. We have fully implemented our pandemic response plan, including significant new safety protocols throughout our operations. We are also focused on business continuity to ensure we continue delivering value to all of our customers. Our workforce remains safe and healthy, and we have experienced no business continuity issues in our global operations or supply chain. Approximately 45% of our global workforce shifted to working remotely beginning in March 2020.
We took decisive actions to mitigate the economic effects of the pandemic to ensure we generated strong cash flow in 2020, including lowering capital spending, improving working capital to generate cash flow, reducing operating costs, and aligning production volumes to match near-term demand.
Understanding near-term demand in our operating segments is critically important to effectively managing our operations, working capital, and costs. We are triangulating customer information, economic and industry data, inventory levels, and our own experience to plan our operations. For 2021:
Specialty catalysts demand is expected to continue to improve through the year on strong consumer demand and continued strength of our UNIPOL® Polypropylene Process Technology licensing business;
Materials Technologies demand is expected to grow year over year on continued strength of pharma/consumer and coatings, as well as further recovery in chemical process demand; and
FCC catalysts demand is expected to improve sequentially throughout the year and approach pre-pandemic levels by the end of the year. Transportation fuel demand and refinery utilization still remain below normal levels for the industry, and the effects of the pandemic are expected to continue to be a headwind until demand more fully recovers.
The above does not assume a double dip recession or a resurgence in the pandemic. See Item 1A. (Risk Factors) in Part I of this Report for more information on the risks we face related to the COVID-19 pandemic. With respect to the above information regarding our expectations for 2021 and other statements regarding future events, see “Forward-Looking Statements,” above.
Impact of Hurricane Laura
During the third quarter, Hurricane Laura caused severe and widespread damage to Lake Charles, Louisiana, and surrounding communities, including catastrophic damage to the regional power grid. To ensure continuity of supply for our customers, our Lake Charles refining catalysts manufacturing facility established a temporary on-site 20MW power generation capability. During the power outage, customer demand was met from inventory in Lake Charles and by shifting FCC and hydroprocessing catalysts production to other manufacturing facilities, which increased our operating costs. This created no significant impact to our customers. While this is an insured event, the total costs do not exceed our deductible.
Event-related costs were approximately $19 million. The costs, included in Catalysts Technologies segment operating income, were primarily related to on-site power generation, incremental operations and logistics costs to supply customers during the outage, temporary housing and employee assistance, and property damage and clean-up.
36


Table of Contents
TOC—Financial Statements
Discrete Items Impacting 2019
Four discrete items (the “Discrete Items”) impacted 2019 full-year results:
Refining Technologies: an FCC catalysts customer’s bankruptcy following a fire resulting in the closure of its refinery;
Specialty Catalysts: a customer-specific inventory correction in the second half of 2019;
Specialty Catalysts: customer-specific temporary reductions in operating rates and catalyst usage due to reduced feedstock supply following an attack in the Middle East; and
Materials Technologies: an equipment failure in one of our silicas manufacturing lines (operations fully restored by mid-July).
These Discrete Items reduced 2019 full-year net sales by approximately $36 million. These Discrete Items also reduced pretax income and Adjusted EBIT by approximately $36 million. The earnings effect included lost margin on lower sales, the costs of adjusting our manufacturing operations in response to lower demand, costs incurred to serve customers and minimize any impact to their operations, and costs related to the FCC catalysts customer bankruptcy. These effects were partially mitigated by an approximately $12 million benefit from cost-reduction activities in response to these events and $8 million of business interruption proceeds from the FCC catalyst customer event, resulting in a net reduction to 2019 pretax income of approximately $16 million. We received insurance recoveries of an additional $16.3 million in the first half of 2020 under our business interruption insurance policy. This claim has been fully resolved.
Net Sales and Gross Margin
GRA-20201231_G3.JPG
Sales for 2020 decreased 11.7% overall and on constant currency compared with the prior year. The decrease was driven by lower sales volumes resulting primarily from the COVID-19 pandemic, partially offset by improved pricing in both segments. Lower sales volumes in Catalysts Technologies were primarily due to lower demand for global transportation fuels and refinery operating rates driven by the COVID-19 pandemic and recession and a generally weaker manufacturing environment during the 2020 first quarter. In Materials Technologies, growth in pharma/consumer end markets was offset by weakness in chemical process end markets.
Gross margin decreased 490 basis points to 35.6% from 40.5% for the prior year. Adjusted Gross Margin decreased 370 basis points to 37.7% from 41.4% for the prior year. The decreases were primarily driven by under-absorbed fixed costs resulting from lower production volumes and inventory reductions, partially offset by improved product mix and cost mitigation actions. Strong sequential improvement in the second half of the year was primarily driven by higher production rates.
Sales for 2019 increased 1.3% overall compared with the prior year, up 3.0% on constant currency. The increase was driven by improved pricing in both segments and all regions. Higher sales volumes in Catalysts Technologies were driven by Specialty Catalyst growth in EMEA and Asia Pacific and the 2018 second quarter
37


Table of Contents
TOC—Financial Statements
polyolefin catalysts acquisition, partially offset by the Discrete Items. Sales volume in Materials Technologies were up driven by growth in the Americas, partially offset by a decline in Asia Pacific and EMEA.
Gross margin increased 80 basis points to 40.5% from 39.7% for the prior year. Adjusted Gross Margin increased 70 basis points to 41.4% from 40.7% for the prior year. Improved pricing, higher sales volumes, favorable mix, and lower depreciation were partially offset by higher manufacturing costs, including a 20 basis point impact related to higher raw materials and energy costs.
The following tables identify the year-over-year increase or decrease in sales attributable to changes in sales volume and/or mix, product price, and the impact of currency translation.
2020 as a Percentage Increase (Decrease) from 2019
Net Sales Variance Analysis Volume Price Currency
Translation
Total
Catalysts Technologies (15.5) % 0.3  % 0.1  % (15.1) %
Materials Technologies (0.6) % 0.3  % (0.4) % (0.7) %
Net sales (12.0) % 0.3  % —  % (11.7) %
By Region:
North America (15.1) % 0.1  % —  % (15.0) %
Europe Middle East Africa (10.7) % 1.3  % 0.5  % (8.9) %
Asia Pacific (12.4) % (0.6) % —  % (13.0) %
Latin America (1.6) % (1.1) % (4.2) % (6.9) %
2019 as a Percentage Increase (Decrease) from 2018
Net Sales Variance Analysis Volume Price Currency
Translation
Total
Catalysts Technologies 0.9  % 2.5  % (1.1) % 2.3  %
Materials Technologies 0.3  % 1.9  % (3.7) % (1.5) %
Net sales 0.6  % 2.4  % (1.7) % 1.3  %
By Region:
North America 0.2  % 2.6  % —  % 2.8  %
Europe Middle East Africa 6.0  % 3.0  % (3.8) % 5.2  %
Asia Pacific (1.8) % 0.7  % (0.2) % (1.3) %
Latin America (20.7) % 4.4  % (3.8) % (20.1) %
Grace Net Income
GRA-20201231_G4.JPG
Net income (loss) attributable to Grace was $(1.8) million for 2020 compared with $126.3 million for the prior year. The decrease was primarily due to lower gross profit including the write-off of obsolete inventory, a loss on early extinguishment of debt, and a write-off of previously capitalized plant engineering and site costs, partially offset by a lower provision for income taxes including the benefit from income tax attributes and lower operating
38


Table of Contents
TOC—Financial Statements
expenses in 2020. The prior year included higher costs related to legacy matters, including higher charges related to the Libby, Montana, dam spillway replacement project (see below) and a charge related to probable future payments with respect to our former ZAI product.
During the 2020 third quarter, we completed a review of contractor bids for the replacement of the upper portion of the dam spillway at the former Libby, Montana, mine site and increased our cost estimate for the total project by $27.0 million, to $95.0 million. The prior-year period included charges of $45.0 million related to these projects. The 2019 fourth quarter included additional charges of $23.0 million related to these projects. See Note 10 to the Consolidated Financial Statements for further discussion.
During the 2020 second quarter, we implemented changes to our Refining Technologies manufacturing operations and global footprint to drive capital and operating efficiencies as well as support global growth.
Hydroprocessing Catalysts Manufacturing Operations: In connection with our ongoing operating excellence initiatives, we have accelerated the implementation of the Grace Manufacturing System at our three hydroprocessing catalyst manufacturing sites, including optimization of plant processes and key organizational changes. Over time, these changes are expected to benefit operating margins in our ART joint venture. Any margin benefits will be recognized through our equity earnings in the joint venture.
As a result of these changes, we recorded a pre-tax charge of $19.7 million in the 2020 second quarter, which is reflected in cost of goods sold, related to a write-off of inventory now deemed obsolete based on the process changes. The cash costs to dispose of this inventory are approximately $1 million.
Middle East FCC Catalysts Plant: In agreement with our local joint venture partner, we have discontinued the previously announced project to build a full-scale FCC catalysts plant in the Middle East. The decision reflects the rapid advance of FCC catalysts technology and the value of maintaining flexibility in our global manufacturing operations to ensure we can supply the dynamic needs of our customers in a cost- and capital-efficient way. We will continue to invest in our existing manufacturing network to support new technology development and provide the flexibility required to produce advanced catalyst and additive platforms.
In the 2020 second quarter, we recorded a pre-tax charge of $19.7 million to write off engineering and site costs. The expected cash costs to implement this change are approximately $1 million.
Net income attributable to Grace was $126.3 million for 2019 compared with $167.6 million for the prior year. The decrease was primarily due to a loss recorded for the annual pension mark-to-market adjustment and higher costs related to legacy matters, including charges of $68.0 million for the estimated costs of construction of a new dam spillway at our former vermiculite mine site and $24.0 million related to probable future payments with respect to our former ZAI product (see Note 10 to the Consolidated Financial Statements), partially offset by lower restructuring and repositioning expenses, higher operating income from our Catalysts Technologies segment, and a lower provision for income taxes.
39


Table of Contents
TOC—Financial Statements
Adjusted EBIT
GRA-20201231_G5.JPG
Adjusted EBIT was $312.2 million for 2020, a decrease of 34.0% compared with the prior year primarily due to lower sales and gross profit, an approximately $19 million impact from hurricane-related costs and lower income from our ART joint venture, partially offset by lower operating expenses.
Adjusted EBIT was $473.1 million for 2019, an increase of 3.5% compared with the prior year primarily due to higher sales and gross profit including the 2019 first quarter benefit of the polyolefin catalysts acquisition, partially offset by the net impact of the Discrete Items, lower income from our ART joint venture, and unfavorable currency transaction effects.
Adjusted EPS
The following table reconciles our Diluted EPS (GAAP) to our Adjusted EPS (non-GAAP):
2020
(In millions, except per share amounts) Pre-Tax Tax Effect After-Tax Per Share
Diluted Earnings Per Share
$ (0.03)
Pension MTM adjustment and other related costs, net $ 94.6  $ 22.6  $ 72.0  1.09 
Loss on early extinguishment of debt 39.4  9.5  29.9  0.45 
Costs related to legacy matters
39.4  9.5  29.9  0.45 
Restructuring and repositioning expenses 36.9  8.7  28.2  0.43 
Inventory write-offs and disposal costs 20.7  5.0  15.7  0.24 
Third-party acquisition-related costs
5.2  1.3  3.9  0.06 
Discrete tax items 3.1  (3.1) (0.05)
Adjusted EPS $ 2.64 
40


Table of Contents
TOC—Financial Statements
2019
(In millions, except per share amounts) Pre-Tax Tax Effect After-Tax Per Share
Diluted Earnings Per Share $ 1.89 
Costs related to legacy matters
$ 103.5  $ 25.2  $ 78.3  1.17 
Pension MTM adjustment and other related costs, net
85.9  24.0  61.9  0.93 
Restructuring and repositioning expenses 13.7  3.0  10.7  0.16 
Benefit plan adjustment 5.0  1.1  3.9  0.06 
Inventory write-offs and disposal costs 3.6  —  3.6  0.05 
Third-party acquisition-related costs
3.6  0.9  2.7  0.04 
Income tax expense related to historical tax attributes(1)
(8.6) 8.6  0.13 
Discrete tax items 3.6  (3.6) (0.05)
Adjusted EPS $ 4.38 
___________________________________________________________________________________________________________________
(1)Our historical tax attribute carryforwards (net operating losses and tax credits) unfavorably affected our tax expense with respect to certain provisions of the Tax Cuts and Jobs Act (“TCJA”). To normalize the effective tax rate, an adjustment was made to eliminate the tax expense impact associated with the historical tax attributes.
2018
(In millions, except per share amounts) Pre-Tax Tax Effect After-Tax Per Share
Diluted Earnings Per Share $ 2.49 
Costs related to legacy matters $ 82.3  $ 17.7  $ 64.6  0.96 
Restructuring and repositioning expenses 46.4  10.0  36.4  0.54 
Pension MTM adjustment and certain pension related costs (15.2) (3.4) (11.8) (0.18)
Third-party acquisition-related costs
7.3  1.6  5.7  0.08 
Amortization of acquired inventory fair value adjustment 6.9  1.5  5.4  0.08 
Loss on early extinguishment of debt 4.8  1.0  $ 3.8  0.06 
Income tax expense related to historical tax attributes(1) (25.6) 25.6  0.38 
Provisional charge related to the U.S. Tax Cuts and Jobs Act of 2017 17.1  (17.1) (0.25)
Discrete tax items 1.4  (1.4) (0.02)
Adjusted EPS $ 4.14 
___________________________________________________________________________________________________________________
(1)Our historical tax attribute carryforwards (net operating losses and tax credits) unfavorably affected our tax expense with respect to certain provisions of the TCJA. To normalize the effective tax rate, an adjustment was made to eliminate the tax expense impact associated with the historical tax attributes.
Return on Equity and Adjusted EBIT Return On Invested Capital
GRA-20201231_G6.JPG GRA-20201231_G7.JPG
Return on equity for 2020 was (0.8)% on a trailing four quarters basis, compared with 31.4% and 49.7% for 2019 and 2018, respectively, on the same basis. The declines were due to lower net income in 2020 and 2019.
41


Table of Contents
TOC—Financial Statements
Adjusted EBIT Return on Invested Capital for 2020 was 13.9% on a trailing four quarters basis, compared with 20.2% and 20.9% for 2019 and 2018, respectively, on the same basis. The decline from 2019 to 2020 is due to lower Adjusted EBIT. The decline from 2019 to 2018 is primarily due to increased growth capital investments that had not yet been placed into service. These assets were placed in service beginning in mid-2020 and will support volume growth over the next few years. We expect Adjusted EBIT Return on Invested Capital to improve as we recover from the pandemic.
We manage our businesses with the objective of maximizing sales, earnings and cash flow over time. Doing so requires that we successfully balance our growth, profitability and working capital and other investments to support sustainable, long-term financial performance. We use Adjusted EBIT Return On Invested Capital as a performance measure in evaluating operating results, in making operating and investment decisions, and in balancing the growth and profitability of our businesses.
Segment Overview—Grace Catalysts Technologies
Following is an overview of the financial performance of Catalysts Technologies for the years ended December 31, 2020, 2019, and 2018.
Net Sales—Grace Catalysts Technologies
GRA-20201231_G8.JPG
Sales were down 15.1% in 2020, or down 15.2% on constant currency, compared with the prior year. The decrease on a constant currency basis was due to lower sales volumes, partially offset by improved pricing. Specialty Catalysts sales decreased 11.9%, primarily due to lower market demand and customer catalyst inventory corrections in response to the COVID-19 pandemic as well as order timing in our chemical catalysts business. In 2020 we signed seven new UNIPOL® polypropylene process technology licenses totaling approximately 2,800 kilotons of annual resin capacity, which will continue to drive long-term catalysts and donor sales. Refining Technologies sales decreased 17.9% due to the effects of the pandemic on global transportation fuels demand and refinery operating rates.
Gross profit was $497.9 million for 2020, a decrease of 22.4% compared with the prior year. Gross margin was 39.2% compared with 42.8% for the prior year, primarily driven by under-absorbed fixed costs resulting from lower production volumes and inventory reductions, partially offset by a 110 basis point benefit from lower raw materials and energy costs, improved pricing, and cost reduction actions to align manufacturing costs with demand levels.
Sales were up 2.3% in 2019, or up 3.4% on constant currency, compared with the prior year. The increase on a constant currency basis was due to improved pricing in all regions and higher sales volumes, partially offset by lower sales volumes from the Discrete Items. The improved pricing in both Refining Technologies and Specialty Catalysts was driven by our focused value-selling efforts. For the trailing 12 months ending December 31, 2019, FCC pricing was up over 200 basis points. Higher sales volumes in Catalysts Technologies were driven by Specialty Catalysts growth in EMEA and Asia Pacific and the 2018 second quarter polyolefin catalysts acquisition, partially offset by lower sales volumes from the Discrete Items. In 2019, we signed six new UNIPOL® Polypropylene Process Technology licenses totaling approximately 2,500 kilotons of annual resin capacity, which
42


Table of Contents
TOC—Financial Statements
will continue to drive long-term catalysts and donor sales. Unfavorable currency translation affected both product groups as the U.S. dollar strengthened, primarily against the euro, compared with the prior-year period.
Gross profit was $641.3 million for 2019, an increase of 5.1% compared with the prior year. Gross margin was 42.8% compared with 41.7% for the prior year. The increases were primarily due to improved pricing, favorable mix, higher sales volumes, and lower depreciation, partially offset by higher manufacturing costs including a 10 basis point impact related to higher raw materials and energy costs and the Discrete Items.
Segment Operating Income (SOI) and Margin—Grace Catalysts Technologies
GRA-20201231_G9.JPG
Segment operating income was $309.6 million for 2020, a decrease of 33.6% compared with the prior year, primarily due to lower sales and gross profit, hurricane-related costs of approximately $19 million, and lower income from our ART joint venture. The ART joint venture contributed $13.5 million to operating income, a decrease of $14.3 million from the prior-year period. Segment operating margin for 2020 decreased to 24.4%, a decline of 680 basis points compared with the prior year.
Segment operating income was $466.4 million for 2019, an increase of 5.8% compared with the prior year, primarily due to higher sales and gross profit, and business interruption insurance recoveries, partially offset by lower income from our ART joint venture, higher operating expenses including from the polyolefin catalysts acquisition, unfavorable effects of currency exchange rates, and higher amortization. The ART joint venture contributed $27.8 million to operating income, a decrease of $4.0 million from the prior-year period primarily due to an increase in expenses charged to the joint venture by the partners. Segment operating margin for 2019 increased to 31.2%, an improvement of 110 basis points compared with the prior year.
In July 2019, a North American FCC catalysts customer filed for bankruptcy protection after announcing that it would not resume operations following a fire in its refinery. We received insurance recoveries of $16.3 million in the first half of 2020 under our business interruption insurance policy. Including the $8.0 million received in the 2019 fourth quarter, we received $24.3 million of insurance recoveries related to this event, reflecting approximately eight quarters of the impact of the incident on earnings. This claim has been fully resolved.
43


Table of Contents
TOC—Financial Statements
Segment Overview—Grace Materials Technologies
Following is an overview of the financial performance of Materials Technologies for the years ended December 31, 2020, 2019, and 2018.
Net Sales—Grace Materials Technologies
GRA-20201231_G10.JPG
Sales were down 0.7% in 2020, or down 0.3% on constant currency, compared with the prior year. The decrease on a constant currency basis was due to lower sales volumes, partially offset by improved pricing. Strength in pharma/consumer end markets was offset by weakness across chemical process end-markets. Coatings sales decreased slightly for the year, with demand rebounding in the second half of the year after pandemic-related weakness in the first half.
Gross profit was $154.0 million for 2020, a decrease of 8.7% compared with the prior year. Gross margin was 33.6% compared with 36.5% for the prior year. The decrease in gross margin was primarily driven by under-absorbed fixed costs resulting from lower production volumes and inventory reductions, partially offset by favorable mix, a 90 basis point benefit from lower raw materials and energy costs, and cost reduction actions to align manufacturing costs with demand levels.
Sales were down 1.5% in 2019, or up 2.2% on constant currency, compared with the prior year. The increase on a constant currency basis was due to improved pricing and higher sales volumes, partially offset by lower sales volumes from one of the Discrete Items. Pricing improved across all regions, driven by EMEA and the Americas. The increase in sales volumes was primarily driven by higher pharma/consumer sales in all regions, partially offset by lower coatings sales in Asia, EMEA, and North America. The pricing improvement and increased sales volumes were more than offset by unfavorable currency translation as the U.S. dollar strengthened, primarily against the euro, compared with the prior-year period. Our Materials Technologies business segment is particularly sensitive to changes in the euro.
Gross profit was $168.6 million for 2019, a decrease of 4.7% compared with the prior year. Gross margin was 36.5% compared with 37.8% for the prior year. The decrease in gross margin was primarily due to higher manufacturing costs including costs directly related to one of the Discrete Items and 50 basis points related to higher raw materials and energy costs, partially offset by improved pricing and lower depreciation expense.

44


Table of Contents
TOC—Financial Statements
Segment Operating Income (SOI) and Margin—Grace Materials Technologies
GRA-20201231_G11.JPG
Segment operating income was $85.0 million for 2020, a decrease of 13.1% compared with the prior year, primarily due to lower gross profit, partially offset by lower operating expenses. Segment operating margin for 2020 decreased to 18.5%, a decline of 270 basis points compared with the prior year.
Segment operating income was $97.8 million for 2019, a decrease of 7.4% compared with the prior year, primarily due to lower gross profit and higher operating expenses, including the effects of one of the Discrete Items. Segment operating margin for 2019 decreased to 21.2%, a decline of 130 basis points compared with the prior year.
Corporate Costs
GRA-20201231_G12.JPG
Corporate costs include functional and other costs such as professional fees, incentive compensation, and insurance premiums. Corporate costs for 2020 decreased 6.5% compared with the prior year, primarily due to lower functional and incentive compensation expenses.
Corporate costs for 2019 decreased 1.1% compared with the prior year, primarily due to lower incentive compensation expenses, partially offset by higher employee-related costs.
Restructuring and Repositioning Expenses
Restructuring expenses for the years ended December 31, 2020, 2019, and 2018, were $1.9 million, $2.6 million, and $14.0 million, respectively. Expenses incurred in 2020 primarily related to changes in estimated contractual costs in connection with a 2018 plant exit. Expenses incurred in 2019 primarily related to severance costs pertaining to the idling of our methanol-to-olefins manufacturing facility and were substantially paid in 2019. Restructuring expenses incurred in 2018 primarily related to the closure of two smaller manufacturing plants, the activities from which have been moved to larger, more cost-effective plants as part of our strategy to capture synergies from our recent catalysts acquisitions. Substantially all costs related to the restructuring programs are
45


Table of Contents
TOC—Financial Statements
expected to be paid by June 30, 2023, but could be paid earlier subject to negotiations around certain plant exit costs.
Repositioning expenses for the years ended December 31, 2020, 2019, and 2018, were $35.0 million, $11.1 million, and $32.4 million, respectively. Expenses incurred in 2020 included a $19.7 million charge to write off engineering and site costs as a result of the decision not to build a full-scale catalysts plant in the Middle East (see “Grace Overview” above). Repositioning expenses in 2020 also included $7.2 million in costs related to our review of strategic alternatives.
In 2020, 2019, and 2018, we incurred expenses related to a multi-year program to transform manufacturing and business processes to extend our competitive advantages and improve our cost position. Expenses in 2018 also included $11.7 million of severance and stock compensation costs related to employee separations, and write-offs of $8.5 million of previously capitalized plant engineering costs as a result of terminating an expansion project no longer necessary due to the polyolefin catalysts acquisition (see Note 20 to the Consolidated Financial Statements). Excluding asset write-offs and stock compensation costs, substantially all of these costs have been or are expected to be settled in cash.
The following table presents the major components of restructuring and repositioning expenses for the years ended December 31, 2020, 2019, and 2018.
Year Ended December 31,
(In millions) 2020 2019 2018
Write-off of engineering costs $ 19.7  $ —  $ 8.5 
Costs related to review of strategic alternatives 7.2  —  — 
Third-party costs of manufacturing and business transformation programs 5.4  7.4  13.7 
Employee severance and accelerated stock compensation 4.4  5.8  12.3 
Costs related to plant closures 1.8  —  13.4 
Other (1.6) 0.5  (1.5)
Total restructuring and repositioning expenses $ 36.9  $ 13.7  $ 46.4 
Defined Benefit Pension Expense
Defined benefit pension expense includes costs under U.S. and non-U.S. defined benefit pension plans that provide benefits to business segment and corporate employees, as well as retirees and former employees of divested businesses where we retained these obligations.
Under mark-to-market accounting, our pension costs consist of two elements: (1) “certain pension costs”—ongoing costs recognized quarterly, which include service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits; and (2) “pension mark-to-market adjustment and other related costs, net”—mark-to-market gains and losses recognized annually in the fourth quarter, or at an interim period should a significant event occur, resulting from changes in actuarial assumptions, such as discount rates and the difference between actual and expected returns on plan assets.
Certain pension costs were $14.4 million, $18.4 million and $15.9 million for 2020, 2019 and 2018, respectively. The decrease from 2019 to 2020 was primarily due to lower interest cost partially offset by higher service cost due to a decrease in discount rates. The increase from 2018 to 2019 was primarily due to a decrease in expected return on assets, partially offset by a decrease in service cost and interest cost due to an increase in discount rates.
Pension mark-to-market adjustment and other related costs, net were $94.6 million, $85.9 million and $(15.2) million for 2020, 2019 and 2018, respectively. These costs are reported in “other (income) expense, net” in our Consolidated Financial Statements. The 2020 mark-to-market pension expense of $94.6 million was primarily due to the decrease in discount rates used to value the projected benefit obligations of our plans from year-end 2019 to year-end 2020, partially offset by higher than expected return on assets. The 2019 mark-to-market pension expense of $85.9 million was primarily due to the decrease in discount rates used to value the projected benefit obligations of our plans from year-end 2018 to year-end 2019, partially offset by higher than expected return on assets. The 2018 mark-to-market pension income of $15.2 million was primarily due to the increase in discount
46


Table of Contents
TOC—Financial Statements
rates used to value the projected benefit obligations of our plans from year-end 2017 to year-end 2018, partially offset by lower than expected return on assets.
Interest and Financing Expenses
Net interest and financing expenses were $74.9 million for 2020, flat compared with 2019 as the effect of a lower interest rate on our term loan was offset by higher interest from the higher outstanding balances of senior notes and lower capitalized interest. Interest and financing expenses were $74.8 million for 2019, a 4.7% decrease compared with 2018, primarily due to higher capitalized interest in 2019 related primarily to the growth capital investments.
Income Taxes
Income tax expense (benefit) for 2020, 2019 and 2018 was $2.2 million, $56.8 million and $78.1 million, respectively, on income before income taxes of $0.5 million, $183.5 million and $244.9 million in 2020, 2019 and 2018, respectively.
The provision for income taxes in 2020 was lower than in 2019 primarily due to lower pre-tax income in 2020 compared with 2019 and the benefit recorded in 2020 from the Global Intangible Low-Taxed Income (“GILTI”) high-tax exclusion (“HTE”) election for tax years 2018 through 2020. The benefit was partially offset by a valuation allowance recorded against the U.S. federal tax credits.
The provision for income taxes in 2019 was lower than in 2018 primarily due to lower taxable income in foreign jurisdictions where the statutory tax rates are higher than the statutory rates of the U.S., and a deduction against the GILTI inclusion under Internal Revenue Code (“IRC”) Section 250 that was not available in 2018 due to U.S. federal net operating loss (“NOL”) carryforwards.
See Note 7 to the Consolidated Financial Statements for additional information regarding income taxes.
Financial Condition, Liquidity, and Capital Resources
Following is an analysis of our financial condition, liquidity and capital resources at December 31, 2020.
Our principal uses of cash are generally capital investments and acquisitions; working capital investments; compensation paid to employees, including contributions to our defined benefit pension plans and defined contribution plans; the repayment of debt and interest payments thereon; and the return of cash to shareholders through the payment of dividends and the repurchase of shares.
On February 8, 2017, we announced that the Board of Directors had authorized a share repurchase program of up to $250 million. On February 28, 2020, we announced that our Board of Directors had increased its share repurchase authorization to $250 million, including approximately $83 million remaining under the previously announced program. During 2020 we repurchased 673,807 shares of Company common stock for $40.4 million before temporarily suspending our share repurchase program in early March in light of the COVID-19 pandemic. We expect to resume our share repurchase program in 2021 while continuing to prioritize reinvestment and reducing our temporarily higher net leverage. As of December 31, 2020, $235.0 million remained under the current authorization.
We paid cash dividends of $80.1 million during 2020. On February 4, 2020, we announced that our Board of Directors had approved an increase in the annual dividend rate, from $1.08 to $1.20 per share of Company common stock, effective with the dividend paid on March 17, 2020. On February 8, 2021, we announced that our Board of Directors had approved a further increase to $1.32 per share of Company common stock, effective with the dividend to be paid on March 23, 2021.
Although the duration and severity of the impact from the COVID-19 pandemic on our operations and liquidity depends on future developments that are difficult to accurately predict at this time, we believe that the cash we expect to generate during 2021 and thereafter, together with other available liquidity and capital resources, are sufficient to finance our operations, growth strategy, expected share repurchase program and expected dividend payments, and to meet our debt, pension, and legacy and other obligations.
47


Table of Contents
TOC—Financial Statements
On June 26, 2020, we issued $750 million aggregate principal amount of 4.875% Notes due in 2027. On July 13, 2020, we used the net proceeds, together with cash on hand, to redeem the $700.0 million Senior Notes due 2021. See Note 5 to the Consolidated Financial Statements for additional information.
Cash Resources and Available Credit Facilities
At December 31, 2020, we had available liquidity of $736.5 million, consisting of $304.5 million in cash and cash equivalents ($142.7 million in the U.S.), $391.8 million available under our revolving credit facility, and $40.2 million of available liquidity under various non-U.S. credit facilities. The $400 million revolving credit facility includes a $100 million sublimit for letters of credit.
Our non-U.S. credit facilities are extended to various subsidiaries that use them primarily to issue bank guarantees supporting trade activity and to provide working capital during occasional cash shortfalls. We generally renew these credit facilities as they expire.
The following table summarizes our non-U.S. credit facilities as of December 31, 2020:

(In millions)
Maximum
Borrowing
Amount
Available
Liquidity
Expiration Date
China $ 12.1  $ 12.1  April 3, 2023
Singapore 18.0  8.2  April 3, 2023
Malaysia 7.0  5.3  April 3, 2023
Other countries 15.3  14.6  various, as well as open-ended
Total $ 52.4  $ 40.2   
Analysis of Cash Flows
The following table summarizes our cash flows for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
(In millions) 2020 2019 2018
Net cash provided by (used for) operating activities from continuing operations
$ 349.6  $ 392.1  $ 342.0 
Net cash provided by (used for) investing activities from continuing operations
(175.8) (210.1) (618.5)
Net cash provided by (used for) financing activities from continuing operations
(157.9) (99.4) 316.5 
Effect of currency exchange rate changes on cash and cash equivalents
7.4  (0.7) (2.5)
Net increase (decrease) in cash and cash equivalents
23.3  81.9  37.5 
Cash and cash equivalents, beginning of period
282.9  201.0  163.5 
Cash and cash equivalents, end of period
$ 306.2  $ 282.9  $ 201.0 
Net cash provided by operating activities in 2020 was $349.6 million compared with $392.1 million in the prior year. The year-over-year change in cash flow is primarily due to lower net income partially offset by improved net working capital performance and $20.0 million in dividends received from our ART joint venture.
Net cash provided by operating activities in 2019 was $392.1 million compared with $342.0 million in the prior year. The year-over-year change in cash flow is primarily due to higher gross profit in 2019 and the $50.0 million accelerated contribution to the U.S. defined benefit pension plans in 2018, partially offset by lower advance payments from customers compared with 2018.
Net cash used for investing activities in 2020 was $175.8 million compared with $210.1 million in 2019 and $618.5 million in 2018. Net cash used for investing activities primarily includes the net cash paid for capital expenditures and businesses acquired. Capital expenditures were lower in 2020 as we reduced our capital spending in response to lower demand caused by the COVID-19 pandemic. In 2019, we acquired the business and assets of Rive Technology, Inc. for $22.8 million, with an additional $2.0 million holdback paid in the 2020 third quarter. In 2018, we completed the purchase of the polyolefin catalysts business of Albemarle Corporation for $418.0 million. Our capital expenditures include investments in new capacity, improved productivity, information technology, and maintenance of our manufacturing and office facilities. We expect to invest
48


Table of Contents
TOC—Financial Statements
approximately $150 million to $160 million in capital expenditures in 2021 and have entered into commitments related to a portion of those expenditures. We expect to fund our capital expenditures from net cash provided by operating activities.
Net cash used for financing activities in 2020 was $157.9 million compared with $99.4 million in 2019. The increased use of cash in 2020 was primarily due to higher repayments of debt, cash paid for repurchases of common stock, and payments of dividends to shareholders in 2020 compared with 2019, together with higher proceeds from the exercise of stock options in 2019.
Net cash used for financing activities in 2019 was $99.4 million compared with cash provided of $316.5 million in 2018. In 2019, higher payments of dividends to shareholders were offset by higher proceeds from the exercise of stock options, while in 2018 we entered into the 2018 Credit Agreement and used a portion of the borrowings to repay in full the borrowings outstanding under our 2014 credit agreement.
Debt and Other Contractual Obligations
Total debt outstanding at December 31, 2020, was $1,990.4 million. Set forth below are our contractual obligations as of December 31, 2020:
Payments Due by Period
(In millions) Total 1 Year or Less 2-3
Years
4-5
Years
More Than 5 Years
Debt $ 1,990.4  $ 15.3  $ 27.9  $ 1,199.6  $ 747.6 
Expected interest payments on debt(1) 402.3  78.8  155.4  114.6  53.5 
Operating lease obligations 46.6  11.8  13.9  5.6  15.3 
Operating commitments(2) 127.6  111.5  14.2  1.9  — 
Pension funding requirements per ERISA(3) 7.4  0.5  1.1  5.8  — 
Funding requirements for non-U.S. retirement plans(4) 52.7  10.2  20.6  21.9  — 
Total Contractual Obligations $ 2,627.0  $ 228.1  $ 233.1  $ 1,349.4  $ 816.4 
___________________________________________________________________________________________________________________
(1)Amounts are based on current interest rates as of December 31, 2020, for principal debt outstanding as of December 31, 2020. Actual interest payments may vary based on any interest rate swaps in effect.
(2)Amounts do not include open purchase commitments, which are routine in nature and normally settle within 90 days, or obligations to employees under annual or long-term incentive programs.
(3)Based on the U.S. qualified pension plans’ status as of December 31, 2020, minimum funding requirements under ERISA have been estimated for the next five years. Amounts in subsequent years or additional payments have not yet been determined.
(4)Based on the non-U.S. retirement plans’ status as of December 31, 2020, funding requirements have been estimated for the next five years. Amounts in subsequent years have not yet been determined.
The table above does not include liabilities related to legacy matters discussed in Note 10 to the Consolidated Financial Statements, which are recorded in the Consolidated Balance Sheets. Certain of these liabilities are expected to require cash disbursements over the course of the next five years, but the amount per period depends on a number of variables, as disclosed, while other estimated balances relate to matters for which the settlement period is unknown.
See Note 10 to the Consolidated Financial Statements for a discussion of Financial Assurances.
Employee Benefit Plans
See Note 8 to the Consolidated Financial Statements for further discussion of Pension Plans and Other Retirement Plans.
Defined Contribution Retirement Plans
We sponsor a defined contribution retirement plan for our employees in the United States. This plan is qualified under section 401(k) of the U.S. tax code. Currently, we contribute an amount equal to 100% of employee contributions, up to 6% of an individual employee’s salary or wages. Our costs related to this benefit
49


Table of Contents
TOC—Financial Statements
plan were $14.3 million, $13.9 million and $12.6 million for the years ended December 31, 2020, 2019 and 2018, respectively.
U.S. salaried employees and certain U.S. hourly employees hired on or after January 1, 2017, participate in an enhanced defined contribution plan instead of a defined benefit pension plan. We contribute 4% of an individual employee’s salary or wages to this plan. Our cost related to this enhanced defined contribution plan was $3.5 million, $2.9 million, and $1.7 million for the years ended December 31, 2020, 2019, and 2018, respectively. We expect these amounts to increase in the future as more employees participate in this plan.
The following table presents cash payments related to our defined contribution plans.
(In millions) 2020 2019 2018
U.S. defined contribution plan $ 14.3  $ 13.9  $ 12.6 
U.S. enhanced defined contribution plan 3.5  2.9  1.7 
Total cash payments $ 17.8  $ 16.8  $ 14.3 
Defined Benefit Pension Plans
We sponsor defined benefit pension plans for our employees in the U.S., Canada, Germany, and a number of other countries, and fund government-sponsored programs in other countries where we operate. Certain of our defined benefit pension plans are advance-funded and others are pay-as-you-go. The assets of the advance-funded plans are held in trusts. Our most significant advance-funded plans cover current and former salaried employees in the U.S. and employees covered by collective bargaining agreements at certain of our U.S. facilities. Our U.S. advance-funded plans are qualified under the U.S. tax code.
In the 2021 first quarter, Grace announced to employees that the U.S. salaried plan would be frozen effective January 1, 2025. As a result, we expect to record mark-to-market income and a curtailment gain totaling approximately $40 million in the 2021 first quarter.
The following table presents the funded status of our fully-funded, underfunded, and unfunded pension plans:
Fully-Funded
Pension Plans(1)
Underfunded
Pension Plans(1)
Unfunded
Pension Plans(2)
(In millions) 2020 2019 2020 2019 2020 2019
Projected benefit obligation $ 36.5  $ 35.6  $ 1,109.8  $ 1,022.8  $ 536.4  $ 448.5 
Fair value of plan assets 47.9  44.1  981.5  936.7    — 
Funded status (PBO basis) $ 11.4  $ 8.5  $ (128.3) $ (86.1) $ (536.4) $ (448.5)
___________________________________________________________________________________________________________________
(1)Plans intended to be advance-funded.
(2)Plans intended to be pay-as-you-go.
We have both fully-funded and underfunded pension plans. Our fully-funded plans have assets in excess of projected benefit obligation (“PBO”) of $11.4 million at December 31, 2020. Underfunded plans include a group of advance-funded plans that are underfunded on a PBO basis by a total of $128.3 million as of December 31, 2020. Additionally, we have several plans that are funded on a pay-as-you-go basis, and therefore, the entire PBO for these plans of $536.4 million at December 31, 2020, is unfunded. The net funded status of all of these plans was $653.3 million as of December 31, 2020, and is presented in the Consolidated Balance Sheets as follows: $11.4 million in “other assets,” $15.7 million in “other current liabilities,” $520.7 million in “unfunded defined benefit pension plans,” and $128.3 million in “underfunded defined benefit pension plans.”
At the December 31, 2020, measurement date for the U.S. advance-funded plans, the PBO was $1,112.8 million as measured under U.S. GAAP. The PBO is measured as the present value (using a 2.41% weighted average discount rate as of December 31, 2020) of vested and non-vested benefits earned from employee service to date, based upon current services and estimated future pay increases for active employees. Of the participants in the U.S. advance-funded plans, approximately 79% are retired or former employees or employees of our former businesses, which shortens the duration of the PBO. Assets available to fund the PBO for the U.S. advance-funded plans at December 31, 2020, were $1,000.7 million, or $112.1 million less than the measured obligation.
50


Table of Contents
TOC—Financial Statements
The following table presents the components of cash contributions for the advance-funded and pay-as-you-go plans:
(In millions) 2020 2019 2018
U.S. advance-funded plans $ 0.5  $ 0.1  $ 50.0 
U.S. pay-as-you-go plans 7.9  6.6  6.9 
Non-U.S. advance-funded plans 1.3  1.5  1.9 
Non-U.S. pay-as-you-go plans 7.5  7.6  7.7 
Total Cash Contributions $ 17.2  $ 15.8  $ 66.5 
We intend to fund non-U.S. pension plans based upon applicable legal requirements and actuarial and trustee recommendations. We contributed $8.8 million related to these plans in 2020.
Other Contingencies
See Note 10 to the Consolidated Financial Statements for a discussion of our other contingent matters.
Inflation
We recognize that inflationary pressures may have an adverse effect on us through higher asset replacement costs and higher raw materials and other operating costs. We try to minimize these impacts by developing alternative formulations, increasing productivity, hedging purchases of certain raw materials, and increasing prices.
Critical Accounting Estimates
The preparation of financial statements in conformity with U.S. GAAP requires that we make estimates and assumptions affecting the assets and liabilities reported at the date of the Consolidated Financial Statements, and the revenues and expenses reported for the periods presented. We believe that our accounting estimates are appropriate and the related balances are reasonable; however, actual amounts could differ from the original estimates, requiring adjustments in future periods. Changes in estimates are recorded in the period in which the change is identified. Our accounting policies are described in Note 1 to the Consolidated Financial Statements. Critical accounting estimates are described in this section.
An accounting estimate is considered critical if the estimate requires management to make assumptions and judgments about matters that were highly uncertain at the time the estimate was made, if different estimates reasonably could have been used, or if changes in the estimate are reasonably likely to occur from period to period that could have a material impact on our financial condition or results of operations. As part of our quarterly disclosure controls and procedures, management has discussed the development, selection and disclosure of the critical accounting estimates with the Audit Committee of the Board of Directors.
Contingent Liabilities
We have recorded a liability for the resolution of contingencies related to asbestos property damage, environmental remediation, and litigation. We record a liability if we have determined that a loss is probable and we are able to reasonably estimate the amount of the loss or have another reasonable basis for recording a liability. We have determined that each of the contingencies identified below involves an accounting judgment that is material to our Consolidated Financial Statements.
Legacy Product Liabilities
We emerged from an asbestos-related Chapter 11 bankruptcy on February 3, 2014, as discussed in Note 10 to the Consolidated Financial Statements. Under the plan of reorganization, all pending and future asbestos-related claims are channeled for resolution to either the PI Trust or the PD Trust. The trusts are the sole recourse for holders of asbestos-related claims. The channeling injunctions issued by the bankruptcy court prohibit holders of asbestos-related claims from asserting such claims directly against us.
We have satisfied all of our financial obligations to the PI Trust. We have contingent financial obligations remaining to the PD Trust. With respect to ZAI PD Claims, the PD Trust was funded with $49.4 million (net of $15 million of attorneys’ fees) to pay claims and expenses. We are also obligated to make up to 10 contingent
51


Table of Contents
TOC—Financial Statements
deferred payments of $8 million per year to the PD Trust during the 20-year period beginning on the fifth anniversary of the Effective Date, with each such payment due only if the assets of the PD Trust in respect of ZAI PD Claims fall below $10 million during the preceding year. For additional discussion of this contingent liability, see Note 10 to the Consolidated Financial Statements, under the heading “Legacy Product Liabilities,” which disclosure is incorporated herein by reference.
Environmental Remediation
We are obligated under applicable law to remediate certain properties related to our business or former businesses. At some sites we outsource all or a portion of the remediation to third parties, and at others we perform the required remediation ourselves. Our environmental remediation obligation has a significant impact on our Consolidated Financial Statements. See disclosure in this Report in Item 1 (Business—Environment, Health, Safety, and Security Matters) and in Note 10 to the Consolidated Financial Statements for a discussion of our environmental remediation liabilities.
At sites where third parties conduct remediation, we estimate our obligations from information available to us from these third parties and other consultants, including actual costs incurred, expected future costs and time to completion. At sites where we conduct remediation, we work with regulatory authorities to define compliance requirements and then estimate the cost required to meet those requirements with information available to us. We base our estimates on our historical knowledge and engineering assessments specific to conditions at each site, and we update our estimates as necessary.
Our estimates can fluctuate significantly due to the extended duration of some remediation projects. The accuracy of our estimates is dependent on the validity of assumptions regarding regulatory approaches and such matters as labor rates, indirect costs and capital costs, which are each difficult to forecast over extended periods. Future changes in estimates, if required, may lead to material adjustments to our Consolidated Financial Statements, and the ultimate resolution of these obligations could have a material impact on our liquidity and capital resources.
For additional discussion of our liabilities related to environmental matters, see Note 10 to the Consolidated Financial Statements, under the heading “Legacy Environmental Liabilities—Vermiculite-Related Matters,” which disclosure is incorporated herein by reference.
Other Legacy Liabilities
Beginning in 1971, as part of implementing a wet milling process at the Libby, Montana, vermiculite mine, we constructed a dam at the mine property that now prevents vermiculite ore tailings from moving into nearby creeks and rivers. Ongoing operation of the dam is regulated by the Montana Department of Natural Resources and Conservation (“DNRC”). In April 2019, the DNRC renewed the permit necessary for operation of the dam. We are legally obligated to operate the dam and construct a new spillway in accordance with the latest permit conditions. We have recorded a liability for the construction of the new spillway based on a current assessment of the project requirements. For additional discussion related to this liability, see Note 10 to the Consolidated Financial Statements, under the heading “Other Legacy Liabilities,” which disclosure is incorporated herein by reference.
Litigation
We are subject to legal proceedings and claims arising out of the normal course of business. To estimate the cost to resolve our legal obligations, we review the facts of each matter to determine the merits of the case and the corresponding probability of a loss. If we determine that a loss is probable, we determine if there is sufficient information to make a reasonable estimate of the loss amount. Our estimates regarding the outcome of our legal proceedings and claims involve substantial uncertainties that could cause our actual losses to differ materially from our estimates. In estimating the likely outcome of a legal proceeding, we consider the nature of the specific claim (or unasserted claim), our experience with similar claims, the jurisdiction in which the proceeding is filed, court rulings, the status of any settlement negotiations, the likelihood of resolution through settlement or alternative dispute resolution, the proceeding’s current status and other relevant information and events. We adjust our recorded liability for litigation contingencies as necessary to reflect our current evaluation of these and other factors.
52


Table of Contents
TOC—Financial Statements
Goodwill and Intangible Assets
We account for business combinations under the acquisition method of accounting, which requires us to allocate the purchase price to the tangible and identifiable intangible assets and liabilities acquired based on their estimated fair values at the acquisition date in accordance with ASC 805 “Business Combinations.” The excess of the purchase price over the fair values of these identifiable assets and liabilities is recorded to goodwill. The assessment of fair value requires management to make significant estimates, including future expected revenues, earnings, and cash flows; expected useful lives; and attrition and discount rates. The allocation of the purchase price may be adjusted during the measurement period, which may not exceed one year after the acquisition date.
We review our finite-lived tangible and intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. We have no indefinite-lived intangible assets. There were no impairment charges recorded in any of the periods presented.
We review our goodwill for impairment on an annual basis at October 31 and whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. We have identified our operating segments as reporting units for goodwill impairment testing. Our Catalysts Technologies reportable segment has two reporting units for goodwill impairment testing, which are our Refining Technologies and Specialty Catalysts operating segments. Our Materials Technologies operating segment represents a single reporting unit for goodwill impairment testing.
We performed a qualitative analysis as of October 31, 2020, and concluded that the estimated fair value of all of our reporting units substantially exceeded their carrying values.
Pension Expenses and Liabilities
We sponsor defined benefit pension plans for our employees in the United States and a number of other countries, including Canada and Germany, and fund government-sponsored programs in other countries where we operate. See Note 8 to the Consolidated Financial Statements for a detailed discussion of our pension plans.
In order to estimate our pension expenses and liabilities we evaluate the range of possible assumptions to be used in the calculation of pension expenses and liabilities. We select the assumptions that we believe to be most indicative of factors such as participant demographics, past experiences and market indices, and provide the assumptions to independent actuaries. These assumptions are updated annually and primarily include factors such as discount rates, expected return on plan assets, mortality rates, retirement rates, and rate of compensation increase. The independent actuaries review our assumptions for reasonableness, and use the assumptions to calculate our estimated liability and future pension expense. We review the actuarial reports for reasonableness and adjust our expenses, assets and liabilities to reflect the amounts calculated in the actuarial reports.
Our method of accounting for actuarial gains and losses relating to our global defined benefit pension plans is referred to as “mark-to-market accounting.” Under mark-to-market accounting, our pension costs consist of two elements: (1) ongoing costs recognized quarterly, which include service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits; and (2) mark-to-market gains and losses recognized annually in the fourth quarter resulting from changes in actuarial assumptions, such as discount rates and the difference between actual and expected returns on plan assets. Should a significant event occur, our pension obligation and plan assets are remeasured at an interim period, and the gains or losses on remeasurement are recognized in that period.
The two key assumptions used in determining our ongoing quarterly pension expense (excluding the effects of the annual mark-to-market adjustment) are the discount rate and expected return on plan assets. Our most significant pension assets and pension liabilities relate to U.S. pension plans.
The assumed discount rate for pension plans reflects the market rates for high-quality corporate bonds currently available and is subject to change based on changes in overall market interest rates. For the U.S. pension plans, the assumed weighted average discount rate was selected in consultation with our independent actuaries, based on a yield curve constructed from a portfolio of high-quality bonds for which the timing and amount of cash outflows approximate the estimated payouts of the plan.
We selected the expected return on plan assets for the U.S. qualified pension plans for 2020 in consultation with our independent actuaries, using an expected return model. The model determines the weighted average
53


Table of Contents
TOC—Financial Statements
return for an investment portfolio based on the target asset allocation and expected future returns for each asset class, which were developed using a building block approach based on observable inflation, available interest rate information, current market characteristics, and historical results.
The following table reflects the sensitivity of 2021 pre-tax expense (excluding the effects of the annual mark-to-market adjustment) and our year-end PBO to a change in the discount rate and expected rate of return on plan assets assumptions for the U.S. pension plans:
Change in Assumption
(In millions)
Effect on 2021
Pre-Tax Pension
Expense
Effect on December 31, 2020 PBO
25 basis point decrease in discount rate $ (1) $ 39 
25 basis point increase in discount rate (37)
25 basis point decrease in expected return on plan assets — 
25 basis point increase in expected return on plan assets (2) — 
Income Taxes
Our effective tax rate is primarily determined based on our pre-tax income and the statutory income tax rates in the jurisdictions in which we operate. The effective tax rate also reflects the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Some of these differences are permanent, such as expenses that are not deductible in our tax returns, and some differences are temporary, reversing over time, such as depreciation expense. These temporary differences create deferred income tax assets and liabilities. Deferred income tax assets are also recorded for NOL and federal tax credit carryforwards.
Deferred income tax assets and liabilities are recognized by applying enacted tax rates to temporary differences that exist as of the balance sheet date. We reduce the carrying amounts of deferred tax assets by a valuation allowance if, based on the available evidence, it is more likely than not that such assets will not be realized. The need to establish valuation allowances for deferred tax assets is assessed quarterly. In assessing the requirement for, and amount of, a valuation allowance in accordance with the more likely than not standard, we give appropriate consideration to all positive and negative evidence related to the realization of the deferred tax assets. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability and foreign source income (“FSI”), the duration of statutory carryforward periods, and our experience with operating loss and tax credit carryforward expirations. A history of cumulative losses is a significant piece of negative evidence used in our assessment. If a history of cumulative losses is incurred for a tax jurisdiction, forecasts of future profitability are not used as positive evidence related to the realization of the deferred tax assets in the assessment.
Our net deferred income tax assets (see Note 7 to the Consolidated Financial Statements) as of December 31, 2020, include U.S. deferred income tax assets representing tax credit and NOL carryforwards of $309.2 million and $10.2 million, respectively, and state and foreign NOL carryforwards of $45.4 million and $9.6 million. We have established valuation allowances in the amount of $38.7 million, consisting primarily of $11.5 million for U.S. tax credit carryforwards as well as state NOL carryforwards of $13.9 million and foreign deferred tax assets of $13.2 million (primarily related to foreign operating loss carryforwards).
The U.S. tax credit carryforwards arose primarily as a result of the payment of intercompany dividends from our foreign affiliates, from the mandatory repatriation under the TCJA, and from research and development credits. The state NOLs arose primarily as a result of the amounts paid as a result of our bankruptcy proceedings.
In order to fully utilize our U.S. federal tax credits before they expire from 2021 to 2040, we will need to generate income of approximately $1.6 billion. We will need to generate approximately $3.1 billion for state income tax purposes during the respective realization periods (ranging from 2021 to 2036) in order to fully realize the state NOLs.
Inherent in determining our effective tax rate are judgments regarding business plans and expectations about future operations. These judgments include the amount and geographic mix of future taxable income, the amount of FSI, limitations on the usage of NOLs and foreign tax credit carryforwards, the impact of ongoing or potential tax audits, and other future tax consequences.
54


Table of Contents
TOC—Financial Statements
Our ability to utilize deferred tax assets may be impacted by certain future events, such as changes in tax legislation or insufficient future taxable income or FSI prior to expiration of certain deferred tax assets.
We recognize the tax benefits of an uncertain tax position if those benefits are more likely than not to be sustained based on existing tax law. Additionally, we establish a reserve for tax positions that are more likely than not to be sustained based on existing tax law, if the ultimate benefit to be sustained upon examination by the relevant taxing authorities is uncertain. Unrecognized tax benefits are subsequently recognized at the time the more likely than not recognition threshold is met, the tax matter is effectively settled or the statute of limitations for the relevant taxing authority to examine and challenge the tax position has expired, whichever is earlier.
Recent Accounting Pronouncements
See Note 1 to the Consolidated Financial Statements for a discussion of recent accounting pronouncements and their effect on us.
55


Table of Contents
TOC—Financial Statements
Item 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Our global operations, raw materials and energy requirements, and debt obligations expose us to various market risks. We use derivative financial instruments to mitigate certain of these risks. The following is a discussion of our primary market risk exposures, how those exposures are managed, and certain quantitative data pertaining to our market risk-sensitive instruments.
Currency Exchange Rate Risk
We operate and/or sell to customers in over 60 countries and in over 30 currencies; therefore, our results of operations are exposed to changes in currency exchange rates. We seek to minimize exposure to these changes by matching revenue streams with expenditures in the same currencies, but it is not always possible to do so. Further, where revenue streams exceed expenditures in a given currency, we seek opportunities to invoice our customers in U.S. dollars or peg the revenue stream to the U.S. dollar at the time of the sale. From time to time, we use financial instruments such as currency forward contracts, swaps, options, or combinations thereof to reduce the risk of certain specific transactions. However, we do not have a policy of hedging all exposures, because management does not believe that such a level of hedging would be cost-effective. Significant uses of derivatives to mitigate the effects of changes in currency exchange rates are as follows.
In May 2016, Grace entered into a fixed-to-fixed cross-currency swap maturing in October 2021 to hedge its net investment in non-U.S. subsidiaries. On every April 1 and October 1, Grace will swap interest payments. Grace will pay euro fixed at the annual rate of 3.426% on €170.0 million and receive U.S. dollars fixed at the annual rate of 5.125% on $190.3 million. The agreement requires an exchange of the notional amounts at maturity. The following table presents the aggregate future cash flows for the cross-currency swaps for the next year as of December 31, 2020.
(In millions) 2021
Payable—interest and principal in euro 174.4 
Receivable—interest and principal in U.S. dollars $ 197.6 
The following table presents the fair value of the cross-currency swaps and their location in the Consolidated Balance Sheets.
(In millions) December 31,
2020
Other current liabilities $ (16.9)
In April 2018, in connection with the Credit Agreement (see Note 5), Grace entered into new cross-currency swaps beginning on April 3, 2018, and maturing on March 31, 2023, to synthetically convert $600.0 million of U.S. dollar-denominated floating rate debt into €490.1 million of euro-denominated debt fixed at 2.0231%. These cross-currency swaps were de-designated and terminated on November 5, 2018, and replaced with new, at-market cross-currency swaps beginning on November 5, 2018, and maturing on March 31, 2023, to synthetically convert $600.0 million of U.S. dollar-denominated floating rate debt into €525.9 million of euro-denominated debt fixed at 1.785%. The agreements require partial exchanges of the notional amounts each quarter and the remaining amounts at maturity. The following table presents the aggregate future cash flows of the cross-currency swaps for each of the next three years as of December 31, 2020.
(In millions) 2021 2022 2023
Payable—interest and principal in euro 14.5  14.4  505.9 
Receivable—interest and principal in U.S. dollars $ 17.9  $ 17.7  $ 577.4 
56


Table of Contents
TOC—Financial Statements
The following table presents the fair values of the derivative contracts and their location in the Consolidated Balance Sheets.
(In millions) December 31,
2020
Other current liabilities $ (0.2)
Other liabilities (50.8)
Net fair value $ (51.0)
There were no significant currency forward exchange agreements outstanding at December 31, 2020.
Interest Rate Risk
As of December 31, 2020, approximately $268.9 million of our borrowings were at variable interest rates and expose us to interest rate risk, excluding $586.5 million hedged by cross-currency swaps effective in November 2018, and $100.0 million hedged by interest rate swaps effective in April 2018. As a result, we have been and will continue to be subject to the fluctuations in interest rates in respect of our floating-rate debt. A 100 basis point increase in the interest rates payable on our variable rate debt outstanding as of December 31, 2020, would increase our annual interest expense by $2.7 million.
In connection with the Credit Agreement (see Note 5), Grace entered into new interest rate swaps beginning on April 3, 2018, and maturing on March 31, 2023, fixing the LIBOR component of the interest on $100.0 million of term debt at 2.775%. While we have and may continue to enter into agreements intending to limit our exposure to higher interest rates, any such agreements may not offer complete protection from this risk.
See Item 8 (Financial Statements and Supplementary Data) under Note 6 (Fair Value Measurements and Risk) to the Consolidated Financial Statements for additional disclosure around market risk, which disclosure is incorporated herein by reference.
57


Table of Contents
TOC—Financial Statements
Item 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
TABLE OF CONTENTS
59
60
62
63
64
65
66
67
68
1.
68
2.
73
3.
73
4.
75
5.
76
6.
79
7.
85
8.
88
9.
95
10.
96
11.
99
12.
100
13.
101
14.
102
15.
103
16.
106
17.
106
18.
108
19.
111
20.
113
21.
114
22.
114
115
_______________________________________________________________________________
The Financial Statement Schedule should be read in conjunction with the Consolidated Financial Statements and Notes thereto. Financial Statement Schedules not included have been omitted because they are not applicable or the required information is shown in the Consolidated Financial Statements or Notes thereto. Financial statements of less than majority-owned persons and other persons accounted for by the equity method have been omitted as provided in Rule 3-09 of the United States Securities and Exchange Commission’s (the “SEC”) Regulation S-X.
58


Table of Contents
TOC—Financial Statements
Management’s Report on Internal Control Over Financial Reporting
Responsibility For Financial Information—We are responsible for the preparation, accuracy, integrity and objectivity of the Consolidated Financial Statements and the other financial information included in this report. Such information has been prepared in conformity with accounting principles generally accepted in the United States of America and accordingly, includes certain amounts that represent management’s best estimates and judgments. Actual amounts could differ from those estimates.
Responsibility For Internal Controls—We and our management are also responsible for establishing and maintaining adequate internal controls over financial reporting. These internal controls consist of policies and procedures that are designed to assess and monitor the effectiveness of the control environment including risk identification, governance structure, delegations of authority, information flow, communications and control activities. A chartered Disclosure Committee oversees Grace’s public financial reporting process and key managers are required to confirm their compliance with Grace’s policies and internal controls quarterly. While no system of internal controls can ensure elimination of all errors and irregularities, Grace’s internal controls, which are reviewed and modified in response to changing conditions, have been designed to provide reasonable assurance that assets are safeguarded, policies and procedures are followed, transactions are properly executed and reported, and appropriate disclosures are made. The concept of reasonable assurance is based on the recognition that there are limitations in all systems of internal control and that the costs of such systems should be balanced with their benefits. The Audit Committee of the Board of Directors, which is composed solely of independent directors, meets regularly with Grace’s senior financial management, internal auditors and independent registered public accounting firm to review audit plans and results, as well as the actions taken by management in discharging its responsibilities for accounting, financial reporting and internal controls. The Audit Committee is responsible for the selection and compensation of the independent registered public accounting firm. Grace’s financial management, internal auditors and independent registered public accounting firm have direct and confidential access to the Audit Committee at all times.
Report On Internal Control Over Financial Reporting—We and our management have evaluated Grace’s internal control over financial reporting as of December 31, 2020. This evaluation was based on criteria for effective internal control over financial reporting set forth in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, we and our management have concluded that Grace’s internal control over financial reporting is effective as of December 31, 2020. Grace’s independent registered public accounting firm that audited our financial statements included in Item 8 has also audited the effectiveness of Grace’s internal control over financial reporting as of December 31, 2020, as stated in their report, which appears on the following page.
Report On Disclosure Controls And Procedures—As of December 31, 2020, we and our management carried out an evaluation of the effectiveness of the design and operation of Grace’s disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based upon that evaluation, we concluded that Grace’s disclosure controls and procedures are effective in ensuring that information required to be disclosed in Grace’s periodic filings and submissions under the Exchange Act is accumulated and communicated to us and our management to allow timely decisions regarding required disclosures, and such information is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.
/s/ HUDSON LA FORCE /s/ WILLIAM C. DOCKMAN
Hudson La Force
President and Chief Executive Officer
(Principal Executive Officer)
William C. Dockman
Senior Vice President and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
Date: February 25, 2021  

59


Table of Contents
TOC—Financial Statements
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of W. R. Grace & Co.
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of W. R. Grace & Co. and its subsidiaries (the “Company”) as of December 31, 2020 and 2019, and the related consolidated statements of operations, of comprehensive income (loss), of equity and of cash flows for each of the three years in the period ended December 31, 2020, including the related notes and financial statement schedule listed in the accompanying index for each of the three years in the period ended December 31, 2020 (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Change in Accounting Principle
As discussed in Note 1 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are
60


Table of Contents
TOC—Financial Statements
being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Environmental Liability for the Libby Mine and Surrounding Area
As described in Note 10 to the consolidated financial statements, the Company is engaged with the U.S. Environmental Protection Agency (the “EPA”) and other federal, state and local governmental agencies in a remedial investigation and feasibility study (“RI/FS”) of the Libby mine and the surrounding area, known as Operable Unit 3 (“OU3”). The RI/FS will study the areas within OU3 requiring remediation and will identify possible remedial action alternatives. Possible remedial actions within OU3 are wide-ranging, from institutional controls such as land use restrictions, to more active measures involving soil removal, containment projects, or other protective measures. As part of the RI/FS process, management contracted an engineering and consulting firm to develop a range of possible remedial alternatives and associated cost estimates for OU3. The estimated costs of remediation are preliminary and consist of several components, each of which may vary significantly as the remedial alternatives are further developed. It is reasonably possible that the ultimate costs of remediation could range between $30 million and $170 million. The ultimate remedy will be determined by the EPA after the RI/FS is finalized. Such remedy will be set forth in a Record of Decision (“ROD”) that is currently expected to be issued by the EPA no earlier than 2024. Depending on the remedial alternatives that the EPA selects in the ROD, the total cost of remediating OU3 may exceed management’s current estimate by material amounts. The Company’s estimated liability for response costs that are currently estimable for OU3 and vermiculite processing sites outside of Libby at December 31, 2020 totaled $71.2 million.
The principal considerations for our determination that performing procedures relating to the environmental liability for the Libby mine and surrounding area is a critical audit matter are (i) the significant judgment by management when developing the environmental liability for the Libby mine and the surrounding area, which in turn led to a high degree of auditor judgment and subjectivity in performing procedures and evaluating audit evidence related to management’s estimated remedial alternatives and the related estimated costs of such remedial alternatives, and (ii) the audit effort involved the use of professionals with specialized skill and knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s estimates of the environmental liability for the Libby mine and surrounding area, including controls over the on-going monitoring of information that may impact the remedial alternatives and the associated costs. These procedures also included, among others, assessing the completeness, accuracy and relevance of the information used by management, and evaluating the remedial alternatives selected by management and the associated costs. Professionals with specialized skill and knowledge were used to assist in assessing the information used by management, and evaluating the remedial alternatives selected by management and the associated costs.

/s/ PricewaterhouseCoopers LLP
Baltimore, Maryland
February 25, 2021
We have served as the Company’s auditor since 1906.
61


Table of Contents
TOC—Financial Statements
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-224767, 333-194171) of W. R. Grace & Co. of our report dated February 25, 2021 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP
Baltimore, Maryland
February 25, 2021

62


Table of Contents
W. R. Grace & Co. and Subsidiaries
Consolidated Statements of Operations
Year Ended December 31,
(In millions, except per share amounts) 2020 2019 2018
Net sales $ 1,729.8  $ 1,958.1  $ 1,932.1 
Cost of goods sold 1,113.3  1,164.4  1,165.4 
Gross profit 616.5  793.7  766.7 
Selling, general and administrative expenses 282.9  299.0  300.4 
Research and development expenses 65.9  64.5  62.7 
Costs related to legacy matters 39.4  103.5  82.3 
Restructuring and repositioning expenses 36.9  13.7  46.4 
Equity in earnings of unconsolidated affiliate (13.5) (27.8) (31.8)
Loss on early extinguishment of debt 39.4  —  4.8 
Interest expense and related financing costs 76.0  76.7  80.2 
Other (income) expense, net 89.0  80.6  (23.2)
Total costs and expenses 616.0  610.2  521.8 
Income (loss) before income taxes 0.5  183.5  244.9 
(Provision for) benefit from income taxes (2.2) (56.8) (78.1)
Net income (loss) (1.7) 126.7  166.8 
Less: Net (income) loss attributable to noncontrolling interests (0.1) (0.4) 0.8 
Net income (loss) attributable to W. R. Grace & Co. shareholders $ (1.8) $ 126.3  $ 167.6 
Earnings Per Share Attributable to W. R. Grace & Co. Shareholders
Basic earnings per share:
Net income (loss) $ (0.03) $ 1.89  $ 2.49 
Weighted average number of basic shares 66.3  66.8  67.2 
Diluted earnings per share:
Net income (loss) $ (0.03) $ 1.89  $ 2.49 
Weighted average number of diluted shares 66.3  66.9  67.3 
Dividends per common share $ 1.20  $ 1.08  $ 0.96 


The Notes to Consolidated Financial Statements are an integral part of these statements.

63


Table of Contents
TOC—Financial Statements
W. R. Grace & Co. and Subsidiaries
Consolidated Statements of Comprehensive Income (Loss)
Year Ended December 31,
(In millions) 2020 2019 2018
Net income (loss) $ (1.7) $ 126.7  $ 166.8 
Other comprehensive income (loss), net of income taxes:    
Defined benefit pension and other postretirement plans
(0.4) (0.7) (0.9)
Currency translation adjustments (49.9) 16.5  32.4 
Gain (loss) from hedging activities 0.8  (4.9) (5.7)
Total other comprehensive income (loss), net of income taxes (49.5) 10.9  25.8 
Comprehensive income (loss) (51.2) 137.6  192.6 
Less: comprehensive (income) loss attributable to noncontrolling interests
(0.1) (0.4) 0.8 
Comprehensive income (loss) attributable to W. R. Grace & Co. shareholders
$ (51.3) $ 137.2  $ 193.4 


The Notes to Consolidated Financial Statements are an integral part of these statements.

64


Table of Contents
W. R. Grace & Co. and Subsidiaries
Consolidated Statements of Cash Flows
Year Ended December 31,
(In millions) 2020 2019 2018
OPERATING ACTIVITIES      
Net income (loss) $ (1.7) $ 126.7  $ 166.8 
Reconciliation to net cash provided by (used for) operating activities:
     
Depreciation and amortization 105.0  100.3  100.8 
Equity in earnings of unconsolidated affiliate (13.5) (27.8) (31.8)
Dividends received from unconsolidated affiliate 20.0  —  — 
Costs related to legacy product, environmental, and other claims 39.4  103.5  82.3 
Cash paid for legacy product, environmental, and other claims (21.0) (19.3) (22.9)
Provision for (benefit from) income taxes 2.2  56.8  78.1 
Cash paid for income taxes (56.0) (52.8) (54.0)
Income tax refunds received 9.6  10.5  0.7 
Defined benefit pension expense (income) 109.0  104.3  0.7 
Cash paid under defined benefit pension arrangements (17.2) (15.8) (66.5)
Stock compensation expense 10.7  14.6  18.6 
Loss on early extinguishment of debt 39.4  —  4.8 
Loss on disposal of assets 23.2  4.2  13.2 
Changes in assets and liabilities, excluding effect of currency translation and acquisitions:
     
Trade accounts receivable 59.7  (18.7) 2.5 
Inventories 62.0  (30.1) (26.1)
Accounts payable (9.3) 28.0  24.2 
Deferred revenue (7.4) (5.3) 35.6 
All other items, net (4.5) 13.0  15.0 
Net cash provided by (used for) operating activities 349.6  392.1  342.0 
INVESTING ACTIVITIES      
Capital expenditures (155.5) (194.1) (216.3)
Business acquired, net of cash acquired (2.0) (22.8) (418.0)
Other investing activities (18.3) 6.8  15.8 
Net cash provided by (used for) investing activities (175.8) (210.1) (618.5)
FINANCING ACTIVITIES      
Borrowings under credit arrangements 15.9  13.0  1,024.0 
Repayments under credit arrangements (49.9) (24.2) (587.8)
Proceeds from issuance of notes 750.0  —  — 
Repayment of notes (700.0) —  — 
Cash paid related to early extinguishment of debt (37.9) —  — 
Cash paid for debt financing costs (7.9) —  (11.8)
Cash paid for repurchases of common stock (40.4) (29.8) (80.0)
Proceeds from exercise of stock options   19.1  6.7 
Dividends paid to shareholders (80.1) (72.6) (64.6)
Cash received from hedge settlement   —  33.1 
Other financing activities (7.6) (4.9) (3.1)
Net cash provided by (used for) financing activities (157.9) (99.4) 316.5 
Effect of currency exchange rate changes on cash and cash equivalents
7.4  (0.7) (2.5)
Net increase (decrease) in cash, cash equivalents, and restricted cash 23.3  81.9  37.5 
Cash, cash equivalents, and restricted cash, beginning of period 282.9  201.0  163.5 
Cash, cash equivalents, and restricted cash, end of period $ 306.2  $ 282.9  $ 201.0 
Supplemental disclosure of cash flow information
Cash paid for interest, net of amounts capitalized
$ 74.2  $ 67.7  $ 75.2 
Capital expenditures included in accounts payable
51.9  49.8  31.0 
Expenditures for other investing activities included in accounts payable
0.4  16.2  16.9 
Net share settled stock option exercises
  9.7  8.2 

The Notes to Consolidated Financial Statements are an integral part of these statements.

65


Table of Contents
W. R. Grace & Co. and Subsidiaries
Consolidated Balance Sheets
December 31,
(In millions, except par value and shares) 2020 2019
ASSETS    
Current Assets    
Cash and cash equivalents $ 304.5  $ 282.5 
Restricted cash and cash equivalents 1.7  0.4 
Trade accounts receivable, less allowance of $2.2 (2019—$13.3)
264.1  307.0 
Inventories 253.8  309.9 
Other current assets 51.2  235.1 
Total Current Assets 875.3  1,134.9 
Properties and equipment, net of accumulated depreciation and amortization of $1,550.1 (2019—$1,497.0)
1,208.8  1,143.8 
Goodwill 562.7  556.9 
Technology and other intangible assets, net 320.8  342.8 
Deferred income taxes 567.1  517.6 
Investment in unconsolidated affiliate 175.5  181.9 
Other assets 55.3  54.7 
Total Assets $ 3,765.5  $ 3,932.6 
LIABILITIES AND EQUITY    
Current Liabilities    
Debt payable within one year $ 15.3  $ 23.1 
Accounts payable 262.1  302.3 
Other current liabilities 281.9  419.7 
Total Current Liabilities 559.3  745.1 
Debt payable after one year 1,975.1  1,957.3 
Unfunded defined benefit pension plans 520.7  434.6 
Underfunded defined benefit pension plans 128.3  85.2 
Other liabilities 347.6  308.2 
Total Liabilities 3,531.0  3,530.4 
Commitments and Contingencies—Note 10
Equity    
Common stock issued, par value $0.01; 300,000,000 shares authorized; outstanding: 66,190,410 (2019—66,735,913)
0.7  0.7 
Paid-in capital 473.2  477.9 
Retained earnings 648.8  730.5 
Treasury stock, at cost: shares: 11,266,223 (2019—10,720,720)
(920.6) (892.2)
Accumulated other comprehensive income (loss) 29.3  78.8 
Total W. R. Grace & Co. Shareholders’ Equity 231.4  395.7 
Noncontrolling interests 3.1  6.5 
Total Equity 234.5  402.2 
Total Liabilities and Equity $ 3,765.5  $ 3,932.6 


The Notes to Consolidated Financial Statements are an integral part of these statements.

66


Table of Contents
TOC—Financial Statements
W. R. Grace & Co. and Subsidiaries
Consolidated Statements of Equity
(In millions) Common
Stock and
Paid-in
Capital
Retained
Earnings
Treasury
Stock
Accumulated
Other
Comprehensive
(Loss) Income
Noncontrolling
Interests
Total
Equity
Balance, December 31, 2017 $ 475.5  $ 573.1  $ (832.1) $ 39.9  $ 6.9  $ 263.3 
Net income (loss) —  167.6  —  —  (0.8) 166.8 
Repurchase of common stock —  —  (80.0) —  —  (80.0)
Stock-based compensation 18.6  —  —  —  —  18.6 
Exercise of stock options (4.2) —  10.6  —  —  6.4 
Payments in consideration of employee tax obligations related to stock-based compensation
(2.9) —  —  —  —  (2.9)
Shares issued
(5.2) —  6.0  —  —  0.8 
Dividends declared
—  (64.3) —  —  —  (64.3)
Other comprehensive income (loss)
—  —  —  25.8  —  25.8 
Effect of adopting ASC 606
—  2.5  —  —  —  2.5 
Effect of adopting ASU 2018-02
—  (2.2) —  2.2  —  — 
Balance, December 31, 2018 481.8  676.7  (895.5) 67.9  6.1  337.0 
Net income (loss) —  126.3  —  —  0.4  126.7 
Repurchase of common stock —  —  (29.8) —  —  (29.8)
Stock-based compensation 14.6  —  —  —  —  14.6 
Exercise of stock options (5.0) —  24.1  —  —  19.1 
Payments in consideration of employee tax obligations related to stock-based compensation
(4.9) —  —  —  —  (4.9)
Shares issued
(7.9) —  9.0  —  —  1.1 
Dividends declared
—  (72.5) —  —  —  (72.5)
Other comprehensive income (loss)
—  —  —  10.9  —  10.9 
Balance, December 31, 2019 478.6  730.5  (892.2) 78.8  6.5  402.2 
Net income (loss) —  (1.8) —  —  0.1  (1.7)
Repurchase of common stock —  —  (40.4) —  —  (40.4)
Stock-based compensation 10.5  —  —  —  —  10.5 
Payments in consideration of employee tax obligations related to stock-based compensation
(4.0) —  —  —  —  (4.0)
Shares issued (11.2) —  12.0  —  —  0.8 
Dividends declared
—  (79.9) —  —  —  (79.9)
Distribution to joint venture partner —  —  —  —  (3.5) (3.5)
Other comprehensive income (loss)
—  —  —  (49.5) —  (49.5)
Balance, December 31, 2020 $ 473.9  $ 648.8  $ (920.6) $ 29.3  $ 3.1  $ 234.5 

The Notes to Consolidated Financial Statements are an integral part of these statements.

67


Table of Contents
TOC—Financial Statements

W. R. Grace & Co. and Subsidiaries
Notes to Consolidated Financial Statements

1. Basis of Presentation and Summary of Significant Accounting and Financial Reporting Policies
W. R. Grace & Co., through its subsidiaries, is engaged in the production and sale of specialty chemicals and specialty materials on a global basis through two reportable segments: Grace Catalysts Technologies, which includes catalysts and related products and technologies used in petrochemical, refining, and other chemical manufacturing applications; and Grace Materials Technologies, which includes specialty materials, including silica-based and silica-alumina-based materials, used in pharma/consumer, coatings, and chemical process applications.
W. R. Grace & Co. conducts all of its business through a single wholly owned subsidiary, W. R. Grace & Co.–Conn. (“Grace–Conn.”). Grace–Conn. owns all of the assets, properties and rights of W. R. Grace & Co. on a consolidated basis, either directly or through subsidiaries.
As used in these notes, the term “Company” refers to W. R. Grace & Co. The term “Grace” refers to the Company and/or one or more of its subsidiaries and, in certain cases, their respective predecessors.
Principles of Consolidation    The Consolidated Financial Statements include the accounts of Grace and entities as to which Grace maintains a controlling financial interest. Intercompany transactions and balances are eliminated in consolidation. Investments in affiliated companies in which Grace can significantly influence operating and financial policies, but does not have a controlling financial interest, are accounted for under the equity method.
Grace conducts a portion of its business through joint ventures with unaffiliated third parties. For joint ventures in which Grace has a controlling financial interest, Grace consolidates the results of such joint ventures in the Consolidated Financial Statements. Grace recognizes a liability for cumulative amounts due to the third parties based on the financial results of the joint ventures, and deducts the amount of income attributable to noncontrolling interests in the measurement of its consolidated net income.
Reportable Segments    Grace reports financial results of each of its reportable segments that engage in business activities that generate revenues and expenses and whose operating results are regularly reviewed by Grace’s Chief Executive Officer.
Use of Estimates    The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements, and the reported amounts of revenues and expenses for the periods presented. Actual amounts could differ from those estimates, and the differences could be material. Changes in estimates are recorded in the period identified. Grace’s accounting measurements that are most affected by management’s estimates of future events are:
The effective tax rate and realization values of net deferred tax assets, which depend on projections of future taxable income (see Note 7);
Pension and postretirement liabilities, which depend on assumptions regarding participant life spans, future inflation, discount rates and total returns on invested funds (see Note 8);
Carrying values of goodwill and other intangible assets, which depend on assumptions of future earnings and cash flows (see Note 4 and Note 20); and
Contingent liabilities, which depend on an assessment of the probability of loss and an estimate of ultimate obligation, such as litigation and arbitration; and product, environmental, and other legacy liabilities (see Note 10).
Revenue Recognition    Grace generates revenues predominantly from sales of manufactured products to customers and in part from licensing of technology. Under ASC 606, revenue from customer arrangements is recognized when control is transferred to the customer.
68


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

1. Basis of Presentation and Summary of Significant Accounting and Financial Reporting Policies (Continued)
Product Sales
Based on the promises made to customers in product sales arrangements, Grace has a performance obligation to manufacture and deliver products to its customers. Grace makes certain other promises in its customer arrangements that are immaterial in the context of the contracts. Revenue is recognized at amounts based on agreed-upon prices in sales contracts and/or purchase orders. Grace offers various incentives to its product sales customers that result in variable consideration, including but not limited to volume discounts, which reward bulk purchases by lowering the price for future purchases, and volume rebates, which encourage customers to purchase volume levels that would reduce their current prices. These incentives are immaterial in the context of the contracts.
For product sales, control is transferred at the point in time at which risk of loss and title have transferred to the customer, which is determined based on shipping terms and contract terms, respectively. Terms of delivery and terms of payment are generally included in customer contracts of sale, order confirmation documents, and invoices. Payment is generally due within 30 to 60 days of invoicing. Grace defers revenue recognition until no other significant Grace performance obligations remain. Grace’s customer arrangements do not contain significant acceptance provisions.
Taxes that Grace collects that are assessed by a governmental authority, and that are both imposed on and concurrent with any of its revenue-producing activities, are excluded from revenue. Grace considers shipping and handling activities that it performs as activities to fulfill the sales of its products. Amounts billed for shipping and handling are included in “net sales,” while costs incurred for shipping and handling are included in “cost of goods sold.”
Technology Licensing
For Grace’s technology licensing business, customer arrangements typically contain multiple deliverables to enable licensees to realize the full benefit of the technology. These deliverables include licensing the technology itself; developing engineering design packages; and providing training, consulting, and technical services. Under these arrangements, the license grant is not a distinct performance obligation, as the licensee only can benefit from the license in conjunction with other integral services such as development of the engineering design package, training, consulting, or technical services provided over the contract period. Therefore, Grace accounts for the license grant and integral services as a single performance obligation. Certain deliverables and services not included in the core bundled deliverables are accounted for as separate performance obligations.
The transaction price is specified in the technology licensing agreements and is substantially fixed. Some services are priced on a per-diem basis, but these are not material in the context of the contracts. Grace invoices its technology licensing customers as certain project milestones are achieved. Payment terms are similar to those of Grace’s product sales.
Revenue for each performance obligation is recognized when control is transferred to the customer, which is typically over a period of time. As a result, Grace generally recognizes revenue for each performance obligation ratably over the period of the contract, which is up to eight years, depending on the scope of the licensee’s project. Based on the timing of payments, Grace records deferred revenue related to these agreements. See Note 17.
Cash Equivalents    Cash equivalents consist of liquid instruments and investments with maturities of three months or less when purchased. The recorded amounts approximate fair value.
Inventories    Inventories are stated at the lower of cost or net realizable value. The method used to determine cost is first-in/first-out, or “FIFO.” Market values for raw materials are based on current cost and, for other inventory classifications, net realizable value. Inventories are evaluated regularly for salability, and slow moving and/or obsolete items are adjusted to expected salable value. Inventory values include direct and certain indirect costs of materials and production. Abnormal costs of production are expensed as incurred.
69


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

1. Basis of Presentation and Summary of Significant Accounting and Financial Reporting Policies (Continued)
Long Lived Assets    Properties and equipment are stated at cost. Depreciation of properties and equipment is generally computed using the straight-line method over the estimated useful life of the asset. Estimated useful lives range from 20 to 30 years for buildings, 3 to 7 years for information technology equipment, 5 to 25 years for operating machinery and equipment, and 5 to 10 years for furniture and fixtures. Interest is capitalized in connection with major project expenditures. Fully depreciated assets are retained in properties and equipment and related accumulated depreciation accounts until they are removed from service. In the case of disposals, assets and related accumulated depreciation are removed from the accounts and the net amount, less any proceeds from disposal, is charged or credited to earnings. Obligations for costs associated with asset retirements, such as requirements to restore a site to its original condition, are accrued at net present value and amortized along with the related asset.
Intangible assets with finite lives consist of technology, customer lists, trademarks, and other intangibles and are amortized over their estimated useful lives, ranging from 1 to 30 years.
Grace reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. There were no impairment charges recorded in any of the periods presented.
Leases    Grace leases certain real estate, office space, vehicles, railcars, and plant and office equipment, substantially all of which are accounted for as operating leases. Finance lease costs and sublease income are not material. Many of Grace’s leases contain renewal options, which are exercisable at Grace’s discretion and may be included in lease terms when they are reasonably certain to be exercised. Grace’s lease agreements do not contain material restrictive covenants or material residual value guarantees. Grace has elected not to recognize in the Consolidated Balance Sheets short-term leases, which are those with an initial term of 12 months or less. Grace has also elected not to separate lease and non-lease components. These elections apply to all asset classes. Where available, Grace uses the interest rate implicit in the lease to calculate the estimated present value of lease payment obligations. Where such a rate is not available, Grace uses an incremental borrowing rate based on credit-adjusted and term-specific discount rates, using a third-party yield curve.
Goodwill    Goodwill arises from business combinations, and it is reviewed for impairment on an annual basis at October 31 and whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. Recoverability is assessed at the reporting unit level most directly associated with the business combination that generated the goodwill. For the purpose of measuring impairment, Grace has identified its operating segments as reporting units. Grace has evaluated its goodwill annually with no impairment charge required in any of the periods presented.
Financial Instruments    Grace uses commodity forward, swap and/or option contracts; currency forward, swap, and/or option contracts; and interest rate swap contracts to manage exposure to fluctuations in commodity prices, currency exchange rates, and interest rates. Grace does not hold or issue derivative financial instruments for trading purposes. Derivative instruments are recorded at fair value in the Consolidated Balance Sheets as either assets or liabilities. For derivative instruments designated as fair value hedges, changes in the fair values of the derivative instruments closely offset changes in the fair values of the hedged items in “other (income) expense, net” in the Consolidated Statements of Operations. For derivative instruments designated as cash flow hedges, the gain or loss on the hedge is reported in “accumulated other comprehensive income (loss)” in the Consolidated Balance Sheets until it is cleared to earnings during the same period in which the hedged item affects earnings. Forward points are excluded from the assessment of effectiveness and are amortized to income on a systematic basis. For derivative instruments designated as net investment hedges, the gains and losses on the hedge, adjusted for the impact of excluded components, are recorded net of tax to “currency translation adjustments” within “accumulated other comprehensive income (loss)” to offset the change in the carrying value of the net investment being hedged. Changes in the fair value of the hedging instrument related to time value, which are excluded from the assessment of hedge effectiveness, are recorded directly to interest expense on a systematic basis. The changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. Cash flows from derivative instruments are reported in the same category as the cash flows from the items being hedged.
70


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

1. Basis of Presentation and Summary of Significant Accounting and Financial Reporting Policies (Continued)
Income Taxes    Deferred tax assets and liabilities are recognized with respect to the expected future tax consequences of events that have been recorded in the Consolidated Financial Statements. Grace reduces the carrying amounts of deferred tax assets by a valuation allowance if, based on the available evidence, it is more likely than not that such assets will not be realized. The need to establish valuation allowances for deferred tax assets is assessed quarterly.
In assessing the requirement for, and amount of, a valuation allowance in accordance with the more likely than not standard, Grace gives appropriate consideration to all positive and negative evidence related to the realization of the deferred tax assets. This assessment considers, among other matters, the nature, frequency, and severity of current and cumulative losses; forecasts of future profitability; domestic and foreign source income; the duration of statutory carryforward periods; and Grace’s experience with operating loss and tax credit carryforward expirations.
Tax benefits from an uncertain tax position are recognized only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Tax benefits recognized in the Consolidated Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. Grace evaluates such likelihood based on relevant facts and tax law. Grace adjusts its recorded liability for income tax matters due to changes in circumstances or new uncertainties, such as amendments to existing tax law. Grace’s ultimate tax liability depends upon many factors, including negotiations with taxing authorities in the jurisdictions in which it operates, outcomes of tax litigation, and resolution of disputes arising from federal, state, and foreign tax audits. Due to the varying tax laws in each jurisdiction management, with the assistance of local tax advisors as necessary, assesses individual matters in each jurisdiction on a case-by-case basis. Grace researches and evaluates its income tax positions, including why it believes they are compliant with income tax regulations, and these positions are documented as appropriate.
The U.S. Tax Cuts and Jobs Act of 2017 (“TCJA”) subjects a U.S. entity to tax on global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. An entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. Grace has elected to account for GILTI as a period expense in the year the tax is incurred. Grace has also adopted the tax law ordering approach for evaluating the impact of GILTI on the assessment of the realizability of US deferred tax assets.
Pension Benefits    Grace’s method of accounting for actuarial gains and losses relating to its global defined benefit pension plans is referred to as “mark-to-market accounting.” Under mark-to-market accounting, Grace’s pension costs consist of two elements: (1) ongoing costs recognized quarterly, which include service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits; and (2) mark-to-market gains and losses recognized annually in the fourth quarter resulting from changes in actuarial assumptions, such as discount rates and the difference between actual and expected returns on plan assets. Should a significant event occur, Grace’s pension obligation and plan assets are remeasured at an interim period, and the gains or losses on remeasurement are recognized in that period.
Stock-Based Compensation    The Company recognizes expenses related to stock-based compensation payment transactions in which it receives employee services in exchange for (a) equity instruments of the Company or (b) liabilities that are based on the fair value of the Company’s equity instruments or that may be settled by the issuance of equity instruments. Stock-based compensation cost for restricted stock units (“RSUs”) and share settled performance-based units (“PBUs”) are measured based on the high/low average of the Company’s common stock on the date of grant. Cash-settled RSUs are remeasured at the end of each reporting period based on the closing fair market value of the Company’s common stock. Stock-based compensation cost for stock options is estimated at the grant date based on each option’s fair value as calculated by the Black-Scholes option pricing model. The Company recognizes stock-based compensation cost as expense ratably on a straight-line basis over the requisite service period.
71


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

1. Basis of Presentation and Summary of Significant Accounting and Financial Reporting Policies (Continued)
Currency Translation    Assets and liabilities of foreign subsidiaries (other than those located in countries with highly inflationary economies) are translated into U.S. dollars at current exchange rates, while revenues, costs and expenses are translated at average exchange rates during each reporting period. The resulting translation adjustments are included in “accumulated other comprehensive income (loss)” in the Consolidated Balance Sheets. The financial statements of any subsidiaries located in countries with highly inflationary economies are remeasured as if the functional currency were the U.S. dollar; the remeasurement creates translation adjustments that are reflected in net income in the Consolidated Statements of Operations.
Reclassifications    Certain amounts in prior years’ Consolidated Financial Statements have been reclassified to conform to the current year presentation. Such reclassifications have not materially affected previously reported amounts in the Consolidated Financial Statements.
Recently Issued Accounting Standards    In December 2019, the FASB issued ASU 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This update clarifies and amends existing guidance, including removing certain exceptions to the general principles in Topic 740 and improves consistent application of and simplifies U.S. GAAP for other areas of Topic 740. Grace will adopt this update on January 1, 2021, when it becomes effective.
Recently Adopted Accounting Standards    In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” This update is intended to ease the potential burden in accounting for and recognizing the effects of reference rate reform. It provides optional practical expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. This update became effective on March 12, 2020, and is available for use through December 31, 2022. Grace expects to utilize the practical expedients provided by this update in accounting for contract modifications and/or hedging transactions during the effective period. Grace expects the update to significantly reduce the effects of reference rate reform on the Consolidated Financial Statements.
In August 2018, the FASB issued ASU 2018-14 “Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20).” This update revises disclosure requirements related to defined benefit pension and other postretirement plans. Grace adopted this update in the 2020 first quarter, and it did not have a material effect on the Consolidated Financial Statements.
In June 2016, the FASB issued ASU 2016-13 “Financial Instruments—Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments.” This update requires companies to implement an impairment model based on expected credit losses, rather than probable incurred losses. Grace adopted this update in the 2020 first quarter, and it did not have a material effect on the Consolidated Financial Statements.
72


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

2. Inventories
Inventories are stated at the lower of cost or net realizable value, and cost is determined using FIFO. Inventories consisted of the following at December 31, 2020 and 2019:
December 31,
(In millions) 2020 2019
Raw materials $ 57.0  $ 64.2 
In process 38.2  55.7 
Finished products 126.6  154.4 
Other 32.0  35.6 
$ 253.8  $ 309.9 
During the three months ended June 30, 2020, Grace implemented changes to its Refining Technologies manufacturing operations to improve capital and operating efficiencies. This included key organizational changes and optimization of plant and manufacturing processes at Grace’s three hydroprocessing catalyst manufacturing sites. As a result of these changes, Grace recorded a pre-tax charge of $19.7 million related to a write-off of inventory now deemed obsolete based on the process changes.
3. Properties and Equipment, and Leases
December 31,
(In millions) 2020 2019
Land $ 26.5  $ 29.5 
Buildings 476.6  438.9 
Information technology and equipment 124.1  131.3 
Machinery, equipment and other 1,956.0  1,754.5 
Projects under construction 175.7  286.6 
Properties and equipment, gross 2,758.9  2,640.8 
Accumulated depreciation and amortization (1,550.1) (1,497.0)
Properties and equipment, net $ 1,208.8  $ 1,143.8 
Capitalized interest costs amounted to $7.0 million, $7.5 million, and $3.2 million in 2020, 2019, and 2018, respectively. Depreciation and finance lease amortization expense relating to properties and equipment was $82.9 million, $78.4 million, and $80.9 million in 2020, 2019, and 2018, respectively.
The following table presents Grace’s lease right-of-use assets, net of accumulated amortization, and operating lease liabilities as of December 31, 2020 and 2019.
December 31,
(in millions) 2020 2019 Balance Sheet Location
Operating lease right of use asset $ 35.1  $ 34.9  Other assets
Operating lease liability—current 10.1  9.3  Other current liabilities
Operating lease liability—noncurrent 25.8  26.2  Other liabilities
73


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

3. Properties and Equipment, and Leases (Continued)
The following table presents Grace’s costs and cash flow information related to operating leases for the year ended December 31, 2020.
Year Ended December 31,
(In millions) 2020 2019
Operating lease cost $ 13.3  $ 12.1 
Short-term and variable lease cost 21.1  17.9 
Total lease cost $ 34.4  $ 30.0 
Cash payments related to operating leases $ 13.2  $ 12.0 
Right-of-use assets obtained in exchange for new operating lease liabilities
10.8  17.0 
Grace’s expense for operating leases was $13.5 million in 2018.
The following table presents the weighted average discount rate and weighted average remaining lease term related to Grace’s operating leases.
  December 31,
2020
Weighted average discount rate 6.2  %
Weighted average remaining lease term 7.7
The following maturity analysis presents minimum expected operating lease payments at December 31, 2020.
  (In millions)
2021 $ 11.8 
2022 8.7 
2023 5.2 
2024 3.4 
2025 2.2 
Thereafter 15.3 
Total undiscounted lease payments 46.6 
Less: imputed interest 10.7 
Present value of lease liabilities $ 35.9 
74


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

4. Goodwill and Other Intangible Assets
The carrying amount of goodwill attributable to each reportable segment and the changes in those balances during the years ended December 31, 2020 and 2019, are as follows:
(In millions) Catalysts Technologies Materials Technologies Total Grace
Balance, December 31, 2018 $ 496.3  $ 44.1  $ 540.4 
Goodwill acquired during the year 17.8  —  17.8 
Foreign currency translation (1.0) (0.3) (1.3)
Balance, December 31, 2019 513.1  43.8  556.9 
Foreign currency translation 4.4  1.4  5.8 
Balance, December 31, 2020 $ 517.5  $ 45.2  $ 562.7 
Grace’s net book value of other intangible assets at December 31, 2020 and 2019, was $320.8 million and $342.8 million, respectively, detailed as follows:
December 31, 2020 December 31, 2019
(In millions) Gross Carrying
Amount
Accumulated
Amortization
Gross Carrying
Amount
Accumulated
Amortization
Technology $ 231.6  $ 74.1  $ 232.5  $ 63.6 
Customer lists 159.7  30.5  161.2  23.9 
Trademarks 31.8  7.0  31.7  5.5 
Other 15.7  6.4  16.1  5.7 
Total $ 438.8  $ 118.0  $ 441.5  $ 98.7 
Amortization expense related to intangible assets was $22.1 million, $21.9 million, and $19.9 million in 2020, 2019, and 2018, respectively.
At December 31, 2020, estimated future annual amortization expense for intangible assets is:
(In millions)
2021 $ 21.8 
2022 21.7 
2023 21.7 
2024 21.7 
2025 21.7 
Thereafter 212.2 
$ 320.8 

75


Table of Contents

Notes to Consolidated Financial Statements (Continued)

5. Debt
Components of Debt
December 31,
(In millions) 2020 2019
2018 U.S. dollar term loan, net of unamortized debt issuance costs of $6.0 at December 31, 2020 (2019—$7.2)
$ 922.6  $ 930.9 
4.875% senior notes due 2027, net of unamortized debt issuance costs of $10.1 at December 31, 2020
739.9  — 
5.625% senior notes due 2024, net of unamortized debt issuance costs of $1.9 at December 31, 2020 (2019—$2.4)
298.1  297.6 
5.125% senior notes due 2021, net of unamortized debt issuance costs (2019—$2.7)
  697.3 
Debt payable to unconsolidated affiliate
25.6  47.4 
Other borrowings(1)
4.2  7.2 
Total debt 1,990.4  $ 1,980.4 
Less debt payable within one year 15.3  $ 23.1 
Debt payable after one year $ 1,975.1  $ 1,957.3 
Weighted average interest rates on total debt 3.5  % 3.8  %
___________________________________________________________________________________________________________________
(1)Represents borrowings under various lines of credit and other borrowings, primarily by non-U.S. subsidiaries.
See Note 6 for a discussion of the fair value of Grace’s debt.
The principal maturities of debt outstanding at December 31, 2020, were as follows:
(In millions)
2021 $ 15.3 
2022 14.2 
2023 13.7 
2024 311.4 
2025 888.2 
Thereafter 747.6 
Total debt $ 1,990.4 
Senior Notes due 2027    
On June 26, 2020, Grace–Conn. (the “Issuer”) and certain of the Company’s existing domestic subsidiaries (together with the Company, the “Guarantors”), completed the sale of $750 million aggregate principal amount of 4.875% Notes due 2027 (the “Senior Notes due 2027”) for net proceeds of $741.6 million. The Senior Notes due 2027 were priced at 100% of par and were offered and sold pursuant to exemptions from registration under the Securities Act of 1933, as amended (the "Securities Act"). The Senior Notes due 2027 were issued pursuant to an indenture, dated as of September 16, 2014 (the “Base Indenture”), as supplemented by that certain third supplemental indenture, dated as of June 26, 2020 (the “Third Supplemental Indenture”), by and among the Issuer, the Guarantors and the trustee thereunder (the “Trustee”). The Base Indenture, together with the Third Supplemental Indenture, are referred to below as the “Indenture.”
On July 13, 2020, Grace used the net proceeds, together with cash on hand, to redeem the $700.0 million Senior Notes due 2021 for $748.0 million, including $10.1 million of interest accrued through the date of redemption and a $37.9 million make-whole premium. During the three months ended September 30, 2020, Grace recognized a charge related to the debt refinancing of $39.4 million, including the make-whole premium.
76


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

5. Debt (Continued)
Interest is payable on the Senior Notes due 2027 on each June 15 and December 15, commencing December 15, 2020.
Grace may redeem all or a portion of the Senior Notes due 2027 at any time prior to June 15, 2023, at a price equal to 100% of the principal amount of the Senior Notes due 2027 redeemed plus accrued and unpaid interest, if any, to but excluding the redemption date plus a make-whole premium. At any time on or after June 15, 2023, Grace may redeem the Senior Notes due 2027, in whole or in part, at the redemption prices set forth in the Third Supplemental Indenture, in each case plus accrued and unpaid interest, if any, to but excluding the redemption date. The Senior Notes due 2027 will mature on June 15, 2027.
If a change of control of the Company occurs while the Senior Notes due 2027 are rated below investment grade, or is followed by a below investment grade rating, subject to certain exceptions, each holder shall have the right to require that the Issuer repurchase all or a portion of such holder’s Senior Notes due 2027 at a purchase price of 101% of the aggregate principal amount thereof, plus accrued and unpaid interest, if any, on the Senior Notes due 2027 repurchased, to but excluding, the date of repurchase.
The Senior Notes due 2027 and guarantees are senior unsecured obligations of the Issuer and the Guarantors, respectively, and will rank equally with all of the existing and future unsubordinated obligations of the Issuer and the Guarantors, respectively. The Senior Notes due 2027 and the guarantees are effectively subordinated to any secured indebtedness to the extent of the value of the assets securing such indebtedness and structurally subordinated to the debt and other liabilities of the Company’s non-guarantor subsidiaries.
The Senior Notes due 2027 were issued subject to covenants that limit the ability of the Company, the Issuer, and certain of the Company’s subsidiaries to: (i) incur liens on assets; (ii) enter into sale and leaseback transactions larger than the greater of $100 million or 2.5% of total assets; and (iii) merge or consolidate with another company; subject to certain exceptions and qualifications. Grace is in compliance with those covenants.
The Senior Notes due 2027 were issued subject to customary events of default, which include (subject in certain cases to customary grace and cure periods), among others, nonpayment of principal or interest; breach of other agreements in the Indenture; failure to pay certain other indebtedness; failure to discharge a final judgment for payment of the greater of (i) $100 million and (ii) 2.5% of Total Assets (as defined in the Indenture) or more (excluding any amounts covered by insurance or indemnities) rendered against the Issuer or any of its significant subsidiaries; and certain events of bankruptcy or insolvency. Generally, if any event of default occurs, the Trustee or the holders of at least 30% in aggregate principal amount of the then outstanding series of Senior Notes due 2027 may declare all the Senior Notes due 2027 of such series to be due and payable immediately.
The foregoing is a summary of the Senior Notes due 2027 and the related indentures, does not purport to be complete, and is qualified in its entirety by reference to the full texts thereof. Grace has filed the full text of such documents with the SEC, which are readily available on the internet at www.sec.gov.
Credit Agreement
On April 3, 2018, Grace entered into a Credit Agreement (the “Credit Agreement”), which provides for new senior secured credit facilities, consisting of:
(a)a $950 million term loan due in 2025, with interest at LIBOR +175 basis points, and
(b)a $400 million revolving credit facility due in 2023, with interest at LIBOR +175 basis points.
The term loan amortizes in equal quarterly installments in aggregate annual amounts of $9.5 million.
The Credit Agreement contains customary affirmative covenants, including, but not limited to: (i) maintenance of existence, and compliance with laws; (ii) delivery of consolidated financial statements and other information; (iii) payment of taxes; (iv) delivery of notices of defaults and certain other material events; and (v) maintenance of adequate insurance. The Credit Agreement also contains customary negative covenants, including but not limited to restrictions on: (i) dividends on, and redemptions of, equity interests and other restricted payments; (ii) liens; (iii) loans and investments; (iv) the sale, transfer or disposition of assets and businesses; (v) transactions with affiliates; and (vi) a maximum first lien leverage ratio.
77


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

5. Debt (Continued)
Events of default under the Credit Agreement include, but are not limited to: (i) failure to pay principal, interest, fees or other amounts under the Credit Agreement when due, taking into account any applicable grace period; (ii) any representation or warranty proving to have been incorrect in any material respect when made; (iii) failure to perform or observe covenants or other terms of the Credit Agreement subject to certain grace periods; (iv) a cross-default and cross-acceleration with certain other material debt; (v) bankruptcy events; (vi) certain defaults under ERISA; and (vii) the invalidity or impairment of security interests.
To secure its obligations under the Credit Agreement, Grace and certain of its U.S. subsidiaries have granted security interests in substantially all equity and debt interests in Grace–Conn. or any other Grace subsidiary owned by them and in substantially all their non-real estate assets and property.
Grace used a portion of the proceeds to repay in full the borrowings outstanding under its 2014 credit agreement, which was terminated, as well as to make a voluntary $50.0 million accelerated contribution to its U.S. qualified pension plans. In connection with the repayment of debt, Grace recorded a $4.8 million loss on early extinguishment of debt, which is included in “other (income) expense” in the Consolidated Statement of Operations.
Grace had no outstanding draws on its revolving credit facility as of December 31, 2020; however, the available credit under the facility was reduced to $391.8 million by outstanding letters of credit.
Senior Notes due 2021 and 2024
On September 16, 2014, Grace–Conn. (the “Issuer”) issued $1,000.0 million of senior unsecured notes (the “Notes”) in two tranches:
(a)$700 million in aggregate principal amount of Notes due 2021 at a coupon rate of 5.125%, and
(b)$300 million in aggregate principal amount of Notes due 2024 at a coupon rate of 5.625%.
The Notes were priced at 100% of par and were offered and sold pursuant to exemptions from registration under the Securities Act of 1933, as amended, (the “Securities Act”). Interest is payable on the Notes on each April 1 and October 1.
Grace may redeem some or all of the Notes at any time at a price equal to the greater of (i) 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest and (ii) the sum, as determined by an independent investment banker, of the present values of the remaining scheduled payments of principal and interest (exclusive of interest accrued to the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the treasury rate plus 50 basis points, in each case, plus accrued and unpaid interest. In the event of a change in control, Grace will be required to offer to purchase the Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest. On July 13, 2020, Grace redeemed the $700.0 million Senior Notes due 2021.
The Notes are jointly and severally guaranteed on a full and unconditional senior unsecured basis by the Company and Alltech Associates, Inc., a wholly-owned subsidiary of the Issuer (the “Guarantors”). The Notes and guarantees are senior obligations of the Issuer and the Guarantors, respectively, and will rank equally with all of the existing and future unsubordinated obligations of the Issuer and the Guarantors, respectively. The Notes are effectively subordinated to any secured indebtedness to the extent of the value of the assets securing such indebtedness, and structurally subordinated to the debt and other liabilities of Grace’s non-guarantor subsidiaries.
The Notes were issued subject to covenants that limit the Issuer’s and certain of its subsidiaries’ ability, subject to certain exceptions and qualifications, to (i) create or incur liens on assets, (ii) enter into any sale and leaseback transaction and (iii) in the case of the Issuer, merge or consolidate with another company. Grace is in compliance with these covenants.
The Notes were also issued subject to customary events of default which include (subject in certain cases to customary grace and cure periods), among others, nonpayment of principal or interest; breach of other agreements in the Indenture; failure to pay certain other indebtedness; failure to discharge a final judgment for the payment of $75 million or more (excluding any amounts covered by insurance or indemnities) rendered against
78


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

5. Debt (Continued)
the Issuer or any of its significant subsidiaries; and certain events of bankruptcy or insolvency. Generally, if any event of default occurs, the trustee or the holders of at least 25% in aggregate principal amount of the then outstanding series of Notes may declare all the Notes of such series to be due and payable immediately.
The foregoing is a summary of the Credit Agreement, the indentures, and the Notes. Grace has filed the full text of such agreements with the SEC, which are readily available on the Internet at www.sec.gov.
6. Fair Value Measurements and Risk
Certain of Grace’s assets and liabilities are reported at fair value on a gross basis. ASC 820 “Fair Value Measurements and Disclosures” defines fair value as the value that would be received at the measurement date in the principal or “most advantageous” market. Grace uses principal market data, whenever available, to value assets and liabilities that are required to be reported at fair value.
Grace has identified the following financial assets and liabilities that are subject to the fair value analysis required by ASC 820:
Fair Value of Debt and Other Financial Instruments    Debt payable is recorded at carrying value. Fair value is determined based on Level 2 inputs, including expected future cash flows (discounted at market interest rates), estimated current market prices, and quotes from financial institutions.
At December 31, 2020, the carrying amounts, net of unamortized debt issuance costs and discounts (see Note 5), and fair values of Grace’s debt were as follows:
December 31, 2020 December 31, 2019
(In millions) Carrying Amount Fair Value Carrying Amount Fair Value
2018 U.S. dollar term loan $ 922.6  $ 904.1  $ 930.9  $ 938.1 
4.875% senior notes due 2027
739.9  784.7  —  — 
5.625% senior notes due 2024
298.1  322.4  297.6  329.2 
5.125% senior notes due 2021
    697.3  727.1 
Other borrowings 29.8  29.8  54.6  54.6 
Total debt $ 1,990.4  $ 2,041.0  $ 1,980.4  $ 2,049.0 
At December 31, 2020, the recorded values of other financial instruments such as cash equivalents and trade receivables and payables approximated their fair values, based on the short-term maturities and floating rate characteristics of these instruments.
Currency Derivatives    Because Grace operates and/or sells to customers in over 60 countries and in over 30 currencies, its results are exposed to fluctuations in currency exchange rates. Grace seeks to minimize exposure to these fluctuations by matching sales with expenditures in the same currencies, but it is not always possible to do so. From time to time, Grace uses financial instruments such as currency forward contracts, options, swaps, or combinations thereof to reduce the risk of certain specific transactions. However, Grace does not have a policy of hedging all exposures, because management does not believe that such a level of hedging would be cost-effective. Forward contracts with maturities of not more than 36 months are used and designated as cash flow hedges of forecasted repayments of intercompany loans. The effective portion of gains and losses on these currency hedges is recorded in “accumulated other comprehensive income (loss)” and reclassified into “other (income) expense, net” to offset the remeasurement of the underlying hedged loans. Forward points are excluded from the assessment of effectiveness and amortized to income on a systematic basis.
Grace also enters into foreign currency forward contracts and swaps to hedge a portion of its net outstanding monetary assets and liabilities. These forward contracts and swaps are not designated as hedging instruments under applicable accounting guidance, and therefore all changes in their fair value are recorded in “other (income) expense, net,” in the Consolidated Statements of Operations. These forward contracts and swaps are intended to offset the foreign currency gains or losses associated with the underlying monetary assets and liabilities.
79


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

6. Fair Value Measurements and Risk (Continued)
The valuation of Grace’s currency exchange rate forward contracts and swaps is determined using an income approach. Inputs used to value currency exchange rate forward contracts and swaps consist of: (1) spot rates, which are quoted by various financial institutions; (2) forward points, which are primarily affected by changes in interest rates; and (3) discount rates used to present value future cash flows, which are based on the London Interbank Offered Rate (LIBOR) curve or overnight indexed swap rates. Total notional amounts for forward contracts and swaps outstanding at December 31, 2020, were $419.2 million.
Cross-Currency Swap Agreements    Grace uses cross-currency swaps designated as cash flow hedges to manage fluctuations in currency exchange rates and interest rates on variable rate debt. Gains and losses on these cash flow hedges are recorded in “accumulated other comprehensive income (loss)” and reclassified into “other (income) expense, net” and “interest expense and related financing costs” during the hedged period.
In connection with the Credit Agreement (see Note 5), Grace entered into new cross-currency swaps beginning on April 3, 2018, and maturing on March 31, 2023, to synthetically convert $600.0 million of U.S. dollar-denominated floating rate debt into €490.1 million of euro-denominated debt fixed at 2.0231%. These cross-currency swaps were de-designated and terminated on November 5, 2018, and replaced with new, at-market cross-currency swaps beginning on November 5, 2018, and maturing on March 31, 2023, to synthetically convert $600.0 million of U.S. dollar-denominated floating rate debt into €525.9 million of euro-denominated debt fixed at 1.785%. Grace received $33.1 million in cash proceeds from the swap settlement. The valuation of these cross-currency swaps is determined using an income approach, using LIBOR and EURIBOR (Euro Interbank Offered Rate) swap curves, currency basis spreads, and euro/U.S. dollar exchange rates.
Debt and Interest Rate Swap Agreements    Grace uses interest rate swaps designated as cash flow hedges to manage fluctuations in interest rates on variable rate debt. The effective portion of gains and losses on these interest rate cash flow hedges is recorded in “accumulated other comprehensive income (loss)” and reclassified into “interest expense and related financing costs” during the hedged interest period.
In connection with the Credit Agreement, Grace entered into interest rate swaps beginning on April 3, 2018, and maturing on March 31, 2023, fixing the LIBOR component of the interest on $100.0 million of term debt at 2.775%. The valuation of these interest rate swaps is determined using an income approach, using prevailing market interest rates and discount rates to present value future cash flows based on the forward LIBOR yield curves. Credit risk is also incorporated into derivative valuations.
The following tables present the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 and 2019:
Fair Value Measurements at December 31, 2020, Using
(In millions) Total Quoted Prices in Active Markets for Identical Assets or Liabilities
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Assets
Currency derivatives $ 1.6  $ —  $ 1.6  $ — 
Total Assets $ 1.6  $   $ 1.6  $  
Liabilities
Currency derivatives $ 17.8  $ —  $ 17.8  $ — 
Variable-to-fixed cross-currency derivatives 51.0  —  51.0  — 
Interest rate derivatives 5.5  —  5.5  — 
Total Liabilities $ 74.3  $   $ 74.3  $  
80


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

6. Fair Value Measurements and Risk (Continued)
Fair Value Measurements at December 31, 2019, Using
(In millions) Total Quoted Prices in Active Markets for Identical Assets or Liabilities
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Assets
Currency derivatives $ 6.1  $ —  $ 6.1  $ — 
Variable-to-fixed cross-currency derivatives 3.4  —  3.4  — 
Total Assets $ 9.5  $   $ 9.5  $  
Liabilities
Currency derivatives $ 0.9  $ —  $ 0.9  $ — 
Interest rate derivatives 3.4  —  3.4  — 
Total Liabilities $ 4.3  $   $ 4.3  $  
The following tables present the location and fair values of derivative instruments included in the Consolidated Balance Sheets as of December 31, 2020 and 2019:
Asset Derivatives Liability Derivatives
December 31, 2020
(In millions)
Balance Sheet
Location
Fair
Value
Balance Sheet
Location
Fair
Value
Derivatives designated as hedging instruments under ASC 815:
Currency contracts Other current assets $ —  Other current liabilities $ 17.7 
Currency contracts Other assets —  Other liabilities 0.1 
Interest rate contracts Other current assets —  Other current liabilities 2.5 
Interest rate contracts Other assets —  Other liabilities 3.0 
Variable-to-fixed cross-currency swaps Other current assets —  Other current liabilities 0.2 
Variable-to-fixed cross-currency swaps Other liabilities —  Other liabilities 50.8 
Derivatives not designated as hedging instruments under ASC 815:
Currency contracts Other current assets 1.9  Other current assets — 
Currency contracts Other current liabilities (0.3) Other current liabilities — 
Total derivatives $ 1.6  $ 74.3 
Asset Derivatives Liability Derivatives
December 31, 2019
(In millions)
Balance Sheet
Location
Fair
Value
Balance Sheet
Location
Fair
Value
Derivatives designated as hedging instruments under ASC 815:
Currency contracts Other current assets $ 2.1  Other current assets $ (3.1)
Currency contracts Other assets 4.0  Other liabilities 4.0 
Interest rate contracts Other current assets —  Other current liabilities 1.0 
Interest rate contracts Other assets —  Other liabilities 2.4 
Variable-to-fixed cross-currency swaps Other current assets 10.2  Other current liabilities — 
Variable-to-fixed cross-currency swaps Other liabilities (6.8) Other liabilities — 
Derivatives not designated as hedging instruments under ASC 815:
Currency contracts Other current assets —  Other current assets (0.2)
Currency contracts Other current assets —  Other current liabilities 0.2 
Total derivatives $ 9.5  $ 4.3 
81


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

6. Fair Value Measurements and Risk (Continued)
The following tables present the location and amount of gains and losses on derivative instruments included in the Consolidated Statements of Operations or, when applicable, gains and losses initially recognized in “other comprehensive income (loss)” (“OCI”) for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31, 2020
(In millions)
Amount of Gain (Loss) Recognized in OCI on Derivatives Location of Gain (Loss) Reclassified from Accumulated OCI into Income Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Derivatives in ASC 815 cash flow hedging relationships:
Interest rate contracts $ (4.0) Interest expense $ (1.8)
Currency contracts(1) 1.8  Other expense 2.3 
Variable-to-fixed cross-currency swaps 7.2  Interest expense 4.0 
Variable-to-fixed cross-currency swaps (55.4) Other expense (55.4)
Total derivatives $ (50.4) $ (50.9)
Location of Gain (Loss) Recognized in Income on Derivatives Amount of Gain (Loss) Recognized in Income on Derivatives
Derivatives not designated as hedging instruments under ASC 815:
Currency contracts Other expense $ 4.9 
___________________________________________________________________________________________________________________
(1)Amount of gain (loss) recognized in OCI includes $(0.7) million excluded from the assessment of effectiveness for which the difference between changes in fair value and periodic amortization is recorded in OCI.
Year Ended December 31, 2019
(In millions)
Amount of Gain (Loss) Recognized in OCI on Derivatives Location of Gain (Loss) Reclassified from Accumulated OCI into Income Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Derivatives in ASC 815 cash flow hedging relationships:
Interest rate contracts $ (2.9) Interest expense $ (0.3)
Currency contracts(1) 2.4  Other expense 1.4 
Variable-to-fixed cross-currency swaps 9.1  Interest expense 13.2 
Variable-to-fixed cross-currency swaps 12.5  Other expense 12.5 
Total derivatives $ 21.1  $ 26.8 
Location of Gain (Loss) Recognized in Income on Derivatives Amount of Gain (Loss) Recognized in Income on Derivatives
Derivatives not designated as hedging instruments under ASC 815:
Currency contracts Other expense $ (0.4)
___________________________________________________________________________________________________________________
(1)Amount of gain (loss) recognized in OCI includes $0.6 million excluded from the assessment of effectiveness for which the difference between changes in fair value and periodic amortization is recorded in OCI.
82


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

6. Fair Value Measurements and Risk (Continued)
Year Ended December 31, 2018
(In millions)
Amount of Gain (Loss) Recognized in OCI on Derivatives Location of Gain (Loss) Reclassified from Accumulated OCI into Income Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Derivatives in ASC 815 cash flow hedging relationships:
Interest rate contracts $ 0.4  Interest expense $ (0.6)
Currency contracts(1) 6.3  Other expense 6.3 
Variable-to-fixed cross-currency swaps (0.6) Interest expense 9.7 
Variable-to-fixed cross-currency swaps 40.5  Other expense 40.5 
Total derivatives $ 46.6  $ 55.9 
Location of Gain (Loss) Recognized in Income on Derivatives Amount of Gain (Loss) Recognized in Income on Derivatives
Derivatives not designated as hedging instruments under ASC 815:
Currency contracts Other expense $ (4.0)
___________________________________________________________________________________________________________________
(1)Amount of gain (loss) recognized in OCI includes $(0.4) million excluded from the assessment of effectiveness for which the difference between changes in fair value and periodic amortization is recorded in OCI.
The following table presents the total amounts of income and expense line items presented in the Consolidated Statements of Operations in which the effects of cash flow hedges are reported.
Year Ended December 31,
2020 2019 2018
(In millions) Interest expense Other income (expense) Interest expense Other income (expense) Interest expense Other income (expense)
Total amounts of income and expense line items in the Consolidated Statements of Operations in which the effects of cash flow hedges are recorded
$ (76.0) $ (89.0) $ (76.7) $ (80.6) $ (80.2) $ 23.2 
Gain (loss) on cash flow hedging relationships in ASC 815
Interest rate contracts
Gain (loss) reclassified from accumulated OCI into income
$ (1.8) $   $ (0.3) $ —  $ (0.6) $ — 
Variable-to-fixed cross-currency swaps
Gain (loss) reclassified from accumulated OCI into income
4.0  (55.4) 13.2  12.5  9.7  40.5 
Currency contracts
Gain (loss) reclassified from accumulated OCI into income
  2.3  —  1.4  —  6.3 
Amount excluded from effectiveness testing recognized in earnings based on amortization approach (included in above)
  1.2  —  2.8  —  3.0 
Net Investment Hedges    Grace uses cross-currency swaps as derivative hedging instruments in certain net investment hedges of its non-U.S. subsidiaries. The gains and losses attributable to these net investment hedges, adjusted for the impact of excluded components, are recorded net of tax to “currency translation adjustments” within “accumulated other comprehensive income (loss)” to offset the change in the carrying value of the net investment being hedged. Recognition in earnings of amounts previously recorded to “currency translation adjustments” is limited to circumstances such as complete or substantially complete liquidation of the net investment in the hedged foreign operation. Changes in the fair value of the hedging instrument related to time value, which are excluded from the assessment of hedge effectiveness, are recorded directly to interest expense on a systematic basis. These gains were $3.0 million, $3.3 million and $2.3 million for the years ended December 31, 2020, 2019, and 2018, respectively. At December 31, 2020, the notional amount of €170.0 million
83


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

6. Fair Value Measurements and Risk (Continued)
of Grace’s cross-currency swaps was designated as a hedging instrument of its net investment in its European subsidiaries.
Grace has also used foreign currency-denominated debt and deferred intercompany royalties as non-derivative hedging instruments in certain net investment hedges. At December 31, 2020, Grace’s deferred intercompany royalties have been fully amortized and de-designated as a hedging instrument of its net investment in its European subsidiaries. In April 2018, in connection with the Credit Agreement, Grace de-designated and repaid its euro-denominated term loan principal that had been designated as a hedge of its net investment in its European subsidiaries.
The following table presents the amount of gains and losses on derivative and non-derivative instruments designated as net investment hedges recorded to “currency translation adjustments” within “accumulated other comprehensive income (loss)” for the years ended December 31, 2020, 2019, and 2018. There were no reclassifications of the effective portion of net investment hedges out of OCI and into earnings for the periods presented.
Year Ended December 31,
(In millions) 2020 2019 2018
Derivatives in ASC 815 net investment hedging relationships:
Cross-currency swap $ (15.9) $ 9.1  $ 6.0 
Non-derivatives in ASC 815 net investment hedging relationships:
Foreign currency denominated debt $   $ —  $ (4.4)
Foreign currency denominated deferred intercompany royalties   0.1  0.5 
$   $ 0.1  $ (3.9)
Credit Risk    Grace is exposed to credit risk in its trade accounts receivable. Grace’s credit evaluation policies mitigate credit risk exposures, and it has a history of minimal credit losses. Grace does not generally require collateral for its trade accounts receivable, but may require a bank letter of credit in certain instances, particularly when selling to customers in cash-restricted countries.
Grace may also be exposed to credit risk in its derivatives contracts. Grace monitors counterparty credit risk and currently does not anticipate nonperformance by counterparties to its derivatives. Grace’s derivative contracts are with internationally recognized commercial financial institutions.
84


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

7. Income Taxes
Provision for Income Taxes    The components of income from continuing operations before income taxes and the related provision for income taxes for 2020, 2019, and 2018 are as follows:
(In millions) 2020 2019 2018
Income from continuing operations before income taxes:      
Domestic $ (76.1) $ 79.2  $ 82.2 
Foreign 76.6  104.3  162.7 
Total $ 0.5  $ 183.5  $ 244.9 
Benefit from (provision for) income taxes:      
Federal—current $ (0.3) $ (6.3) $ (4.9)
Federal—deferred 24.8  (19.8) (29.3)
State and local—current   (0.5) 1.6 
State and local—deferred (7.2) (5.8) (3.5)
Foreign—current (35.1) (42.4) (49.9)
Foreign—deferred 15.6  18.0  7.9 
Total $ (2.2) $ (56.8) $ (78.1)
The difference between the benefit from (provision for) income taxes on continuing operations at the U.S. federal income tax rate of 21% and Grace’s overall income tax provision is summarized as follows:
(In millions) 2020 2019 2018
Tax provision at U.S. federal income tax rate $ (0.1) $ (38.5) $ (51.4)
Change in benefit (provision) resulting from:
GILTI high-tax exclusion amended return 25.2  —  — 
Decrease (increase) in valuation allowance (13.5) (4.2) (6.3)
Nontaxable income/non-deductible expenses (4.6) (2.5) (1.6)
U.S. taxes on foreign earnings (3.9) (16.7) (30.9)
State and local income taxes, net (3.4) (3.4) (1.9)
Research and development credit 3.3  3.4  9.4 
Unrecognized tax benefit (accruals) releases (3.1) 2.3  5.7 
Effect of tax rate differential in foreign jurisdictions (2.0) (2.9) (11.3)
Compensation-related adjustments (1.8) (1.7) (3.4)
Provision to return adjustments (0.3) 3.0  (0.7)
Benefits (charges) related to U.S. tax reform   —  17.1 
Other 2.0  4.4  (2.8)
Benefit from (provision for) income taxes $ (2.2) $ (56.8) $ (78.1)
Our 2020 effective tax rate was significantly higher than the 21% U.S. statutory rate primarily due to proportionally lower pre-tax income and to an increase to the valuation allowance on U.S. federal tax credits and the higher statutory rates in effect for our foreign subsidiaries, partially offset by the benefit from the Global Intangible Low-Taxed Income (“GILTI”) high-tax exclusion (“HTE”) tax benefit elected for tax years 2018 through 2020.
On July 20, 2020, the U.S. Treasury Department released final regulations related to the GILTI HTE. Grace has recognized a benefit associated with the GILTI HTE regulations that resulted in a tax benefit related to 2018 and 2019 of $25.2 million resulting from the election and the re-establishment of certain U.S. federal net operating loss carryforwards, research and development credit carryforwards, and foreign tax credit carryforwards.
85


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

7. Income Taxes (Continued)
Deferred Tax Assets and Liabilities    As of December 31, 2020 and 2019, the tax attributes giving rise to deferred tax assets and liabilities consisted of the following items.
December 31,
(In millions) 2020 2019
Deferred tax assets:
Tax credit carryforwards $ 309.2  $ 294.7 
Pension liabilities 139.2  107.7 
Net operating loss carryforwards 65.2  60.3 
Environmental remediation liabilities 50.3  47.0 
Research and development 32.9  26.6 
Unrealized currency gains and losses 30.7  12.1 
Reserves and allowances 29.6  14.8 
Operating lease liabilities 7.4  8.1 
Compensation-related 4.0  5.4 
Prepaid royalties 1.1  6.3 
Other 6.8  6.9 
Total deferred tax assets $ 676.4  $ 589.9 
Deferred tax liabilities:
Intangible assets $ (36.5) $ (27.7)
Properties and equipment (20.5) (18.6)
Operating lease assets (7.4) (8.0)
Other (16.6) (1.4)
Total deferred tax liabilities $ (81.0) $ (55.7)
Valuation allowances (38.7) (24.1)
Net deferred tax assets $ 556.7  $ 510.1 
Grace reduces the carrying amounts of deferred tax assets by a valuation allowance if, based on the available evidence, it is more likely than not that such assets will not be realized (see Note 1). Based on all available evidence considered, Grace believes it is more likely than not that some portion of the U.S federal foreign tax credit carryforwards recorded will not ultimately be realized. As of December 31, 2020, a valuation allowance of $11.5 million was recorded against the more-likely-than-not U.S. federal foreign tax credit carryforwards expiring in 2021.
Tax Attributes—Tax Credit and Net Operating Loss Carryforwards    Grace has $317.4 million in federal tax credit carryforwards and $13.1 million in federal net operating loss carryforwards before valuation allowances and unrecognized tax benefits. In order to fully utilize the credits before they expire (from 2021 to 2040), Grace would need to generate income of approximately $1.6 billion.
Grace has state net operating loss carryforwards of $47.4 million and state tax credits of $1.6 million before valuation allowances and unrecognized tax benefits. In order to fully utilize the state tax attributes before they expire (from 2021 to 2036), Grace would need to generate approximately $3.1 billion in state taxable income.
86


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

7. Income Taxes (Continued)
The following table presents Grace’s tax effected net operating loss carryforwards and the related valuation allowances.
December 31,
(In millions) 2020 2019
Net operating loss carryforwards
U.S. state net operating losses $ 45.4  $ 49.5 
U.S. federal net operating losses 10.2  1.2 
Foreign net operating losses 9.6  9.6 
Net operating loss carryforwards $ 65.2  $ 60.3 
Net operating loss—valuation allowances
U.S. state—NOL valuation allowances $ (13.9) $ (10.1)
Foreign—NOL valuation allowances (6.5) (8.0)
Net operating loss—valuation allowances $ (20.4) $ (18.1)
Unrecognized Tax Benefits    The balance of unrecognized tax benefits at December 31, 2020, was $18.6 million compared with $15.4 million at December 31, 2019. A rollforward of the balance of unrecognized tax benefits for the three years ended December 31, 2020, follows.
December 31,
(In millions) 2020 2019 2018
Balance at beginning of year $ 15.4  $ 14.1  $ 17.7 
Increase (decrease) in positions taken in prior periods 0.2  2.6  1.2 
Positions taken in the current period 3.4  2.9  0.9 
Decrease due to settlements with tax authorities (0.4) (4.2) (5.7)
Balance at end of year $ 18.6  $ 15.4  $ 14.1 
If the balance of unrecognized tax benefits as of December 31, 2020, of $18.6 million is ultimately recognized, it would reduce the effective tax rate. A portion of this balance relates to tax positions that impact Grace’s deferred tax assets as of December 31, 2020. Grace accrues potential interest and any associated penalties related to unrecognized tax benefits in “benefit from (provision for) income taxes” in the Consolidated Statements of Operations. Grace accrued $0.2 million of interest and penalties associated with these unrecognized tax benefits in 2020. Grace believes that the amount of the liability for unrecognized tax benefits will not change materially in the next 12 months.
Grace is subject to taxation in the U.S. and various state and foreign jurisdictions and is under continual audit by various tax authorities. As of December 31, 2020, tax years 2017 through 2019 are subject to examination by the U.S. tax authorities. In the significant non-U.S. jurisdiction, tax years 2017 through 2019 are subject to examination by the German tax authorities. Grace has tax attributes generated in prior years that are otherwise closed by statute and were carried forward into years that are open to examination. Those attributes may still be subject to adjustment to the extent utilized in open years.
87


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

8. Pension Plans and Other Retirement Plans
Pension Plans    The following table presents the funded status of Grace’s pension plans:
December 31,
(In millions) 2020 2019
Overfunded defined benefit pension plans $ 11.4  $ 8.5 
Underfunded defined benefit pension plans (128.3) (85.2)
Unfunded defined benefit pension plans (520.7) (434.6)
Total underfunded and unfunded defined benefit pension plans (649.0) (519.8)
Pension liabilities included in other current liabilities (15.7) (14.8)
Net funded status $ (653.3) $ (526.1)
Fully-funded plans include several advance-funded plans where the fair value of the plan assets exceeds the projected benefit obligation ("PBO"). Underfunded plans include a group of advance-funded plans that are underfunded on a PBO basis. Unfunded plans include several plans that are funded on a pay-as-you-go basis, and therefore, the entire PBO is unfunded.
Grace maintains defined benefit pension plans covering current and former employees of certain business units and divested business units who meet age and service requirements. Benefits are generally based on final average salary and years of service. Grace funds its U.S. qualified pension plans (“U.S. qualified pension plans”) in accordance with U.S. federal laws and regulations. Non-U.S. pension plans (“non-U.S. pension plans”) are funded under a variety of methods, as required under local laws and customs. The U.S. salaried plan was closed to new entrants after January 1, 2017. In the 2021 first quarter, Grace announced to employees that the U.S. salaried plan will be frozen effective January 1, 2025.
Grace also provides, through nonqualified plans, supplemental pension benefits in excess of U.S. qualified pension plan limits imposed by federal tax law. These plans cover officers and higher-level employees and serve to increase the combined pension amount to the level that they otherwise would have received under the U.S. qualified pension plans in the absence of such limits. The nonqualified plans are unfunded and Grace pays the costs of benefits as they are due to the participants.
At the December 31, 2020, measurement date for Grace’s defined benefit pension plans, the PBO was $1,682.7 million as measured under U.S. GAAP compared with $1,507.0 million as of December 31, 2019. The PBO reflects the present value (using a 2.41% weighted average discount rate for U.S. plans and a 0.84% weighted average discount rate for non-U.S. plans as of December 31, 2020) of vested and non-vested benefits earned from employee service to date, based upon current services and estimated future pay increases for active employees.
On an annual basis a full remeasurement of pension assets and pension liabilities is performed based on Grace’s estimates and actuarial valuations. These valuations reflect the terms of each pension plan and use participant-specific information as well as certain key assumptions provided by management.
Defined Contribution Retirement Plans    Grace sponsors a defined contribution retirement plan for its employees in the United States. This plan is qualified under section 401(k) of the U.S. tax code. Currently, Grace contributes an amount equal to 100% of employee contributions, up to 6% of an individual employee’s salary or wages. Grace’s cost related to this benefit plan was $14.3 million, $13.9 million, and $12.6 million for the years ended December 31, 2020, 2019, and 2018, respectively.
U.S. salaried employees and certain U.S. hourly employees hired on or after January 1, 2017, participate in an enhanced defined contribution plan instead of a defined benefit pension plan. Grace contributes 4% of an individual employee’s salary or wages to this plan. Grace’s cost related to this enhanced defined contribution plan established in the U.S. was $3.5 million, $2.9 million, and $1.7 million for the years ended December 31, 2020, 2019, and 2018, respectively.
88


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

8. Pension Plans and Other Retirement Plans (Continued)
Analysis of Plan Accounting and Funded Status    The following table summarizes the changes in benefit obligations and fair values of retirement plan assets during 2020 and 2019:
Defined Benefit Pension Plans
U.S. Non-U.S. Total
(In millions) 2020 2019 2020 2019 2020 2019
Change in Projected Benefit Obligation:
Benefit obligation at beginning of year $ 1,137.8  $ 1,027.1  $ 369.2  $ 305.6  $ 1,507.0  $ 1,332.7 
Service cost 18.9  15.7  11.1  8.6  30.0  24.3 
Interest cost 30.2  38.3  4.1  5.4  34.3  43.7 
Actuarial (gain) loss—change in discount rates 106.0  144.1  52.7  58.2  158.7  202.3 
Actuarial (gain) loss—other changes 8.9  (10.7) (3.7) 4.1  5.2  (6.6)
Benefits paid (79.1) (76.7) (8.4) (8.4) (87.5) (85.1)
Currency exchange translation adjustments   —  35.0  (4.3) 35.0  (4.3)
Benefit obligation at end of year $ 1,222.7  $ 1,137.8  $ 460.0  $ 369.2  $ 1,682.7  $ 1,507.0 
Change in Plan Assets:
Fair value of plan assets at beginning of year
$ 955.7  $ 871.1  $ 25.2  $ 19.5  $ 980.9  $ 890.6 
Actual return on plan assets 115.7  154.6  2.3  4.1  118.0  158.7 
Employer contributions 8.4  6.7  8.8  9.1  17.2  15.8 
Benefits paid (79.1) (76.7) (8.4) (8.4) (87.5) (85.1)
Currency exchange translation adjustments   —  0.8  0.9  0.8  0.9 
Fair value of plan assets at end of year $ 1,000.7  $ 955.7  $ 28.7  $ 25.2  $ 1,029.4  $ 980.9 
Funded status at end of year (PBO basis) $ (222.0) $ (182.1) $ (431.3) $ (344.0) $ (653.3) $ (526.1)
Amounts recognized in the Consolidated Balance Sheets consist of:
Noncurrent assets $ 11.4  $ 8.5  $   $ —  $ 11.4  $ 8.5 
Current liabilities (7.2) (7.3) (8.5) (7.5) (15.7) (14.8)
Noncurrent liabilities (226.2) (183.3) (422.8) (336.5) (649.0) (519.8)
Net amount recognized $ (222.0) $ (182.1) $ (431.3) $ (344.0) $ (653.3) $ (526.1)
Amounts recognized in Accumulated Other Comprehensive (Income) Loss consist of:
Prior service credit $ (2.0) $ (2.6) $ (0.1) $ (0.1) $ (2.1) $ (2.7)
Net amount recognized $ (2.0) $ (2.6) $ (0.1) $ (0.1) $ (2.1) $ (2.7)
Defined Benefit Pension Plans
U.S. Non-U.S.
2020 2019 2020 2019
Weighted Average Assumptions Used to Determine Benefit Obligations as of December 31:
Discount rate 2.41  % 3.13  % 0.84  % 1.41  %
Rate of compensation increase 4.50  % 4.50  % 2.58  % 2.59  %
Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended December 31:
Discount rate for determining service cost 3.40  % 4.46  % 1.61  % 2.42  %
Discount rate for determining interest cost 2.75  % 3.86  % 1.12  % 1.84  %
Expected return on plan assets 5.25  % 5.75  % 4.17  % 4.43  %
Rate of compensation increase 4.50  % 4.10  % 2.59  % 2.59  %
89


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

8. Pension Plans and Other Retirement Plans (Continued)
The following table presents the components of net periodic benefit cost (income) and other amounts recognized in “other comprehensive (income) loss.”
(In millions) 2020 2019 2018
U.S. Non-U.S. U.S. Non-U.S. U.S. Non-U.S.
Net Periodic Benefit Cost (Income)
Service cost $ 18.9  $ 11.1  $ 15.7  $ 8.6  $ 19.2  $ 9.5 
Interest cost 30.2  4.1  38.3  5.4  40.9  5.0 
Expected return on plan assets (48.3) (1.0) (48.2) (0.9) (57.2) (1.0)
Amortization of prior service cost (credit) (0.6)   (0.6) —  (0.6) — 
Annual mark-to-market adjustment (gain) loss
47.5  47.1  26.8  59.1  (3.4) (9.2)
Net curtailment and settlement gain     —  —  (2.3) — 
Net periodic benefit cost (income) $ 47.7  $ 61.3  $ 32.0  $ 72.2  $ (3.4) $ 4.3 
Other Changes in Plan Assets and Benefit Obligations Recognized in OCI
Amortization of prior service cost (credit) $ 0.6  $   $ 0.6  $ —  $ 0.6  $ — 
Total recognized in OCI
0.6    0.6  —  0.6  — 
Total recognized in net periodic benefit cost (income) and OCI
$ 48.3  $ 61.3  $ 32.6  $ 72.2  $ (2.8) $ 4.3 
During 2020 the pension plans experienced a loss on liability mainly due to the decrease in discount rates from the prior year. A change in the mortality assumption for the U.S. pension plans to better reflect anticipated future experience also contributed to the loss. The loss was partially offset due to return on assets greater than expected and salary increases during the year less than expected.
The tables below present the funded status of U.S. and non-U.S. pension plans.
Funded Status of U.S. Pension Plans Fully-Funded U.S. Qualified
Pension Plans(1)
Underfunded U.S.
Qualified Pension Plans(1)
Unfunded Pay-As-You-Go
U.S. Nonqualified Plans(2)
(In millions) 2020 2019 2020 2019 2020 2019
Projected benefit obligation $ 36.5  $ 35.6  $ 1,076.3  $ 993.8  $ 109.9  $ 108.3 
Fair value of plan assets 47.9  44.1  952.8  911.5    — 
Funded status (PBO basis) $ 11.4  $ 8.5  $ (123.5) $ (82.3) $ (109.9) $ (108.3)
Funded Status of Non-U.S. Pension Plans Underfunded Non-U.S.
Pension Plans(1)
Unfunded Pay-As-You-Go
Non-U.S. Pension Plans(2)
(In millions) 2020 2019 2020 2019
Projected benefit obligation $ 33.5  $ 29.0  $ 426.5  $ 340.2 
Fair value of plan assets 28.7  25.2    — 
Funded status (PBO basis) $ (4.8) $ (3.8) $ (426.5) $ (340.2)
___________________________________________________________________________________________________________________
(1)Plans intended to be advance-funded.
(2)Plans intended to be pay-as-you-go. The U.S. unfunded plans are Grace’s supplemental executive retirement plan and other supplemental executive pension arrangements, and the non-U.S. plans primarily relate to an unfunded German pension plan.
The accumulated benefit obligation for all defined benefit pension plans was approximately $1,590 million and $1,423 million as of December 31, 2020 and 2019, respectively.
The following table presents the funded status of defined benefit pension plans that are underfunded or unfunded on an accumulated benefit obligation basis.
90


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

8. Pension Plans and Other Retirement Plans (Continued)

(In millions)
U.S. Non-U.S. Total
2020 2019 2020 2019 2020 2019
Projected benefit obligation $ 1,186.2  $ 1,102.1  $ 429.4  $ 342.1  $ 1,615.6  $ 1,444.2 
Accumulated benefit obligation 1,144.2  1,058.6  384.0  306.7  1,528.2  1,365.3 
Fair value of plan assets 952.8  911.6  1.3  0.8  954.1  912.4 
Estimated Expected Future Benefit Payments Including Future Service for the Fiscal Years Ending
(In millions)
Pension Plans Total
Payments
U.S. Non-U.S.(1)
Benefit
Payments
Benefit
Payments
2021 $ 84.5  $ 9.7  $ 94.2 
2022 77.5  9.4  86.9 
2023 76.4  9.6  86.0 
2024 76.0  10.1  86.1 
2025 74.2  10.2  84.4 
2026 - 2030 348.6  60.5  409.1 
___________________________________________________________________________________________________________________
(1)Non-U.S. estimated benefit payments for 2021 and future periods have been translated at the applicable December 31, 2020, exchange rates.
Discount Rate Assumption    The assumed discount rate for pension plans reflects the market rates for high-quality corporate bonds currently available and is subject to change based on changes in overall market interest rates. For the U.S. qualified pension plans, the assumed weighted average discount rate of 2.41% as of December 31, 2020, was selected by Grace, in consultation with its independent actuaries, based on a yield curve constructed from a portfolio of high quality bonds for which the timing and amount of cash outflows approximate the estimated payouts of the plan.
As of December 31, 2020 and 2019, the German pension plans represented approximately 92% and 91%, respectively, of the benefit obligation of the non-U.S. pension plans. The assumed weighted average discount rate as of December 31, 2020, for Germany of 0.70% was selected by Grace, in consultation with its independent actuaries, based on a yield curve constructed from a portfolio of euro-denominated high quality bonds for which the timing and amount of cash outflows approximate the estimated payouts of the plans. The assumed discount rates for the remaining non-U.S. pension plans were determined based on the nature of the liabilities, local economic environments and available bond indices.
Investment Guidelines for Advance-Funded Pension Plans    The investment goal for the U.S. qualified pension plans subject to advance funding is to earn a long-term rate of return consistent with the related cash flow profile of the underlying benefit obligation. The plans are pursuing a well-defined risk management strategy designed to reduce investment risks as their funded status improves.
The U.S. qualified pension plans have adopted a diversified set of portfolio management strategies to optimize the risk reward profile of the plans:
Liability hedging portfolio: primarily invested in intermediate-term and long-term investment grade corporate bonds in actively managed strategies.
Return-seeking portfolio: invested in a diversified set of assets designed to deliver performance in excess of the underlying liabilities with controls regarding the level of risk.
Global public equities: the portfolio contains both domestic U.S. and non-U.S. equities that are both passively and actively managed. Benchmarks for individual managers include S&P 500 and Russell 2000 benchmarks as well as MSCI ACWI ex US index.
91


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

8. Pension Plans and Other Retirement Plans (Continued)
Other investments: may include high yield bonds: fixed income portfolio of securities below investment grade including non-U.S. issuers. These portfolios combine income generation and capital appreciation opportunities globally.
Liquidity portfolio: invested in short-term assets intended to pay periodic plan benefits and expenses.
For 2020, the expected long-term rate of return on assets for the U.S. qualified pension plans was 5.25%. Average annual returns over one-, three-, five-, and ten-year periods were approximately 13%, 9%, 10%, and 8%, respectively.
The expected return on plan assets for the U.S. qualified pension plans for 2020 was selected by Grace, in consultation with its independent actuaries, using an expected return model. The model determines the weighted average return for an investment portfolio based on the target asset allocation and expected future returns for each asset class, which were developed using a building block approach based on observable inflation, available interest rate information, current market characteristics, and historical results.
The target allocation of investment assets at December 31, 2020, and the actual allocation at December 31, 2020 and 2019, for Grace’s U.S. qualified pension plans are as follows:
Target
Allocation
Percentage of Plan Assets
December 31,
U.S. Qualified Pension Plans Asset Category 2020 2020 2019
Global equities 22  % 23  % 22  %
Multi-asset credit % 3  % %
Liability-hedging assets 75  % 74  % 75  %
Total 100  % 100  % 100  %
The following tables present the fair value hierarchy for the U.S. qualified pension plan assets measured at fair value as of December 31, 2020 and 2019.
Fair Value Measurements at December 31, 2020, Using

(In millions)
Total Quoted Prices in Active Markets for Identical Assets or Liabilities
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Common/collective trust funds $ 8.1  $ —  $ 8.1  $ — 
Annuity and immediate participation contracts 21.1  —  21.1  — 
$ 29.2  $   $ 29.2  $  
Investments measured at net asset value(1) 971.5 
Total Assets at Fair Value $ 1,000.7 
___________________________________________________________________________________________________________________
(1)In accordance with ASC 820-10, certain investments that are measured at net asset value (“NAV”) per share (or its equivalent) have not been classified in the fair value hierarchy. NAV is provided by the investment account manager as a practical expedient to estimate fair value. Fair values presented in the table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets.
92


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

8. Pension Plans and Other Retirement Plans (Continued)
Fair Value Measurements at December 31, 2019, Using

(In millions)
Total Quoted Prices in Active Markets for Identical Assets or Liabilities
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Common/collective trust funds $ 8.0  $ —  $ 8.0  $ — 
Annuity and immediate participation contracts 20.5  —  20.5  — 
$ 28.5  $   $ 28.5  $  
Investments measured at net asset value(1) 927.2 
Total Assets at Fair Value $ 955.7 
___________________________________________________________________________________________________________________
(1)In accordance with ASC 820-10, certain investments that are measured at NAV per share (or its equivalent) have not been classified in the fair value hierarchy. NAV is provided by the investment account manager as a practical expedient to estimate fair value. Fair values presented in the table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets.
Non-U.S. pension plans accounted for approximately 3% of total global pension assets at December 31, 2020 and 2019. Each of these plans, where applicable, follows local requirements and regulations. Some of the local requirements include the establishment of a local pension committee, a formal statement of investment policy and procedures, and routine valuations by plan actuaries.
The target allocation of investment assets for non-U.S. pension plans varies depending on the investment goals of the individual plans. The plan assets of the Canadian pension plan represent approximately 95% and 96% of the total non-U.S. pension plan assets at December 31, 2020 and 2019, respectively The expected long-term rate of return on assets for the Canadian pension plan was 4.25% for 2020.
The target allocation of investment assets at December 31, 2020, and the actual allocation at December 31, 2020 and 2019, for the Canadian pension plan are as follows:
Target
Allocation
Percentage of Plan Assets
December 31,
Canadian Pension Plan Asset Category 2020 2020 2019
Equity securities 23  % 25  % 25  %
Bonds 65  % 63  % 62  %
Other investments 12  % 12  % 13  %
Total 100  % 100  % 100  %
The plan assets of the other country plans represent approximately 5% and 4% in the aggregate of total non-U.S. pension plan assets at December 31, 2020 and 2019, respectively.
93


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

8. Pension Plans and Other Retirement Plans (Continued)
The following tables present the fair value hierarchy for the non-U.S. pension plan assets measured at fair value as of December 31, 2020 and 2019.
Fair Value Measurements at December 31, 2020, Using
(In millions) Total Quoted Prices in Active Markets for Identical Assets or Liabilities
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Corporate bonds $ 0.5  $ —  $ 0.5  $ — 
Insurance contracts and other investments 0.5  —  0.5  — 
Cash 0.2  0.2  —  — 
$ 1.2  $ 0.2  $ 1.0  $  
Investments measured at net asset value(1) 27.5 
Total Assets at Fair Value $ 28.7 
___________________________________________________________________________________________________________________
(1)In accordance with ASC 820-10, certain investments that are measured at NAV per share (or its equivalent) have not been classified in the fair value hierarchy. NAV is provided by the investment account manager as a practical expedient to estimate fair value. Fair values presented in the table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets.
Fair Value Measurements at December 31, 2019, Using
(In millions) Total Quoted Prices in Active Markets for Identical Assets or Liabilities
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Corporate bonds $ 0.4  $ —  $ 0.4  $ — 
Insurance contracts and other investments 0.5  —  0.5  — 
Cash 0.1  0.1  —  — 
$ 1.0  $ 0.1  $ 0.9  $  
Investments measured at net asset value(1) 24.2 
Total Assets at Fair Value $ 25.2 
___________________________________________________________________________________________________________________
(1)In accordance with ASC 820-10, certain investments that are measured at NAV per share (or its equivalent) have not been classified in the fair value hierarchy. NAV is provided by the investment account manager as a practical expedient to estimate fair value. Fair values presented in the table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheets.
Plan Contributions and Funding    Grace intends to satisfy its funding obligations under the U.S. qualified pension plans and to comply with all of the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”). For ERISA purposes, funded status is calculated on a different basis than under U.S. GAAP. Based on the U.S. qualified pension plans’ status as of December 31, 2020, there is a $0.5 million minimum required payment under ERISA for 2021.
Grace intends to fund non-U.S. pension plans based on applicable legal requirements and actuarial and trustee recommendations. Grace expects to make contributions of approximately $10 million related to its non-U.S. pension plans in 2021.
94


Table of Contents

Notes to Consolidated Financial Statements (Continued)

9. Other Balance Sheet Accounts
December 31,
(In millions) 2020 2019
Other Current Assets
Non-trade accounts receivable $ 23.1  $ 24.1 
Income taxes receivable (see Note 7) 7.6  4.2 
Fair value of currency, interest rate, and commodity contracts (see Note 6) 2.2  15.6 
Plant under construction—unconsolidated affiliate (see Note 19)   173.9 
Other current assets 18.3  17.3 
$ 51.2  $ 235.1 
December 31,
(In millions) 2020 2019
Other Current Liabilities
Accrued compensation $ 60.6  $ 53.6 
Deferred revenue (see Note 17) 33.8  35.0 
Fair value of currency, interest rate, and commodity contracts (see Note 6) 21.6  2.6 
Liability for dam spillway replacement (see Note 10) 20.3  4.7 
Pension liabilities (see Note 8) 15.7  14.8 
Environmental contingencies (see Note 10) 13.8  17.8 
Operating lease liabilities (see Note 3) 10.1  9.3 
Accrued interest (see Note 5) 5.8  13.3 
Income taxes payable (see Note 7) 5.1  8.6 
Liability to unconsolidated affiliate for plant under construction (see Note 19)   173.9 
Other accrued liabilities 95.1  86.1 
$ 281.9  $ 419.7 
Accrued compensation includes salaries and wages as well as estimated current amounts due under the annual and long-term incentive programs.
December 31,
(In millions) 2020 2019
Other Liabilities
Environmental contingencies (see Note 10) $ 95.4  $ 97.5 
Liability for dam spillway replacement (see Note 10) 69.3  61.7 
Fair value of currency and interest rate contracts (see Note 6) 53.9  13.2 
Operating lease liabilities (see Note 3) 25.8  26.2 
Legacy product liability (see Note 10) 24.0  24.0 
Deferred revenue (see Note 17) 23.4  29.5 
Retained obligations of divested businesses 12.2  12.7 
Deferred income taxes (see Note 7) 10.4  7.5 
Asset retirement obligation 9.6  9.4 
Unrecognized tax benefits (see Note 7) 3.9  4.1 
Other noncurrent liabilities 19.7  22.4 
$ 347.6  $ 308.2 
95


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

10. Commitments and Contingent Liabilities
Legacy Matters
Over the years, Grace operated numerous types of businesses that are no longer part of its ongoing operations. As Grace divested or otherwise ceased operating these businesses, it retained certain liabilities and obligations, which Grace refers to as legacy liabilities. These liabilities include product, environmental, and other liabilities. Although the outcome of each of the matters discussed below cannot be predicted with certainty, Grace has assessed its risk and has recorded estimated liabilities as required under U.S. GAAP.
Legacy Product Liabilities    Grace emerged from an asbestos-related Chapter 11 bankruptcy on February 3, 2014 (the “Effective Date”). Under its plan of reorganization, all pending and future asbestos-related claims are channeled for resolution to either a personal injury trust (the “PI Trust”) or a property damage trust (the “PD Trust”). The trusts are the sole recourse for holders of asbestos-related claims. The channeling injunctions issued by the bankruptcy court prohibit holders of asbestos-related claims from asserting such claims directly against Grace.
Grace has satisfied all of its financial obligations to the PI Trust. Grace has contingent financial obligations remaining to the PD Trust. With respect to property damage claims related to Grace’s former Zonolite attic insulation product (“ZAI PD Claims”), the PD Trust was funded with $49.4 million (net of $15 million of attorneys’ fees) to pay claims and expenses. Grace is also obligated to make up to 10 contingent deferred payments of $8 million per year to the PD Trust during the 20-year period beginning on February 3, 2019, with each such payment due only if the assets of the PD Trust in respect of ZAI PD Claims fall below $10 million during the preceding year. As of December 31, 2020, the PD Trust has paid out approximately $38 million in ZAI PD Claims and expenses, leaving a balance of approximately $18 million, including the benefit of realized investment gains.
Due to the limited claims history, the unique nature of this product, and the uncertainty of future claims patterns, an actuarial analysis was completed to estimate the range of possible future payments. The analysis was conducted by a third-party actuarial firm directed by Grace and using historical claims data provided by the ZAI trustee. Certain key assumptions employed in the analysis were (1) projections of the future number of filed claims, assuming a percentage increase in claims during earlier years and annual decreases in later years; (2) application of historical percentages of claims closed with indemnity payment compared to total closed claims, applied on a regional basis; and (3) application of the average claim payout, which reflects the average indemnity cost per claim closing with payment. As a result of the analysis and taking into account the relative uncertainty of future claims activity, Grace determined that contingent funding obligations beyond 2025 are not reasonably estimable. Grace estimates that the reasonable range of payments over the period of 2021 to 2025 is expected to be between $16 million and $24 million and projects that the first payment could be due as early as 2022. In the 2019 fourth quarter, Grace recorded a $24.0 million liability related to probable future obligations to fund the PD Trust for ZAI PD Claims. Grace’s maximum financial obligation over the next 18 years is $80.0 million, and no single year’s payment can exceed $8.0 million.
With respect to other asbestos property damage claims (“Other PD Claims”), claims unresolved as of the Effective Date are to be litigated in the bankruptcy court and any future claims are to be litigated in a federal district court, in each case pursuant to procedures approved by the bankruptcy court. To the extent any such Other PD Claims are determined to be allowed claims, they are to be paid in cash by the PD Trust. Grace is obligated to make a payment to the PD Trust every six months in the amount of any Other PD Claims allowed during the preceding six months plus interest (if applicable) and the amount of PD Trust expenses for the preceding six months (the “PD Obligation”). Grace has not paid any Other PD Claims since emergence. Annual expenses have been approximately $0.2 million per year. The aggregate amount to be paid under the PD Obligation is not capped, and Grace may be obligated to make additional payments to the PD Trust in respect of the PD Obligation. Grace has accrued for those unresolved Other PD Claims that it believes are probable and estimable. Grace has not accrued for other unresolved or unasserted Other PD Claims as it does not believe that payment is probable.
All payments to the PD Trust required after the Effective Date are secured by the Company’s obligation to issue 77,372,257 shares of Company common stock to the PD Trust in the event of default, subject to customary anti-dilution provisions.
96


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

10. Commitments and Contingent Liabilities (Continued)
This summary of the commitments and contingencies related to the Chapter 11 proceeding does not purport to be complete and is qualified in its entirety by reference to the plan of reorganization and the exhibits and documents related thereto, which have been filed with the SEC and are readily available on the internet at www.sec.gov.
Legacy Environmental Liabilities    Grace is subject to loss contingencies resulting from extensive and evolving federal, state, local and foreign environmental laws and regulations relating to its manufacturing operations. Grace has procedures in place to minimize such contingencies; nevertheless, it has liabilities associated with past operations and additional claims may arise in the future, which may be material. To address its legacy liabilities, Grace accrues for anticipated costs of response efforts where an assessment has indicated that a probable liability has been incurred and the cost can be reasonably estimated. These accruals do not take into account any discounting for the time value of money.
Grace’s environmental liabilities are reassessed regularly and adjusted when circumstances become better defined or response efforts and their costs can be better estimated, typically as a matter moves through the life-cycle of environmental investigation and remediation. These liabilities are evaluated based on currently available information relating to the nature and extent of contamination, risk assessments, feasibility of response actions, and apportionment amongst other potentially responsible parties, all evaluated in light of prior experience.
At December 31, 2020, Grace’s estimated liability for legacy environmental response costs totaled $109.2 million, compared with $115.3 million at December 31, 2019, and was included in “other current liabilities” and “other liabilities” in the Consolidated Balance Sheets. These amounts are based on agreements in place or on Grace’s estimate of costs where no formal remediation plan or agreement to pay exists, yet there is sufficient information to estimate response costs.
Grace recorded pre-tax charges of $1.6 million, $1.7 million, and $73.8 million for legacy environmental matters in 2020, 2019, and 2018, respectively, which is included in “costs related to legacy matters” in the Consolidated Statements of Operations.
Vermiculite-Related Matters
Grace purchased a vermiculite mine in Libby, Montana, in 1963 and operated it until 1990. Vermiculite concentrate from the Libby mine was used in the manufacture of attic insulation and other products. Some of the vermiculite ore contained naturally occurring asbestos.
Grace is engaged with the U.S. Environmental Protection Agency (the “EPA”) and other federal, state and local governmental agencies in a remedial investigation and feasibility study (“RI/FS”) of the Libby mine and the surrounding area, known as Operable Unit 3 (“OU3”). The RI/FS will study the areas within OU3 requiring remediation and will identify possible remedial action alternatives. Possible remedial actions within OU3 are wide-ranging, from institutional controls such as land use restrictions, to more active measures involving soil removal, containment projects, or other protective measures.
As part of the RI/FS process, Grace contracted an engineering and consulting firm to develop a range of possible remedial alternatives and associated cost estimates for OU3. Based on this work, Grace recorded a pre-tax charge of $70.0 million during the three months ended September 30, 2018, for the estimated costs of remediation of OU3. Grace believes that this amount should provide for a protective remedy meeting the statutory requirements of the Comprehensive Environmental Response, Compensation, and Liability Act.
The estimated costs of remediation are preliminary and consist of several components, each of which may vary significantly as the remedial alternatives are further developed. It is reasonably possible that the ultimate costs of remediation could range between $30 million and $170 million. Grace is working closely with the EPA, and the ultimate remedy will be determined by the EPA after the RI/FS is finalized. Such remedy will be set forth in a Record of Decision (“ROD”) that is currently expected to be issued by the EPA no earlier than 2024. Costs associated with the more active remedial alternatives would be expected to be incurred over a decade or more. Grace will reevaluate its estimated liability as remedial alternatives evolve based on further work by the engineering and consulting firm and discussions with the EPA as the RI/FS process moves toward a ROD. Technical memoranda expected prior to the issuance of the ROD may provide insight into the likely remedial
97


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

10. Commitments and Contingent Liabilities (Continued)
alternatives ultimately selected, allowing Grace to update its cost of remediation estimate. Depending on the remedial alternatives that the EPA selects in the ROD, the total cost of remediating OU3 may exceed Grace’s current estimate by material amounts. The amounts set forth above do not include possible liability for natural resources damage. Based on ecological studies conducted by the EPA, Grace does not believe that natural resources damage has occurred. However, if a party were to be successful in asserting a natural resources damage claim, liability related to such obligation could be material.
Grace has cooperated with the EPA in investigating and remediating a number of formerly owned or operated sites that processed Libby vermiculite into finished products. Grace has recorded a liability for remaining expected response costs, including costs for EPA oversight and potential future site remediation, where a review has indicated that liability is probable and the cost is estimable. The EPA may commence additional investigations in the future at other sites that processed Libby vermiculite. Liability for unaccrued additional investigation and remediation costs is probable but not yet estimable, and could be material.
Grace recorded pre-tax charges of $0.1 million, $0.0 million, and $70.2 million in 2020, 2019, and 2018, respectively, for future costs related to vermiculite-related matters. Grace’s estimated liability for response costs that are currently estimable for OU3 and vermiculite processing sites outside of Libby at December 31, 2020 and 2019, totaled $71.2 million and $76.0 million, respectively. It is possible that Grace’s ultimate liability for these vermiculite-related matters will exceed current estimates by material amounts.
Non-Vermiculite-Related Environmental Matters
Grace recorded pre-tax charges of $1.5 million, $1.7 million, and $3.6 million to increase non-vermiculite-related environmental reserves in 2020, 2019, and 2018, respectively. At December 31, 2020, Grace’s estimated legacy environmental liability for response costs at sites not related to its former vermiculite mining and processing activities totaled $38.0 million, compared with $39.3 million at December 31, 2019. This liability relates to Grace’s former businesses or operations, including its share of liability at off-site disposal facilities. Grace’s estimated liability is based upon regulatory requirements and environmental conditions at each site. As Grace receives new information, its estimated liability may change materially.
Other Legacy Liabilities    Beginning in 1971, as part of implementing a wet milling process at the Libby, Montana, vermiculite mine, Grace constructed a dam at the mine property that now prevents vermiculite ore tailings from moving into nearby creeks and rivers. Ongoing operation of the dam is regulated by the Montana Department of Natural Resources and Conservation (“DNRC”). In April 2019, the DNRC renewed the permit necessary for operation of the dam. Grace is legally obligated to operate the dam and construct a new spillway in accordance with the latest permit conditions.
Construction of the new dam spillway at the former mine site is a key element of Grace’s overall remediation strategy. The project includes both an upper spillway and a lower spillway that are being managed as two separate projects with different engineering design and construction timelines. In 2019, Grace contracted a third-party engineering and consulting firm to develop an initial range of cost estimates for the total project. Based on this work, Grace recorded a liability of $68.0 million in 2019 for the estimated costs of the project. These costs were preliminary and subject to change as new information becomes available, including defining the final scope of the projects through the contract bidding process. During the three months ended September 30, 2020, Grace completed a review of contractor bids for the replacement of the upper spillway and increased its cost estimate for this portion of the project by $27.0 million, bringing the estimate for the total project to $95.0 million. Regarding the lower spillway, final engineering will be completed and submitted to the state of Montana for design approval in 2021, after which Grace will seek contract bids for this portion of the project. Grace believes it is reasonably possible that the ultimate costs of the two spillway projects could range between $80 million and $120 million. As Grace receives new information, its estimated liability may change materially. Construction will begin in 2021 and is expected to take three to four years.
Commercial and Financial Commitments and Contingencies
Purchase Commitments    Grace uses purchase commitments to ensure supply and to minimize the volatility of major components of direct manufacturing costs including natural gas, certain metals, rare earths, and other materials. Such commitments are for quantities that Grace fully expects to use in its normal operations.
98


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

10. Commitments and Contingent Liabilities (Continued)
Guarantees and Indemnification Obligations    Grace is a party to many contracts containing guarantees and indemnification obligations. These contracts primarily consist of:
Product warranties with respect to certain products sold to customers in the ordinary course of business. These warranties typically provide that products will conform to specifications. Grace accrues a warranty liability on a transaction-specific basis depending on the individual facts and circumstances related to each sale.
Performance guarantees offered to customers under certain licensing arrangements. Grace has not established a liability for these arrangements based on past performance.
Licenses of intellectual property by Grace to third parties in which Grace has agreed to indemnify the licensee against third party infringement claims.
Contracts providing for the sale or spin-off of a former business unit or product line in which Grace has agreed to indemnify the buyer or resulting entity against certain liabilities related to activities prior to the closing of the transaction, including environmental, tax, and employee liabilities.
Indemnification obligations of Grace as a tenant of real property leases; and guarantees of real property lease obligations of third parties, typically arising out of (a) leases entered into by former subsidiaries of Grace, or (b) the assignment or sublease of a lease by Grace to a third party.
Financial Assurances    Financial assurances have been established for a variety of purposes, including insurance and environmental matters, trade-related commitments and other matters. At December 31, 2020, Grace had gross financial assurances issued and outstanding of $141.1 million, composed of $77.8 million of surety bonds issued by various insurance companies and $63.3 million of standby letters of credit and other financial assurances issued by various banks.
11. Restructuring Expenses and Repositioning Expenses
Restructuring Expenses  Restructuring costs in 2020 primarily related to an increase in estimated contractual costs related to a 2018 plant exit. Costs in 2019 primarily related to severance costs pertaining to the idling of our methanol-to-olefins (“MTO”) manufacturing facility, which were substantially paid in 2019. Costs in 2018 primarily related to the closure of two small manufacturing plants, the activities from which were moved to larger, more cost-effective plants as part of Grace’s strategy to capture synergies from catalysts acquisitions. These costs are included in “restructuring and repositioning expenses” in the Consolidated Statements of Operations, and are not included in segment operating income.
The following table presents restructuring expenses by reportable segment for the years ended December 31, 2020, 2019, and 2018.
Year Ended December 31,
(In millions) 2020 2019 2018
Catalysts Technologies $ 1.8  $ 1.6  $ 13.7 
Materials Technologies 0.1  1.0  0.5 
Corporate   —  (0.2)
Total restructuring expenses $ 1.9  $ 2.6  $ 14.0 
Substantially all costs related to the restructuring programs are expected to be paid by June 30, 2023, but could be paid earlier subject to negotiations around certain plant exit costs.
The following table presents components of the change in the restructuring liability for the years ended December 31, 2020, 2019, and 2018:
99


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

11. Restructuring Expenses and Repositioning Expenses (Continued)
(In millions) Total
Balance, December 31, 2017 $ 6.7 
Accruals for severance and other costs 10.1 
Payments (6.1)
Balance, December 31, 2018 $ 10.7 
Accruals for severance and other costs 2.6 
Payments (10.2)
Currency translation adjustments and other 0.7 
Balance, December 31, 2019 $ 3.8 
Accruals for severance and other costs 3.2 
Payments (3.1)
Balance, December 31, 2020 $ 3.9 
Repositioning Expenses    Repositioning expenses for the years ended December 31, 2020, 2019, and 2018 were $35.0 million, $11.1 million, and $32.4 million respectively.
During 2020, Grace implemented changes to its Refining Technologies manufacturing operations and global footprint to drive capital and operating efficiencies and to support global growth. Grace, in agreement with its local joint venture partner, discontinued the previously announced project to build a full-scale fluid catalytic cracking catalysts plant in the Middle East. As a result, repositioning expenses in 2020 included a charge of $19.7 million to write off engineering and site costs. Repositioning expenses in 2020 also included $7.2 million in costs related to our review of strategic alternatives.
In 2020, 2019, and 2018, Grace incurred expenses related to a multi-year program to transform manufacturing and business processes to extend Grace’s competitive advantages and improve its cost position. Expenses in 2018 also included $11.7 million of severance and stock compensation costs related to employee separations and write-offs of $8.5 million of previously capitalized plant engineering costs as a result of terminating a manufacturing plant expansion project no longer necessary due to the polyolefin catalysts acquisition (see Note 20). Excluding asset write-offs and stock compensation costs, substantially all of these costs have been or are expected to be settled in cash.
12. Other (Income) Expense, net
Components of other (income) expense, net are as follows:
Year Ended December 31,
(In millions) 2020 2019 2018
Defined benefit pension (income) expense other than service cost $ 79.5  $ 79.9  $ (27.8)
Business interruption insurance recoveries (16.3) (10.7) — 
Hurricane-related costs 13.2  —  — 
Net (gain) loss on sales of investments and disposals of assets 5.9  4.5  4.9 
Third-party acquisition-related costs 5.2  3.6  7.3 
Currency transaction effects (0.1) (0.8) (3.6)
Other miscellaneous (income) expense 1.6  4.1  (4.0)
Total other (income) expense, net $ 89.0  $ 80.6  $ (23.2)
During 2020, Hurricane Laura caused severe and widespread damage to Lake Charles, Louisiana, and surrounding communities, including catastrophic damage to the regional power grid. The hurricane-related costs were primarily due to on-site power generation, incremental operations and logistics costs to supply customers during the outage, temporary housing and employee assistance, and property damage and clean-up. In addition
100


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

12. Other (Income) Expense, net (Continued)
to the amount shown above, Grace’s equity in earnings from unconsolidated affiliate was reduced by $1.9 million due to hurricane-related costs incurred by the joint venture.
In July 2019, a North American FCC catalysts customer filed for bankruptcy protection after announcing it would not resume refinery operations following a fire in its refinery. Grace received $16.3 million during the six months ended June 30, 2020, under its business interruption insurance policy. Including the $8.0 million received in the 2019 fourth quarter, Grace received $24.3 million of insurance recoveries related to this event, reflecting approximately eight quarters of the impact of the incident on earnings. This claim has been fully resolved.
13. Other Comprehensive Income (Loss)
The following tables present the pre-tax, tax, and after-tax components of Grace’s other comprehensive income (loss) for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31, 2020
(In millions)
Pre-Tax Amount Tax Benefit/ (Expense) After-Tax Amount
Amortization of net prior service credit included in net periodic benefit cost and other costs (credits), net
$ (0.5) $ 0.1  $ (0.4)
Currency translation adjustments (53.6) 3.7  (49.9)
Gain (loss) from hedging activities 1.6  (0.8) 0.8 
Other comprehensive income (loss) attributable to W. R. Grace & Co. shareholders
$ (52.5) $ 3.0  $ (49.5)
Year Ended December 31, 2019
(In millions)
Pre-Tax Amount Tax Benefit/ (Expense) After-Tax Amount
Amortization of net prior service credit included in net periodic benefit cost and other costs (credits), net
$ (0.9) $ 0.2  $ (0.7)
Currency translation adjustments 18.5  (2.0) 16.5 
Gain (loss) from hedging activities (7.0) 2.1  (4.9)
Other comprehensive income (loss) attributable to W. R. Grace & Co. shareholders
$ 10.6  $ 0.3  $ 10.9 
Year Ended December 31, 2018
(In millions)
Pre-Tax Amount Tax Benefit/ (Expense) After-Tax Amount
Amortization of net prior service credit included in net periodic benefit cost and other costs (credits), net
$ (1.2) $ 0.3  $ (0.9)
Currency translation adjustments 34.6  (2.2) 32.4 
Gain (loss) from hedging activities (10.0) 4.3  (5.7)
Other comprehensive income (loss) attributable to W. R. Grace & Co. shareholders
$ 23.4  $ 2.4  $ 25.8 
101


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

13. Other Comprehensive Income (Loss) (Continued)
The following table presents the changes in accumulated other comprehensive income (loss), net of tax, for the years ended December 31, 2020, 2019, and 2018:
Defined Benefit Pension and Other Postretirement Plans Currency Translation Adjustments Gain (Loss) from Hedging Activities Total
Balance, December 31, 2017 $ 0.9  $ 41.6  $ (2.6) $ 39.9 
OCI before reclassifications
—  32.4  11.1  43.5 
Amounts reclassified from accumulated OCI
(0.9) —  (16.8) (17.7)
Net current-period other comprehensive income (loss)
(0.9) 32.4  (5.7) 25.8 
Effect of adopting ASU 2018-02
0.2  2.2  (0.2) 2.2 
Balance, December 31, 2018 $ 0.2  $ 76.2  $ (8.5) $ 67.9 
OCI before reclassifications
—  16.5  14.0  30.5 
Amounts reclassified from accumulated OCI
(0.7) —  (18.9) (19.6)
Net current-period other comprehensive income (loss)
(0.7) 16.5  (4.9) 10.9 
Balance, December 31, 2019 $ (0.5) $ 92.7  $ (13.4) $ 78.8 
OCI before reclassifications
—  (49.9) (33.7) (83.6)
Amounts reclassified from accumulated OCI
(0.4) —  34.5  34.1 
Net current-period other comprehensive income (loss)
(0.4) (49.9) 0.8  (49.5)
Balance, December 31, 2020 $ (0.9) $ 42.8  $ (12.6) $ 29.3 
Grace is a global enterprise operating in many countries with local currency generally deemed to be the functional currency for accounting purposes. The currency translation amount represents the adjustments necessary to translate the balance sheets valued in local currencies to the U.S. dollar as of the end of each period presented, and to translate revenues and expenses at average exchange rates for each period presented, as well as amounts related to net investment hedges. See Note 6 for a discussion of hedging activities. See Note 8 for a discussion of pension plans.
14. Shareholders’ Equity
Under its Amended and Restated Certificate of Incorporation, the Company is authorized to issue 300,000,000 shares of common stock, $0.01 par value per share. As of December 31, 2020, the W. R. Grace & Co. 2018 Stock Incentive Plan (together with the 2014 Stock Incentive Plan, collectively, the “Stock Incentive Plans”) had 6,474,722 shares of unissued stock reserved for issuance in the event of the exercise of stock options or the issuance or settlement of stock-based compensation or awards. Shares issuable upon the exercise of stock options or the issuance or settlement of stock-based compensation or awards are covered by reissuing treasury stock, to the extent available; otherwise they are covered through newly issued shares. In 2020, 15,960 common shares were issued to members of the Board of Directors, in partial payment of their annual retainer, and 112,344 shares were issued to settle vested PBUs and vested tranches of RSUs.
102


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

14. Shareholders’ Equity (Continued)
The following table sets forth information relating to common stock activity for the years ended December 31, 2020, 2019, and 2018:
(In millions, except shares) Number of Shares Aggregate Proceeds
Balance of outstanding shares, December 31, 2017 67,780,410 
Stock options exercised 243,502  $ 6.7 
Shares issued 72,590 
Shares forfeited through net share exercise (132,393)
Shares repurchased (1,171,141)
Balance of outstanding shares, December 31, 2018 66,792,968 
Stock options exercised 388,174  $ 19.1 
Shares issued 94,796 
Shares forfeited through net share exercise (130,256)
Shares repurchased (409,769)
Balance of outstanding shares, December 31, 2019 66,735,913 
Stock options exercised —  $ — 
Shares issued 128,304 
Shares repurchased (673,807)
Balance of outstanding shares, December 31, 2020 66,190,410 
15. Stock Incentive Plans
The Stock Incentive Plans are administered by the Compensation Committee of the Board of Directors. Pursuant to the Stock Incentive Plans, the Company maintains Long-term Incentive Plans (the “LTIP”) under which it issues RSUs, PBUs, and stock options.
The Company has granted nonstatutory stock options to certain key employees under the Stock Incentive Plans. Stock options are generally non-qualified and are at exercise prices not less than 100% of the average per share fair market value on the date of grant. Stock-based compensation awards granted under the Company’s stock incentive plans are generally subject to a vesting period from the date of the grant ranging from 1 - 3 years. Currently outstanding options expire on various dates through May 2030.
On May 9, 2018, the Company’s stockholders approved the W. R. Grace & Co. 2018 Stock Incentive Plan. Under this new plan, stock options have a 10-year life. The Company began issuing stock-based compensation awards from this plan in the second half of 2018. The Company’s prior grants were issued under the previous plan in which options have a 5-year life.
103


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

15. Stock Incentive Plans (Continued)
The following table sets forth information relating to such options during 2020, 2019, and 2018.
Number of
Shares
Average
Exercise
Price
Weighted-
Average
Grant Date
Fair Value
Balance, December 31, 2017 1,813,450  $ 72.04 
Options exercised (243,502) 61.92 
Options forfeited (90,862) 69.82 
Options terminated (33,481) 75.07 
Options granted 428,190  67.36  $ 12.30 
Balance, December 31, 2018 1,873,795  72.34 
Options exercised (388,174) 74.33 
Options forfeited (35,216) 71.21 
Options terminated (74,583) 77.30 
Options granted 189,787  78.11  $ 17.94 
Balance, December 31, 2019 1,565,609  72.30 
Options exercised —  — 
Options forfeited (26,696) 60.26 
Options terminated (473,582) 76.67 
Options granted 348,005  55.34  $ 9.64 
Balance, December 31, 2020 1,413,336  66.89 
The following is a summary of nonvested option activity for the year ended December 31, 2020.
Number Of
Shares
Weighted-
Average
Grant Date
Fair Value
Nonvested options outstanding at beginning of year 506,593  $ 14.81 
Granted 348,005  9.64 
Vested (269,148) 13.93 
Forfeited (20,787) 9.90 
Nonvested options outstanding at end of year 564,663  12.16 
As of December 31, 2020, the intrinsic value (the difference between the exercise price and the market price) for options outstanding was immaterial and for options exercisable was zero. The total intrinsic value of all options exercised during the years ended December 31, 2019 and 2018 was $0.8 million and $1.6 million, respectively. No options were exercised in 2020. A summary of our stock options outstanding and exercisable at December 31, 2020, follows:
Exercise Price Range Number Outstanding Number Exercisable Outstanding Weighted- Average Remaining Contractual Life (Years) Exercisable Weighted- Average Exercise Price
$40 - $50
1,802  —  9.35 $ — 
$50 - $60
326,051  —  9.17 — 
$60 - $70
640,777  522,178  1.31 67.92 
$70 - $80
444,706  326,495  3.90 72.65 
1,413,336  848,673 
104


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

15. Stock Incentive Plans (Continued)
At December 31, 2020, the weighted-average remaining contractual term of all options outstanding and exercisable was 3.95 years.
Options Granted     For the years ended December 31, 2020, 2019, and 2018, the Company recognized non-cash stock-based compensation expense with respect to stock option grants of $2.8 million, $3.1 million, and $5.8 million, respectively, which is included in “selling, general and administrative expenses” in the Consolidated Statements of Operations. The actual tax benefit realized from stock option arrangements totaled $0.6 million, $1.9 million, and $2.2 million for the years ended December 31, 2020, 2019 and 2018, respectively.
The Company values options using the Black-Scholes option-pricing model, which was developed for use in estimating the fair value of traded options. The risk-free rate is based on the U.S. Treasury yield curve published as of the grant date, with maturities approximating the expected term of the options. The expected term of the options is estimated using the simplified method as allowed by ASC 718-20, whereby the average between the vesting period and contractual term is used. The expected volatility was estimated using actual Company stock volatility. The following summarizes the weighted average assumptions used for estimating the fair value of stock options granted during 2020, 2019, and 2018, respectively.
2020 2019 2018
Expected volatility
22.7% - 29.4%
22.7% - 23.1%
22.9% - 24.4%
Weighted average expected volatility 22.9% 23.0% 23.7%
Expected term
5.5 - 6.5 years
5.5 - 6.5 years
3.0 - 6.5 years
Risk-free rate 1.18% 2.58% 2.55%
Dividend yield 2.2% 1.4% 1.4%
Total unrecognized stock-based compensation expense at December 31, 2020, was $2.1 million, and the weighted-average period over which this expense will be recognized is 0.8 of a year.
Restricted Stock and Performance Based Units    In 2019, the Company modified a majority of its 2017 and 2018 cash-settled LTIP awards to be stock-settled. The following is a summary of RSUs and PBUs awarded under the LTIP.
2020 2019 2018
PBUs granted under the LTIP 120,161 88,174 93,216
RSUs granted under the LTIP 68,658 57,900 86,698
Shares covered by awards forfeited under the LTIP 17,250 17,323 44,279
Weighted average grant date fair value of PBUs $55.33 $78.11 $67.39
Weighted average grant date fair value of RSUs $55.05 $76.91 $67.54
Approximate percentage of awards expected to settle in common stock(1) 96  % 96  % 94  %
Approximate percentage of awards expected to settle in cash(1) % % %
___________________________________________________________________________________________________________________
(1)    Assumes full vesting.
The PBUs cliff vest after the completion of the performance periods ending December 31, 2022, 2021, and 2020. The RSUs vest in three equal annual installments. Vesting for all awards is subject to continued employment through the payment date (subject to certain exceptions for retirement, death or disability, change in control scenarios, and in the discretion of the Compensation Committee).
PBUs and RSUs are recorded at fair value at the date of grant. The common stock settled portion is considered an equity award with the payout being valued based on the Company’s stock price on the grant date. The cash settled portion of the award is considered a liability award with payout being remeasured each reporting period based on the Company’s current stock price. PBU equity awards are remeasured each reporting period based on the expected payout of the award, which may range from 0% to 200% of the targets for such awards; therefore, these portions of the awards are subject to volatility until the payout is finally determined at the end of
105


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

15. Stock Incentive Plans (Continued)
the performance period. During 2020, 2019, and 2018, the Company recognized $8.0 million, $9.2 million, and $13.2 million in compensation expense for these awards. As of December 31, 2020, $11.0 million of total unrecognized compensation expense related to the awards is expected to be recognized over the remaining weighted-average service period of 0.9 years.
16. Earnings Per Share
The following table shows a reconciliation of the numerators and denominators used in calculating basic and diluted earnings per share.
Year Ended December 31,
(In millions, except per share amounts) 2020 2019 2018
Numerators
Net income (loss) attributable to W. R. Grace & Co. shareholders $ (1.8) $ 126.3  $ 167.6 
Denominators
Weighted average common shares—basic calculation 66.3  66.8  67.2 
Dilutive effect of employee stock options 0.1 0.1
Weighted average common shares—diluted calculation
66.3  66.9  67.3 
Basic earnings per share $ (0.03) $ 1.89  $ 2.49 
Diluted earnings per share $ (0.03) $ 1.89  $ 2.49 
There were approximately 1.6 million, 1.0 million and 1.7 million anti-dilutive options outstanding for the years ended December 31, 2020, 2019, and 2018, respectively.
On February 8, 2017, the Company announced that its Board of Directors had authorized a share repurchase program of up to $250 million. On February 28, 2020, Grace announced that its Board of Directors had increased its share repurchase authorization to $250 million, including approximately $83 million remaining under the previously announced program. The timing of the repurchases and the actual amount repurchased will depend on a variety of factors, including the market price of the Company’s shares, strategic priorities for the deployment of capital, and general market and economic conditions. During 2020, 2019, and 2018, the Company repurchased 673,807; 409,769; and 1,171,141 shares of Company common stock for $40.4 million, $29.8 million, and $80.0 million, respectively, pursuant to the terms of the share repurchase program. As of December 31, 2020, $235.0 million remained under the current authorization.
17. Revenues
Grace generates revenues from customer arrangements primarily by manufacturing and delivering specialty chemicals and specialty materials, and by licensing technology, through its two reportable segments. See Note 18 for additional information about Grace’s reportable segments.
106


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

17. Revenues (Continued)
Disaggregation of Revenue    The following tables present Grace’s revenues by geography and product group, within its respective reportable segments, for the years ended December 31, 2020, 2019, and 2018.
Year Ended December 31, 2020
(In millions)
North America Europe Middle East Africa (EMEA) Asia Pacific Latin America Total
Polyolefin and Chemical Catalysts
$ 172.3  $ 231.7  $ 201.1  $ 16.5  $ 621.6 
Refining Catalysts 216.6  279.1  120.4  33.7  649.8 
Total Catalysts Technologies
$ 388.9  $ 510.8  $ 321.5  $ 50.2  $ 1,271.4 
Pharma/Consumer $ 61.5  $ 60.9  $ 19.8  $ 20.3  $ 162.5 
Coatings 25.4  66.6  35.8  9.7  137.5 
Chemical process 28.5  69.4  36.1  6.6  140.6 
Other 4.1  13.3  0.3  0.1  17.8 
Total Materials Technologies $ 119.5  $ 210.2  $ 92.0  $ 36.7  $ 458.4 
Total Grace $ 508.4  $ 721.0  $ 413.5  $ 86.9  $ 1,729.8 
Year Ended December 31, 2019
(In millions)
North America EMEA Asia Pacific Latin America Total
Polyolefin and Chemical Catalysts
$ 191.4  $ 283.0  $ 213.7  $ 17.2  $ 705.3 
Refining Catalysts 291.4  288.4  171.7  39.9  791.4 
Total Catalysts Technologies
$ 482.8  $ 571.4  $ 385.4  $ 57.1  $ 1,496.7 
Pharma/Consumer $ 45.2  $ 59.1  $ 20.1  $ 20.2  $ 144.6 
Coatings 25.9  67.8  36.9  9.2  139.8 
Chemical process 38.1  79.1  32.3  6.6  156.1 
Other 5.8  14.2  0.7  0.2  20.9 
Total Materials Technologies $ 115.0  $ 220.2  $ 90.0  $ 36.2  $ 461.4 
Total Grace $ 597.8  $ 791.6  $ 475.4  $ 93.3  $ 1,958.1 
Year Ended December 31, 2018
(In millions)
North America EMEA Asia Pacific Latin America Total
Polyolefin and Chemical Catalysts
$ 192.6  $ 255.4  $ 193.2  $ 20.3  $ 661.5 
Refining Catalysts 282.8  266.0  193.4  59.8  802.0 
Total Catalysts Technologies
$ 475.4  $ 521.4  $ 386.6  $ 80.1  $ 1,463.5 
Pharma/Consumer $ 36.2  $ 58.0  $ 19.0  $ 19.4  $ 132.6 
Coatings 28.1  75.3  43.3  8.7  155.4 
Chemical process 35.2  81.6  32.2  8.3  157.3 
Other 6.8  15.9  0.4  0.2  23.3 
Total Materials Technologies $ 106.3  $ 230.8  $ 94.9  $ 36.6  $ 468.6 
Total Grace $ 581.7  $ 752.2  $ 481.5  $ 116.7  $ 1,932.1 
Contract Balances    Grace invoices customers for product sales once performance obligations have been satisfied, generally at the point of delivery, at which point payment becomes unconditional. Accordingly, Grace’s product sales contracts generally do not give rise to material contract assets or liabilities under ASC 606; however, from time to time certain customers may pay in advance, which results in a contract liability. In the technology licensing business, Grace typically invoices licensees at the time that contractual milestones are achieved. However, in respect of the milestone billings, Grace is frequently obligated to provide services in future periods, and this results in recording contract liabilities.
107


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

17. Revenues (Continued)
The following table presents Grace’s deferred revenue balances as of December 31, 2020 and 2019:
December 31,
(In millions) 2020 2019
Current $ 33.8  $ 35.0 
Noncurrent 23.4  29.5 
Total $ 57.2  $ 64.5 
Grace records deferred revenues when cash payments are received or due in advance of performance. The change in deferred revenue reflects cash payments from customers received or due in advance of satisfying performance obligations, offset by $31.0 million of revenue recognized that was included in the deferred revenue balance as of December 31, 2019.
The noncurrent portion of deferred revenue will be recognized as performance obligations under the technology licensing agreements are satisfied, which is expected to be over the next four years.
Remaining performance obligations represent the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied). The aggregate amount of the transaction price allocated to remaining performance obligations for such contracts with a duration of more than one year was approximately $148 million as of December 31, 2020, and includes certain amounts reported as deferred revenue above. In accordance with the available practical expedient, Grace does not disclose information about remaining performance obligations that have original expected durations of one year or less, which generally relate to customer prepayments on product sales and are generally satisfied in less than one year. Grace expects to recognize revenue related to remaining performance obligations over several years, as follows:
Year Approximate percentage of revenue related to remaining performance obligations recognized
2021 27  %
2022 19  %
2023 17  %
2024 16  %
Thereafter through 2030 21  %
For the years ended December 31, 2020, 2019, and 2018, revenue recognized from performance obligations related to prior periods was not material. Grace has not capitalized any costs to obtain or fulfill contracts with customers under ASC 606. No material impairment losses have been recognized on any receivables or contract assets arising from contracts with customers.
18. Segment Information
Grace is a global producer of specialty chemicals and specialty materials. Grace’s two reportable business segments are Grace Catalysts Technologies and Grace Materials Technologies. Grace Catalysts Technologies includes catalysts and related products and technologies used in petrochemical, refining, and other chemical manufacturing applications. Advanced Refining Technologies (“ART”), Grace’s joint venture with Chevron U.S.A. Inc. (“Chevron”), is managed in this segment. (See Note 19.) Grace Catalysts Technologies comprises two operating segments, Grace Specialty Catalysts and Grace Refining Technologies, which are aggregated into one reportable segment based upon similar economic characteristics, the nature of the products and production processes, type and class of customer, and channels of distribution. Grace Materials Technologies includes specialty materials, including silica-based and silica-alumina-based materials, used in pharma/consumer, coatings, and chemical process applications. The table below presents information related to Grace’s reportable segments. Only those corporate expenses directly related to the reportable segments are allocated for reporting purposes. All remaining corporate items are reported separately and labeled as such.
108


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

18. Segment Information (Continued)
Grace excludes defined benefit pension expense from the calculation of segment operating income. Grace believes that the exclusion of defined benefit pension expense provides a better indicator of its reportable segment performance as defined benefit pension expense is not managed at a reportable segment level.
Grace defines Adjusted EBIT to be net income attributable to W. R. Grace & Co. shareholders adjusted for interest income and expense; income taxes; costs related to legacy matters; restructuring and repositioning expenses and asset impairments; pension costs other than service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits; gains and losses on sales or exits of businesses, product lines, and certain other investments; third-party acquisition-related costs and the amortization of acquired inventory fair value adjustment; gains and losses on modification or extinguishment of debt; the effects of these items on equity in earnings of unconsolidated affiliate; and certain other items that are not representative of underlying trends.
Reportable Segment Data
Year Ended December 31,
(In millions) 2020 2019 2018
Net Sales
Catalysts Technologies $ 1,271.4  $ 1,496.7  $ 1,463.5 
Materials Technologies 458.4  461.4  468.6 
Total $ 1,729.8  $ 1,958.1  $ 1,932.1 
Adjusted EBIT      
Catalysts Technologies segment operating income $ 309.6  $ 466.4  $ 440.9 
Materials Technologies segment operating income 85.0  97.8  105.6 
Corporate costs (68.0) (72.7) (73.5)
Certain pension costs (14.4) (18.4) (15.9)
Total $ 312.2  $ 473.1  $ 457.1 
Depreciation and Amortization
Catalysts Technologies $ 85.3  $ 81.9  $ 81.7 
Materials Technologies 15.0  14.2  15.5 
Corporate 4.7  4.2  3.6 
Total $ 105.0  $ 100.3  $ 100.8 
Capital Expenditures
Catalysts Technologies $ 107.8  $ 114.6  $ 150.3 
Materials Technologies 36.2  68.8  56.1 
Corporate 13.6  10.7  9.9 
Total $ 157.6  $ 194.1  $ 216.3 
Total Assets
Catalysts Technologies $ 2,294.9  $ 2,556.1  $ 2,326.6 
Materials Technologies 448.2  430.3  375.9 
Corporate 1,022.4  946.2  862.8 
Total $ 3,765.5  $ 3,932.6  $ 3,565.3 
Corporate costs include functional costs and other costs such as professional fees, incentive compensation, and insurance premiums. Certain pension costs include only ongoing costs recognized quarterly, which include service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits.
See Note 17 for sales of similar products within each reportable segment.
109


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

18. Segment Information (Continued)
Reconciliation of Reportable Segment Data to Financial Statements
Grace Adjusted EBIT for the years ended December 31, 2020, 2019, and 2018 is reconciled below to income (loss) before income taxes presented in the accompanying Consolidated Statements of Operations.
Year Ended December 31,
(In millions) 2020 2019 2018
Grace Adjusted EBIT $ 312.2  $ 473.1  $ 457.1 
Pension MTM adjustment and other related costs, net (94.6) (85.9) 15.2 
Loss on early extinguishment of debt (39.4) —  (4.8)
Costs related to legacy product, environmental and other claims
(39.4) (103.5) (82.3)
Restructuring and repositioning expenses (36.9) (13.7) (46.4)
Inventory write-offs and disposal costs(1) (20.7) (3.6) — 
Third-party acquisition-related costs
(5.2) (3.6) (7.3)
Taxes and interest included in equity in earnings of unconsolidated affiliate (0.7) 0.1  (0.4)
Benefit plan adjustment   (5.0) — 
Amortization of acquired inventory fair value adjustment
  —  (6.9)
Interest expense, net (74.9) (74.8) (78.5)
Net income (loss) attributable to noncontrolling interests 0.1  0.4  (0.8)
Income (loss) before income taxes $ 0.5  $ 183.5  $ 244.9 
___________________________________________________________________________________________________________________
(1)Inventory write-off in 2020 related to the changes in hydroprocessing catalysts manufacturing operations (see Note 2). Inventory write-off in 2019 related to the idling of Grace’s MTO manufacturing facility.
110


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

18. Segment Information (Continued)
Geographic Area Data
The table below presents information related to the geographic areas in which Grace operates. Sales are attributed to geographic areas based on the location to which the product is transported.
Year Ended December 31,
(In millions) 2020 2019 2018
Net Sales
United States $ 459.8  $ 540.2  $ 533.8 
Canada 48.6  57.6  47.9 
Total North America 508.4  597.8  581.7 
Europe Middle East Africa 721.0  791.6  752.2 
Asia Pacific 413.5  475.4  481.5 
Latin America 86.9  93.3  116.7 
Total $ 1,729.8  $ 1,958.1  $ 1,932.1 
Long-Lived Assets(1)
United States $ 799.1  $ 937.9  $ 793.0 
Canada 23.2  18.9  16.5 
Total North America 822.3  956.8  809.5 
Germany 267.4  228.2  172.5 
Rest of Europe Middle East Africa 41.0  45.2  48.9 
Total Europe Middle East Africa 308.4  273.4  221.4 
Asia Pacific 72.2  80.3  72.9 
Latin America 5.9  7.2  6.7 
Total $ 1,208.8  $ 1,317.7  $ 1,110.5 
___________________________________________________________________________________________________________________
(1)Long-lived assets as of December 31, 2019 and 2018, include properties and equipment and the current asset related to a hydroprocessing catalyst plant to be transferred to ART upon completion. (See Note 19.)
19. Related Party Transactions
Unconsolidated Affiliate    Grace accounts for its 50% ownership interest in ART, its joint venture with Chevron, using the equity method of accounting. Grace’s investment in ART amounted to $175.5 million and $181.9 million as of December 31, 2020 and 2019, respectively. ART is a private, limited liability company, taxed as a partnership, and accordingly does not have a quoted market price available. During 2020, Grace received dividends of $20.0 million from ART.
111


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

19. Related Party Transactions (Continued)
The table below presents the components of Grace’s “equity in earnings of unconsolidated affiliate” in the Consolidated Statements of Operations.
Year Ended December 31,
(In millions) 2020 2019 2018
Operating income $ 17.5  $ 28.2  $ 32.7 
Depreciation and amortization (3.3) (0.5) (0.5)
Interest expense and income taxes (0.7) 0.1  (0.4)
Equity in earnings of unconsolidated affiliate 13.5  27.8  31.8 
The table below presents summary financial data related to ART’s balance sheet and results of operations.
December 31,
(In millions) 2020 2019
Summary Balance Sheet information:
Current assets $ 286.4  $ 300.7 
Noncurrent assets 235.8  237.8 
Total assets $ 522.2  $ 538.5 
Current liabilities $ 173.0  $ 177.1 
Noncurrent liabilities 0.3  0.3 
Total liabilities $ 173.3  $ 177.4 
Year Ended December 31,
(In millions) 2020 2019 2018
Summary Statement of Operations information:
Net sales $ 481.9  $ 527.5  $ 487.5 
Costs and expenses applicable to net sales 431.4  453.4  410.6 
Income before income taxes 28.2  59.0  65.5 
Net income 27.0  56.5  64.2 
Grace and ART transact business on a regular basis and maintain several agreements in order to operate the joint venture. These agreements and the resulting transactions are treated as related party activities with an unconsolidated affiliate. Product manufactured by Grace for ART is accounted for on a net basis, with a mark-up, which reduces “cost of goods sold” in the Consolidated Statements of Operations. Grace also receives reimbursement from ART for fixed costs; research and development; selling, general and administrative services; and depreciation. Grace records reimbursements against the respective line items in Grace’s Consolidated Statements of Operations. The table below presents summary financial data related to transactions between Grace and ART.
Year Ended December 31,
(In millions) 2020 2019 2018
Product manufactured for ART $ 261.1  $ 260.8  $ 229.1 
Mark-up on product manufactured for ART included as a reduction of Grace’s cost of goods sold
5.1  5.1  4.5 
Charges for fixed costs; research and development; selling, general and administrative services; and depreciation to ART
54.3  51.1  41.8 
112


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

19. Related Party Transactions (Continued)
The table below presents balances in Grace’s Consolidated Financial Statements related to ART.
December 31,
(in millions) 2020 2019
Trade accounts receivable $ 28.3  $ 17.5 
Other current assets   173.9 
Accounts payable 19.8  37.7 
Debt payable within one year 3.5  9.9 
Debt payable after one year 22.1  37.5 
Other current liabilities   173.9 
The current asset and current liability as of December 31, 2019, in the table above represented spending related to a residue hydroprocessing catalyst production plant that has been constructed in Lake Charles, Louisiana. Grace managed the design and construction of the plant, and the asset was included in “other current assets” in Grace’s Consolidated Balance Sheets until commissioning and start-up activities were completed. Grace had likewise recorded a liability for the transfer of the asset to ART upon completion, included in “other current liabilities” in the Consolidated Balance Sheets. Grace transferred the asset to ART in the 2020 third quarter.
Grace and ART maintain an agreement whereby ART loans Grace funds for maintenance capital expenditures at manufacturing facilities used to produce catalysts for ART. Grace makes principal and interest payments on the loans on a monthly basis. These unsecured loans have repayment terms of up to 8 years, unless earlier repayment is demanded by ART. The loans bear interest at the three-month LIBOR plus 1.25%.
Grace and Chevron provide lines of credit in the amount of $15.0 million each at a commitment fee of 0.1% of the credit amount. These agreements have been approved by the ART Executive Committee for renewal until February 2022. No amounts were outstanding at December 31, 2020 and 2019.
Joint Venture Arrangement    In 2018, Grace formed a joint venture in a developing country in Asia. The purpose of the joint venture is to establish a logistics facility and catalyst testing laboratory and to be the exclusive FCC catalysts and additives supplier to certain customers in the country. Grace’s joint venture partner is the parent company of the customers. Grace has an 87.5% ownership interest in the joint venture and consolidates the activities of the entity. Grace’s Consolidated Balance Sheets as of December 31, 2020 and 2019, include trade accounts receivable of $2.2 million and $3.6 million, respectively, from these customers. Grace’s Consolidated Statements of Operations for the years ended December 31, 2020, 2019, and 2018, include $11.3 million, $11.8 million, and $14.0 million, respectively, of revenues from these customers.
20. Acquisitions
Rive Technology, Inc. On June 17, 2019, Grace completed the acquisition of the business and assets of Rive Technology, Inc. for $22.8 million, with an additional $2.0 million holdback payment remitted in the three months ended September 30, 2020. The business is included in the Refining Technologies operating segment of the Catalysts Technologies reportable segment. The acquisition included Rive’s MOLECULAR HIGHWAY® zeolite technology for catalytic processes, which allows Grace to offer a broader spectrum of products for converting crude oil to petrochemical feedstocks.
Polyolefin catalysts business of Albemarle Corporation On April 3, 2018, using cash on hand and borrowings under the Credit Agreement, Grace acquired the assets of the polyolefin catalysts business of Albemarle Corporation. Grace acquired the business for $418.0 million, net of cash acquired and including customary post-closing adjustments. The business is included in the Specialty Catalysts operating segment of the Catalysts Technologies reportable segment. The acquisition is complementary to Grace’s existing specialty catalysts business and strengthens Grace’s commercial relationships, catalysts technology portfolio, and manufacturing network.
113


Table of Contents
TOC—Financial Statements

Notes to Consolidated Financial Statements (Continued)

21. Quarterly Financial Information (Unaudited)
(In millions, except per share amounts) March 31 June 30 September 30(2) December 31(3)
2020
Net sales $ 421.5  $ 418.7  $ 419.4  $ 470.2 
Gross profit 159.6  119.3  156.4  181.2 
Net income (loss) 42.1  (9.6) 6.7  (40.9)
Net income (loss) attributable to W. R. Grace & Co. shareholders
42.0  (7.3) 7.0  (43.5)
Net income (loss) per share:(1)
Basic earnings (loss) per share: $ 0.63  $ (0.11) $ 0.11  $ (0.66)
Diluted earnings (loss) per share: 0.63  (0.11) 0.11  (0.66)
Dividends declared per share 0.30  0.30  0.30  0.30 
___________________________________________________________________________________________________________________
(1)Per share results for the four quarters may differ from full-year per share results, as a separate computation of the weighted average number of shares outstanding is made for each quarter presented.
(2)Third quarter “net income (loss),” “net income (loss) attributable to W. R. Grace & Co. shareholders,” and the related earnings per share data include the effects of a pre-tax charge of $27.0 million for estimated costs to construct a new dam spillway at the former vermiculite mine site in Libby, Montana, as well as a $39.4 million loss on early extinguishment of debt.
(3)Fourth quarter “net income (loss),” “net income (loss) attributable to W. R. Grace & Co. shareholders,” and the related earnings per share data include the effects of the annual pension mark-to-market adjustment, as well as charges related to legacy items (see Note 10).
(In millions, except per share amounts) March 31(2) June 30 September 30 December 31(3)
2019
Net sales $ 469.5  $ 513.6  $ 470.5  $ 504.5 
Gross profit 188.6  209.4  191.0  204.7 
Net income (loss) 24.6  76.4  53.8  (28.1)
Net income (loss) attributable to W. R. Grace & Co. shareholders
24.7  76.2  53.7  (28.3)
Net income (loss) per share:(1)
Basic earnings (loss) per share: $ 0.37  $ 1.14  $ 0.81  $ (0.42)
Diluted earnings (loss) per share: 0.37  1.14  0.80  (0.42)
Dividends declared per share 0.27  0.27  0.27  0.27 
___________________________________________________________________________________________________________________
(1)Per share results for the four quarters may differ from full-year per share results, as a separate computation of the weighted average number of shares outstanding is made for each quarter presented.
(2)First quarter “net income (loss),” “net income (loss) attributable to W. R. Grace & Co. shareholders,” and the related earnings per share data include the effects of a pre-tax charge of $45.0 million for estimated costs to construct a new dam spillway at the former vermiculite mine site in Libby, Montana.
(3)Fourth quarter “net income (loss),” “net income (loss) attributable to W. R. Grace & Co. shareholders,” and the related earnings per share data include the effects of the annual pension mark-to-market adjustment, as well as charges related to legacy items (see Note 10).
22. Subsequent Event
On February 25, 2021, Grace entered into a definitive agreement to acquire the Fine Chemistry Services business of Albemarle Corporation (“Albemarle”) for approximately $570 million, including $300 million to be paid in cash at closing and $270 million to be funded through the issuance to Albemarle of non-participating preferred equity of a newly created wholly owned Grace subsidiary. The cash portion of the transaction is expected to be funded through a combination of debt and cash on hand. This acquisition would strengthen and expand Grace’s existing pharma portfolio, within the Materials Technologies segment. The transaction is subject to customary closing conditions, including receipt of certain regulatory approvals.
114


Table of Contents
TOC—Financial Statements
W. R. GRACE & CO. AND SUBSIDIARIES
FINANCIAL STATEMENT SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

For the Year Ended December 31, 2020
(In millions) Balance at beginning of period Additions charged to costs and expenses Deductions Other,
net(1)
Balance at end of period
Valuation and qualifying accounts deducted from assets:
Allowances for notes and accounts receivable $ 13.7  $ 0.6  $ (12.1) $ 0.1  $ 2.3 
Valuation allowance for deferred tax assets(2) 24.1  15.5  (0.9) —  38.7 
For the Year Ended December 31, 2019
(In millions) Balance at beginning of period Additions charged to costs and expenses Deductions Other,
net(1)
Balance at end of period
Valuation and qualifying accounts deducted from assets:
Allowances for notes and accounts receivable $ 12.0  $ 3.2  $ (1.5) $ —  $ 13.7 
Valuation allowance for deferred tax assets(3) 19.9  9.2  (5.0) —  24.1 
For the Year Ended December 31, 2018
(In millions) Balance at beginning of period Additions charged to costs and expenses Deductions Other,
net(1)
Balance at end of period
Valuation and qualifying accounts deducted from assets:
Allowances for notes and accounts receivable $ 12.0  $ —  $ —  $ —  $ 12.0 
Valuation allowance for deferred tax assets(4) 12.0  10.7  (2.8) —  19.9 
___________________________________________________________________________________________________________________
(1)Effects of currency translation.
(2)The valuation allowance increased $14.6 million from December 31, 2019, to December 31, 2020. The increase was primarily due to projected consolidated taxable income, causing the expiration of foreign tax credits in 2021.
(3)The valuation allowance increased $4.2 million from December 31, 2018, to December 31, 2019. The increase was primarily due to the projected taxable income in certain foreign jurisdictions.
(4)The valuation allowance increased $7.9 million from December 31, 2017, to December 31, 2018. The increase was primarily due to changes in expected foreign tax credit utilization.
115


Table of Contents
TOC—Financial Statements
Item 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Item 9A.    CONTROLS AND PROCEDURES
Except as provided below, the disclosure required by this Item appears in Item 8 under the headings “Management’s Report on Internal Control Over Financial Reporting” and “Report of Independent Registered Public Accounting Firm,” which disclosure is incorporated herein by reference.
There was no change in Grace’s internal control over financial reporting during the quarter ended December 31, 2020, that has materially affected, or is reasonably likely to materially affect, Grace’s internal control over financial reporting.
Item 9B.    OTHER INFORMATION
None.
116


Table of Contents
TOC—Financial Statements
PART III

Item 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information required by this Item regarding Grace’s executive officers appears at Part I after Item 4 of this report. The other information required by this Item is incorporated by reference to the definitive proxy statement that Grace will file with the SEC no later than 120 days after December 31, 2020 (the “2021 Proxy Statement”).
Item 11.    EXECUTIVE COMPENSATION
The information required by this Item is incorporated by reference to the 2021 Proxy Statement.
Item 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required by this Item is incorporated by reference to the 2021 Proxy Statement.
Item 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this Item is incorporated by reference to the 2021 Proxy Statement.
Item 14.    PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by this Item is Incorporated by reference to the 2021 Proxy Statement.
117


Table of Contents
TOC—Financial Statements
PART IV

Item 15.    EXHIBITS, FINANCIAL STATEMENT SCHEDULES
Financial Statements and Schedules.    The required information is set forth in Item 8, which is incorporated herein by reference.
Exhibits.    The exhibits to this Report are listed below. Other than exhibits that are filed herewith, all exhibits listed below are incorporated by reference.
In reviewing the agreements included as exhibits to this and other Reports filed by Grace with the Securities and Exchange Commission, please remember they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about Grace or other parties to the agreements. The agreements generally contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement. These representations and warranties:
are not statements of fact, but rather are used to allocate risk to one of the parties if the statements prove to be inaccurate;
may have been qualified by disclosures that were made to the other parties in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;
may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and do not reflect more recent developments.
Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about Grace may be found elsewhere in this report and Grace’s other public filings, which are available without charge through the Securities and Exchange Commission’s website at http://www.sec.gov.
Exhibit No. Exhibit Location
2.1 Exhibit 2.01 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
2.2 Exhibit 2.02 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
2.3 Exhibit 2.1 to Form 8-K (filed 1/28/16) SEC File No.: 001-13953
2.4 Exhibit 2.4 to Form 10-K (filed 2/22/18) SEC File No.: 001-13953
2.5 Filed herewith.
3.1 Exhibit 3.01 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
3.2 Exhibit 3.01 to Form 8-K (filed 1/23/15) SEC File No.: 001-13953
4.1 Exhibit 4.01 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
118


Table of Contents
TOC—Financial Statements
Exhibit No. Exhibit Location
4.2 Exhibit 10.1 to Form 8-K (filed 11/25/15) SEC File No.: 001-13953
4.3 Exhibit 4.04 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
4.4 Exhibit 4.05 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
4.5 Exhibit 4.06 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
4.6 Exhibit 4.07 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
4.7 Exhibit 4.08 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
4.8 Exhibit 4.1 to Form 8-K (filed 9/19/14) SEC File No.: 001-13953
4.9 Exhibit 4.2 to Form 8-K (filed 9/19/14) SEC File No.: 001-13953
4.10 Exhibit 4.3 (included as Exhibit A-1 to Exhibit 4.2) to Form 8-K (filed 9/19/14) SEC File No.: 001-13953
4.11 Exhibit 4.4 (included as Exhibit A-2 to Exhibit 4.2) to Form 8-K (filed 9/19/14) SEC File No.: 001-13953
4.12 Exhibit 4.1 to Form 8-K (filed 4/03/18) SEC File No.: 001-13953
4.13 Exhibit 4.2 to Form 10-Q (filed 5/09/18) SEC File No.: 001-13953
4.14 Exhibit 4.14 to Form 10-K (filed 2/27/20) SEC File No.: 001-13953
4.15
Exhibit 4.2 to Form 8-K (filed 6/26/20) SEC File No.: 001-13953
4.16
Exhibit 4.3 (included as Exhibit A to Exhibit 4.2) to Form 8-K (filed 6/26/20) SEC File No.: 001-13953
10.1 Exhibit 10.02 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953
10.2 Exhibit 10.03 to Form 8-K (filed 2/07/14) SEC File No.: 001-13953*
10.3 Exhibit 10.2 to Form 8-K (filed 2/09/16) SEC File No.: 001-13953*
10.4 Exhibit 10.1 to Form 8-K (filed 2/09/16) SEC File No.: 001-13953*
119


Table of Contents
TOC—Financial Statements
Exhibit No. Exhibit Location
10.5 Exhibit 10.3 to Form 8-K (filed 2/09/16) SEC File No.: 001-13953*
10.6 Exhibit 10.7 to Form 10-K (filed 3/28/02) SEC File No.: 001-13953*
10.7 Exhibit 10.8 to Form 10-K (filed 3/28/02) SEC File No.: 001-13953*
10.8 Exhibit 10.17 to Form 10-K (filed 3/13/03) SEC File No.: 001-13953*
10.9 Exhibit 10.2 to Form 8-K (filed 2/04/16) SEC File No.: 001-13953*
10.10 Exhibit 10.1 to Form 8-K (filed 5/12/15) SEC File No.: 001-13953*
10.11 Exhibit 10.1 to Form 8-K (filed 1/28/16) SEC File No.: 001-13953
10.12 Exhibit 10.1 to Form 8-K (filed 3/07/08) SEC File No.: 001-13953*
10.13 Exhibit 10.20 to Form 10-K (filed 2/25/15) SEC File No.: 001-13953*
10.14 Exhibit 10.1 to Form 10-Q (filed 5/07/15) SEC File No.: 001-13953*
10.15 Exhibit 10.1 to Form 10-Q (filed 5/09/18) SEC File No.: 001-13953*
10.16 Exhibit 10.2 to Form 10-Q (filed 5/09/18) SEC File No.: 001-13953*
10.17 Exhibit 10.1 to Form 8-K (filed 5/14/18) SEC File No.: 001-13953*
10.18 Exhibit 10.2 to Form 10-Q (filed 8/08/18) SEC File No.: 001-13953*
10.19 Exhibit 10.3 to Form 10-Q (filed 8/08/18) SEC File No.: 001-13953*
10.20 Exhibit 10.4 to Form 10-Q (filed 8/08/18) SEC File No.: 001-13953*
10.21 Exhibit 10.5 to Form 10-Q (filed 8/08/18) SEC File No.: 001-13953*
10.22 Exhibit 99.1 to Form 8-K (filed 2/20/19) SEC File No.: 001-13953*
10.23 Filed herewith*
21 Filed herewith
23 Filed herewith
24 Filed herewith
31(i).1 Filed herewith
31(i).2 Filed herewith
32  Furnished herewith
95  Filed herewith
120


Table of Contents
TOC—Financial Statements
Exhibit No. Exhibit Location
101.INS Inline XBRL Instance Document The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Filed herewith
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Filed herewith
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Filed herewith
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Filed herewith
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Filed herewith
104 Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibit 101) Filed herewith
___________________________________________________________________________________________________________________
*    Management contracts and compensatory plans, contracts or arrangements required to be filed as exhibits to this Report.
Item 16.    FORM 10-K SUMMARY
None.
121


Table of Contents
TOC—Financial Statements
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
W. R. GRACE & CO.
By: /s/ HUDSON LA FORCE
Hudson La Force
President and Chief Executive Officer
(Principal Executive Officer)
By: /s/ WILLIAM C. DOCKMAN
William C. Dockman
Senior Vice President and Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)
Dated: February 25, 2021
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on February 25, 2021.
Signature   Title
R. F. Cummings, Jr.* }
D. H. Gulyas* }
J. Fasone Holder* }
H. R. Slack* } Directors
C. J. Steffen* }
M. E. Tomkins* }  
S. Yanai* }

/s/ HUDSON LA FORCE President and Chief Executive Officer and Director
(Principal Executive Officer)
Hudson La Force
/s/ WILLIAM C. DOCKMAN Senior Vice President and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
William C. Dockman

___________________________________________________________________________________________________________________
*By signing her name hereto, Cherée H. Johnson is signing this document on behalf of each of the persons indicated above pursuant to powers of attorney duly executed by such persons and filed with the Securities and Exchange Commission.
By: /s/ CHERÉE H. JOHNSON
Cherée H. Johnson
(Attorney-in-Fact)

122
CONFIDENTIAL    EXECUTION DRAFT

SALE, PURCHASE AND CONTRIBUTION AGREEMENT
BY AND AMONG
ALBEMARLE CORPORATION,
W. R. GRACE & CO.-CONN.
And
FINE CHEMICAL MANUFACTURING SERVICES LLC
Dated as of February 25, 2021
21360825


TABLE OF CONTENTS
Page
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
5
6
6
-1-

TABLE OF CONTENTS
(continued)
Page
6
6
6
6
6
6
7
7
7
7
7
7
7
7
8
8
8
8
8
8
8
8
9
9
9
9
9
9
9
9
9
10
10
10
10
10
10
10
11
11
11
-2-

TABLE OF CONTENTS
(continued)
Page
11
11
11
11
12
12
12
12
12
12
13
13
13
13
13
13
13
13
13
14
14
15
15
15
15
15
15
16
16
16
16
16
16
17
17
17
17
17
17
17
17
-3-

TABLE OF CONTENTS
(continued)
Page
17
17
18
18
18
18
18
18
19
19
19
19
19
19
19
19
20
20
20
20
20
20
20
20
21
21
21
21
21
21
21
21
21
22
22
22
22
22
22
22
22
-4-

TABLE OF CONTENTS
(continued)
Page
23
23
23
23
23
23
23
23
23
24
24
24
24
24
24
24
24
24
24
25
25
25
25
25
25
25
26
26
26
26
26
27
27
27
27
28
30
32
32
32
-5-

TABLE OF CONTENTS
(continued)
Page
33
34
34
35
35
36
38
38
38
39
39
40
40
40
40
41
43
44
46
47
47
50
51
51
52
52
52
53
53
53
54
54
55
55
56
56
57
57
57
58
-6-

TABLE OF CONTENTS
(continued)
Page
58
59
59
60
61
61
63
65
66
68
69
70
70
76
76
77
78
78
81
81
81
81
82
82
82
83
83
83
84
85
85
85
86
86
87
89
89
95
95
95
96
-7-

TABLE OF CONTENTS
(continued)
Page
96
96
97
97
97
98
98
98
98
100
100
100
100
101
101
101
101
102
102
103
103
103


-8-


EXHIBIT
Exhibit A-1    Form of Assignment and Assumption Agreement and Bill of Sale
Exhibit A-2    Form of Deed of Transfer of Owned Real Property (Tyrone)
Exhibit A-3    Form of Deed of Transfer of Owned Real Property (South Haven)
Exhibit B    Form of Intellectual Property Assignment Agreement
Exhibit C-1    Form of Sales Agreement (New Johnsonville)
Exhibit C-2    Form of Sales Agreement (Bromine)
Exhibit D    Form of SPV Operating Agreement
Exhibit E    Form of Transition Services Agreement
Exhibit F    Principles of Scope of Phase II at the South Haven, Michigan Manufacturing Facility
Exhibit G     Pollution Policy
SELLER DISCLOSURE SCHEDULES
Section 1.54    Excluded Equipment
Section 1.68    Financial Statements
Section 1.100    Net Working Capital
Section 1.102    Owned Real Property
Section 1.104    Permitted Encumbrances
Section 1.137    Required Information
Section 1.139    Retention Agreement Recipients
Section 1.156    Seller’s Knowledge Parties
Section 1.158    Shared Contracts
Section 1.188    Transferred Permits
Section 1.189    Transferred Records
Section 2.1(b)(xvi)    Certain Excluded Assets
Section 2.2(a)(vii)    Certain Assumed Liabilities
Section 2.2(b)(x)    Certain Excluded Liabilities
Section 3.2    No Conflict
Section 3.4    Financial Information Procedures and Methodologies
Section 3.7(b)    Compliance with Laws
Section 3.8(a)    Transferred Intellectual Property
Section 3.8(b)    Transferred Intellectual Property Encumbrances
Section 3.8(f)    Royalties, Honoraria, Fees or Other Payments
Section 3.10(a)    Business Employees
Section 3.10(b)    Seller Benefit Plans
Section 3.11(e)    Improper Exclusions from Seller Benefit Plans
Section 3.12(c)    Unresolved or Unpaid Tax Claims or Deficiencies
Section 3.13(a)    Material Contracts
Section 3.14(a)    Environmental Matters
Section 3.15(a)    Key Customers
Section 3.15(b)    Key Suppliers
Section 3.15(c)    Key Distributors
-9-


Section 3.15(d)(i)    Notices from Key Customers, Key Suppliers and Key Distributors
Section 3.15(d)(ii)    Changes related to Key Customers, Key Suppliers and Key Distributors
Section 3.19    Transferred Permits
Section 3.20    Product Warranty Claims
Section 3.22(a)    Compliance with Drug Laws
Section 3.24    Relationships with Related Parties
Section 5.1    Conduct of Business Prior to the Closing
Section 5.6(d)    Pre-Closing Integration
Section 5.10(d)    Form of Authorization to Share Information
Section 7.1(b)    Governmental Approvals
Section 7.2(g)    Third Party Consents and Approvals
Section 8.2(e)    Specified Indemnity
PURCHASER DISCLOSURE SCHEDULES
Section 4.2    No Conflict
-10-


SALE, PURCHASE AND CONTRIBUTION AGREEMENT
This SALE, PURCHASE AND CONTRIBUTION AGREEMENT is made as of February 25, 2021, by and between Albemarle Corporation, a Virginia corporation (the “Seller”), W. R. Grace & Co.-Conn., a Connecticut corporation (the “Purchaser”), and Fine Chemical Manufacturing Services LLC, a Delaware limited liability company (the “SPV”).
WHEREAS, the Seller and certain of its Subsidiaries are engaged in the Business (as hereinafter defined);
WHEREAS, the Seller and its Subsidiaries own all of the Transferred Assets (as hereinafter defined);
WHEREAS, the Purchaser is the sole member of the SPV and owns all of the issued and outstanding membership interests of the SPV;
WHEREAS, the Seller wishes to sell to the SPV, and the Purchaser wishes to purchase from the Seller on behalf of the SPV, 52.6% of each of the Transferred Assets (as hereinafter defined), and in connection therewith the Purchaser is willing to assume from the Seller 52.6% of each of the Assumed Liabilities, subject to adjustment to account for any adjustments to Purchase Price hereunder and to account for the Transferred Intellectual Property sold to and purchased by (and to be held by) the Purchaser (the “Purchaser-Owned IP”), upon the terms and subject to the conditions set forth herein (the “Sale and Purchase”);
WHEREAS, the Seller, the Purchaser and the SPV intend that for income Tax purposes, (a) the transfer of the Transferred Assets in exchange for the Purchase Price (as hereinafter defined) pursuant to the Sale and Purchase shall be treated as a sale and purchase of 52.6% of each of the Transferred Assets (and an assumption of 52.6% of each of the Assumed Liabilities by the Purchaser), subject to adjustment to account for any adjustments to Purchase Price hereunder and to account for the Purchaser-Owned IP, in a transaction subject to Section 1001 of the Code (as hereinafter defined) and (b) the Contribution and the Preferred Issuance, together, shall be treated as a contribution of 47.4% of each of the Transferred Assets to the SPV (and an assumption of 47.4% of each of the Assumed Liabilities by the SPV), subject to adjustment to account for any adjustments to Purchase Price hereunder and to account for the Purchaser-Owned IP, in an exchange pursuant to Situation 2 of IRS Revenue Ruling 99-5, 1999-1 C.B. 434 and Section 721 of the Code; and
WHEREAS, at the Closing, the Purchaser, the Seller and the SPV wish to enter into that certain SPV Operating Agreement (as hereinafter defined), pursuant to which, in exchange for a contribution of 47.4% of each of the Transferred Assets to the SPV (and an assumption of 47.4% of each of the Assumed Liabilities (as hereinafter defined) by the SPV), subject to adjustment to account for any adjustments to Purchase Price hereunder and to account for the Purchaser-Owned IP (the “Contribution”), the SPV will issue to the Seller the Preferred Equity (as hereinafter defined) of the SPV (the “Preferred Issuance”).



NOW, THEREFORE, in consideration of the foregoing premises and the respective representations, warranties, covenants and agreements contained in this Agreement, and intending to be legally bound hereby, the Seller, the Purchaser and the SPV hereby agree as follows:
Article I.
DEFINITIONS
When used in this Agreement, the following terms shall have the meanings specified:
Section 1.12021 Bonus Stub Period.
2021 Bonus Stub Period” shall have the meaning set forth in Section 5.8(c).
Section 1.22021 Bonus Stub Period Performance Bonuses.
2021 Bonus Stub Period Performance Bonuses” shall have the meaning set forth in Section 5.8(c).
Section 1.3Accrued 2020 Performance Bonuses.
Accrued 2020 Performance Bonuses” shall have the meaning set forth in Section 5.8(c).
Section 1.4Accrued 2021 Performance Bonuses.
Accrued 2021 Performance Bonuses” shall have the meaning set forth in Section 5.8(c).
Section 1.5Accrued Performance Bonuses.
Accrued Performance Bonuses” shall have the meaning set forth in Section 5.8(c).
Section 1.6Act 2.
Act 2” means the Land Recycling Standards and Remediation Act, 35 P.S. 6026.101 et seq.
Section 1.7Action.
Action” means any claim, action, law, litigation, suit, arbitration, charge, grievance, labor dispute, audit, inquiry, proceeding or investigation by or before any Governmental Authority or arbitral board or body.
Section 1.8Additional Employee Data.
-2-


Additional Employee Data” shall have the meaning set forth in Section 3.10(a).
Section 1.9Affiliate.
Affiliate” means, with respect to any specified Person, any other Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such specified Person.
Section 1.10Aggregate Transaction Value.
Aggregate Transaction Value” means $570,000,000, which is the sum of (a) the Purchase Price and (b) the aggregate Preferred Unit Face Value of the Preferred Equity.
Section 1.11Agreement.
Agreement” means this Sale, Purchase and Contribution Agreement between the parties hereto (including the Exhibits and Schedules hereto) and all amendments hereto made in accordance with the provisions of Section 11.9.
Section 1.12Alternative Financing
.
Alternative Financing” shall have the meaning set forth in Section 5.13(a).
Section 1.13Antitrust Law.
Antitrust Law” means the Sherman Antitrust Act of 1890, the Clayton Antitrust Act of 1914, the HSR Act, the Federal Trade Commission Act of 1914 and all other Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or significant impediments or lessening of competition or the creation or strengthening of a dominant position through merger or acquisition, in any case that are applicable to the transactions contemplated by this Agreement or the other Transaction Documents.
Section 1.14Allocation Schedule.
Allocation Schedule” shall have the meaning set forth in Section 2.6(a).
Section 1.15Anti-Corruption Laws.
Anti-Corruption Laws” means (a) the U.S. Foreign Corrupt Practices Act of 1977, as amended; (b) the U.K. Bribery Act 2010, as amended; and (c) any other applicable Law related to anti-bribery or anti-corruption.
-3-


Section 1.16Assumed Liabilities.
Assumed Liabilities” shall have the meaning set forth in Section 2.2(a).
Section 1.17Baseline Net Working Capital.
Baseline Net Working Capital” means $52,500,000.
Section 1.18Basket.
Basket” shall have the meaning set forth in Section 8.4(b).
Section 1.19Beneficial Ownership Regulation
.

Beneficial Ownership Regulation” means 31 C.F.R. § 1010.230.
Section 1.20Business.
Business” means the Fine Chemistry Services Business of the Seller which provides services and develops and manufactures active ingredients, advanced intermediates, regulatory starting materials and functional excipients for the pharmaceutical, nutraceutical and agrochemical industries, as well as intermediates and finished catalysts for specialty chemical synthesis and together with the operations of that business located in Tyrone, Pennsylvania and South Haven, Michigan. Notwithstanding the preceding sentence, “Business” shall not, in any case, include the business of researching, developing, manufacturing, producing, having made or produced, marketing or selling (or providing services related to the foregoing) flame retardants, oilfield and drilling-related chemicals or products, lithium or lithium-containing products, bromine or bromine-containing products, cesium and cesium-containing products, halogens or halogen-containing products, aluminum or aluminum-containing products, catalysts, catalyst precursors, catalyst components, catalyst supports, catalyst intermediates, catalyst activators, catalyst additives or their components, metallocenes or their components, zeolites or their components, metal organics, products or catalysts used in the Metal Organic Chemical Vapor Deposition (MOCVD) process, sorbents or their intermediates precursors or delivery systems, polymer additives, heat stabilizers, curatives, cure promoters or chain extenders, or orthoalkylated intermediates for pesticides including diethylaniline (DEA) and methyl- ethylaniline (MEA) (the “Excluded Products”), the processes used to manufacture the Excluded Products, or the uses of Excluded Products.
Section 1.21Business Day.
Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to be closed in the City of New York.
-4-


Section 1.22Business Employee.
Business Employee” means each employee, independent contractor, or other service provider of the Seller or any of its Affiliates who (i) is employed or retained by the Seller or any of its Subsidiaries or Affiliates at the Manufacturing Facilities primarily in connection with the Business and is identified on Section 3.10(a) of the Seller Disclosure Schedule, or (ii) is otherwise employed or retained by the Seller or any of its Subsidiaries or Affiliates primarily in connection with the Business and is identified on Section 3.10(a) of the Seller Disclosure Schedule.
Section 1.23Business Products.
Business Products” shall have the meaning set forth in Section 3.20.
Section 1.24CARES Act.
CARES Act” means the Coronavirus Aid, Relief, and Economic Security Act of 2020, as amended, and any similar or successor Law or any administrative or other guidance published with respect thereto by any Governmental Authority.
Section 1.25Closing.
Closing” shall have the meaning set forth in Section 2.7.
Section 1.26Closing Date.
Closing Date” shall have the meaning set forth in Section 2.7.
Section 1.27Closing Date Employees.
Closing Date Employees” shall have the meaning set forth in Section 5.8(a).
Section 1.28Closing Date Cash Payment.
Closing Date Cash Payment” means an amount equal to the sum of the Purchase Price, plus the Preliminary Net Working Capital minus the Baseline Net Working Capital.
Section 1.29Code.
Code” means the Internal Revenue Code of 1986, as amended.
Section 1.30Common Interests.
Common Interests” shall have the meaning set forth in Section 4.8.
Section 1.21Confidential Information.
-5-


Confidential Information” shall have the meaning set forth in the Confidentiality Agreement.
Section 1.32Confidentiality Agreement.
Confidentiality Agreement” shall have the meaning set forth in Section 5.3(a).
Section 1.33Confidential Management Presentation.
Confidential Management Presentation” means the Project Eagle Management Presentation dated January 2020 provided to the Purchaser in connection with the transactions contemplated by this Agreement.
Section 1.34Consultant.
Consultant” shall have the meaning set forth in Section 8.7(a).
Section 1.35Contract.
Contract” means any written or oral contract (including unwritten undertakings or practices based on any course of dealing), subcontract, agreement, lease, license, note, mortgage, indenture, deed of trust, commitment, sale or purchase order and any other instrument or agreement of any kind, and any amendments or supplements thereto.
Section 1.36Contribution.
Contribution” shall have the meaning set forth in the Recitals.
Section 1.37control.
control” (including the terms “controlled by” and “under common control with”), with respect to the relationship between or among two or more Persons, means the possession, directly or indirectly, or as trustee, personal representative or executor, of the power to direct or cause the direction of the affairs or management of a Person, whether through the ownership of voting securities, as trustee, personal representative or executor, by contract or otherwise.
Section 1.38Cooperation Indemnitees
.

Cooperation Indemnitees” shall have the meaning set forth in Section 5.13(b).
Section 1.39COVID Actions.
-6-


COVID Actions” means any commercially reasonable actions that the Seller reasonably determines are necessary to take in relation to the Business to (a) comply with any quarantine, “shelter in place”, “stay at home”, workforce reduction, social distancing, shut down, closure, sequester or any other Law or Governmental Order adopted in response to COVID-19 applicable to the Business or the Manufacturing Facilities, (b) reduce the risk of exposure to or spread of COVID-19 at the Manufacturing Facilities and other facilities of the Seller and its Subsidiaries at which the Business operates, or (c) reduce the risk of environmental or safety issues resulting from a Manufacturing Facility not having sufficient qualified personnel to continue operations due to an outbreak of, or exposure to, COVID-19.
Section 1.40Current Employees.
Current Employees” shall have the meaning set forth in Section 5.8(a).
Section 1.41De Minimis Claim.
De Minimis Claim” shall have the meaning set forth in Section 8.4(b).
Section 1.42Disclosure Schedules.
Disclosure Schedules” means the Seller Disclosure Schedule and the Purchaser Disclosure Schedule, each of which forms a part of this Agreement.
Section 1.43Debt Commitment Letter.
Debt Commitment Letter” shall have the meaning set forth in Section 4.6(a).
Section 1.44Debt Financing.
Debt Financing” shall have the meaning set forth in Section 4.6(a).
Section 1.45Debt Financing Agreements.
Debt Financing Agreements” shall have the meaning set forth in Section 4.6(a).
Section 1.46Dispute Notice.
Dispute Notice” shall have the meaning set forth in Section 2.11(c).
Section 1.47Disputed Items.
Disputed Items” shall have the meaning set forth in Section 2.11(c).
Section 1.48Drug Laws.
-7-


Drug Laws” means any Law related to the business of processing, manufacturing, labeling, distributing and selling any drug or drug component, including, but not limited to active pharmaceutical ingredients, meant for human or animal use, and any rule, regulation, directive, order, guidance or decision promulgated or issued pursuant thereto and applicable to the Seller or any of its Subsidiaries. For the avoidance of doubt, Drug Laws shall include the FDCA and 21 C.F.R. Parts 210 and 211 promulgated thereunder and the Chemical Diversion and Trafficking Act and any regulations promulgated thereunder.
Section 1.49Employee Records.
Employee Records” means all job application, background check, training, personnel, discipline, performance (including all performance evaluations for each of the last three performance years), employee compensation, work authorization (including I-9, visas, work permits, employment passes, and other legal or regulatory documentation), medical and benefits and labor relations documents and records relating to the employment of the Business Employees.
Section 1.50Encumbrance.
Encumbrance” means any security interest, pledge, hypothecation, mortgage, lien, encumbrance, license, easement, right of way, servitude, lease or sublease, deed of trust, option, right of first refusal, attachment, levy, charge, claim, imposition, conditional sale or title retention arrangement or other restriction of any kind or any other interest in property or assets (or the income or profits therefrom), whether consensual or nonconsensual and whether arising by Contract or under any Law or otherwise.
Section 1.51Environmental Law.
Environmental Law” means any Law relating to human health or the environment; human or environmental exposure to any Hazardous Material or  employee or occupational safety, including, but not limited to, Mich. Comp. Laws §§ 324.20101 to 324.20142 and Act 2.
Section 1.52Environmental Losses.
Environmental Losses” shall have the meaning set forth in Section 8.7(h).
Section 1.53Environmental Permit.
Environmental Permit” means any permit, approval, identification number, registration, notification, license or other authorization that the Business is required to possess or obtain pursuant to any applicable Environmental Law with respect to the Business or the Manufacturing Facilities.
Section 1.54Equipment.
-8-


Equipment” means the machinery, equipment, furniture, fixtures, furnishings, parts, spare parts, tools, supplies, leasehold improvements, vehicles and other tangible property that is owned or leased by the Seller or any of its Subsidiaries (wherever located and whether or not carried on Seller’s or any of its Subsidiaries’ books), together with any express or implied warranty by the manufacturer, seller or lessor of any item or component thereof, and any maintenance records or other documentation relating thereto, in each case, that is primarily used or held for use in the Business, but excluding those items set forth on Section 1.54 of the Seller Disclosure Schedule.
Section 1.55ERISA.
ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time.
Section 1.56ESA.
ESA” means an environmental site assessment.
Section 1.57Estimated Purchase Price Statement.
Estimated Purchase Price Statement” shall have the meaning set forth in Section 2.10.
Section 1.58Excluded Assets.
Excluded Assets” shall have the meaning set forth in Section 2.1(b).
Section 1.59Excluded Claim.
Excluded Claim” means all claims related to any Action that the Seller has or may have against third parties, solely to the extent such claim is not primarily related to the Business, the Transferred Assets or the Assumed Liabilities or primarily arises from, or relates to, the Excluded Assets or Excluded Liabilities.
Section 1.60Excluded Liabilities.
Excluded Liabilities” shall have the meaning set forth in Section 2.2(b).
Section 1.61Excluded Taxes.
Excluded Taxes” means, without duplication, all Taxes for, attributable to, or with respect to, any Pre-Closing Tax Period (including any Taxes that are allocable under Section 6.1 to a Pre-Closing Tax Period), any Taxes attributable to any deferred revenue or prepaid amount received prior to the Closing by the Seller with respect to the Business, the Seller’s share of Transfer Taxes pursuant to Section 6.3 and any payroll
-9-


Taxes attributable to any Pre-Closing Tax Period that the Seller or any of its Subsidiaries has elected to defer pursuant to the CARES Act.
Section 1.62Existing Stock.
Existing Stock” shall have the meaning set forth in Section 5.5(b).
Section 1.63FDA.
FDA” means the United States Food and Drug Administration.
Section 1.64FDCA.
FDCA” means the United States Federal Food, Drug, and Cosmetic Act.
Section 1.65FDCA Debarment List.
FDCA Debarment List” means a public list of firms or persons currently debarred pursuant to sections 306(a) or (b) of the FDCA.
Section 1.66Final Net Working Capital.
Final Net Working Capital” shall have the meaning set forth in Section 2.11(a).
Section 1.67Final Phase II Reports.
Final Phase II Report” shall have the meaning set forth in Section 8.7(a).
Section 1.68Financial Statements.
Financial Statements” means the combined carve-out statements of income of the Business set forth in Section 1.68 of the Seller Disclosure Schedule.
Section 1.69Financing Sources
.
Financing Sources” means each party to the Debt Financing Agreements and any other lender, agent, lead arranger, arranger, administrative agent, collateral agent or any other agent in respect of the Debt Financing (including any Alternative Financing) and any Affiliates and Representatives of any of the foregoing.
Section 1.70GAAP.
GAAP” means United States generally accepted accounting principles applied on a basis consistent with the Seller’s audited financial statements.
-10-


Section 1.71Goodwill.
Goodwill” means the goodwill of the Seller and its Subsidiaries related to, associated with or attributable to the Business.
Section 1.72Governmental Authority.
Governmental Authority” means any federal, national, foreign, domestic, supranational, state, provincial, municipal, local or other government, governmental, quasi-governmental, regulatory, self-regulatory, national stock exchange or administrative authority, agency, commission, branch, department, official or entity or any court of competent jurisdiction or arbitrator.
Section 1.73Governmental Order.
Governmental Order” means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.
Section 1.74Hazardous Material.
Hazardous Material” means  petroleum and petroleum products, by-products or breakdown products, lead, radon, radioactive materials, asbestos-containing materials, polychlorinated biphenyls, pesticides, per- and polyfluoroalkyl substances, and dangerous or toxic organisms (including Legionella and Stachybotrys species) to the extent such organisms are regulated by any Governmental Authority under applicable Environmental Laws; or any other chemicals, materials, wastes or substances defined or regulated by any Governmental Authority under applicable Environmental Laws as or included in the definition of “toxic substances,” “hazardous wastes,” “hazardous substances,” “pollutants,” “contaminants”, “hazardous materials” or similar substances.
-11-


Section 1.75HSR Act.
HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder.
Section 1.76Indebtedness.
Indebtedness” of any Person means, without duplication,  all obligations of such Person for borrowed money,  all obligations of such Person evidenced by any note, bond, debenture, other debt security or similar instruments,  all lease obligations of such Person which are required to be capitalized in accordance with GAAP,  all interest rate or currency obligations of such Person, including swaps, hedges or similar agreements,  all obligations of such Person evidenced by letters of credit, surety bonds, bank guarantees and similar instruments (to the extent drawn),  all obligations of such Person in respect of accrued but unpaid dividends,  all obligations of such Person in respect of the deferred purchase price of goods, equity or services, including earn-outs, contingent payments or similar arrangements, all guarantees, direct or indirect, by such Person of any of the items set forth in clauses (a) - (g) of any other Person and  with respect to each of the foregoing, the outstanding principal amount plus all unpaid interest, breakage costs, prepayment or redemption penalties or premiums, or other unpaid fees, expenses or obligations owed in respect of the acceleration, termination or cancellation thereof.
Section 1.77Indemnified Party.
Indemnified Party” means a Purchaser Indemnified Party or a Seller Indemnified Party, as the case may be.
Section 1.78Indemnifying Party.
Indemnifying Party” means the Seller pursuant to Section 8.2 or the Purchaser pursuant to Section 8.3, as the case may be.
Section 1.79Independent Accountant.
Independent Accountant” means Ernst & Young (or, if such firm shall decline or is unable to act, another nationally recognized firm with expertise in accounting matters reasonably acceptable to the Seller and the Purchaser).
Section 1.80In-Licensed Intellectual Property.
In-Licensed Intellectual Property” means all Intellectual Property that the Seller or any of its Subsidiaries is licensed or otherwise authorized to use pursuant to the Transferred IP Agreements.
Section 1.81Intellectual Property.
-12-


Intellectual Property” means all of the following rights in any jurisdiction throughout the world:  patents and patent applications, and all related continuations, continuations in part, divisionals, reissues, reexaminations, substitutions and extensions thereof, utility models and utility model applications, and industrial designs;  trademarks, service marks, trade names, logos, trade dress and internet domain names, social media names, together with the goodwill connected with the use thereof and symbolized thereby;  copyrights, including copyrights in computer software;  registrations and applications for registration of any of the foregoing under clauses (a)(c) of this definition;  trade secrets, know-how, formulae, methods, techniques, processes (including manufacturing processes), invention disclosures and conception records, and other confidential and proprietary information; and  the right to sue at law or in equity for all claims or causes of action arising out of or related to any past, present or future infringement, misappropriation or violation of any of the foregoing, including the right to receive all proceeds and damages therefrom.
Section 1.82Intellectual Property Assignment Agreement.
Intellectual Property Assignment Agreement” means the Intellectual Property Assignment Agreement, to be entered into by the Purchaser and the Seller as of the Closing Date, substantially in the form attached hereto as Exhibit B.
Section 1.83Intended Tax Treatment.
Intended Tax Treatment” shall have the meaning set forth in Section 6.5.
Section 1.84IP Agreements.
IP Agreements” means all Contracts concerning Intellectual Property or IT Assets to which the Seller or any of its Subsidiaries is a party or beneficiary or by which the Seller or any of its Subsidiaries, or any of its or their properties or assets, may be bound, including all (a) licenses of Intellectual Property by the Seller or any of its Subsidiaries to any Person, (b) licenses of Intellectual Property by any Person to the Seller or any of its Subsidiaries, (c) Contracts between any Person and the Seller or any of its Subsidiaries relating to the transfer, development, maintenance or use of Intellectual Property or IT Assets, and (d) consents, settlements, decrees, orders, injunctions, judgments or rulings governing the use, validity or enforceability of Intellectual Property or IT Assets.
Section 1.85IRS.
IRS” means the Internal Revenue Service.
Section 1.86IT Assets.
IT Assets” means software (together with its configuration and customization), systems, servers, computers, hardware, firmware, middleware, networks,
-13-


data communications lines, routers, hubs, switches and all other information technology equipment, and all associated documentation.
Section 1.87Key Customer.
Key Customer” shall have the meaning set forth in Section 3.15(a).
Section 1.88Key Distributors.
Key Distributors” shall have the meaning set forth in Section 3.15(c).
Section 1.89Key Supplier.
Key Supplier” shall have the meaning set forth in Section 3.15(b).
Section 1.90Law.
Law” means any statute, law, ordinance, regulation, rule, code, requirement, international treaty or convention or rule of law (including common law requirement or rule), international treaties or conventions or other requirement with similar effect promulgated or issued by any Governmental Authority or any Governmental Order.
Section 1.91Leave Employees.
Leave Employees” shall have the meaning set forth in Section 5.8(a).
Section 1.92Liabilities.
Liabilities” means any and all debts, liabilities, claims, demands, expenses, guarantees, commitments or obligations of any kind, character or nature whatsoever, whether direct or indirect, accrued or unaccrued, fixed or variable, known or unknown, absolute or contingent, asserted or unasserted, matured or unmatured or determined or determinable, due or to become due, including those arising under any Law, Action or Governmental Order and those arising under any Contract.
Section 1.93Local Conveyance Documents.
Local Conveyance Documents” means the Assignment and Assumption Agreement and Bill of Sale, Deed of Transfer of Owned Real Property (Tyrone) and Deed of Transfer of Owned Real Property (South Haven), in substantially the forms of Exhibits A-1 through A-3.
Section 1.94Loss.
Loss” shall have the meaning set forth in Section 8.2.
Section 1.95Manufacturing Facilities.
-14-


Manufacturing Facilities” means the manufacturing facilities of the Business located on the Owned Real Property in South Haven, Michigan and Tyrone, Pennsylvania.
Section 1.96Marketing Period
.
Marketing Period” means the “Marketing Period” as defined in the Debt Commitment Letter.
Section 1.97Material Adverse Effect.
Material Adverse Effect” means any event, circumstance, condition, state of facts, change or effect, that (i) is, or would reasonably be expected to be, materially adverse to the assets, liabilities, business, results of operations or the financial condition of the Business, taken as a whole or (ii) would reasonably be expected to prevent or materially delay the ability of the Seller to perform its obligations under this Agreement or to consummate the transactions contemplated hereby; provided, however, that none of the following, either alone or in combination, shall be deemed to constitute a “Material Adverse Effect”, or be taken into account in determining, whether there has been a “Material Adverse Effect” for purposes of clause (i):  events, circumstances, changes or effects that generally affect the industries or segments thereof in which the Business operates, including legal and regulatory changes and changes in the price of commodities or raw materials;  general business, economic or political conditions (or changes therein);  events, circumstances, changes or effects generally affecting the financial, credit or securities markets in the United States or in any other country or region in the world, including changes in interest rates or foreign exchange rates;  events, circumstances, changes or effects arising out of, or attributable to, the public announcement of the execution of this Agreement or the other Transaction Documents, any actions taken or not taken by the Seller in accordance with the express requirements of this Agreement (other than Section 5.1) or the other Transaction Documents, or actions taken or not taken by the Seller at the written request of the Purchaser or any public communication by the Purchaser in respect of plans or intentions with respect to the Business or Business Employees;  events, circumstances, changes or effects arising out of, or attributable to, strikes, slowdowns, lockouts or work stoppages (pending or threatened);  events, circumstances, changes or effects arising out of, or attributable to, acts of armed hostility, sabotage, terrorism or war (whether or not declared), including any escalation or worsening thereof;  events, circumstances, changes or effects arising out of, or attributable to, earthquakes, hurricanes, tsunamis, tornadoes, floods, mudslides or other natural disasters, weather-related conditions, explosions or fires;  events, circumstances, changes or effects arising out of, or attributable to, changes or modifications in GAAP, or applicable Law after the date hereof;  events, circumstances, changes or effects arising out of, or attributable to, an epidemic, pandemic or disease outbreak (including the COVID-19 virus) and including the taking of any COVID Action; or  the failure, in and of itself, by the Business to meet any internal or other estimates, expectations, forecasts,
-15-


plans, projections or budgets for any period; provided, that, with respect to a matter described in clauses (a), (b), (c), (f), (g), (h), (i) and (j) such matter shall be deemed to constitute a “Material Adverse Effect”, or shall be taken into account in determining whether there has been a “Material Adverse Effect”, to the extent it has a disproportionate adverse effect on the Business relative to other comparable businesses operating in the industries in which the Business operates.
Section 1.98Material Contracts.
Material Contracts” shall have the meaning set forth in Section 3.13(a).
Section 1.99Most Cost-Effective Manner.
Most Cost-Effective Manner” shall have the meaning set forth in Section 8.7(c)(iii).
Section 1.100Net Working Capital.
Net Working Capital” means, as of 12:01 a.m. New York time on the Closing Date, the amount that is the difference between  the current assets of the Business identified as line items on Section 1.100 of the Seller Disclosure Schedule (excluding cash and cash equivalents) and  the current liabilities of the Business identified as line items on Section 1.100 of the Seller Disclosure Schedule (excluding trade payables).
Section 1.101Non-Transferred Environmental Permit.
Non-Transferred Environmental Permit” shall have the meaning set forth in Section 5.4(b).
Section 1.102Owned Real Property.
Owned Real Property” means the real property identified in Section 1.102 of the Seller Disclosure Schedule, together with all buildings, improvements and fixtures thereon and all easements, rights-of-way, licenses, rights to use real property, appurtenances and other rights and benefits associated with such land and together with all improvements, fixtures and other rights and appurtenants thereto.
Section 1.103Permits.
Permits” means all permits, licenses, franchises, certificates of occupancy, qualifications, orders, agreements and authorizations issued by any Governmental Authority, including Environmental Permits.
Section 1.104Permitted Encumbrances.
-16-


Permitted Encumbrances” means  statutory liens for current Taxes not yet due or delinquent (or the validity or amount of which is being contested in good faith by appropriate proceedings and for which adequate reserves have been established in the Financial Statements);  mechanics’, materialmens’, carriers’, workers’, repairers’, landlords’ and other Encumbrances or security obligations arising by operation of Law, or pledges, deposits or other Encumbrances securing the performance of bids, trade contracts, leases or statutory obligations (including workers’ compensation, unemployment insurance or other social security legislation), in each case incurred in the ordinary course of business consistent with past practice, and for amounts which are not yet due or delinquent and which are not material;  Encumbrances arising under conditional sales contracts and equipment leases with third parties;  variations, if any, between tax lot lines and property lines;  minor deviations, if any, of fences or shrubs from designated property lines;  Encumbrances identified on Section 1.104 of the Seller Disclosure Schedule;  any zoning, entitlement, conservation restriction and other land use and environmental regulations, in each case, imposed by Governmental Authorities and which are not violated by the current use or occupancy of such real property or the operation of the Business thereon;  Encumbrances that will be released and fully discharged at or prior to the Closing; (i) all covenants, conditions, restrictions, easements, charges, rights of way, other Encumbrances and other similar matters of record set forth in any local or municipal recording or like office; and (j) any matter appearing in the Title Commitment or that can be determined by a Survey of the Owned Real Property, in each case not otherwise in the nature of the liens addressed elsewhere in this definition and that do not, individually or in the aggregate, materially impair the use of the Owned Real Property to which they apply.
Section 1.105Person.
Person” means any individual, partnership, firm, corporation, limited liability company, association, trust, unincorporated organization or other entity, as well as any syndicate or group that would be deemed to be a person under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended.
Section 1.106Plan.
Plan” means each (i) “employee benefit plan” as defined in Section 3(3) of ERISA, whether or not subject to ERISA, (ii) employment, consulting, severance, change in control, transaction bonus, retention or other similar agreement or plan or (iii) other plan, agreement or arrangement providing for compensation, bonuses, equity or equity-based compensation, incentives, deferred compensation, severance, change in control, health, medical, dental, vision, life insurance, welfare, fringe benefits, perquisites, disability or sick leave benefits, supplemental unemployment benefits, post-employment or retirement or other benefits, in each case that is sponsored, maintained, administered, or contributed to by any Person or any of its Affiliates, or with respect to which the Person or any of its Affiliates is a party, for the benefit of any current or former employee, director or independent contractor of the Person or any of its Affiliates, and/or
-17-


their spouses, dependents or beneficiaries, or with respect to which the Person or any of its Affiliates has any Liabilities contingent or otherwise.
Section 1.107Pollution Policy.
Pollution Policy” shall have the meaning set forth in Section 7.2(d).
Section 1.108Post-Closing Adjustment.
Post-Closing Adjustment” shall have the meaning set forth in Section 2.11(a).
Section 1.109Post-Closing Tax Period.
Post-Closing Tax Period” means any Tax period beginning after the Closing Date, and the portion of any Straddle Period beginning after the Closing Date.
Section 1.110Post-Signing Insurance Proceeds.
Post-Signing Insurance Proceeds” shall have the meaning set forth in Section 2.1(a)(vii).
Section 1.111Pre-Closing IT Integration Completion
.

Pre-Closing IT Integration Completion” shall have the meaning set forth in Section 5.6(d).

Section 1.112Pre-Closing Tax Period.
Pre-Closing Tax Period” means any Tax period ending on or prior to the Closing Date, and the portion of any Straddle Period ending on or prior to the Closing Date.
Section 1.113Preferred Equity.
Preferred Equity” means 2,700 Preferred Units having an aggregate Preferred Unit Face Value of $270,000,000, which Preferred Units are to be issued to the Seller in connection with the Contribution.
Section 1.114Preferred Issuance.
Preferred Issuance” shall have the meaning set forth in the Recitals.
Section 1.115Preferred Unit Face Value.
-18-


Preferred Unit Face Value” has the meaning set forth in the SPV Operating Agreement.
Section 1.116Preferred Units.
Preferred Units” has the meaning set forth in the SPV Operating Agreement.
Section 1.117Preliminary Net Working Capital.
Preliminary Net Working Capital” shall have the meaning set forth in Section 2.10.
Section 1.118Protected Communications.
Protected Communications” shall have the meaning set forth in Section 5.9.
Section 1.119Public Announcement.
Public Announcement” shall have the meaning set forth in Section 11.4.
Section 1.120Purchase Price.
Purchase Price” shall have the meaning set forth in Section 2.1(a).
Section 1.121Purchaser.
Purchaser” shall have the meaning set forth in the Preamble.
Section 1.122Purchaser 401(k) Plan.
Purchaser 401(k) Plan” shall have the meaning set forth in Section 5.8(j).
Section 1.123Purchaser Benefit Plan.
Purchaser Benefit Plan” means any Plan to which the Purchaser or any Affiliate is a party, or with respect to which the Purchaser or any Affiliate has any Liabilities or that are maintained, contributed to or sponsored by the Purchaser or any Affiliate, in each case for the benefit of any current or former employees, directors or independent contractors of the Purchaser or any Affiliate and/or their spouses, dependents or beneficiaries.
Section 1.124Purchaser DC Plan Contributions.
Purchaser DC Plan Contributions” means all employer contributions that are required to be made by the Purchaser or one of its Affiliates under any Purchaser
-19-


Benefit Plan that is a tax-qualified defined contribution plan with respect to amounts deemed to be “eligible compensation” thereunder.
Section 1.125Purchaser Disclosure Schedule.
Purchaser Disclosure Schedule” means the Disclosure Schedule delivered by the Purchaser to the Seller in connection with this Agreement.
Section 1.126Purchaser Environmental Liabilities.
Purchaser Environmental Liabilities” means any Liability or Loss to the extent relating to, or arising out of, any Releases of Hazardous Materials at, in, on or from any Manufacturing Facility or Owned Real Property on or after the Closing Date; any Releases of Hazardous Materials at any third-party site to which such Hazardous Materials were transported or disposed of, or arranged for the transportation or disposal of, from any Manufacturing Facility or Owned Real Property or otherwise in connection with the Business on or after the Closing Date; any exposure on or after the Closing Date to Hazardous Materials in connection with the operation of the Business at any Manufacturing Facility or Owned Real Property or to any Hazardous Material included in any product or material manufactured, marketed, sold or distributed on or after the Closing Date from any Manufacturing Facility or Owned Real Property; any act or omission on or after the Closing Date in connection with the Business, the Manufacturing Facilities or any Owned Real Property, including the manufacture, marketing, sale or distribution of products by the Business on or after the Closing Date, that results in a violation of, or failure to comply with, any applicable Environmental Laws or Environmental Permit; and any Action under any Environmental Law or Environmental Permit brought with respect to environmental conditions arising on or after the Closing Date at any Manufacturing Facility or Owned Real Property (for the avoidance of doubt, “Purchaser Environmental Liabilities” shall not include any Seller Environmental Liabilities set forth in Section 1.151 except as otherwise set forth in Section 8.7).
Section 1.127Purchaser FSA Plan.
Purchaser FSA Plan” shall have the meaning set forth in Section 5.8(f).
Section 1.128Purchaser Fundamental Representations.
Purchaser Fundamental Representations” shall have the meaning set forth in Section 8.1.
Section 1.129Purchaser Indemnified Party.
Purchaser Indemnified Party” shall have the meaning set forth in Section 8.2.
Section 1.130Purchaser-Owned IP
-20-


.

Purchaser-Owned IP” shall have the meaning set forth in the Recitals.
Section 1.131Registered Intellectual Property.
Registered Intellectual Property” means all the following rights issued by, registered or filed with, renewed by or the subject of a pending application before any Governmental Authority or Internet domain name registrar in any jurisdiction throughout the world: (a) patents and patent applications, and all related continuations, continuations-in-part, divisionals, reissues, reexaminations, substitutions and extensions thereof; (b) registered trademarks, service marks, and internet domain names or other registrations related to trademarks, or applications related thereto; (c) registered copyrights and applications for copyright registration.
Section 1.132Related Party.
Related Party” means, with respect to any Person, such Person’s Affiliates and its and their respective current and former directors, officers and controlling persons.
Section 1.133Related Party Contract.
Related Party Contract” means any Contract between the Seller or any of its Subsidiaries, on the one hand, and a Related Party of any such Person, on the other hand.
Section 1.134Release.
Release” means disposing, discharging, injecting, spilling, leaking, pumping, pouring, leaching, dumping, emitting, escaping, or emptying into or onto the environment including upon any soil, sediment, subsurface strata, surface water, or groundwater, whether sudden or non-sudden and whether accidental or non-accidental, or any release, emission or discharge as those terms are defined in any applicable Environmental Law.
Section 1.135Remedial Action.
Remedial Action” means any action required by a Governmental Authority to investigate, clean up, remove, remediate, monitor, or assess, or conduct remedial or corrective actions with respect to, any Release of Hazardous Materials.
Section 1.136Representatives.
Representatives” means with respect to any Person, such Person’s Affiliates and its and their respective directors, officers, employees, agents and advisors.
-21-


Section 1.137Required Information
.
Required Information” means all information regarding the business, operations and financial condition of the Business, the Seller and its Subsidiaries that is reasonably requested by the Purchaser and that is customarily included in marketing materials for indebtedness of the type to be provided under the Debt Financing Agreements, including all financial and company information regarding the Business, the Seller and its Subsidiaries that is required by the Debt Financing Agreements (including, if applicable, any debt commitment letters in connection with any Alternative Financing); provided that the only financial information that the Seller shall provide, if requested, shall be as set forth on Section 1.137 of the Seller Disclosure Schedule.
Section 1.138Retained Names and Marks.
Retained Names and Marks” shall have the meaning set forth in Section 5.5(a).
Section 1.139Retention Agreement Recipients.
Retention Agreement Recipients” mean the individuals set forth on Section 1.139 of the Seller Disclosure Schedule.
Section 1.140Retention Agreements.
Retention Agreements” mean the retention agreements of the Seller pursuant to which the Retention Agreement Recipients shall be entitled to receive cash bonuses in connection with the transactions contemplated by this Agreement payable after the Closing Date by the Purchaser or one of its Subsidiaries or Affiliates pursuant to the terms thereof, and the terms of this Agreement.
Section 1.141Return Deadline.
Return Deadline” shall have the meaning set forth in Section 5.8(a).
Section 1.142Sale and Purchase.
Sale and Purchase” shall have the meaning set forth in the Recitals.
Section 1.143Sales Contracts.
Sales Contracts” shall have the meaning set forth in Section 3.13(a)(ii).
Section 1.144Sales Agreements.
-22-


Sales Agreements” means the sales agreements to be entered by the Purchaser and the Seller as of the Closing Date, substantially in the forms attached hereto as Exhibits C-1 and C-2.
Section 1.145Sanctions.
Sanctions” shall have the meaning set forth in Section 3.7(b).
Section 1.146Securities Act.
Securities Act” shall have the meaning set forth in Section 3.25(a).
Section 1.147Seller.
Seller” shall have the meaning set forth in the Preamble.
Section 1.148Seller 401(k) Plan.
Seller 401(k) Plan” shall have the meaning set forth in Section 5.8(j).
Section 1.149Seller Benefit Plan.
Seller Benefit Plan” means any Plan to which the Seller or any Subsidiary or Affiliate is a party, or with respect to which the Seller or any Subsidiary thereof has any Liabilities or that are maintained, contributed to or sponsored by the Seller or any Subsidiary or Affiliate thereof, in each case for the benefit of any Business Employees and/or their spouses, dependents or beneficiaries.
Section 1.150Seller Disclosure Schedule.
Seller Disclosure Schedule” means the Disclosure Schedule delivered by the Seller to the Purchaser in connection with this Agreement.
Section 1.151Seller Environmental Liabilities.
Seller Environmental Liabilities” means all Liabilities or Losses to the extent arising from or related to the presence or any Releases of Hazardous Materials at, in, on or from the Manufacturing Facility or Owned Real Property located in South Haven, Michigan prior to the Closing Date; any Releases of Hazardous Materials at any third-party site to which such Hazardous Materials were transported or disposed of, or arranged for the transportation or disposal of, by the Seller from any Manufacturing Facility or Owned Real Property or otherwise in connection with the Business prior to the Closing Date; any exposure prior to the Closing Date (i) to Hazardous Materials in connection with the Seller’s operation of the Business at any Manufacturing Facility or Owned Real Property or (ii) to any Hazardous Material included in any product or material manufactured, marketed, sold or distributed prior to the Closing Date by the Seller from any Manufacturing Facility or Owned Real Property or by the Business; and
-23-


any act or omission by the Seller prior to the Closing Date in connection with the Business, the Manufacturing Facilities or any Owned Real Property, including the manufacture, marketing, sale or distribution of products by the Business prior to the Closing Date, that has resulted in or results in a violation of, or failure to comply with, any applicable Environmental Laws or Environmental Permit.
Section 1.152Seller FSA Plan.
Seller FSA Plan” shall have the meaning set forth in Section 5.8(f).
Section 1.153Seller Fundamental Representations.
Seller Fundamental Representations” shall have the meaning set forth in Section 8.1.
Section 1.154Seller Indemnified Party.
Seller Indemnified Party” shall have the meaning set forth in Section 8.3.
Section 1.155Seller Indemnified Remedial Action or Environmental Noncompliance.
Seller Indemnified Remedial Action or Environmental Noncompliance” shall have the meaning set forth in Section 8.7(i).
Section 1.156Seller’s Knowledge; Knowledge of the Seller.
Seller’s Knowledge”, “Knowledge of the Seller” or any similar term used in this Agreement means the actual (but not constructive or imputed) knowledge, after reasonable inquiry of the employees of the Seller or its Subsidiaries responsible for the relevant subject matter (including the head of intellectual property of the Seller) of the Persons identified on Section 1.156 of the Seller Disclosure Schedule.
Section 1.157Seller Restricted Parties.
Seller Restricted Parties” shall have the meaning set forth in Section 5.3(c).
Section 1.158Shared Contracts.
Shared Contract” means any Contract to which the Seller or any of its Subsidiaries is a party for the provision of goods and/or services that are used in both the Business and any other businesses (other than the Business) of the Seller and its Subsidiaries, all of which are set forth in Section 3.13(a)(xiv) of the Seller Disclosure Schedule.
Section 1.159Shared Information.
-24-


Shared Information” shall have the meaning set forth in Section 5.3(c).
Section 1.160SPV.
SPV” shall have the meaning set forth in the Preamble.
Section 1.161SPV Operating Agreement.
SPV Operating Agreement” means the Amended and Restated Limited Liability Company Agreement of the SPV, substantially in the form attached hereto as Exhibit D.
Section 1.162Straddle Period.
Straddle Period” means any Tax period beginning on or prior to, and ending after, the Closing Date.
Section 1.163Subsidiary.
Subsidiary” of any Person means any corporation, partnership, limited liability company or other organization, whether incorporated or unincorporated, which is controlled, directly or indirectly, by such Person.
Section 1.164Survey.
Survey” shall have the meaning set forth in Section 5.12.
Section 1.165Tax; Taxes.
Tax” or “Taxes” means any federal, state local, or non-U.S. income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental, customs duties, capital stock, franchise, profits, withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, value added alternative or add-on minimum, estimated or other tax, duty, impost, tariff, assessment or other similar charge in the nature of a tax imposed by any Governmental Authority, whether disputed or not, together with any interest, additions, charges or penalties in respect thereof.
Section 1.166Tax Returns.
Tax Returns” means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof required to be filed with a Governmental Authority with respect to Taxes.
Section 1.167Termination Date.
-25-


Termination Date” shall have the meaning set forth in Section 9.1(a).
Section 1.168Third-Party Claim.
Third-Party Claim” shall have the meaning set forth in Section 8.5(b).
Section 1.169Third-Party Rights.
Third-Party Rights” shall have the meaning set forth in Section 2.5(b).
Section 1.170Title Commitment.
Title Commitment” shall have the meaning set forth in Section 5.12(a).
Section 1.171Title Insurance.
Title Insurance” shall have the meaning set forth in Section 2.8(e).
Section 1.172Title Insurer.
Title Insurer” shall have the meaning set forth in Section 2.8(e).
Section 1.173Title Policy.
Title Policy” shall have the meaning set forth in Section 2.8(e).
Section 1.174Trade Accounts Payable.
Trade Accounts Payable” means all trade accounts payable of the Seller and its Subsidiaries and all accrued payables of the Seller and its Subsidiaries for goods received from, but not invoiced by, vendors or suppliers, in each case, arising out of the operation of the Business prior to the Closing Date.
Section 1.175Trade Controls.
Trade Controls” shall have the meaning set forth in Section 3.7(b).
Section 1.176Transaction Documents.
Transaction Documents” means this Agreement, the Local Conveyance Documents, the Intellectual Property Assignment Agreement, the Sales Agreements, the SPV Operating Agreement, the Transition Services Agreement and any other Contract entered into, or any other document or certificate delivered, in connection with this Agreement or any of the other Transaction Documents.
Section 1.177Transfer Date.
Transfer Date” shall have the meaning set forth in Section 5.8(a).
-26-


Section 1.178Transfer Taxes.
Transfer Taxes” means any sales, use, transfer, conveyance, ad valorem, stamp, stamp duty, value added, recording or other similar tax, fee or charge imposed by any Governmental Authority upon the sale, transfer or assignment of any Transferred Asset or any interest therein pursuant to this Agreement, or upon the recording of such sale, transfer or assignment, together with any interest, additions or penalties imposed in respect thereof.
Section 1.179Transferred Accounts Receivable.
Transferred Accounts Receivable” means all accounts receivable (other than from the Seller, or any of its Subsidiaries), notes receivable, rebates receivable, employee advances and other miscellaneous receivables of the Seller or any of its Subsidiaries, in each case, arising out of the operation of the Business prior to the Closing Date and including any unpaid fees and interest relating thereto.
Section 1.180Transferred Assets.
Transferred Assets” shall have the meaning set forth in Section 2.1(a).
Section 1.181Transferred Contracts.
Transferred Contracts” means the Contracts (other than Transferred IP Agreements) to which the Seller or any of its Subsidiaries is a party that are primarily related to the Business or any of the Transferred Assets, including those Contracts identified on Section 1.181 of the Seller Disclosure Schedule.
Section 1.182Transferred Employee.
Transferred Employee” shall have the meaning set forth in Section 5.8(a).
Section 1.183Transferred Information.
Transferred Information” means originals of (or if originals are unavailable, copies of) all sales and promotional literature, customer lists, prospective customer lists, correspondence and other sales-related materials, research and development records, production records, service and warranty records, equipment logs, operation guides and manuals, studies, reports and personnel records, in each case, whether in hard copy or computer format, in each case to the extent used or held for use in, or primarily related to, the Business and in the possession or control of the Seller or any of its Subsidiaries.
Section 1.184Transferred Intellectual Property.
Transferred Intellectual Property” means the Intellectual Property owned by the Seller or any of its Subsidiaries, in each case, that is primarily used or held for use
-27-


in the Business, including the Registered Intellectual Property identified on Section 3.8(a) of the Seller Disclosure Schedule.
Section 1.185Transferred Inventory.
Transferred Inventory” means all inventories, raw materials, packaging materials, work in process, semi-finished and finished goods, purchased supplies, other supplies and spare parts and materials used for maintaining production machinery and equipment, in each case, to the extent such inventories are owned, used or held for use by the Seller or any of its Subsidiaries in, or are primarily related to, the Business.
Section 1.186Transferred IP Agreements.
Transferred IP Agreements” means all IP Agreements that are primarily related to the Business.
Section 1.187Transferred IT Assets.
Transferred IT Assets” means all IT Assets owned, used or held for use by Seller and its Subsidiaries that are primarily related to the Business.
Section 1.188Transferred Permits.
Transferred Permits” means the Permits of the Seller or any of its Subsidiaries used or held for use in, or primarily related to, the Business, including those set forth on Section 1.188 of the Seller Disclosure Schedule.
Section 1.189Transferred Records.
Transferred Records” means all books of account, general, financial, accounting, real property, records, invoices, customer records, shipping records, supplier lists, other distribution lists, Tax records, Employee Records (other than those that are prohibited by applicable Law from being transferred to the Purchaser, copies of which (to the extent permitted by applicable Law) will be made available to the Purchaser upon Purchaser’s request), correspondence, documents, lists, plans, files related to Intellectual Property (including invention disclosures and conception records), financial statements, internal audit or compliance reports, drug master files and similar documents, records, papers and files (and any supporting documentation relating thereto) and other documents, records, papers and files, including all pending, interim and final analytical data, physical or chemical properties data, toxicological and environmental data and exposure-related data, and including all records required under applicable Environmental Laws, whether in hard copy or computer format, in each case, to the extent in the possession or control of the Seller or any of its Subsidiaries and used or held for use in, or related to, the Business, and including those documents set forth in Section 1.189 of the Seller Disclosure Schedule; provided, that the Seller may redact information not related to the Business from the Transferred Records prior to the delivery of the Transferred
-28-


Records to the Purchaser and may retain a copy of any Transferred Records (which shall be held subject to Section 5.3) to the extent required by applicable Law.
Section 1.190Transition Services Agreement.
Transition Services Agreement” means the transition services agreement to be entered into by the Purchaser and the Seller as of Closing, substantially in the form attached hereto as Exhibit E.
Section 1.191Treasury Regulations.
Treasury Regulations” means the Treasury Regulations promulgated by the United States Department of Treasury.
Section 1.192Trigger Levels.
Trigger Levels” means the following Environmental Laws in each case as in effect on the Closing Date: (a) for soil, those Environmental Laws known as (i) Table 3. Soil: Nonresidential Part 201 Generic Cleanup Criterial and Screening Levels, Mich. Admin. Code r. 299.48, under the Laws of the State of Michigan or (ii) 25 Pa. Code § 250, Appendix A, Tables 3a (Medium Specific Concentrations (MSCs) for Organic Regulated Substances in Soil: Direct Contact Values), 3b (MSCs for Organic Regulated Substances in Soil: Soil-to-Groundwater Values), 4a (MSCs for Inorganic Regulated Substances in Soil: Direct Contact Values), and 4b (MSCs for Inorganic Regulated Substances in Soil: Soil-to-Groundwater Values) under the Laws of the Commonwealth of Pennsylvania; (b) for water, those Environmental Laws known as (i) Table 1. Groundwater: Residential and Nonresidential Part 201 Generic Cleanup Criteria and Screening Levels, Mich. Admin. Code r. 299.44, under the Laws of State of Michigan or (ii) 25 Pa. Code § 250, Appendix A, Tables 1 (MSCs for Organic Regulated Substances in Groundwater) and 2 (MSCs for Inorganic Substances in Groundwater) under the Laws of the Commonwealth of Pennsylvania; and (c) for gas, those Environmental Laws known as (i) Nonresidential Groundwater Volatilization to Indoor Air Inhalation Criteria, Table 1. Groundwater: Residential and Nonresidential Part 201 Generic Cleanup Criteria and Screening Levels, Mich. Admin. Code r. 299.44, and Soil Volatilization and Volatile Soil Inhalation Criteria found in Table 3. Soil: Nonresidential Part 201 Generic Cleanup Criterial and Screening Levels, Mich. Admin. Code r. 299.48, under the Laws of State of Michigan or (ii) the Pennsylvania Department of Environmental Protection’s Vapor Intrusion Screening Values Table, attached hereto as Schedule 1.192.
Section 1.193WARN Act.
WARN Act” means the Worker Adjustment Retraining and Notification Act of 1988, as amended.
Article II.
-29-


SALE AND PURCHASE
Upon the terms and subject to the conditions of this Agreement, at the Closing, the Seller shall (a) transfer to the SPV 52.6% of the Transferred Assets, free and clear of all Encumbrances, other than Permitted Encumbrances, in exchange for the payment of the Purchase Price by the Purchaser and the assumption by the Purchaser and the SPV of 52.6% of the Assumed Liabilities, and (b) contribute to the SPV 47.4% of the Transferred Assets, free and clear of all Encumbrances, other than Permitted Encumbrances, in exchange for the Preferred Equity and the assumption by the SPV of 47.4% of the Assumed Liabilities (in each case, such percentages subject to adjustment to account for any adjustment to Purchase Price hereunder and to account for the Purchaser-Owned IP).
Section 2.1Sale and Purchase of Assets.
(a)Upon the terms and subject to the conditions of this Agreement, in exchange for $300,000,000, subject to adjustment pursuant to Section 2.10 and Section 2.11, less (i) the amount of the Accrued 2021 Performance Bonuses, (ii) the amount of (A) the Accrued 2020 Performance Bonuses (to the extent unpaid as of the Closing Date), plus (B) to the extent the Accrued 2020 Performance Bonuses are unpaid as of the Closing Date, the aggregate Purchaser DC Plan Contributions required to be made with respect to such Accrued 2020 Performance Bonuses, and (iii) the amount payable to the Retention Agreement Recipients under the Retention Agreements (together with the employer portion of any payroll, social security, disability, workers compensation, unemployment or similar Taxes payable by the Purchaser related to such Accrued Performance Bonuses and amounts payable under the Retention Agreements) (the “Purchase Price”), which shall be paid at the Closing by the Purchaser or the SPV to the Seller in immediately available funds, at the Closing, the Seller shall, and shall cause its Subsidiaries to, sell, assign, transfer, convey and deliver, to the SPV, the designee of the Purchaser (or, in the case of the Purchaser-Owned IP, the Purchaser), and the SPV, as the designee of the Purchaser (or, in the case of the Purchaser-Owned IP, the Purchaser), shall purchase from the Seller and its Subsidiaries, subject to Section 2.1(b) and Section 2.5, 52.6% (such percentage subject to adjustment to account for any adjustment to Purchase Price hereunder and to account for the Purchaser-Owned IP) of all right, title and interest in and to all of the assets, properties and rights of any kind of the Seller or any of its Subsidiaries that are primarily related to, or used or held for use in, the Business (the “Transferred Assets”), free and clear of all Encumbrances, other than Permitted Encumbrances, including the following:
(i)the Owned Real Property, the Manufacturing Facilities and all Equipment;
(ii)the Transferred Intellectual Property and Transferred IT Assets;
(iii)the Transferred Inventory;
(iv)the Transferred Contracts, the Transferred IP Agreements and rights and benefits under Shared Contracts to the extent primarily related to the Business;
-30-


(v)(A) all prepaid expenses to the extent primarily related to the Business or any Transferred Asset and (B) the Transferred Accounts Receivable;
(vi)all claims against third parties, defenses and rights of offset or counterclaim (whether known or unknown) primarily related to the Business, any Transferred Asset or any Assumed Liability;
(vii)the proceeds from any insurance policies of the Seller or any of its Subsidiaries with respect to any insurance recoveries, in each case, solely to the extent arising out of or relating to any damage or destruction to, or loss of, any Transferred Assets to the extent any such damage or destruction remains unrepaired, in whole or in part, or any such asset has not been replaced, as of the Closing Date (such rights, the “Post-Signing Insurance Proceeds”);
(viii)all of the Seller’s rights under warranties, indemnities, and all similar rights against third parties solely to the extent related to any Transferred Assets;
(ix)the Transferred Permits;
(x)the Transferred Records;
(xi)the Transferred Information; and
(xii)the Goodwill.
(a)The Seller shall not sell, convey, assign, transfer, deliver or contribute, nor cause any of its Subsidiaries to sell, convey, assign, transfer, deliver or contribute, to the Purchaser or any of its Subsidiaries, and neither the Purchaser nor any of its Subsidiaries shall purchase or receive, any of the following assets of the Seller or of any of its Subsidiaries (the “Excluded Assets”):
(i)all rights to refunds, credits or other benefits attributable to Excluded Taxes (other than any Tax assets, if any, included in the calculation of Net Working Capital);
(ii)all rights of the Seller or its Subsidiaries under any Contracts, except for the Seller’s or any of its Subsidiaries’ (A) rights under the Transferred Contracts, (B) rights under the Transferred IP Agreements, (C) rights under Shared Contracts to the extent primarily related to the Business and (D) rights under any other Contracts that constitute Transferred Assets;
(iii)the company seal, minute books, charter documents, stock or equity record books and such other books and records pertaining to the organization, existence or capitalization of the Seller or its Subsidiaries, as well as any other written records or materials, in each case, that do not constitute Transferred Records or Transferred Information;
-31-


(iv)all real property of the Seller other than the Owned Real Property;
(v)all rights, title and interest of the Seller or its Subsidiaries under this Agreement and the other Transaction Documents, any documents delivered or received in connection herewith or therewith and all other agreements entered into by the Seller or any Subsidiary thereof in connection with the transactions contemplated by this Agreement (other than confidentiality or non-disclosure agreements);
(vi)all Excluded Claims;
(vii)all Tax Returns and other Tax records of the Seller or its Subsidiaries, other than those (A) relating primarily to the Transferred Assets or the Business which are reasonably necessary for the Purchaser to comply with applicable Laws and (B) without duplication, relating exclusively to the Transferred Assets or the Business;
(viii)all current and prior insurance policies of the Seller or its Subsidiaries and all rights of any nature with respect thereto, including all insurance recoveries thereunder and rights to assert claims with respect to any such insurance recoveries, other than in respect of any Post-Signing Insurance Proceeds;
(ix)all rights, title and interest of the Seller or its Subsidiaries in and to the Retained Names and Marks, other than as expressly provided in Section 5.5;
(x)all accounts receivable of the Seller or its Subsidiaries that are not Transferred Accounts Receivable;
(xi)all Intellectual Property of the Seller or its Subsidiaries that is not Transferred Intellectual Property or In-Licensed Intellectual Property;
(xii)all rights and interest of the Seller or its Subsidiaries under credit support instruments and any similar instruments (including letters of credit, consignments, setoff rights, indemnities, guarantees, liens, security arrangements, any other documents or rights intended to secure payment), in each case, that are not primarily related to the Business;
(xiii)all personnel, discipline, performance, employee compensation, medical and benefits and labor relations records relating to the Business Employees, other than (A) Employee Records, (B) any such other records that are required to be provided to the Purchaser by Law or, (C) to the extent not prohibited by Law, as necessary to comply with Section 5.8;
(xiv)all customer credit files of the Seller or its Subsidiaries that are not primarily related to the Business;
(xv)all assets, insurance policies and other funding vehicles of the Seller Benefit Plans; and
-32-


(xvi)the assets identified on Section 2.1(b)(xvi) of the Seller Disclosure Schedule.
Section 2.2Assumption and Exclusion of Liabilities.
a.At the Closing, in connection with the Sale and Purchase and upon the terms and subject to the conditions set forth in this Agreement, the SPV, as designee of the Purchaser, shall assume, and agree to pay, perform and discharge when due, 52.6% of the Liabilities of the Seller and its Subsidiaries in and to the following (and only the following) (the “Assumed Liabilities”):
i.except as otherwise set forth herein, all of the Liabilities of the Seller or any of its Subsidiaries to the extent arising out of, or relating to, the Transferred Assets (excluding the Transferred Contracts, the Transferred IP Agreements and the Shared Contracts which are addressed in Section 2.2(a)(ii) and Trade Accounts Payable), in each case, solely to the extent arising from and after the Closing Date, other than any Liabilities arising from, or relating to, an act or omission by the Seller or any of its Subsidiaries prior to the Closing Date;
ii.all Liabilities of the Seller or its Subsidiaries arising under, or relating to, the Transferred Contracts and the Transferred IP Agreements and that portion of the Shared Contracts that primarily relates to the Business in connection with performance thereof, in each case arising on or after the Closing Date, other than any Liabilities arising from, or relating to, an act or omission by the Seller or any of its Subsidiaries prior to the Closing Date;
iii.all Liabilities for Taxes, other than Excluded Taxes, that are imposed with respect to the Business or the Transferred Assets for any Post-Closing Tax Period (excluding, for the avoidance of doubt, any income taxes of the Seller or any of its Subsidiaries);
iv.all of the Liabilities assumed by the Purchaser pursuant to Section 5.8;
v.all Purchaser Environmental Liabilities;
vi.all Liabilities included in the Final Net Working Capital, whenever arising; and
vii.all other Liabilities identified on Section 2.2(a)(vii) of the Seller Disclosure Schedule.
b.The Seller and its Subsidiaries shall retain, and shall be responsible for paying, performing and discharging when due, and the Purchaser and its Subsidiaries shall not assume or have any responsibility for, any Liabilities of the Seller or any of its Subsidiaries other than the Assumed Liabilities (all Liabilities not being assumed are collectively, the “Excluded
-33-


Liabilities”). The Excluded Liabilities shall include the following Liabilities of the Seller or any of its Subsidiaries:
i.all Liabilities for Excluded Taxes;
ii.all Seller Environmental Liabilities;
iii.all Trade Accounts Payable;
iv.all Liabilities arising under, or relating to, the Seller Benefit Plans other than (A) the amount payable to the Retention Agreement Recipients under the Retention Agreements and (B) the Accrued Performance Bonuses;
v.all Liabilities arising under, or relating to, any product sold or delivered by Seller or any of its Affiliates prior to the Closing Date;
vi.all Liabilities that relate to any employee, independent contractor, or other individual service provider of Seller or any of its Subsidiaries or Affiliates who does not become a Transferred Employee pursuant to Section 5.8 of this Agreement, regardless of when they arise;
vii.all Liabilities with respect to Indebtedness of the Seller or any of its Subsidiaries;
viii.all Liabilities arising under, or relating to, any Excluded Assets;
ix.all Liabilities of the Seller or any of its Subsidiaries that are not Assumed Liabilities; and
x.all other Liabilities identified on Section 2.2(b)(x) of the Seller Disclosure Schedule.
Section 2.3Contribution of Transferred Assets and Assumed Liabilities.
At the Closing, upon the terms and subject to the conditions set forth in this Agreement and the SPV Operating Agreement, the Seller shall effect the Contribution by means of contributing to the SPV, 47.4% of all right, title and interest in and to the Transferred Assets free and clear of all Encumbrances, other than Permitted Encumbrances, and assigning to the SPV, and the SPV shall assume, and agree to pay, perform and discharge when due, 47.4% of the Assumed Liabilities, and in exchange therefore, the SPV shall effect the Preferred Issuance by means of issuing to the Seller the Preferred Equity (in each case, such percentage subject to adjustment to account for any adjustment to Purchase Price hereunder and to account for the Purchaser-Owned IP).
Section 2.4Procedures for the Transfer of Transferred Assets
-34-


. The Seller and the Purchaser shall effect on the Closing Date the transfer, assignment or contribution of the Transferred Assets and the assumption and assignment or contribution of the Assumed Liabilities from the Seller or any of its Subsidiaries, as applicable, to the SPV (or, in the case of the Purchaser-Owned IP, the Purchaser) pursuant to the Local Conveyance Documents and the Intellectual Property Assignment Agreement.
Section 2.5Shared Contracts; Assignment of Contracts and Rights; Post-Signing Insurance Proceeds.
a.Each Shared Contract shall be assigned, transferred, and conveyed or contributed only with respect to (and preserving the meaning of) those parts that primarily relate to the Business or appropriately amended prior to, on or after the Closing, so that the Purchaser shall be entitled to all of the rights and benefits of those parts of the Shared Contract that primarily relate to the Business and shall assume only the portion of any Liabilities thereunder that constitute Assumed Liabilities.
b.Anything in this Agreement to the contrary notwithstanding, this Agreement shall not constitute an agreement to assign any Contract at the Closing that otherwise would be a Transferred Contract or a Transferred IP Agreement or any right thereunder if an attempted assignment, without the consent of a third party, would constitute a breach of such Contract or adversely affect the rights of the Purchaser or its Subsidiaries thereunder or be ineffective with respect to any party thereto. The Seller will use its commercially reasonable efforts to obtain the consent of the other parties to any such Contract in connection with the transfer of such Contract or any claim or right or any benefit arising thereunder for the assignment thereof to the Purchaser. If, on the Closing Date, any such consent is not obtained, or if an attempted transfer or assignment thereof would be ineffective or a violation of applicable Law so that the Purchaser would not in fact receive all such rights (or, in the case of a Shared Contract, all of the rights thereunder primarily related to the Business), the Seller will cooperate in an arrangement reasonably agreed upon by the parties under which the Purchaser or its designated Subsidiary would, in compliance with applicable Law, obtain all of the benefits (or, in the case of a Shared Contract, all of the rights thereunder primarily related to the Business) and assume the obligations and bear the economic burdens associated with such Contract, claim, right or benefit that constitute Assumed Liabilities, including by the Seller subcontracting, sublicensing or subleasing to the Purchaser, or under which the Seller would enforce, for the benefit of the Purchaser, and at the expense of the Purchaser, any and all of its and its Subsidiaries’ rights against a third party thereto (including any Governmental Authority) associated with such Contract, claim, right or benefit (collectively, “Third-Party Rights”), and the Seller would promptly pay to the Purchaser when received all monies received by it or its Subsidiaries under any such Contract or any claim or right or any benefit arising thereunder. Promptly upon obtaining the requisite third-party consent thereto, such Contract or right, if otherwise includable in the Transferred Assets, shall promptly be transferred and assigned to the Purchaser or its designee hereunder for no additional consideration. The provisions of this Section 2.5 shall in no way impose upon the Seller any obligation to incur out-of-pocket expenses in connection with obtaining consents unless the Purchaser agrees to reimburse the Seller for such expenses to the Seller. Following the Closing Date and prior to the date that a
-35-


Contract is assigned to the Purchaser in accordance with this Section 2.5(b), the Purchaser shall not have any Liability under such Contract (including due to the breach thereof by the Seller).
c.From and after the Closing, the Seller shall use commercially reasonable efforts to exercise all rights under any insurance policies of the Seller or any of its Subsidiaries (including all rights to assert claims) arising out of or relating to any damage or destruction to, or loss of, any Transferred Asset, to the extent such damage or destruction remained unrepaired, in whole or in part, or any such asset had not been replaced, as of the Closing Date.
Section 2.6Allocation of Purchase Price.
a.At or prior to the Closing Date, the Purchaser shall determine the amount of, and deliver a written schedule to Seller which allocates the amount of, the Purchase Price attributable to the Purchaser-Owned IP. Within 120 days after the Closing, the Seller shall determine and deliver to the Purchaser a written schedule (including as amended pursuant to this Section 2.6(a) or Section 2.6(b), the “Allocation Schedule”) that allocates the Purchase Price (together with any other amounts treated for U.S. federal income Tax purposes as paid for the Transferred Assets other than the Purchaser-Owned IP) among the Transferred Assets other than the Purchaser-Owned IP in accordance with Section 1060 of the Code and the Treasury Regulations promulgated thereunder (and any similar provision of state, local or foreign Law, as appropriate). The Purchaser may dispute any amounts reflected on the Allocation Schedule by providing written notice to the Seller of the disputed items, and setting forth in reasonable detail the basis of such dispute, within 30 days following receipt of the Allocation Schedule. If the Purchaser disputes any portion of the Allocation Schedule, the Seller and the Purchaser shall attempt to resolve any such dispute through good faith negotiations within 30 days following the Seller’s receipt of the Purchaser’s dispute notice, and shall amend the Allocation Schedule to reflect the resolution (if any) of such dispute. The Seller and the Purchaser shall prepare and file all Tax Returns (including IRS Form 8594) in a manner consistent with the Allocation Schedule, except to the extent a dispute was unable to be resolved with respect thereto, and shall not take any position inconsistent therewith in any Tax Return, audit, examination, claim, adjustment, litigation or other proceeding with respect to Taxes, unless required to do so by applicable Law. Nothing contained herein shall prevent the Seller, the Seller’s Affiliates, the Purchaser or the Purchaser’s Affiliates from settling any proposed deficiency or adjustment by any Governmental Authority based upon or arising out of the Allocation Schedule or the allocation of the Purchase Price among the Transferred Assets. The parties hereto will promptly inform one another of any challenge by any Governmental Authority to any allocation made in accordance with the Allocation Schedule, and the parties agree to consult and keep one another informed with respect to the status of, and any discussion, proposal or submission with respect to, such challenge.
b.To the extent that there is an adjustment to the Purchase Price (or any other amount treated for U.S. federal income tax purposes as paid for the Transferred Assets) subsequent to the Closing Date, the parties shall negotiate in good faith to allocate such adjustment to the Transferred Assets to which it relates and shall amend the Allocation Schedule accordingly.
Section 2.7Closing
-36-


. Subject to the terms and conditions of this Agreement, the Sale and Purchase and the Contribution and the assumption of the Assumed Liabilities in connection with the Sale and Purchase and the Contribution shall take place at a closing (the “Closing”) to be held at the offices of Troutman Pepper Hamilton Sanders LLP, 875 Third Avenue, New York, New York 10022 at 10:00 a.m. New York time (a) on the later of (i) May 31, 2021, subject to the satisfaction or waiver of all of the conditions set forth in Article VII on or before the fifth Business Day prior to such date (other than those conditions that by their nature can only be satisfied or waived at the Closing, but subject to the satisfaction or waiver of those conditions at that time) or (ii) the fifth Business Day following the day on which all of the conditions set forth in Article VII (other than those conditions that by their nature can only be satisfied or waived at the Closing, but subject to the satisfaction or waiver of those conditions at that time) are satisfied or waived; or (b) at such other place or at such other time or on such other date as the Seller and the Purchaser may mutually agree upon in writing (the day on which the Closing takes place, the “Closing Date”).
Section 2.8Closing Deliveries by the Seller
. At the Closing, the Seller shall deliver or cause to be delivered to the Purchaser or the Title Insurer, as the case may be:
a.duly executed counterparts of (i) each Local Conveyance Document, (ii) the SPV Operating Agreement, and (iii) each other Transaction Document that is to be executed at the Closing and, in each case, to which the Seller or any of its Subsidiaries is a party;
b.a receipt for the Closing Date Cash Payment;
c.the certificate referenced in Section 7.2(a)(iii);
d.a duly completed IRS Form W-9 executed by the Seller or a certificate, dated as of the Closing Date, as to the non-foreign status of the Seller pursuant to Treasury Regulations Section 1.1445-2(b)(2), in a form reasonably acceptable to the Purchaser;
e.with respect to the Owned Real Property, affidavits and such other customary documentation delivered by the Seller as shall be reasonably required by a title company selected by the Purchaser (provided such title company is not an Affiliate of Purchaser) (the “Title Insurer”) in form and substance acceptable to the Seller reasonably required for similar transactions in the state where each Owned Real Property is located, to be committed to issue title insurance policies (each, a “Title Policy”, and collectively, the “Title Insurance”) with respect to the Owned Real Property insuring the Purchaser or its designee as the fee simple owner of the Owned Real Property, subject only to Permitted Encumbrances, and the Title Insurer shall be ready, willing and able to issue such Title Policy to Purchaser with customary endorsements; provided, however, that Purchaser’s actual payment of the premium for the Title Policy shall not be a condition to Closing; and
f.evidence that all monetary liens and encumbrances have been released or discharged in connection with the Owned Real Property.
-37-


Section 2.9Closing Deliveries by the Purchaser
. At the Closing, the Purchaser and the SPV shall deliver to the Seller:
a.the Closing Date Cash Payment by wire transfer in immediately available funds to the bank account specified by the Seller in writing at least two Business Days prior to the Closing;
b.the Preferred Equity (which shall be evidenced by the execution and delivery of the SPV Operating Agreement);
c.executed counterparts of (i) each Local Conveyance Document, (ii) the SPV Operating Agreement, and (iii) each other Transaction Document that is to be executed at the Closing and, in each case, to which the Purchaser or any of its Subsidiaries (including the SPV) is a party; and
d.the certificate referenced in Section 7.1(a)(iii).
Section 2.10Preliminary Adjustment of Purchase Price
. The Seller shall provide to the Purchaser at least three Business Days prior to the Closing Date a written statement (the “Estimated Purchase Price Statement”) setting forth in reasonable detail the Seller’s good faith calculation of the estimated Net Working Capital (the “Preliminary Net Working Capital”) prepared in accordance with the policies and procedures used in the preparation of the Baseline Net Working Capital as set forth on Section 1.100 of the Seller Disclosure Schedule, together with reasonable supporting calculations. The Estimated Purchase Price Statement shall also set forth the Seller’s good faith calculation of the Purchase Price payable as of the Closing Date, determined in accordance with this Section 2.10. The Purchase Price shall be  increased by the amount, if any, that the Preliminary Net Working Capital exceeds the Baseline Net Working Capital or decreased by the amount, if any, that the Baseline Net Working Capital exceeds the Preliminary Net Working Capital. The Estimated Purchase Price Statement shall be accompanied by a certificate executed by a senior financial officer of the Seller to the effect that the Preliminary Net Working Capital has been calculated in good faith in accordance with this Section 2.10. To the extent that any foreign currency conversions are necessary in connection with the preparation of Preliminary Net Working Capital, such conversions shall be consistent with the method for conversion of foreign currency as used by the Seller in preparation of its audited financial statements using the applicable exchange rate as of the date immediately prior to the date of the Estimated Purchase Price Statement.
Section 2.11Final Net Working Capital; Adjustment of Purchase Price.
a.Within 60 days after the Closing Date, the Purchaser shall prepare and deliver to the Seller a statement (the “Post-Closing Adjustment”) setting forth in reasonable detail its calculation of Net Working Capital (the “Final Net Working Capital”) prepared in accordance with the policies and procedures used in the preparation of the Baseline Net Working Capital as set forth on Section 2.10 of the Seller Disclosure Schedule. The Post-Closing
-38-


Adjustment shall also set forth the Purchaser’s calculation of the Purchase Price, determined in accordance with this Section 2.11. The Post-Closing Adjustment shall be accompanied by a certificate executed by a senior financial officer of the Purchaser to the effect that the Post-Closing Adjustment has been prepared in good faith in accordance with this Section 2.11(a). To the extent that any foreign currency conversions are necessary in connection with the preparation of the Final Net Working Capital, such conversions shall be consistent with the method for conversion of foreign currency as used by the Seller in the preparation of its audited financial statements using the applicable exchange rate as of the Closing Date.
b.During the 45-day period following delivery of the Post-Closing Adjustment, during normal business hours and upon reasonable advance notice, the Purchaser shall provide reasonable access to the Seller to all workpapers and other books and records utilized by the Purchaser or its Representatives in the preparation of the Post-Closing Adjustment (in the case of accountant work papers of the outside independent accountant of the Purchaser, subject to the Seller entering into a customary confidentiality agreement with respect thereto), in each case, as reasonably requested by the Seller solely for the purpose of the Seller’s review of the Post-Closing Adjustment.
c.If the Seller disagrees with the Purchaser’s calculation of Final Net Working Capital, the Seller shall, within 45 days after the Seller’s receipt of the Post-Closing Adjustment, deliver a written notice (the “Dispute Notice”) to the Purchaser disagreeing with such calculation. The Dispute Notice will set forth the Seller’s objections, if any, to the Post-Closing Adjustment in reasonable detail, the Seller’s grounds for such disagreement and the Seller’s calculation of Final Net Working Capital. The Dispute Notice shall specify those items deemed to be in dispute (the “Disputed Items”), and all other matters included in the Post-Closing Adjustment delivered by the Purchaser shall be deemed to be final and binding on the parties hereto. The failure by the Seller to deliver to the Purchaser the Dispute Notice within such period shall be deemed to constitute the Seller’s acceptance of the Post-Closing Adjustment. After timely delivery of the Dispute Notice by the Seller, the parties will use commercially reasonable efforts to resolve any Disputed Items, and any resolution by the Seller and the Purchaser of such Disputed Items in writing shall be final and binding on the parties hereto.
d.If any Disputed Items cannot be resolved by the parties within 30 days after the Seller delivers the Dispute Notice to the Purchaser, such Disputed Items shall be referred to the Independent Accountant. Unless otherwise agreed, not later than 30 days after the referral of any Disputed Items to the Independent Accountant, the Seller and the Purchaser shall concurrently submit written statements to the Independent Accountant (with a copy to the other party) setting forth their respective positions regarding the Disputed Items which remain in dispute. The Seller and the Purchaser shall instruct the Independent Accountant to render its decision resolving the dispute within 30 days after submission of the written statements, and during such period, the parties shall use commercially reasonable efforts to make available to the Independent Accountant during normal business hours such employees, information, books and records as may be reasonably requested by the Independent Accountant to make its final determination (in the case of accountant work papers of the outside independent accountant of
-39-


the Purchaser, subject to the Independent Accountant entering into a customary confidentiality agreement with respect thereto). In resolving any Disputed Item, the Independent Accountant (i) shall be bound by the provisions of this Section 2.11 and the definitions set forth in this Agreement; (ii) shall limit its review to the Disputed Items submitted to the Independent Accountant for resolution and not otherwise investigate matters independently; and (iii) shall further limit its review of the Disputed Items solely to whether the Disputed Items have been prepared in accordance with this Section 2.11 and the definitions set forth in this Agreement or contain any mathematical or clerical error. The determination of any Disputed Items cannot, however, be in excess of, or less than, the greatest or lowest value, respectively, claimed for any such item in the Post-Closing Adjustment or the Dispute Notice. The Seller and the Purchaser agree that the resolution by the Independent Accountant of any Disputed Items shall be final and binding on the parties hereto. All fees and expenses of the Independent Accountant relating to the work, if any, to be performed by the Independent Accountant hereunder shall be borne by the Seller and the Purchaser in inverse proportion as they may prevail on the matters resolved by the Independent Accountant, which proportionate allocation shall be calculated on an aggregate basis based on the relative dollar values of the amounts in dispute and shall be determined by the Independent Accountant. The Seller and the Purchaser agree that the procedure set forth in this Section 2.11 for resolving disputes with respect to Final Net Working Capital and the Post-Closing Adjustment shall be the sole and exclusive method for resolving such disputes; provided, however, that the parties hereto agree that judgment may be entered upon the determination of the Independent Accountant in any court having jurisdiction over the party against which such determination is to be enforced.
e.If the Final Net Working Capital as finally determined pursuant to this Section 2.11  is less than the Preliminary Net Working Capital, then the Purchase Price shall be decreased by the amount of such shortfall, and the Seller shall pay such amount to the Purchaser, as an adjustment to the Purchase Price; or  is more than the Preliminary Net Working Capital, then the Purchase Price shall be increased by the amount of such excess, and the Purchaser shall pay such amount to the Seller, as an adjustment to the Purchase Price. Any such payment pursuant to the preceding sentence will be made by wire transfer of immediately available funds, to an account (or accounts) designated by the Purchaser or the Seller, as the case may be, on the later of (A) the third Business Day after acceptance or deemed acceptance by the Seller of the Post-Closing Adjustment (as contemplated by Section 2.11(c) above) or (B) the third Business Day following resolution of all Disputed Items (as contemplated by Section 2.11(c) or (d) above). Any payment required pursuant to this Section 2.11(e) shall constitute a payment in respect of the Purchase Price.
f.If the delivery deadline date for the Post-Closing Adjustment or the Dispute Notice is a day that is not a Business Day, the applicable delivery deadline date shall be the immediately following Business Day.
g.Notwithstanding any provision set forth in this Section 2.11 or elsewhere in this Agreement to the contrary, there is no general agreement among the parties to submit disputes under this Agreement to arbitration (other than disputes with respect to the Post-Closing Adjustment, which shall be resolved solely in accordance with this Section 2.11).
-40-


Section 2.12Withholding
. The Purchaser shall be entitled to deduct and withhold such amounts as the Purchaser is required to deduct and withhold under the Code, or any provision of state, local or non-U.S. Tax law, with respect to the making of any payment under this Agreement; provided, however, that if the Seller delivers valid documentation which both the Seller and the Purchaser reasonably agree completely obviates the need for such withholding (including, but not limited to, a duly executed IRS Form W-9 or certificate of nonforeign status pursuant to Section 2.8(d) with respect to withholding pursuant to Section 1445 of the Code, absent a change in Law), then the Purchaser shall not be entitled to deduct and withhold any corresponding amounts otherwise payable to the Seller hereunder. The Purchaser shall use commercially reasonable efforts to provide the Seller with written notice as soon as reasonably practicable upon becoming aware that any such deduction or withholding is required, and the parties shall use commercially reasonable efforts, to mitigate any such deduction or withholding. To the extent that amounts are so deducted and withheld by the Purchaser and remitted to the proper Governmental Authority, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person otherwise entitled to such payment hereunder.
Article III.
REPRESENTATIONS AND WARRANTIES OF THE SELLER
The Seller hereby represents and warrants to the Purchaser and the SPV, subject to such exceptions as are disclosed in the applicable section of the Seller Disclosure Schedule, as follows:
Section 3.1Organization, Authority and Qualification of the Seller.
a.The Seller is a corporation duly organized, validly existing and in good standing under the laws of the Commonwealth of Virginia and has all necessary corporate power and authority to enter into this Agreement and the other Transaction Documents to which it is a party, to carry out its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery by the Seller of this Agreement and the other Transaction Documents to which it is a party, the performance by the Seller of its obligations hereunder and thereunder and the consummation by the Seller of the transactions contemplated hereby and thereby have been duly authorized by all requisite corporate action on the part of the Seller. This Agreement has been, and upon their execution, the other Transaction Documents to which the Seller is a party, will be, duly executed and delivered by the Seller, and (assuming due authorization, execution and delivery by the Purchaser) this Agreement constitutes, and upon their execution, each of the other Transaction Documents to which the Seller is a party, will constitute, a legal, valid and binding obligation of the Seller, enforceable against the Seller in accordance with their respective terms, subject to the effect of any applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws relating to or affecting creditors’ rights generally and subject to the effect of general principles of equity (regardless of whether considered in a proceeding at law or in equity).
-41-


b.The Seller has the corporate power and authority to operate the Business as now operated and is duly qualified to do business, and, to the extent legally applicable, is in good standing, in each jurisdiction where the character of its owned, operated or leased properties or the nature of its activities makes such qualification necessary, except for jurisdictions where the failure to be so qualified or in good standing has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
Section 3.2No Conflict
. Assuming that all consents, approvals, authorizations and other actions described in Section 3.3 or set forth in Section 3.2 or Section 7.1(b) of the Seller Disclosure Schedule have been obtained, all filings and notifications described in Section 3.3 or set forth in Section 3.2 or Section 7.1(b) of the Seller Disclosure Schedule have been made, any applicable waiting period has expired or been terminated, the execution, delivery and performance by the Seller of this Agreement and each of the other Transaction Documents to which it is a party and the consummation by the Seller of the transactions contemplated hereby and thereby, do not and will not  violate, conflict with, or result in the breach of any provision of the articles of incorporation or bylaws of the Seller;  conflict with or violate any Law or Governmental Order applicable to the Seller or the Business;  conflict with, result in any breach of, constitute a default (or an event which, with or without the giving of notice or lapse of time, or both, would become such a default) under, require any consent under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material Contract to which the Seller or any of its Subsidiaries is a party or result in the creation of any Encumbrance upon any of the Transferred Assets, except, in the case of clauses (b), (c) and (d), as would not have, or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
Section 3.3Governmental Consents and Approvals
. Except as set forth in Items 2-6 of Section 7.2(g) of the Seller Disclosure Schedule, the execution, delivery and performance by the Seller of this Agreement and each Transaction Document to which it is a party does not require any consent, approval, authorization or other order or declaration of, action by, filing with or notification to, any Governmental Authority, other than  compliance with, and filings under, the HSR Act and any other applicable filings and approvals in the jurisdictions set forth on Section 7.1(b) of the Seller Disclosure Schedule and any other applicable Antitrust Laws; or  where the failure to obtain such consent, approval, authorization or action, or to make such filing or notification, would not, and would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect.
-42-


Section 3.4Financial Information.
a.The Financial Statements, subject to the notes thereto, were derived from the audited consolidated financial statements of the Seller and represent, in all material respects, the combined income of the Business as of the dates thereof for the periods covered thereby. The Financial Statements were prepared from the books and records of the Business in accordance with the accounting procedures and methodologies set forth on Section 3.4 of the Seller Disclosure Schedule. The Seller makes no representation that the Financial Statements were prepared in accordance with, or comply with, GAAP.
b.The Financial Statements represent in all material respects the financial position of the Business as of the respective dates thereof and the results of operations of the Business for the periods covered thereby.
c.The Business has not incurred since December 31, 2019, any material Liabilities, other than  as specifically reflected in the Financial Statements, Liabilities incurred in the ordinary course of business consistent with past practice since December 31, 2019, Excluded Liabilities or Liabilities that would not have, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Neither the Seller nor any of its Subsidiaries has taken out any loan, received any loan assistance, received any other financial assistance, or requested any of the foregoing, in each case under the CARES Act.
Section 3.5Absence of Changes; No Material Adverse Effect
. Since December 31, 2019,  the Business has been conducted in the ordinary course of business consistent with past practice,  without limiting the generality of the foregoing, neither the Seller nor any of its Subsidiaries has taken any action or omitted to take any action which, if taken or omitted to be taken after the date hereof and prior to the Closing Date, would require the consent of the Purchaser pursuant to Section 5.1(c)(i), (ii), (iii), (iv), (v), (vi), (vii), (ix), (xi), (xii), (xiv) or (xv) and  there has not occurred any fact, circumstance, effect, change, event, condition, state of facts or development that has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
Section 3.6Litigation
. There is no Action by or against the Seller and specifically or primarily relating to or in connection with the Business pending or, to the Seller’s Knowledge, threatened before any Governmental Authority  pursuant to which money damages in excess of $100,000 are sought,  involving any non-monetary relief (including any criminal proceeding, investigation or indictment),  that would, or would reasonably be expected to materially and adversely affect the legality, validity or enforceability of this Agreement or any other Transaction Document or  that would, or would reasonably be expected to, prevent or materially delay the consummation by the Seller of the transactions contemplated by this Agreement or any other Transaction Documents. The Seller is not, in connection with the Business or the Transferred Assets, subject to any order, judgment, preliminary or permanent injunction, temporary restraining order, award, citation, decree, consent decree or writ of any Governmental Authority.
-43-


Section 3.7Compliance with Laws.
a.The Seller conducts, and during the last three years has conducted, the Business, in all material respects, in accordance with all Laws and Governmental Orders applicable to the Business. To the Knowledge of the Seller, no event has occurred or circumstance exists that (with or without notice or lapse of time or both) would reasonably be expected to constitute or result in a material violation by the Seller of, or a material failure on the part of the Seller to comply with, any Law, Permit or Governmental Order in connection with the operation of Business.
b.Each of the Seller and its Subsidiaries and, to the Knowledge of the Seller, their respective officers, directors, employees and Representatives acting on their behalf, are, and in the past three years have been, in connection with the Business, in compliance, in all material respects, with  all applicable Anti-Corruption Laws and  U.S. and any applicable foreign economic sanction Laws, including economic sanctions administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control (collectively, “Sanctions”) and U.S. and applicable foreign Laws pertaining to export and import controls, including those administered by the U.S. Departments of Commerce and State, and applicable anti-money laundering Laws (collectively, “Trade Controls”).
c.None of the Seller or its Subsidiaries, or their directors, officers, or employees, nor to the Knowledge of the Seller, any agents acting on their behalf, is or has been in connection with the Business identified on any Sanctions-related list of restricted or blocked persons; organized, resident, or located in any country or territory that is itself the subject of Sanctions; or owned or controlled by any Person or Persons described in clause (i) or (ii).
d.There have been no claims, complaints, charges, investigations, voluntary disclosures, or proceedings under Trade Controls involving the Seller or its Subsidiaries in connection with the Business, and to the Knowledge of the Seller, there are no pending or threatened claims or investigations involving suspect or confirmed violations thereof in connection with the Business.
Section 3.8Intellectual Property.
a.Section 3.8(a) of the Seller Disclosure Schedule contains a true and correct list of all of the Transferred Intellectual Property consisting of Registered Intellectual Property, including for each such item  the record owner, and, if, to the Knowledge of the Seller, different, the legal owner and beneficial owner of such item,  the jurisdiction in which such item is issued, registered or pending and  the issuance, registration or application date and number of such item. As of the date hereof, each such item of Registered Intellectual Property is in effect, subsisting and not abandoned, all maintenance and prosecution fees relating thereto that are due on or before the date hereof have been paid and, to the Knowledge of the Seller, is valid and enforceable.
b.Except as set forth on Section 3.8(b) of the Seller Disclosure Schedule, the Seller is the sole and exclusive owner of all right, title and interest, free and clear of all
-44-


Encumbrances (other than Permitted Encumbrances) in and to the Transferred Intellectual Property and, to the Knowledge of the Seller, otherwise has all necessary licenses, rights, permissions and authorizations to use all other Intellectual Property used in the Business, including all computer software licenses. The Transferred Intellectual Property, the In-Licensed Intellectual Property and the Intellectual Property licensed to the Purchaser under Section 5.5 constitute all of the Intellectual Property used or held for use in connection with the operation of the Business, and there is no other Intellectual Property that is used by, material to, or necessary for, the operation of the Business or for the continued operation of the Business after the Closing in substantially the same manner as operated prior to the Closing. After the Closing, there will be no Intellectual Property owned or used by the Seller or its Subsidiaries that is necessary for the Business as of the Closing as to which no provision is made in the Transaction Documents for continued use thereof after the Closing by the Purchaser.
c.Neither the Transferred Intellectual Property nor the Business as conducted by the Seller interferes with, dilutes, infringes, misappropriates or otherwise violates any Intellectual Property rights of any third party, and has not done so in the last six years (except that the foregoing representation is given to the Knowledge of the Seller with respect to patents). The Seller has, with respect to the operation of the Business, undertaken patent clearance searches and reviews consistent with the Seller’s reasonable business judgment, and such patent clearance searches and reviews have not identified any products or services that, in the Seller’s reasonable judgment, infringe, or are reasonably likely to infringe, a valid third party patent. To the Knowledge of the Seller, no third party currently interferes with, dilutes, infringes upon, misappropriates, or violates and nor during the last three years has any third party interfered with, diluted, infringed upon, misappropriated, or otherwise violated any Transferred Intellectual Property. There is no claim against the Seller or any of its Subsidiaries pending or, to the Knowledge of the Seller, threatened which  alleges any infringement, misappropriation, misuse or violation of any Intellectual Property of a third party,  invites the Seller or such Subsidiary to take a license under any Intellectual Property of a third party or consider the applicability of any Intellectual Property of a third party to the conduct of the Business or  challenges the ownership, use, validity or enforceability of any Transferred Intellectual Property. Neither the Seller nor any of its Subsidiaries has made any written claim against any third party alleging any infringement, misappropriation or other violation of any Transferred Intellectual Property. Other than rejections in routine patent and trademark prosecution in pending patent or trademark applications, none of the Transferred Intellectual Property is subject to any outstanding order, judgment, injunction, decree, ruling or agreement adversely affecting the Seller’s or its Subsidiaries’ use thereof or rights thereto, or that would impair the validity or enforceability thereof.
d.Each current and former employee, consultant and contractor of the Seller and its Subsidiaries that is or was involved in the conception, development or reduction to practice of any Transferred Intellectual Property for the Business has entered into a valid, written non-disclosure and invention assignment agreement whereby such employees, consultants or contractors have assigned to the Seller all of their right, title and interest in and to the Transferred Intellectual Property that are conceived of or developed by such employees, consultants and contractors. To the Knowledge of the Seller, no current or former employee, consultant or
-45-


contractor of the Seller or any of its Subsidiaries is in default or breach of any term of any employment agreement, non-disclosure agreement, assignment of invention agreement or similar agreement relating to the protection, ownership, development, use or transfer of Transferred Intellectual Property or, to the Seller’s Knowledge, any other Intellectual Property.
e.The Seller and its Subsidiaries have taken reasonable measures to maintain the confidentiality and value of all confidential information and trade secrets used or held for use in the operation of the Business. To the Knowledge of the Seller, other than disclosures made in the Seller’s reasonable business judgment, no material confidential information or trade secrets used or held for use in the Business have been disclosed by the Seller or any of its Subsidiaries to any Person except pursuant to non-disclosure and/or license agreements that obligate such Person to keep such confidential information or trade secrets confidential both during and, for a reasonable period, after the term of such agreement.
f.Except as set forth on Section 3.8(f) of the Seller Disclosure Schedule, there are no royalties, honoraria, fees or other payments payable by the Seller or any of its Subsidiaries to any Person under any Transferred IP Agreement, including for the acquisition, licensing, sublicensing or use of any Transferred Intellectual Property. The consummation of the transactions contemplated by the Transaction Documents will not result in any of the following pursuant to the terms of any Contract to which the Seller or any of its Subsidiaries is a party:  the grant, license or assignment to any Person of any interest in or to, the modification or loss of any rights with respect to, or the creation of any Encumbrance on, any Transferred Intellectual Property, or any Intellectual Property owned by or licensed to the Purchaser or its Affiliates prior to Closing; or  the Purchaser or its Affiliates being (A) bound by or subject to any non-compete or licensing obligation, covenant not to sue, or other restriction on or modification of the current or contemplated operation or scope of its business, which that Person was not bound by or subject to prior to the Closing, or (B) obligated to (1) pay any royalties, honoraria, fees or other payments to any Person in excess of those payable prior to the Closing or (2) provide or offer any discounts or other reduced payment obligations, in each case, to any Person in excess of those provided to that Person prior to Closing.
g.To the Knowledge of the Seller, the Transferred IT Assets are free from material bugs and other defects, have not materially malfunctioned or failed within the past three years, and to the Knowledge of the Seller, do not contain any viruses, Trojan horses, malware or similar devices. The Seller and its Subsidiaries have implemented reasonable backup, security and disaster recovery measures, and to the Knowledge of the Seller, no Person has gained unauthorized access to any IT Assets used in the Business.
Section 3.9Real Property.
a.Section 1.102 of the Seller Disclosure Schedule sets forth a true and complete list of each parcel of Owned Real Property and the identity of the owner of each such parcel of Owned Real Property. The Seller has a good, valid and marketable fee simple ownership interest in each parcel of Owned Real Property, free and clear of all Encumbrances other than Permitted Encumbrances, and has the full right, power and authority to convey the Owned Real Property to the Purchaser. Copies of the Seller’s title insurance policies, opinions,
-46-


abstracts, surveys and vesting deeds in the Seller’s control and possession relating to the Owned Real Property have been previously delivered to the Purchaser.
b.Except as set forth on Section 5.1(c)(iv)(B) of the Seller Disclosure Schedule, there are no material repairs or capital repairs (other than capital repairs in the ordinary course of business) required or contemplated with respect to the Manufacturing Facilities, building systems and other improvements on the Owned Real Property.
c.Each Owned Real Property has physical and, to the Knowledge of the Seller, vehicular and pedestrian access to and from public roadways as may be necessary to the operation of the business. To the Knowledge of the Seller, no fact or condition exists which would result in the termination of (i) the current access from each parcel of the Owned Real Property, and (ii) continued use, operation, maintenance, repair and replacement of all existing and currently committed utility lines used by the Seller in connection with the Business, except where such termination would not have a Material Adverse Effect.
d.The Owned Real Property constitutes all real estate and rights in real property that are used or necessary in connection with the operation of the Business in the manner currently conducted.
e.There are no pending or, to the Knowledge of the Seller, threatened condemnation or expropriation proceedings, lawsuits or proceedings relating to the Owned Real Property or any part thereof or other legal matters affecting adversely the current use or occupancy thereof.
f.The Seller, in respect of each Manufacturing Facility, holds all approvals of Governmental Authorities (including licenses and Permits) required in connection with the ownership, occupation or operation thereof, and each Manufacturing Facility is, and has been during the past three years, operated and maintained in all material respects in accordance with applicable Law, including any fire, health, building, use, occupancy or zoning Law.
g.Except for Permitted Encumbrances, there are no oral or written leases, subleases, licenses, concessions or other agreements, written or oral, granting to any party or parties (other than the Seller) the right of use or occupancy of any portion of the Owned Real Property, or options granting any right to purchase or lease, any portion of the Manufacturing Facilities or Owned Real Property, and, other than the Seller, there is no Person in possession of any portion of the Owned Real Property.
h.The Seller has not received any notice of any violation of any applicable zoning ordinance or other Law relating to, or any notice that any work is required pursuant to applicable Law to be done upon or in connection with, the operation of the Manufacturing Facilities or the operation of the Owned Real Property.
i.There is no Action before any Governmental Authority pending or, to the Seller’s Knowledge, threatened, to change the zoning or building ordinances or any other Laws affecting the Owned Real Property.
-47-


Section 3.10Employees; Employee Benefit Matters.
a.Section 3.10(a) of the Seller Disclosure Schedule contains a complete, true and correct list of all the Business Employees and indicates for each such Business Employee, to the extent applicable and to the extent permissible under applicable Law, such Business Employee’s (to the extent applicable) name, title (including whether an employee, independent contractor or other service provider), and employee identification number. The Seller has made available, or will make available as soon as possible following the date hereof, but not less than 30 days prior to the Closing Date, to the Purchaser the following information with respect to each such Business Employee prior to the date hereof: (A) date of birth and years of employment/service, (B) employing or contracting legal entity, country, and location of employment or service, (C) rate of base salary, hourly wage rate, rate of commissions or retainer arrangement as in effect on the date of this Agreement, including any increases scheduled to take effect following the date of this Agreement, (D) annual incentive cash bonus for 2021 at target and maximum payouts, (E) the amount of annual cash bonus paid for 2019 and 2020 (or if not yet paid for 2020, the amount earned and to be paid), (F) immigration status (and, to the extent that the Business Employee requires a visa, work permit or employment pass or other legal or regulatory approval for his or her employment, type of visa, permit, pass, or approval and country of citizenship), (G) social security number, and (H) work email addresses (clauses (A) through (H), together, the “Additional Employee Data”). Section 3.10(a) of the Seller Disclosure Schedule is subject to change between the date hereof and the Closing Date and the Seller shall provide updated schedules that are mutually agreed by the Purchaser and the Seller, as well as updated Additional Employee Data to the extent necessary to reflect or relate to such changes. The Seller shall update Section 3.10(a) of the Seller Disclosure Schedule and the Additional Employee Data provided to reflect changes in the Business Employees no less frequently than every 30 days and again no later than the Closing Date, with each update to be mutually agreed in advance by the Purchaser and the Seller. The Seller represents and warrants to the Purchaser that each individual who is employed or retained by the Seller or any Subsidiary or Affiliate of the Seller primarily in connection with the Business is identified on Section 3.10(a) of the Seller Disclosure Schedule.
b.Section 3.10(b) of the Seller Disclosure Schedule lists all material Seller Benefit Plans.
c.The Seller has provided or made available to the Purchaser, for each Seller Benefit Plan,  true and complete copies of all current plan documents (including all amendments and modifications thereof) and a summary plan description (if any), or, to the extent not in writing, a summary of material terms thereof;  the most recent determination or opinion letter from the IRS received with respect to each Seller Benefit Plan that is intended to be qualified under Section 401(a) of the Code, if any; and  all material correspondence and documentation, and all non-routine filings made, with any Governmental Authority with respect to each Seller Benefit Plan within three years of the date hereof.
d.    Each Seller Benefit Plan has been administered in compliance in all material respects with its terms and applicable Laws;  no claims, disputes, government audits,
-48-


examinations or investigations are pending or, to the Knowledge of the Seller, threatened with respect to any Seller Benefit Plan, other than ordinary claims for benefits; and  each Seller Benefit Plan that is intended to be qualified under Section 401(a) of the Code has received a currently effective favorable determination letter or, if applicable, can rely upon an opinion letter from the IRS as to the qualification of the prototype plan on which it is based, and, to the Knowledge of the Seller, nothing has occurred that would reasonably be expected to adversely affect such qualification.
Section 3.11Labor Matters.
a.There are, and during the past three years there have been, no collective bargaining, labor union, or other similar employee representative agreements or arrangements that are applicable to any of the Business Employees.
b.During the past six years there have been no, and there are currently no,  pending, or to the Knowledge of the Seller, threatened strikes or lockouts with respect to any Business Employees;  union organizing efforts pending or, to the Knowledge of the Seller, threatened with respect to the Business or the Business Employees;  unfair labor practice, labor dispute (other than routine individual grievances) or labor arbitration claims or proceedings pending or, to the Knowledge of the Seller, threatened in writing against the Business or with respect to the Business Employees; or  slowdowns or work stoppages in effect or, to the Knowledge of the Seller, threatened with respect to the Business Employees.
c.The Seller and its Subsidiaries, as applicable, have complied in all material respects with all applicable Laws relating to labor and employment with respect to the Business and the Business Employees, including wages, salaries and commissions, payment for hours worked, payment for overtime, payment for vacation and sick pay, employee and independent contractor classifications, classification of Business Employees as exempt or non-exempt, collective bargaining, employment discrimination, unemployment, occupational safety and health, immigration status, workers’ compensation, and the payment of payroll and similar Taxes, and are not liable for the payment of Taxes, fines, penalties or other amounts for failure to comply with any of the foregoing. There has been no “mass layoff” or “plant closing” (as defined by the WARN Act or any similar state or local Law) with respect to the Business during the past three years or for which any Liabilities remain unsatisfied.
d.Neither the Seller nor any of its Subsidiaries is engaged in, nor has at any time engaged in, any unfair or discriminatory labor or employment practice, nor is any charge or complaint relating to any unfair or discriminatory labor or employment practice pending or threatened against the Seller or any such Subsidiary with respect to the Business or the Business Employees. Neither the Seller nor any of its Subsidiaries has any obligation to compensate or make any payment of any kind to any Business Employee, director or officer, other than current obligations for payment of wages and salary, accrued but unused vacation pay and other benefits. All severance and employee pension plans applicable to Business Employees are funded to the full extent required by applicable Laws, and all amounts properly accrued as Liabilities with respect to any Business Employee, director or officer that have not been paid have been properly accounted for on the Seller’s books. There is no accrued and outstanding, due but unpaid,
-49-


payment (wages, allowances, and otherwise) or other benefit required to be provided to any current or former Business Employee, director or officer (including any outsourced workers or dispatched workers) under applicable Laws.
e.Except as set forth on Section 3.11(e) of the Seller Disclosure Schedule, (i) no Business Employee or other individual engaged by the Seller or any of its Subsidiaries primarily in connection with the Business as an independent contractor, temporary employee, leased employee or any other service provider compensated other than through reportable wages (as an employee) has been improperly excluded from any Seller Benefit Plan, and (ii) none of the Seller or any of its Subsidiaries utilizes the services of any leased employees within the meaning of Section 414(n) of the Code in connection with the Business.
Section 3.12Taxes.
a.All income Tax Returns and all other material Tax Returns required to have been filed by the Seller with respect to the Transferred Assets or the Business have been timely filed (taking into account any extension of time to file granted or obtained) and such Tax Returns are true, correct and complete in all material respects.
b.All income Taxes and all other material Taxes (whether or not shown on any Tax Return) required to be paid by the Seller with respect to the Transferred Assets or the Business have been timely paid.
c.No claim or deficiency for any material amount of Taxes has been proposed, asserted or assessed in writing by any Governmental Authority against the Seller in respect of the Transferred Assets or the Business, which remains unresolved or unpaid, except for any claims or deficiencies that are being contested in good faith by appropriate proceedings and are described on Section 3.12(c) of the Seller Disclosure Schedule. Within the last four years, no claim has been made by a Governmental Authority in a jurisdiction where the Seller does not file Tax Returns with respect to the Business or any of the Transferred Assets that the Seller is or may be subject to taxation by that jurisdiction with respect to the Business or such Transferred Asset, which remains unresolved.
d.There are no Encumbrances for Taxes (other than Permitted Encumbrances) upon any of the Transferred Assets or the Business.
e.There are no waivers or extensions of any statute of limitations currently in effect with respect to Taxes or Tax Returns with respect to the Business or the Transferred Assets (other than extensions that arise as a result of filing Tax Returns by the extended due date therefor in the ordinary course of business).
f.The Seller is not a party to any Tax sharing, Tax allocation, Tax indemnity or similar agreement or arrangement with respect to the Transferred Assets or the Business.
g.The Seller is not a foreign person as defined in Treasury Regulations Section 1.1445-2(b)(2)(i).
-50-


h.Notwithstanding anything to the contrary contained in this Agreement (including any other representations and warranties contained in this Agreement), the representations and warranties contained in Section 3.10 and this Section 3.12 (A) are the sole and exclusive representations and warranties made by the Seller relating to Tax matters with respect to the Transferred Assets and the Business, including compliance with and liabilities arising under Tax Laws and (B) other than the representations contained in Section 3.12(f) cannot be relied upon with respect to Taxes attributable to any Tax periods (or portions thereof) beginning after, or Tax positions taken after, the Closing Date.
Section 3.13Material Contracts.
a.Section 3.13(a) of the Seller Disclosure Schedule sets forth a true and complete list of each of the following Contracts (excluding purchase orders) to which the Seller or any of its Subsidiaries is a party, and that relates primarily to the Business and is in effect as of the date of this Agreement (such contracts and agreements being “Material Contracts”):
i.(A) Contracts for the purchase of products, materials, supplies, goods, equipment or other assets or for the receipt of services or (B) any other Contract, in each case, which provided for consideration or payments by the Seller or its Subsidiaries in excess of $350,000 in the aggregate in 2020;
ii.(A) Contracts for the sale or furnishing of products, materials, supplies, goods, equipment or other assets or services by the Seller or its Subsidiaries to customers of the Business or (B) any other Contract, in each case, which provided for consideration or payments by such customers in excess of $350,000 in 2020 (any such Contracts, “Sales Contracts”);
iii.Contracts with any Key Customer or Key Supplier;
iv.all Contracts that are material to the control of the quality or processing related to the products under the Sales Contracts;
v.Contracts that (A) include a covenant not to compete or other covenant restricting the freedom of the Business to compete in any line of business with any Person or in any geographic area (including any exclusivity covenant), or a covenant not to solicit any individual or class of individuals for employment, (B) require the Business to purchase or sell a minimum amount of products or services on an annual basis or grant “most favored nation” pricing or similar rights to any Person, or (C) relate to capacity reservations or include any obligation to accept orders;
vi.Contracts that involve the creation, assumption or guarantee of Indebtedness for an amount, individually or in the aggregate, in excess of $350,000, or the extension of credit to any Person (not involving accounts receivable) or the creation of an Encumbrance on any Transferred Assets;
vii.Related Party Contracts;
-51-


viii.Contracts relating to any partnership, joint venture or limited liability company of the Business, or involving the sharing of revenues, profits or royalties of the Business;
ix.Contracts relating to the acquisition or disposition of any Person, business, product line or real property (whether by merger, sale of stock, sale of assets or otherwise) (A) pursuant to which, after the Closing, the Business will have any obligations (contingent or otherwise) or (B) for consideration with an aggregate value of $350,000 or more;
x.all Contracts with distributors, sales representatives, sales consultants and sales agents with respect to the Business, including but not limited to, all exclusive sales representative or exclusive distribution Contracts;
xi.Contracts under which the Business is lessor of or permits any third party to hold or operate any Owned Real Property;
xii.Contracts requiring capital expenditures in excess of $350,000 in any one fiscal year;
xiii.leases, rental or occupancy agreements, licenses, installment and conditional sale agreements, and other Contracts that (A) provide for the ownership of, leasing of, title to, use of, or any leasehold or other interest in any real or personal property and (B) in the case of personal property, involve aggregate payments in excess of $350,000 in any calendar year;
xiv.any Shared Contract;
xv.any Contract with any Governmental Authority;
xvi.any IP Agreement or Transferred IP Agreement, other than any: (A) Contract with a current or former employee or individual independent contractor of the Seller or any of its Subsidiaries entered into in connection with the engagement of that Person by the Seller or any of its Subsidiaries, which Contract includes a license from that Person to the Seller or one of its Subsidiaries to use Intellectual Property owned or sublicensable by that Person, but only where the Intellectual Property licensed thereunder is not specifically identified; or (B) Contracts for any commercially available off the shelf software that (1) is not material to the Business, (2) has not been modified or customized for use in the Business, and (3) is licensed to the Seller or any of its Subsidiaries for a one time or annual fee of $100,000 or less;
xvii.any Contract relating to the resolution or settlement of any actual or threatened Action that involves (A) the payment of money damages in excess of $100,000, individually or in the aggregate, or (B) any obligation (other than the payment of money damages) of the Seller with respect to the Business;
-52-


xviii.all Contracts with Business Employees or independent contractors providing for annual base compensation opportunity in excess of $100,000;
xix.all Contracts with Key Customers relating to access, sharing of data and other information for purposes of compliance with the Drug Laws; and
xx.any Contract not otherwise listed in this Section 3.13(a) that is material to the Business, taken as a whole.
b.The Seller has made available to the Purchaser true and complete copies of each Material Contract. Each Material Contract is valid and binding on the Seller and, to the Knowledge of the Seller, the counterparty thereto, is enforceable by the Seller or a Subsidiary of the Seller in accordance with its terms and is in full force and effect, subject to the effect of any applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws relating to or affecting creditors’ rights generally and subject to the effect of general principles of equity (regardless of whether considered in a proceeding at law or in equity). Neither the Seller nor, to the Knowledge of the Seller, any other party thereto, is in breach of or default, in any material respect, under the terms of, or has provided or received any notice of material breach, material default or intention to terminate, any Material Contract. To the Knowledge of the Seller, no event or circumstance has occurred, and there does not exist any event or circumstance that, with or without notice or lapse of time or both, would, or would reasonably be expected to, constitute an event of material default under any Material Contract or result in or permit a termination thereof or would cause or permit the acceleration of or other material changes of or to any right or obligation or the loss of any material benefit thereunder. There are no material disputes pending or, to the Seller’s Knowledge, threatened, under any Material Contract.
Section 3.14Environmental Matters.
a.Except as set forth on Section 3.14(a) of the Seller Disclosure Schedule,  the Seller is conducting, and has conducted during the last six years, the Business and the Transferred Assets in compliance in all material respects with applicable Environmental Law;  in connection with the Business, the Seller has obtained and is in compliance in all material respects with all Environmental Permits that are necessary to conduct the Business and the Transferred Assets in the manner currently conducted and all applications for renewals necessary for continuity of such Environmental Permits have been timely filed and, to Seller’s Knowledge, all such Environmental Permits are transferrable to the Purchaser except Seller’s Tyrone pesticide establishment registration, EPA Establishment 3377-PA-001;  there are no Hazardous Materials (A) present at, on, about, under or migrating to or from either the Manufacturing Facilities, the Owned Real Property or any other real property (including all buildings, improvements and fixtures located thereon) currently owned, leased or operated in connection with the Business or, to the Seller’s Knowledge, any real property formerly owned, leased or operated in connection with the Business or (B) that have been disposed of, transported, or arranged for transportation by the Seller or any of its Subsidiaries, or any of their respective predecessors, in connection with the Business, to any place or location that, in each case, require Remedial Action or otherwise could reasonably be expected to result in material Liabilities on
-53-


the part of the Business; and  there is no Action pending or, to the Seller’s Knowledge, threatened in writing, in connection with the Business, against the Seller or its predecessors, that relates to any violation or alleged violation of, or any Liability or alleged Liability under, any applicable Environmental Law.
b.The Seller does not own nor does it require ownership of any pesticide product registrations under the Federal Insecticide, Fungicide and Rodenticide Act, 7 U.S.C. 346a, to conduct the Business.
c.The Seller has made available to the Purchaser true, correct and complete copies of all (A) Phase I or Phase II environmental site assessment reports or (B) baseline environmental assessments or (C) environmental compliance reports or audit reports relating to the Business, the Manufacturing Facilities or the Owned Real Property to the extent such assessments and reports in this subsection (c) were prepared in connection with the Seller’s purchase of the Manufacturing Facilities or during the last ten years and are in the possession or control of the Seller, Environmental Permits required under applicable Environmental Laws for the ownership and operations of the Business, the Manufacturing Facilities and the Owned Real Property, and all non-privileged material correspondence and documents relating to the Business’s compliance with, or liability under, applicable Environmental Law.
d.Notwithstanding anything in this Agreement to the contrary, the representations and warranties contained in this Section 3.14 and, to the extent they specifically apply, Sections 3.3, 3.19 and 3.20 are the only representations and warranties being made by the Seller in this Agreement with respect to matters arising under applicable Environmental Laws or Environmental Permits related to the Business, the Owned Real Property, or the other Transferred Assets.
Section 3.15Customers, Suppliers and Distributors.
a.Section 3.15(a) of the Seller Disclosure Schedule sets forth a true and complete list of the ten largest customers (measured by dollar volume of sales) of the Business during the 12-month period ended December 31, 2019 (the “Key Customers”).
b.Section 3.15(b) of the Seller Disclosure Schedule sets forth a true and complete list of the ten largest suppliers (measured by dollar volume of sales) of the Business during the 12-month period ended December 31, 2019 (the “Key Suppliers”).
c.Section 3.15(c) of the Seller Disclosure Schedule sets forth a true and complete list of the ten largest distributors, sales representatives, sales consultants and sales agents (measured in terms of dollars paid by the Business) of the Business during the 12-month period ended December 31, 2019 (collectively, the “Key Distributors”).
d.Except as set forth in Section 3.15(d)(i) of the Seller Disclosure Schedule, since January 1, 2018, none of the Key Customers, Key Suppliers or Key Distributors has notified the Seller that it intends to  cease or materially decrease purchasing from or selling to the Business,  materially modify the terms on which it sells to or purchases from the Business
-54-


(including any material changes in pricing or terms) as compared to past practices, or  materially alter any purchases from or sales to the Business. Except as set forth in Section 3.15(d)(ii) of the Seller Disclosure Schedule, since January 1, 2020, except in connection with normal expiration of Contracts in the ordinary course of business, no Key Supplier, Key Customer or Key Distributor has (A)  ceased or decreased materially its purchasing from or selling to the Business from the levels achieved during the 12-month period ended December 31, 2019, (B) made any material adverse change in the terms and conditions on which it was doing business with the Seller and its Subsidiaries with respect to the Business as of the 12-month period ended December 31, 2019 or (C) materially altered any purchases from or sales to the Business. There is no pending or, to the Knowledge of the Seller, threatened material dispute or controversy with any Key Supplier, Key Customer or Key Distributor.
Section 3.16Inventory
. All Transferred Inventory was manufactured, purchased, acquired or ordered, and has been maintained, in the ordinary course of business and consistent with the regular past inventory practices of the Seller and, with respect to the Business, with the exception of “off-spec” inventory held for rework, is of a quality useable and saleable in the ordinary course of business and fit for the purpose for which it was manufactured, purchased, acquired or ordered. The quantities of each item of Transferred Inventory are consistent with the regular past inventory practices of the Seller with respect to the Business. All Transferred Inventory is carried on the books and records of the Seller at the lower of cost or net realizable value in accordance with GAAP, which value is reasonable based upon the current operations of the Business and is not subject to any material write-down or write-off. All labor and overhead costs reflected in the value of Transferred Inventory were capitalized in accordance with GAAP.
Section 3.17Title to Assets; Sufficiency of Assets
. The Seller, or a Subsidiary of the Seller, has good, valid and marketable title to or, in the case of leased or licensed assets, a valid leasehold interest or license in, all of the Transferred Assets (other than the Owned Real Property, which is addressed in Section 3.9), free and clear of all Encumbrances other than Permitted Encumbrances. The Transferred Assets that are tangible assets of any kind or description (including the Equipment) are in good operating condition and repair in all material respects, ordinary wear and tear excepted, and suitable in all material respects for their current use and have been maintained in accordance with written standards, policies and procedures of the Business as made available to the Purchaser. The Transferred Assets and the employment of the Business Employees, together with the services and assets to be provided, the licenses to be granted and the other arrangements contemplated by this Agreement or the other Transaction Documents, constitute (and immediately following the Closing, will constitute) all of the assets, rights and properties necessary to conduct the Business on or immediately after the Closing Date in the same manner as currently conducted by the Seller.
Section 3.18Brokers
-55-


. Except for Bank of America, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the transactions contemplated by this Agreement or the other Transaction Documents based upon arrangements made by or on behalf of the Seller. The Seller shall be solely responsible for the fees and expenses of Bank of America.
Section 3.19Governmental Licenses and Permits.
a.The Seller holds, and is operating in compliance in all material respects with, and in the past three years has operated in compliance in all material respects with, all Transferred Permits. All such Transferred Permits are in full force and effect. Section 3.19 of the Seller Disclosure Schedule contains a true, correct and complete list of the Transferred Permits.
b.To the Knowledge of the Seller,  the Seller has fulfilled and performed all of its material obligations with respect to the Transferred Permits, and  no event has occurred which allows, and, to the Knowledge of the Seller, there does not exist any event or circumstances which, with or without notice or lapse of time or both, would allow, revocation or termination thereof or results in any other material impairment of the rights of the holder of any Transferred Permit. No Action is pending or, to the Knowledge of the Seller, threatened to revoke, withdraw, suspend, cancel, terminate, materially modify, or limit any Transferred Permit, and there are no facts or circumstances (including the consummation of the transactions contemplated by the Transaction Documents) that are reasonably likely to give rise to any material adverse change in any Transferred Permit or any failure to materially comply with applicable Laws or any term or requirement thereof in any material respect.
Section 3.20Product Liability; Product Warranties
. The Seller has provided the Purchaser complete and accurate copies or forms of all written customer warranties currently in effect with respect to the Business (and accurate written summaries of all oral customer warranties) other than customer purchase orders that deviate from the standard terms of the Seller’s form purchase order. Except as set forth on Section 3.20 of the Seller Disclosure Schedule,  there is not, and during the last three years, there has not been any claim pending or, to the Knowledge of the Seller, threatened against the Seller with respect to the Business for any product returns, product liability or warranty obligations relating to any products or services of the Business that are, or were during such period, manufactured, produced, marketed, distributed or sold by or for the Business (such products and services, collectively the “Business Products”) with a value of more than $350,000 individually or in the aggregate,  the Business Products, and the manufacturing, production, marketing, sale and distribution thereof, comply, and in the last three years have complied in all material respects with all applicable Laws,  there are not, and during the last three years, there have not been any defects or deficiencies in any such Business Products that have resulted, or would reasonably be expected to result in a claim or claims against the Business with a value of greater than $350,000, individually or in the aggregate, and  none of the Business Products designed, manufactured, packaged, labeled, shipped or sold by the Seller in the last three years has been subject to, or is subject to, any recall mandated by any Governmental Authority or is being, or has been in the
-56-


last three years, demanded or requested in writing by any customer and, to the Knowledge of the Seller, there exist no facts or circumstances that would be reasonably likely to result in any such recall.
Section 3.21Transferred Accounts Receivable
.  All of the Transferred Accounts Receivable arise from bona fide transactions of the Business and  as of the date hereof, the Seller has not received written notice of any valid claims or set offs or other defenses or counterclaims with respect to such Transferred Accounts Receivable (including any notices pursuant to which an obligor is refusing to pay, or contesting payment of, all or a material portion of any Transferred Accounts Receivable). Since December 31, 2019, there have been no write-offs in excess of $200,000 of any receivables that would comprise Transferred Accounts Receivable if in existence as of the date hereof.
Section 3.22Drug Laws.
a.The Seller is, and for the past three years has been, operating the Business in compliance with all applicable Drug Laws in all material respects. Except as set forth in Section 3.22(a) of the Seller Disclosure Schedule, in connection with the Business, the Seller has not received any FDA Form 483 (Inspectional Observations) or FDA Establishment Inspection Reports in the last three years. Seller has made available to Purchaser copies of all documentation received from the FDA and any other Governmental Authority concerning the Business, together with all responses thereto.
b.In connection with the Business, the Seller and its agents and contractors have processed, developed, investigated, tested, manufactured, prepared, assembled, processed, packaged, labeled, stored, sold, distributed, marketed and promoted the products, as applicable, in compliance in all material respects with the Drug Laws and good manufacturing practices. In connection with the Business, the Seller has all necessary and applicable Permits required by United States or comparable state or foreign Governmental Authorities, to permit the processing, manufacture, labeling, storage, importation, exportation, sale, distribution, marketing and promotion of the products in jurisdictions where such persons currently conduct such activities; and are in compliance, in all material respects, with all terms and conditions of each such Permit, and, to the Knowledge of the Seller, no event has occurred or condition or state of facts exists which would constitute a material breach or material default under, or would cause revocation or termination of any such Permit.
c.In connection with the Business, the Seller has not received any notice or other communication from the FDA or any other Governmental Authority contesting the processing, development, investigation, testing, manufacturing, preparing, assembling, processing, packaging, labeling, storage, uses, labeling, marketing, distribution, or sale of any product, or otherwise alleging any violation of any Drug Law applicable to any product.
d.In connection with the Business, neither the Seller, nor any officer or employee of the Seller, or any of their respective Affiliates: is subject to any obligation arising under any inspection, investigation, warning letter, notice of violation letter, suit, claim, action,
-57-


injunction, or proceeding relating to or arising under the FDCA or related regulations; is the subject of any civil or criminal proceedings that involve a matter within or related to the FDA’s or any other Governmental Authority’s jurisdiction under the Drug Laws; has engaged in any conduct for which such person has been or could reasonably be expected to be subject to a civil money penalty or criminal penalty under the FDCA; is listed on any FDA Debarment List, or has made an untrue statement of a material fact or fraudulent statement to any Governmental Authority, failed to disclose a material fact required by applicable Law to any Governmental Authority, or committed an act, made a statement, or failed to make a statement that, at the time such disclosure was made, would reasonably be expected to constitute a material violation of any Drug Laws.
e.In connection with the Business, the Seller maintains all necessary licenses and registrations required under the Drug Laws and has provided the Purchaser with all relevant documentation and reports relating to these licenses and registrations.
Section 3.23Insurance
. With respect to the Business, the Seller maintains the general liability, product liability and other types of insurance of the type and in such amounts customarily maintained by Persons conducting businesses similar to the Business. All insurance policies maintained by the Seller with respect to the Business and the Transferred Assets are in full force and effect, shall be maintained until Closing, and are sufficient for compliance in all material respects with applicable Laws. The Seller has not received notice of, nor to the Knowledge of the Seller is there threatened, any cancellation, termination or reduction of coverage with respect to any such policy. There are no known and incurred but unreported material claims thereunder in respect of the Business or any Transferred Assets.
Section 3.24Relationships with Related Parties
. Except as set forth on Section 3.24 of the Seller Disclosure Schedule, no Related Party of the Seller  has any interest in any property (real, personal, or mixed and whether tangible or intangible), used in or pertaining to the Business as currently conducted and  except for the ownership of less than 2% of the outstanding common stock of a publicly-held corporation, owns of record or as a beneficial owner, an equity interest or any other financial interest in a Person that has had business dealings or a material financial interest in any transaction with the Business.
Section 3.25Investment Representations.
a.The Seller is an “accredited investor” as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”), is acquiring the Preferred Equity for its own account and not with a view to the distribution thereof, and has no present intention of selling, granting any participation in or otherwise distributing the Preferred Equity. Seller understands and acknowledges that (i) none of the Preferred Equity have been registered under the Securities Act or any state or foreign securities Laws, in reliance upon specific exemptions thereunder for transactions not involving any public offering, (ii) none of the Preferred Equity
-58-


are traded or tradable on any securities exchange or over-the-counter, and (iii) the Preferred Equity may not be sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of except as permitted under the SPV Operating Agreement and unless such transfer, sale, assignment, pledge, hypothecation or other disposition is pursuant to the terms of an effective registration statement under the Securities Act and are registered under any applicable state or foreign securities Laws or pursuant to an exemption from registration under the Securities Act and any applicable state or foreign securities Laws.
b.The Seller acknowledges that, except as set forth in this Agreement and the SPV Operating Agreement, the Purchaser and the SPV have made no representations, warranties, agreements or undertakings to the Seller with respect to the transactions contemplated hereby and by the other Transaction Documents. The Purchaser further represents and warrants that, in executing and delivering this Agreement and the other Transaction Documents to which it is a party, it has not relied on any statement or representation other than the Purchaser’s and the SPV’s representations and warranties and statements set forth in Article IV and the SPV Operating Agreement.
Section 3.26Disclaimer of the Seller.
a.EXCEPT AS EXPRESSLY SET FORTH IN THIS ARTICLE III OR IN ANY OTHER TRANSACTION DOCUMENT AND NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, NONE OF THE SELLER, ITS SUBSIDIARIES OR THEIR REPRESENTATIVES MAKES OR HAS MADE ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF THE BUSINESS, ANY OF THE TRANSFERRED ASSETS OR THE ASSUMED LIABILITIES. NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, EXCEPT AS EXPRESSLY SET FORTH IN THIS ARTICLE III OR IN ANY OTHER TRANSACTION DOCUMENT, NONE OF THE SELLER, ITS SUBSIDIARIES OR THEIR REPRESENTATIVES MAKES OR HAS MADE ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, WITH RESPECT TO (I) THE EXCLUDED ASSETS OR THE EXCLUDED LIABILITIES; (II) MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR USE OR PURPOSE OR ANY OTHER WARRANTIES ARISING UNDER THE UNIFORM COMMERCIAL CODE (OR SIMILAR LAWS); (III) THE OPERATION OF THE BUSINESS BY THE PURCHASER ON OR AFTER THE CLOSING DATE; OR (IV) THE PROBABLE SUCCESS, PROFITABILITY OR PROSPECTS OF THE BUSINESS ON OR AFTER THE CLOSING DATE AND ANY SUCH REPRESENTATION OR WARRANTY IS HEREBY EXPRESSLY DISCLAIMED.
b.EXCEPT IN CONNECTION WITH THE REPRESENTATIONS AND WARRANTIES SET FORTH IN THIS ARTICLE III OR IN ANY OTHER TRANSACTION DOCUMENT, THE COVENANTS AND OBLIGATIONS OF THE SELLER SET FORTH HEREIN AND THEREIN AND THE INDEMNIFICATION PROVIDED IN ARTICLE VIII OR IN ANY OTHER TRANSACTION DOCUMENT WITH RESPECT THERETO, NONE OF THE SELLER, ITS SUBSIDIARIES OR THEIR REPRESENTATIVES WILL HAVE OR BE SUBJECT TO ANY LIABILITY OR INDEMNIFICATION OBLIGATION TO THE
-59-


PURCHASER, ITS REPRESENTATIVES OR TO ANY OTHER PERSON RESULTING FROM THE PROVISION TO THE PURCHASER OR ITS REPRESENTATIVES, OR THE PURCHASER’S OR ITS REPRESENTATIVES’ USE OF, ANY INFORMATION RELATING TO THE BUSINESS, INCLUDING THE CONFIDENTIAL MANAGEMENT PRESENTATION AND ANY INFORMATION, DOCUMENTS, PROJECTIONS, FORECASTS, BUSINESS PLANS, OFFERING MATERIALS OR OTHER MATERIAL MADE AVAILABLE TO THE PURCHASER OR ITS REPRESENTATIVES OR POTENTIAL FINANCING SOURCES, WHETHER ORALLY OR IN WRITING, IN CERTAIN “DATA ROOMS,” MANAGEMENT PRESENTATIONS, FUNCTIONAL “BREAK-OUT” DISCUSSIONS, “EXPERT SESSIONS,” SITE TOURS OR VISITS, DILIGENCE CALLS OR MEETINGS, RESPONSES TO QUESTIONS SUBMITTED ON BEHALF OF THE PURCHASER OR ITS REPRESENTATIVES OR IN ANY OTHER FORM IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR THE OTHER TRANSACTION DOCUMENTS, IN EACH CASE, OTHER THAN IN THE CASE OF FRAUD.
Article IV.
REPRESENTATIONS AND WARRANTIES OF THE PURCHASER AND SPV
The Purchaser and the SPV hereby represent and warrant to the Seller, subject to such exceptions as are disclosed in the Purchaser Disclosure Schedule, as follows:
Section 4.1Organization, Authority and Qualification of the Purchaser
. The Purchaser is a corporation duly organized, validly existing and in good standing under the laws of the State of Connecticut and has all necessary corporate power and authority to enter into this Agreement and the other Transaction Documents to which it is a party, to carry out its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The SPV is a limited liability company duly organized, validly existing and in good standing under the laws of the State of Delaware and has all necessary limited liability company power and authority to enter into this Agreement and the other Transaction Documents to which it is a party, to carry out its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery by each of the Purchaser and the SPV of this Agreement and the other Transaction Documents to which it is a party, the performance by each of the Purchaser and the SPV of its obligations hereunder and thereunder and the consummation by each of the Purchaser and the SPV of the transactions contemplated hereby and thereby have been duly authorized by all requisite action on the part of the Purchaser and the SPV, respectively. This Agreement has been, and upon their execution, the other Transaction Documents to which the Purchaser or the SPV is a party, will be, duly executed and delivered by the Purchaser or the SPV, as applicable. Assuming due authorization, execution and delivery by the Seller, this Agreement constitutes, and upon their execution, each of the other Transaction Documents to which the Purchaser or the SPV, as applicable, is a party, will constitute, a legal, valid and binding obligation of the Purchaser or the SPV, enforceable against the Purchaser or the SPV in accordance with their respective terms, subject to the effect of any applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or
-60-


other similar Laws relating to or affecting creditors’ rights generally and subject to the effect of general principles of equity (regardless of whether considered in a proceeding at law or in equity).
Section 4.2No Conflict
. Assuming that all consents, approvals, authorizations and other actions described in Section 4.3 or set forth in Section 4.2 of the Purchaser Disclosure Schedule or Section 7.1(b) of the Seller Disclosure Schedule have been obtained, all filings and notifications described in Section 4.3 or set forth in Section 4.2 of the Purchaser Disclosure Schedule or Section 7.1(b) of the Seller Disclosure Schedule have been made, any applicable waiting period has expired or been terminated, the execution, delivery and performance by the Purchaser of this Agreement and each of the other Transaction Documents to which the Purchaser or the SPV, as applicable, is a party and the consummation by the Purchaser or the SPV of the transactions contemplated hereby and thereby, do not and will not  violate, conflict with or result in the breach of any provision of the certificate of incorporation or bylaws (or similar organizational documents) of the Purchaser or the SPV;  conflict with or violate any Law or Governmental Order applicable to the Purchaser or the SPV; or  conflict with, result in any breach of, constitute a default (or an event which, with or without the giving of notice or lapse of time, or both, would become such a default) under, require any consent under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material Contract to which the Purchaser or the SPV is a party, except, in the case of clauses (b) and (c), as would not materially and adversely affect the ability of the Purchaser and the SPV to carry out their obligations under, and to consummate the transactions contemplated by, this Agreement or the other Transaction Documents.
Section 4.3Governmental Consents and Approvals
. The execution, delivery and performance by each of the Purchaser and the SPV of this Agreement and each Transaction Document to which it is a party does not require any consent, approval, authorization or other order or declaration of, action by, filing with or notification to, any Governmental Authority, other than  compliance with, and filings under, the HSR Act and any other applicable filings and approvals in the jurisdictions set forth on Section 7.1(b) of the Seller Disclosure Schedule and any other applicable Antitrust Laws; or  where the failure to obtain such consent, approval, authorization or action, or to make such filing or notification, would not prevent or materially delay the consummation by the Purchaser of the transactions contemplated by this Agreement or the other Transaction Documents.
Section 4.4Litigation
. There is no Action by or against the Purchaser or any of its Subsidiaries (including the SPV) pending or, to the knowledge of the Purchaser or the SPV, threatened before any Governmental Authority, that would materially and adversely affect the legality, validity or enforceability of this Agreement or any other Transaction Document to which Purchaser or the SPV is a party or would prevent or materially delay the consummation of the transactions contemplated by this Agreement or the other Transaction Documents.
-61-


Section 4.5Brokers
. Except for Goldman Sachs & Co. and Moelis & Company LLC, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the transactions contemplated by this Agreement or the other Transaction Documents based upon arrangements made by or on behalf of the Purchaser or the SPV. The Purchaser shall be solely responsible for the fees and expenses of Goldman Sachs & Co. and Moelis & Company LLC.
Section 4.6Debt Financing
.
a.The Purchaser has delivered to the Seller a true, correct and complete and fully executed copy of the debt commitment letter, dated on or about the date hereof, among the Purchaser and the lender party thereto (as the same may be amended or replaced pursuant to Section 5.13(c), the “Debt Commitment Letter”), pursuant to which the lender party thereto has agreed, upon the terms and subject to the conditions of the Debt Commitment Letter, to lend the amounts set forth in the Debt Commitment Letter for the purposes of financing the transactions contemplated by this Agreement (the “Debt Financing”). The Debt Commitment Letter and the related fee letter are referred to collectively in this Agreement as the “Debt Financing Agreements”.
b.As of the date hereof, each commitment represented by the Debt Financing Agreements is a legal, valid and binding obligation of the Purchaser (except as the enforceability thereof may be limited by bankruptcy, insolvency, moratorium, fraudulent conveyance and other similar Laws affecting creditors’ rights generally and by general principles of equity), and to the knowledge of the Purchaser, the other parties thereto. None of the Debt Financing Agreements has been amended or modified prior to the date hereof and none of the respective commitments contained in the Debt Financing Agreements have been withdrawn, modified or rescinded in any respect as of the date hereof. Except for the fee letter relating to the Debt Financing (a complete copy of which has been provided to the Seller, with only the fee amounts, other economics and market flex (none of which would adversely affect the full amount or availability of the Debt Financing) redacted), as of the date hereof, there are no side letters or other agreements, contracts or arrangements related to the funding or investment, as applicable, of the Debt Financing other than as expressly set forth in the Debt Financing Agreements.
c.The Purchaser has paid (or caused to be paid) any and all commitment fees or other fees payable by it (or its Affiliates) in connection with the Debt Financing Agreements that were payable on or prior to the date hereof. The only conditions precedent or other contingencies related to the obligations of the Financing Sources to fund the full amount of Debt Financing are those expressly set forth in or contemplated by the Debt Commitment Letter. As of the date hereof, no event had occurred which, with or without notice, lapse of time or both, would constitute a default or breach on the part of the Purchaser, or to the knowledge of the Purchaser, any Financing Source, under any term of the Debt Financing Agreements. Subject to the satisfaction of the conditions set forth in Article VII and the completion of the Marketing
-62-


Period, as of the date hereof, the Purchaser has no reason to believe that it would be unable to satisfy on a timely basis any term or condition of the Debt Financing Agreements required to be satisfied by it on or prior to the Closing Date.
d.The Purchaser represents that it will have at the Closing adequate funds, not including any proceeds received from the Debt Financing, to purchase the Transferred Assets and assume the Assumed Liabilities at Closing and that it will consummate the transactions described in this Agreement. After giving effect to the transactions contemplated by this Agreement and assuming the accuracy of the representations and warranties of the Seller set forth in Article III, the Purchaser will not (i) be insolvent (either because its financial condition is such that the sum of its debts is greater than the fair value of its assets or because the fair salable value of its assets is less than the amount required to pay its probable Liability on its existing debts as they mature), (ii) have unreasonably small capital with which to engage in its business, or (iii) have incurred debts beyond its ability to pay as they become due.
Section 4.7Operations of the SPV
. The SPV is a wholly-owned Subsidiary of the Purchaser and was organized solely for the purpose of entering into this Agreement and the other Transaction Documents to which it is a party and consummating the transactions contemplated hereby and thereby and has not engaged in any activities or business, and has incurred no liabilities or obligations whatsoever, in each case, other than those incident to its organization and the execution of this Agreement and the consummation of the transactions contemplated hereby.
Section 4.8Issuance of Preferred Equity
. Upon the due execution of the SPV Operating Agreement, and the consummation of the Closing in accordance with the terms of this Agreement, the Preferred Equity shall have been duly authorized and validly issued and shall be non-assessable and free and clear of all Encumbrances (other than those arising under applicable federal and state securities Laws), and no further payment or contribution shall be required with respect thereto, and assuming the accuracy of the representations and warranties of the Seller set forth in Section 3.25, shall have been issued in compliance with all applicable federal and state securities Laws. The Purchaser owns all of the common membership interests of the SPV (the “Common Interests”), which constitute, as of the date hereof and shall constitute immediately prior to the issuance of the Preferred Equity to the Seller at the Closing, all of the authorized and issued membership interests and other equity interests in the SPV. The Common Interests have been duly authorized and validly issued and are non-assessable and free and clear of all Encumbrances (other than those arising under applicable federal and state securities Laws), and no further payment or contribution is required with respect thereto. There are no outstanding securities convertible into, or exchangeable for, or authorized options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, or other contracts or commitments that could require the Purchaser or the SPV to issue, sell, or otherwise cause to become outstanding, any Common Interests, Preferred Units or other membership interests or equity interests in the SPV. There are no agreements, including, without limitation, relating to registration rights, investor rights, co-sale rights, rights of first refusal, preemptive rights, voting or other similar agreements or
-63-


understandings to which the Purchaser is a party or is bound with respect to the SPV or to which the SPV is a party or is bound. There are no outstanding Plans with respect to the SPV, and there are no outstanding stock appreciation, phantom stock, profit participation or similar rights with respect to the membership interests of the SPV. Immediately after the Closing, the Purchaser will own 100% of the Common Interests, and the Seller will own 100% of the Preferred Units.
Section 4.9Independent Investigation; Seller’s Representations.
a.The Purchaser has conducted to its satisfaction its own independent investigation, review and analysis of the business, operations, assets, Liabilities, results of operations, financial condition, software, technology and prospects of the Business, which investigation, review and analysis was performed by the Purchaser and its Representatives. The Purchaser acknowledges that it and its Representatives have been provided adequate access to the personnel, properties, facilities and records of the Business for such purpose. In entering into this Agreement, the Purchaser acknowledges that it has relied upon its own investigation, review and analysis and, except as otherwise provided in this Agreement, not on any statements, representations or opinions of the Seller or any of its Representatives (except the specific representations and warranties of the Seller set forth in Article III or any other Transaction Document).
b.The Purchaser hereby acknowledges and agrees that notwithstanding anything herein to the contrary other than the specific representations and warranties made in Article III or in any other Transaction Document, none of the Seller, its Subsidiaries or their Representatives makes or has made, and the Purchaser has not and is not relying on, any representation or warranty, express or implied, at law or in equity, in respect of the Business, any of the Transferred Assets or the Assumed Liabilities, including with respect to (A) the Excluded Assets or the Excluded Liabilities; (B) merchantability or fitness for any particular use or purpose or any other warranties arising under the Uniform Commercial Code (or similar Laws); (C) the operation of the Business by the Purchaser after the Closing Date; or (D) the probable success, profitability or prospects of the Business after the Closing Date; and none of the Seller, its Subsidiaries or their Representatives will have or be subject to any liability or indemnification obligation to the Purchaser, its Representatives or to any other Person resulting from the distribution to the Purchaser or its Representatives of, or the Purchaser’s or its Representatives’ use of, any information relating to the Business, including the Confidential Management Presentation and any information, documents, offering materials or other material made available to the Purchaser or its Representatives or potential financing sources, whether orally or in writing, in certain “data rooms,” management presentations, functional “break-out” discussions, “expert sessions,” site tours or visits, diligence calls or meetings, responses to questions submitted on behalf of the Purchaser or its Representatives or in any other form in connection with the transactions contemplated by this Agreement or the other Transaction Documents, in each case, other than in the case of fraud. The Purchaser and its Representatives have received and may continue to receive from the Seller, its Subsidiaries and their Representatives certain estimates, projections, forecasts, plans and budgets for the Business and certain plan and budget information. The Purchaser acknowledges that these estimates, projections, forecasts, plans and budgets and the assumptions on which they are based were prepared for specific purposes and
-64-


may vary significantly from each other. Further, the Purchaser acknowledges that there are uncertainties inherent in attempting to make such estimates, projections, forecasts, plans and budgets, that the Purchaser is taking full responsibility for making its own evaluation of the adequacy and accuracy of all estimates, projections, forecasts, plans and budgets so furnished to it, and that the Purchaser is not relying on any estimates, projections, forecasts, plans or budgets furnished by the Seller or its Representatives, and the Purchaser shall not, and shall cause its Representatives not to, hold any such Person liable with respect thereto, other than in the case of fraud.
Article V.
ADDITIONAL AGREEMENTS
Section 5.1Conduct of Business Prior to the Closing
. From the date of this Agreement and until the earlier of the Closing Date and the date on which this Agreement is validly terminated pursuant to Section 9.1 (except  as set forth in Section 5.1 of the Seller Disclosure Schedule,  as expressly required by this Agreement, the other Transaction Documents or applicable Law or any COVID Action or  as the Purchaser shall otherwise consent to in writing (such consent not to be unreasonably withheld, delayed or conditioned)), (A) the Seller shall, and shall cause its Subsidiaries to, use commercially reasonable efforts to (I) conduct the Business in the ordinary course consistent with past practice; (II) preserve intact in all material respects the business organization of the Business and maintain the Transferred Assets; and (III) preserve the goodwill of the customers, suppliers and others having business relations with the Business; and (B) without limiting the generality of the foregoing, the Seller shall not, and shall cause its Subsidiaries not to, to the extent relating to the Business or the Transferred Assets:
i.subject, or permit or allow any of the Transferred Assets (whether tangible or intangible) to be subjected to any Encumbrance, other than Permitted Encumbrances;
ii.change any method of accounting or accounting practice or policy used by the Seller as of the date hereof, other than such changes as are required by GAAP or a Governmental Authority;
iii.except as required by applicable Laws or the terms of any Seller Benefit Plans as they exist on the date hereof, (A) grant or announce any increase in the salaries, bonus opportunities or other compensation or benefits payable or to become payable to any of the Business Employees, other than any base salary, wage rate or bonus opportunity increases made in the ordinary course of business consistent with past practice; provided that any such increase shall not be greater than (1) 3% in the aggregate with respect to the aggregate base salaries and wages payable to all Business Employees and (2) 6% with respect to the base salaries or wages payable to any individual Business Employee or (B) enter into or adopt any employee benefit plan or employment or severance agreement, or amend any Seller Benefit Plan, in each case, with respect to any Business Employee, other than changes in welfare benefits of the Seller or any of its
-65-


Subsidiaries or Affiliates in the ordinary course of business consistent with past practice that apply equally to all similarly situated employees of the Seller or any of its Subsidiaries or Affiliates, as the case may be;
iv.(A) sell, lease, sublease, license, abandon or otherwise transfer any Owned Real Property or Transferred Assets, other than sales of Transferred Inventory in the ordinary course of business or (B) acquire any assets that are material to the Business, individually or in the aggregate, except for purchases of inventory in the ordinary course of business;
v.sell, license, abandon or otherwise transfer any Transferred Intellectual Property, other than non-exclusive licenses granted to customers in connection with the sale or provision of goods or services in the ordinary course of business consistent with past practice;
vi.(A) other than in the ordinary course of business consistent with past practice, (1) extend, amend, cancel or terminate, or waive any right under, any Material Contract or any Permit or (2) or enter into any Contract which, if entered into prior to the date hereof, would be a Material Contract or Transferred Assets; or (B) enter into any Contract for the sale or furnishing of products, materials, supplies, goods, equipment or other assets or services which (1) has a term in excess of 12 months or (2) provides for annual payments to the Seller or any of its Subsidiaries in excess of $350,000;
vii.make, change, revoke or amend any material Tax election, file any material amended non-income Tax Return, adopt or change any Tax accounting method which has a material impact on Taxes with respect to the operation of the Business or ownership of the Transferred Assets, adopt or change any Tax accounting period, enter into any closing agreement with any Governmental Authority with respect to a material amount of Taxes, or settle or compromise any material Tax claim, in each case, to the extent such action is with respect to the Business or any of the Transferred Assets;
viii.acquire, by merger or consolidation with, or by purchase of all or a substantial portion of the assets or equity of, or by any other manner, any business or entity which would constitute a Transferred Asset or Assumed Liability;
ix.(A) incur any Indebtedness in excess of $350,000, individually or in the aggregate, or (B) make any loans, advances or capital contributions to, or investments in, any other Person;
x.enter into any Contract that restricts the freedom of the Business or any of its existing or future Affiliates to (A) compete in any line of business with any Person or in any geographic area or (B) solicit any individual or class of individuals for employment;
-66-


xi.settle or compromise any pending or threatened Action, other than settlements involving solely money damages in an amount not exceeding $100,000, individually or in the aggregate;
xii.disclose or allow to be disclosed any confidential information or trade secrets of the Business to any Person, other than (A) to employees of the Seller or its Subsidiaries and (B) to third parties, in each case that are subject to a confidentiality or non-disclosure covenant protecting against further disclosure thereof;
xiii.fail to notify the Purchaser promptly of any material infringement, misappropriation or other violation of, or conflict with, any Transferred Intellectual Property of which the Seller or any of its Subsidiaries becomes aware and to consult with the Purchaser regarding the actions (if any) to take to protect such Intellectual Property;
xiv.fail to (A) invoice customers and collect Transferred Accounts Receivable or (B) pay or discharge any Liabilities when due, in each case, in the ordinary course of business consistent with past practice;
xv.allow levels of inventory to vary materially from the levels the Business maintains in the ordinary course of business;
xvi.adopt a plan or agreement of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other material reorganization; or
xvii.agree to take any of the actions specified in Section 5.1(i)-(xvi).
Notwithstanding anything to the contrary in this Agreement, (A) the Seller shall be permitted to declare and pay any cash dividends or make cash distributions or cash transfers (including in connection with any “cash sweep” arrangements) prior to the Closing Date; (B) the Seller may settle any Indebtedness owing by the Seller or any of its Subsidiaries, including by repayment or capitalization, prior to the Closing Date; (C) nothing contained in this Agreement shall be construed to give to the Purchaser directly or indirectly, rights to control or direct the Business’s operations prior to the Closing; and (D) prior to the Closing, the Seller shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision of the operations of the Business.
Section 5.2Access to Information and Manufacturing Facilities.
a.From the date of this Agreement until the Closing, upon reasonable notice, the Seller shall, and shall cause its Subsidiaries to  afford the Purchaser and its authorized Representatives reasonable access to the offices, properties (including the Manufacturing Facilities and Owned Real Property) and books and records of the Business; and  furnish to the authorized Representatives of the Purchaser such additional available information regarding the Business (or copies thereof), as the Purchaser may from time to time reasonably request; provided, that (A) any such access or furnishing of information shall be conducted at the
-67-


Purchaser’s expense, during normal business hours, under the supervision of the Seller’s personnel and in such a manner as not to interfere with the normal operations of the Business; (B) all requests for access pursuant to this Section 5.2(a) shall be made in writing and shall be directed to and coordinated with the Seller or a person or persons designated by the Seller in writing; and (C) the Purchaser shall not, and shall cause its Representatives not to, contact any of the employees, customers, distributors or suppliers of the Seller in connection with the transactions contemplated by this Agreement or the other Transaction Documents, whether in person or by telephone, mail, or other means of communication, without the specific prior written authorization of the Seller. Notwithstanding anything to the contrary in this Agreement, the Seller shall not be required to provide any access or disclose any information to the Purchaser or its Representatives if such disclosure would, in the Seller’s reasonable discretion (in the case of clauses (2), (3) and (4), after consultation with outside counsel), (1) put the Seller or the Business at a competitive disadvantage if the transactions contemplated by this Agreement and the other Transaction Documents are not consummated; (2) jeopardize, or result in a loss or waiver of, any attorney-client or other legal privilege; (3) contravene any applicable Law, fiduciary duty or agreement that exists on the date of this Agreement; or (4) result in disclosure of any proprietary information or trade secrets of the Seller, its Subsidiaries or third parties; provided that, in the cases of clauses (2), (3) and (4), the Seller shall notify the Purchaser in reasonable detail of the circumstances giving rise to such privilege, Law, duty, agreement or trade secret and cooperate to permit disclosure of such information in a manner consistent herewith. When accessing any of the Seller’s properties, the Purchaser shall, and shall cause its Representatives to, comply with all of the Seller’s safety and security requirements for the applicable property. Notwithstanding anything to the contrary in this Agreement, (I) in no event shall the Seller be required to provide any information exclusively relating to any Excluded Assets or any Excluded Liabilities, except to the extent such information is material to the Business or responsive to any of the representations of the Seller set forth in this Agreement; and (II) neither the Purchaser nor any of its Representatives shall be allowed to sample or analyze any soil or groundwater or other environmental media, or any building material, without the prior written consent of the Seller, which consent may be withheld in the sole discretion of the Seller. For the avoidance of doubt, the Purchaser or its Representatives shall be allowed to perform a Phase I ESA in accordance with ASTM Standard E1527-13 at the Owned Real Property located in Tyrone, Pennsylvania and complete the scope of work, including proposed sampling locations, sample collection methods, media, analytes, analytical methods, quality control measures, and schedule for a Phase II ESA at the Owned Real Property located in South Haven, Michigan consistent with Exhibit F.
b.In order to facilitate the resolution of any claims made against or incurred by the Seller relating to the Business (other than any Action between the Purchaser and the Seller or any of their respective Affiliates arising from any Transaction Documents) and for purposes of compliance with securities, environmental, employment, accounting and other Laws and regulations including stock exchange rules and regulations, until the seventh anniversary of the Closing Date, the Purchaser shall  retain the books and records and financial and operational data relating to the Business that are transferred to the Purchaser by the Seller or otherwise pursuant to this Agreement for periods prior to the Closing Date; and  subject to applicable Law (including attorney-client or other privilege) upon reasonable advance written notice, afford the
-68-


Representatives of the Seller reasonable access (including the right to make, at the Seller’s expense, copies), during normal business hours, to such books and records; provided, that (A) if any such information is or becomes comingled with books and records of the Purchaser and its Affiliates, the Purchaser shall be entitled to withhold, in its reasonable discretion, any information that does not relate to the Business and (B) any such access or furnishing of information shall be conducted at the Seller’s expense, under the supervision of the Purchaser’s personnel and in such a manner as not to interfere with the normal operations of the Business.
c.In order to facilitate the resolution of any claims made against, or incurred by, the Purchaser relating to the Business (other than any Action between the Purchaser and the Seller or any of their respective Affiliates arising from any Transaction Documents) and for purposes of compliance with securities, environmental, employment, accounting and other Laws and regulations, including stock exchange rules and regulations, until the seventh anniversary of the Closing Date, the Seller shall, and shall cause its Subsidiaries to,  retain the books and records and financial and operational data relating to the Business relating to periods prior to the Closing Date which did not constitute Transferred Records or Transferred Information; and subject to applicable Law (including attorney-client or other privilege), upon reasonable notice, afford the Representatives of the Purchaser reasonable access (including the right to make, at the Purchaser’s expense, copies), during normal business hours, to such books and records.
Section 5.3Confidentiality.
a.The terms of the confidentiality agreement, dated as of November 25, 2019 (the “Confidentiality Agreement”), between the Seller and the Purchaser are hereby incorporated herein by reference and shall continue in full force and effect until the Closing and shall survive the Closing and remain in full force and effect until their expiration in accordance with the terms of the Confidentiality Agreement; provided, however, that, upon the Closing, the confidentiality and non-use obligations contained in the Confidentiality Agreement shall terminate in respect of that portion of the Confidential Information primarily relating to the Business and the transactions contemplated by this Agreement or the other Transaction Documents. If this Agreement is, for any reason, terminated prior to the Closing, the Confidentiality Agreement shall nonetheless continue in full force and effect in accordance with its terms.
b.Nothing provided to the Purchaser pursuant to Section 5.2(a) shall in any way amend or diminish the Purchaser’s obligations under the Confidentiality Agreement. The Purchaser acknowledges and agrees that, subject to Section 5.3(a), any Confidential Information made available to the Purchaser or its Representatives pursuant to Section 5.2(a) or otherwise by the Seller or any of its Representatives prior to the Closing Date shall be subject to the terms and conditions of the Confidentiality Agreement.
c.Following the Closing, the Seller shall, and shall cause its Affiliates and its and their respective Representatives (collectively, “Seller Restricted Parties”) to  maintain the confidentiality of,  not use, and  not divulge to any Person, any confidential, non-public or proprietary information concerning the Business and/or the Transferred Assets (including, for the avoidance of doubt, any information accessed or obtained by the Seller Restricted Parties
-69-


pursuant to Section 5.2(b)) (such information, to the extent not exclusively related to the Business and/or the Transferred Assets, the “Shared Information”), in each case, except (A) with the prior written consent of the Purchaser; (B) if, based on the advice of outside counsel, such Seller Restricted Party is required to report such information in order to comply with (1) applicable securities Laws and regulations, including stock exchange rules and regulations or (2) any other applicable Laws or a Governmental Order in connection with a dispute with or claim by a third party; provided, that with respect to clause (2) such Seller Restricted Party shall provide the Purchaser with prompt written notice of such requirement so that the Purchaser may seek an appropriate protective order or other appropriate remedy, and such Seller Restricted Party shall reasonably cooperate with the Purchaser (at the Purchaser’s request) to obtain such order or remedy; provided, further, that, in the event such order or remedy is not obtained, such Seller Restricted Party shall furnish only that portion of such information which, in the opinion of its outside counsel, it is legally required to disclose and shall exercise its commercially reasonable efforts (at the Purchaser’s request) to obtain reliable assurance that confidential treatment will be accorded any such information so disclosed; or (C) with respect to Shared Information, pursuant to non-disclosure agreements (or license agreements containing non-disclosure obligations) that (1) obligate the recipient of such Shared Information to maintain the confidentiality thereof and not use such Shared Information and (2) impose perpetual confidentiality obligations on the recipient with respect to trade secrets.
Section 5.4Regulatory and Other Authorizations; Notices and Consents.
a.Each of the Purchaser and the Seller shall use its reasonable best efforts to,  promptly obtain all authorizations, consents, orders and approvals of all Governmental Authorities that may be or become necessary for its execution and delivery of, and the performance of its obligations pursuant to, this Agreement and the other Transaction Documents;  cooperate fully with the other party in promptly seeking to obtain all such authorizations, consents, orders and approvals; and  provide such other information to any Governmental Authority as such Governmental Authority may reasonably request in connection herewith. Each party hereto agrees to, and shall cause its respective Affiliates, as applicable, to, make, as promptly as practicable, (A) in any event no later than ten Business Days after the date of this Agreement, its respective filing, if necessary, pursuant to the HSR Act with respect to the transactions contemplated by this Agreement or the other Transaction Documents and to supply as promptly as practicable to the appropriate Governmental Authorities any additional information and documentary material that may be requested pursuant to the HSR Act, and (B) in any event within 30 Business Days after the date of this Agreement, its respective filings and notifications, if any, pursuant to any other applicable Antitrust Law in the jurisdictions set forth on Section 7.1(b) of the Seller Disclosure Schedule with respect to the transactions contemplated by this Agreement, and to supply as promptly as practicable to the appropriate Governmental Authorities any additional information and documentary material that may be reasonably requested pursuant to the applicable Antitrust Law. The Purchaser shall pay all filing fees with respect any filings required pursuant to HSR Act or the Antitrust Laws in the jurisdictions set forth in Section 7.1(b).
-70-


b.If, upon the Closing Date, any Governmental Authority has not transferred any Environmental Permit to Purchaser or, if any Environmental Permit is not transferrable (e.g., the Seller’s Tyrone pesticide establishment registration, EPA Establishment 3377-PA-001), and any Governmental Authority has not issued a substantively equivalent Environmental Permit to Purchaser (each, a “Non-Transferred Environmental Permit”), then the Seller shall maintain such Non-Transferred Environmental Permits in its name until the applicable Governmental Authority transfers or issues such Environmental Permit to the Purchaser. Immediately upon the Closing Date and to the extent allowed by and in accordance with applicable Law, the Seller shall grant or cause to be granted to the Purchaser the right to operate the Business, including the Transferred Assets, under each of the Non-Transferred Environmental Permits. From and after the date of this Agreement, the Seller will make available to the Purchaser each person who is required to sign all requisite transfer applications and other documents necessary to effect the transfer of or otherwise obtain the Non-Transferred Environmental Permits, and the Seller shall cause such persons to execute and deliver all such applications and documents. As of the Closing Date and thereafter, the Seller will, without further consideration, cooperate to the maximum extent possible with the Purchaser to enter into any arrangement, including the execution of such documents and instruments as may reasonably be deemed necessary or desirable to cause the Purchaser or its Affiliates to: (i) be allowed to operate under the Non-Transferred Environmental Permits, including, without limitation, designating the Purchaser as an “operator”, “permittee”, or “licensee” under the Environmental Permits and approving and signing all operator change forms or revisions prepared by the Purchaser at or immediately after the Closing; and (ii) receive transfer of or obtain such Non-Transferred Environmental Permits or to become the successor thereto as the Governmental Authority may require.
c.Notwithstanding anything to the contrary contained in Section 5.4(a) or elsewhere in this Agreement,  neither the Purchaser nor any of its Affiliates shall have any obligation under this Agreement to divest or agree to divest (or cause any of its Affiliates or the Seller to divest or agree to divest) any of the Purchaser’s assets, properties, businesses, or product lines or the Transferred Assets or to agree (or cause any of its Affiliates or the Seller to agree) to any limitation or restriction on any of its assets, properties, businesses, or product lines or the Transferred Assets and  the Purchaser shall, and shall cause its Affiliates to, defend through litigation on the merits any Action by any Governmental Authority in order to avoid entry of, or to have vacated or terminated, any decree, order or judgment (whether temporary, preliminary or permanent) that would prevent the Closing prior to the Termination Date.
d.Each party shall not extend or consent to any extension of any applicable waiting or review period or enter into any agreement with any Governmental Authority to not consummate the transaction contemplated by this Agreement, except upon the prior consent of the other party. Each party to this Agreement shall promptly notify the other party of any substantive communication it or any of its Representatives receives from any Governmental Authority relating to the matters that are the subject of this Agreement and permit the other party to review in advance any proposed substantive communication by such party to any Governmental Authority. Each of the parties to this Agreement shall permit outside counsel of the other party to be present or participate in any materially substantive call, discussion or meeting with any Governmental Authority in respect of any filings, investigation (including any
-71-


settlement of an investigation), litigation or other inquiry unless it consults with the other party in advance and unless prohibited by such Governmental Authority, gives the other party the opportunity to attend and participate in such call, discussion or meeting; provided that such consultation is not required by the Purchaser’s outside counsel to communicate with the Governmental Authorities in the jurisdictions set forth in Section 7.1(b) of the Seller Disclosure Schedule, except to the extent the Seller has engaged outside competition counsel in such jurisdiction. Each party hereto shall, and shall cause its Representatives to, coordinate and cooperate fully with each other in exchanging such information and providing such assistance as the other party hereto may reasonably request in connection with the foregoing and in seeking early termination of any applicable waiting periods, including under the HSR Act. Each party to this Agreement shall, and shall cause its outside counsel to, provide the other party’s outside counsel with copies of all correspondence, filings (excluding the Purchaser’s HSR Form) or communications between the parties or any of their respective Representatives, on the one hand, and any Governmental Authority or members of its staff, on the other hand, with respect to this Agreement and the transactions contemplated by this Agreement or the other Transaction Documents; provided, however, that materials may be redacted (i) to remove references concerning the valuation of the Business and competitively sensitive information; (ii) as necessary to comply with contractual arrangements or applicable Law; and (iii) as necessary to address reasonable attorney-client or other privilege or confidentiality concerns.
e.Except as otherwise permitted pursuant to this Section 5.4, the Purchaser shall not, and shall cause its Affiliates not to, enter into any merger, acquisition, or joint venture, or any agreement to effect any merger, acquisition, or joint venture that would reasonably be expected to make it materially more difficult, or to increase the time required by more than 30 days, to  obtain the expiration or termination of the waiting period under the HSR Act, or any other applicable Antitrust Law, applicable to the transactions contemplated by this Agreement or the other Transaction Documents or  obtain all authorizations, consents, orders and approvals of Governmental Authorities necessary for the consummation of the transactions contemplated by this Agreement or the other Transaction Documents.
Section 5.5Retained Names and Marks.
a.The Purchaser hereby acknowledges that all right, title and interest in and to the “ALBEMARLE” and “ALBEMARLE CORPORATION” names and the Albemarle logo, together with all variations and acronyms thereof, and all trademarks, service marks, Internet domain names, trade names, trade dress, company names and other identifiers of source and any associated Goodwill owned by the Seller other than the Transferred Intellectual Property (collectively, the “Retained Names and Marks”), are owned solely by the Seller or its Subsidiaries, and that, except as expressly provided in this Section 5.5, any and all right of the Business to use the Retained Names and Marks shall terminate as of the Closing and shall immediately revert to the Seller, along with any and all Goodwill associated therewith. Each of the Purchaser and its Subsidiaries further acknowledges that neither the Purchaser nor any of its Subsidiaries is acquiring any rights on or after the Closing Date, to use the Retained Names and Marks after Closing, except for the rights expressly provided in Section 5.5(b).
-72-


b.The Purchaser shall be entitled to use, solely in connection with the operation of the Business as operated immediately prior to the Closing Date, all of the existing stocks of signs, letterheads, labels, office forms, packaging, invoice stock, advertisements and promotional materials, inventory and other documents and materials that are included in the Transferred Assets and contain the Retained Names and Marks (“Existing Stock”) for:  with respect to any Existing Stock that constitutes exterior or interior facility signage, a period of 90 days after the Closing and  with respect to all other Existing Stock, the longer of (A) 90 days after the date of Closing and (B) 45 days after receipt by the Purchaser of any Existing Stock in transit as of the Closing Date, after which period the Purchaser shall remove or obliterate all Retained Names and Marks from such Existing Stock or cease using such Existing Stock; provided, however, that the Purchaser shall use commercially reasonable efforts to ensure that all such Existing Stock used by it hereunder following the Closing shall, to the extent practicable, display a notice, in a format reasonably acceptable to the Seller, indicating that the Business was formerly owned by the Seller, and is now owned and operated by the Purchaser. Notwithstanding anything to the contrary in this Section 5.6, the Purchaser (A) may, at all times after the Closing, (1) keep records and other historical or archived documents containing or referencing the Retained Names and Marks for record and archival purposes, and (2) refer to the historical fact that the Business was previously conducted under the Retained Names and Marks, (B) has no obligation to retrieve or alter any materials that display any Retained Names and Marks and are, as of the Closing, in the possession and control of a third party, or to revise any Contracts, unless required by applicable Law, and (C) may use any Retained Names and Marks (1) to the extent applicable Law would restrict the ability of the Purchaser or any of its Affiliates from operating the Business in any respect (but only while so restricted) and (2) as otherwise required under applicable Law.
c.Except as expressly provided in this Section 5.5, no other right to use the Retained Names and Marks is granted hereunder by the Seller to the Purchaser or any of its Affiliates whether by implication or otherwise, and nothing hereunder permits the Purchaser or any of its Affiliates to use the Retained Names and Marks in any manner other than in connection with Existing Stock. The Purchaser shall use commercially reasonable efforts to ensure that all uses of the Retained Names and Marks provided in this Section 5.5 shall be only with respect to goods and services of a level of quality substantially similar to the quality of goods and services with respect to which the Retained Names and Marks were used in the Business prior to the Closing. Any and all Goodwill generated by the use of the Retained Names and Marks under this Section 5.5 shall inure solely to the benefit of the Seller. In no event shall the Purchaser or any of its Affiliates use the Retained Names and Marks hereunder in any manner that may reasonably be expected to damage or tarnish the reputation of the Seller or the Goodwill associated with the Retained Names and Marks.
d.The Purchaser agrees that the Seller shall have no responsibility for claims by third parties arising out of, or relating to, the use by the Purchaser and its Affiliates of any Retained Names and Marks after the Closing Date. In addition to any and all other available remedies, the Purchaser shall indemnify and hold harmless the Seller Indemnified Parties from and against any and all such claims that may arise out of the use of the Retained Names and Marks by the Purchaser or any of its Affiliates  in accordance with the terms and conditions of
-73-


this Section 5.5, other than such claims (A) that the Retained Names and Marks, consistent with the use of such Retained Names and Marks prior to the Closing, infringe or dilute the Intellectual Property rights of any third party, (B) that constitute Excluded Liabilities, or (C) for which the Seller is obligated to indemnify a Purchaser Indemnified Party under Section 8.2; or  in violation of or outside the scope permitted by this Section 5.5. Notwithstanding anything in this Agreement to the contrary, the Purchaser hereby acknowledges that in the event of any breach or threatened breach of this Section 5.5, the Seller, in addition to any other remedies available to it, shall be entitled to seek a preliminary injunction, temporary restraining order or other equivalent relief restraining the Purchaser or any of its Affiliates from any such breach or threatened breach, but may not seek to terminate the Purchaser’s right to use the Retained Names and Marks in accordance with the terms of this Section 5.5.
Section 5.6IP Matters.
a.To the extent there exists any Intellectual Property owned by the Seller or its Affiliates after the Closing (other than the Retained Names and Marks) that was used but not primarily used in the operation of the Business as of the Closing, the Seller, on behalf of itself and its Affiliates, hereby grants to the Purchaser and its Affiliates a perpetual, irrevocable, non-exclusive, worldwide, assignable, sublicensable, royalty-free and fully-paid-up license to use such Intellectual Property in connection with the operation of the Business (and natural evolutions thereof).
b.Prior to the Closing Date, the Seller shall effect any necessary corrective recordals with all patent, trademark, and copyright offices and domain name registrars and other similar authorities with respect to the Registered Intellectual Property included in the Transferred Assets  that is still recorded in the name of legal predecessors of the Seller or any Person other than the Seller, or  where the relevant recordals of the patent, copyright, and trademark offices, and domain name registrars, and other similar authorities with respect to such Intellectual Property are materially incorrect for any other reason.
c.Within 30 days following the date of this Agreement, the Seller shall provide a schedule identifying any actions that must be taken within 12 months from the date thereof in connection with the prosecution of all Registered Intellectual Property included in the Transferred Assets, including any responses to office actions.
d.The parties hereto shall, and shall cause their respective Affiliates to, use commercially reasonable efforts to take, or cause to be taken, all appropriate action to complete the items set forth on Section 5.6(d) of the Seller Disclosure Schedule (the completion of all such items, as reasonably agreed by the parties, the “Pre-Closing IT Integration Completion”).
Section 5.7Insurance
. From and after the Closing Date, the Transferred Assets and the Business shall cease to be insured by the Seller’s insurance policies or by any of its self-insured programs in respect of any claims or potential claims arising out of or relating to any events or circumstances occurring from and after the Closing Date. For the avoidance of doubt, the Seller shall retain all rights to
-74-


control its insurance policies and programs, including the right to exhaust, settle, release, commute, buy back or otherwise resolve disputes with respect to any of its insurance policies and programs, other than in respect of disputes relating to any Post-Signing Insurance Proceeds. The Purchaser agrees to arrange for its own insurance policies with respect to the Business and the Purchaser covering all periods from and after the Closing Date and agrees not to seek, through any means, to benefit from the Seller’s insurance policies that may provide coverage for claims relating in any way to the Business or the Transferred Assets from and after the Closing; provided, that this Section 5.7 shall not be construed to limit Purchaser’s rights to the Post-Signing Insurance Proceeds or indemnification by the Seller granted under this Agreement.
Section 5.8Employees.
a.Prior to and effective as of the Closing Date, the Purchaser shall, or shall cause one of its Affiliates to, offer employment to each Business Employee who  is actively employed on such date or is absent from employment due to vacation or temporary illness not reasonably expected to exceed five days (the “Current Employees”) or  (A) is absent from work due to an authorized leave of absence (including but not limited to a leave of absence due to a short-term or long-term disability) or is categorized by the Seller as active but absent due to workers’ compensation and (B) has the right to return to employment following expiration of such absence under applicable Law, effective as of the expiration of the leave (the “Leave Employees” and, together with the Current Employees, the “Closing Date Employees”). All such offers of employment to (1) Current Employees shall provide for employment with the Purchaser or an Affiliate of the Purchaser to commence effective as of 12:00 A.M., local time, on the day immediately following the Closing Date and (2) Leave Employees shall provide for employment with the Purchaser or an Affiliate of the Purchaser to commence at the expiration of such Leave Employees’ authorized leave; provided, however that if such Leave Employee does not return to active service prior to the end of a period of six months following the commencement of the applicable leave (the “Return Deadline”), such offer shall become null and void upon the Return Deadline and such Leave Employee shall in no event become a Transferred Employee (as defined below). All such offers of employment shall be made in accordance with the applicable provisions of this Section 5.8 and to the extent that any Business Employee receives an offer in accordance with this Section 5.8 and does not accept such offer and commence employment with the Purchaser or any of its Affiliates, neither the Purchaser nor any of its Affiliates shall have any Liability with respect to such Business Employee (including, but not limited to, any Liability for severance or any other compensation). Each Closing Date Employee who (a) accepts an offer of employment from the Purchaser or one of its Affiliates, (b) executes any employment or similar agreement to the extent reasonably required by the Purchaser and presented to the Closing Date Employee prior to the Closing Date, (c) provides all of the necessary documentation (including, without limitation, I-9) required by applicable Law for employment, and (d) commences employment with the Purchaser or an Affiliate of the Purchaser shall be referred to herein as a “Transferred Employee”; provided, that a Leave Employee shall be treated as a Transferred Employee upon the expiration of the Leave Employee’s authorized leave to the extent that such expiration and return to active service occurs prior to the applicable Return Deadline. The date a Transferred Employee commences, or is
-75-


deemed to commence, employment with the Purchaser or an Affiliate of the Purchaser shall be referred to herein as the “Transfer Date.”
b.The Purchaser shall, or shall cause its Affiliates to, provide each Transferred Employee, for a period of no less than 12 months after the Transfer Date until the termination of such Transferred Employee’s employment with the Purchaser and its Affiliates, with  employment in a position that is comparable to such Transferred Employee’s position immediately prior to the Transfer Date (except with respect to the number of employees that report to such position);  an annual base salary (or in case of an hourly employee, a base hourly wage rate), overtime pay, commissions, and annual bonus opportunities (excluding any equity-based compensation and any opportunities relating to a long-term incentive plan), as applicable, as provided to such Transferred Employee immediately prior to the Transfer Date; and  employee benefits under plans, programs and arrangements that will provide benefits to such Transferred Employee that are substantially comparable, in the aggregate (taking into account any other consideration provided to such Transferred Employee relating to employee benefits immediately prior to the foregoing date), to the benefits provided by the Seller and its Subsidiaries (disregarding benefits under any defined benefit pension, retiree welfare, non-qualified deferred compensation, retention bonus or equity-based compensation plans, policies or programs), in each case, as of immediately prior to the Transfer Date. Notwithstanding the foregoing, nothing contemplated by this Agreement shall be construed as requiring either the Purchaser or any of its Affiliates to continue the employment of any Transferred Employee for any period on or after the Closing Date.
c.The Purchase Price shall be reduced at the Closing by an amount equal to   all amounts earned and payable based on actual performance results under the applicable annual cash based bonus plans or policies in which such Transferred Employees participated for the 2020 performance period, to the extent not paid prior to the Closing by the Seller or one of its Subsidiaries or Affiliates (the “Accrued 2020 Performance Bonuses”), and  all amounts earned and payable at “target” levels of performance under the applicable annual cash-based bonus plans or policies in which such Transferred Employee participated for the 2021 performance period as of immediately prior to the applicable Transfer Date, with such amounts to be prorated for days of service provided by the Transferred Employee during the portion of the 2021 performance period that occurs from the beginning of such performance period through the Transfer Date (the “Accrued 2021 Performance Bonuses” and together with the Accrued 2020 Performance Bonuses, the “Accrued Performance Bonuses”), plus the employer portion of any payroll, social security, disability, workers compensation, unemployment or similar Taxes payable by the Purchaser resulting therefrom. The Purchaser agrees to pay the Accrued 2020 Performance Bonuses on behalf of the Seller to each applicable Transferred Employee on the next payroll date after such Transferred Employee’s Transfer Date. The Purchaser agrees to pay the Accrued 2021 Performance Bonuses on behalf of the Seller to each applicable Transferred Employee on or before the date that the Purchaser pays performance bonuses to its employees for 2021. From and after the Transfer Date, each Transferred Employee who participated in an annual cash-based bonus plan sponsored by the Seller or any of its Affiliates as of such date shall be eligible to receive an annual cash-based bonus for the remaining 2021 performance period based on all amounts earned and payable at actual performance determined based on the goals
-76-


applicable under the Seller’s annual cash-based bonus plans or policies in which such Transferred Employee participates for the 2021 performance period, and the Purchaser shall be liable for the payment of the amounts, if any (such amounts, the “2021 Bonus Stub Period Performance Bonuses”), earned thereunder based on actual performance and subject to such Transferred Employee’s continued service with the Purchaser through the applicable payment date in accordance with the terms of the applicable bonus plan or policy, with such 2021 Bonus Stub Period Performance Bonus, if any, to be prorated to reflect only the days of service provided by such Transferred Employee to the Purchaser or any of its Subsidiaries or Affiliates during the portion of the 2021 performance period that occurs after the Transfer Date (such portion, the “2021 Bonus Stub Period”). Notwithstanding the foregoing, in the event that a Transferred Employee whose employment with the Purchaser or any of its Subsidiaries or Affiliates is terminated thereby during the 2021 performance period without “cause,” such Transferred Employee shall be eligible to receive payment of his or her (A) 2021 Bonus Stub Period Performance Bonus earned based on actual performance under the applicable cash-based bonus plan or policy of the Purchaser, if any, for 2021 prorated to reflect his or her days of service to the Purchaser and/or any of its Affiliates during the 2021 Bonus Stub Period and (B) the Accrued 2021 Performance Bonus.
d.With respect to each Transferred Employee who is terminated without “cause” during the one-year period immediately following the Closing Date, the Purchaser or its Affiliates shall provide severance payments to such Transferred Employee that are no less favorable than those severance payments applicable to such Transferred Employee as of immediately prior to the Transfer Date after taking into account any service that such Transferred Employee has with the Purchaser or its Affiliates as of the date of such termination of employment, including, for the avoidance of doubt, service credited under Section 5.8(e).
e.With respect to each Transferred Employee, effective from and after the Transfer Date, if and to the extent that the Seller provides the Purchaser with such information as needed to implement the following (unless prohibited by applicable Law), the Purchaser shall, or shall cause its Affiliates to, use commercially reasonable efforts to  recognize, for purposes of eligibility and benefit levels under Purchaser Benefit Plans that provide for vacation or severance benefits, service with the Seller and its Subsidiaries or Affiliates prior to the Transfer Date to the extent that such service was recognized under the corresponding Seller Benefit Plan (if any) covering such Transferred Employees, except as would result in the duplication of benefits, recognize, for the purposes of vesting and eligibility under any Purchaser Benefit Plan that is a tax-qualified defined contribution plan, service with the Seller and its Subsidiaries or Affiliates prior to the Transfer Date to the extent that such service was recognized under the corresponding Seller Benefit Plan that is a tax-qualified defined contribution plan covering such Transferred Employees, except as would result in the duplication of benefits, and  with respect to Purchaser Benefit Plans that are health and welfare plans, (A) waive any pre-existing condition exclusion, actively-at-work requirement or waiting period under all employee health and other welfare benefit plans established or maintained by the Purchaser or its Affiliates in which such Transferred Employee participates, except to the extent such pre-existing condition, exclusion, requirement or waiting period would have applied to such individual under the corresponding Seller Benefit Plan (if any), (B) provide credit for co-payments, deductibles or similar payments
-77-


made or incurred by the Transferred Employees prior to the Transfer Date under the corresponding Seller Benefit Plan (if any), covering such Transferred Employees with respect to all employee health and other welfare benefit plans established or operated by the Purchaser or its Affiliates in which such Transferred Employees participate (other than flexible spending accounts) for the plan year in which the Transfer Date occurs, and (C) be liable for any continued health coverage that such Transferred Employees will be eligible to receive on and after the Transfer Date, if any, under Section 4980B of the Code, Sections 601 through 607 of ERISA or other applicable Law (but excluding any such continuation coverage to which the Transferred Employees are eligible as the result of the termination of the Transferred Employee’s employment with the Seller and its Subsidiaries).
f.With respect to each Transferred Employee, immediately prior to such Transferred Employee’s Transfer Date, the Transferred Employee shall cease to contribute to the Seller’s flexible spending account plan (the “Seller FSA Plan”). Transferred Employees who elected to participate in the Seller FSA Plan for the plan year beginning January 1 of the year during which the Closing occurs shall become participants in a flexible spending account plan of the Purchaser or its Affiliate (the “Purchaser FSA Plan”) as if their participation in the Purchaser FSA Plan had been continuous from such January 1 and at the same level of coverage elected under the Seller FSA Plan. Following the Transfer Date, each Transferred Employee will be reimbursed by the Purchaser or its Affiliate under the Purchaser FSA Plan for qualifying medical and dependent care expenses incurred by such Transferred Employee at any time during the year during which the Closing occurs, up to the amount of the elections made by each Transferred Employee under the Seller FSA Plan for such year, reduced by amounts previously reimbursed by the Seller or its Affiliate pursuant to the Seller FSA Plan for such year. To effectuate the foregoing, as soon as practicable after each Transfer Date (and in any event within 30 days following the Closing), the Seller shall provide the Purchaser with a summary of account balances and confirm whether the amounts of the account balances (if any) under the Seller FSA Plan for the Transferred Employees are positive or negative in the aggregate immediately prior to such Transfer Date, and the Seller shall pay to the Purchaser such aggregate balance (if positive) or the Purchaser shall pay to the Seller such aggregate balance (if negative) with respect to all Transferred Employees who become covered under the Purchaser FSA Plan for the plan year during which the Closing occurs.
g.If any Transferred Employee requires a visa, work permit or employment pass or other legal or regulatory approval for his or her employment with the Purchaser or its Affiliates, the Purchaser shall, and shall cause its Affiliates to, use commercially reasonable efforts to cause any such visa, permit, pass or other approval to be obtained and in effect prior to the Transfer Date, and the Seller shall, and shall cause its Subsidiaries or Affiliates to, take all reasonably necessary or appropriate action, as reasonably requested by the Purchaser, to assist in obtaining any such visa, permits, pass or other approval prior to the Transfer Date.
h.Each of the Purchaser and its Affiliates shall comply in all material respects with applicable Laws regarding confidentiality of Employee Records transferred to it hereunder.
-78-


i.The Purchaser shall, or shall cause its relevant Affiliate to, grant each Transferred Employee vacation time in an amount equal to such Transferred Employee’s accrued and unused vacation hours. If such Transferred Employee terminates employment with the Purchaser or an Affiliate of the Purchaser prior to using such vacation time, the Purchaser or its relevant Affiliate shall pay such Transferred Employee an amount equal to compensation for any such remaining vacation time (with such vacation time granted pursuant to this Section 5.8(i) deemed to be used first before any further vacation time accrued after the Transfer Date) upon such employment termination equal to the amount of such unused remaining vacation time that such Transferred Employee would have received if the Seller’s vacation policy as of the Transfer Date were in effect at the time of such employment termination.
j.As soon as administratively practicable following the Closing Date, the Purchaser shall permit each Transferred Employee who was eligible to participate in a defined contribution plan sponsored by the Seller or one of its Subsidiaries or Affiliates that is intended to be “qualified” within the meaning of Section 401(a) of the Code (the “Seller 401(k) Plan”) to elect to rollover to a defined contribution plan sponsored by the Purchaser or one of its Affiliates that is intended to be “qualified” within the meaning of Section 401(a) of the Code (the “Purchaser 401(k) Plan”), each such Transferred Employee’s account balance when distributed from the Seller 401(k) Plan, including, to the extent administratively practicable, any outstanding participant loans from the Seller 401(k) Plan.
k.The Purchaser expressly agrees that it assumes all obligations to provide any required notice under the WARN Act, or other applicable Laws, and to pay all severance payments, damages for wrongful dismissal and related costs, with respect to the termination of any Transferred Employee employed by the Purchaser or its Affiliates that occurs on or after the Closing Date.
l.Nothing in this Section 5.8, express or implied, shall  confer upon any Business Employee, or legal representative or beneficiary thereof, any rights or remedies, including any right to employment or continued employment for any specified period, or compensation or benefits of any nature or kind whatsoever under this Agreement,  be construed to prevent the Purchaser or any of its Affiliates from terminating or modifying to any extent or in any respect any Purchaser Benefit Plan,  amend, or be deemed to amend, any benefit plan or  constitute the establishment of, or an amendment to, any benefit plan.
m.After the Closing Date, the Seller and its Subsidiaries and Affiliates, on the one hand, and Purchaser and its Affiliates, on the other hand, shall cooperate in good faith with each other to provide such information regarding the Business Employees on an ongoing basis as may be reasonably necessary to facilitate and implement the intent of this Section 5.8, including determinations of eligibility for, and payments of benefits to, such employees and their spouses, dependents and beneficiaries, as applicable. The Purchaser and its Affiliates shall not disseminate any communications about employment to the Business Employees prior to the Closing Date without the prior approval of the Seller, and the Seller shall not disseminate any such communications about employment offers without the prior approval of the Purchaser, which approval in each case shall not be unreasonably withheld, conditioned, or delayed.
-79-


Notwithstanding the foregoing, nothing contained in this Agreement shall prevent either party from making any and all public disclosures legally required to comply with any applicable Laws; provided, that, each party shall provide the other party with advance notice as to the form and content of any such disclosures.
n.All amounts payable under the Retention Agreements to the Retention Agreement Recipients (plus the employer portion of any payroll, social security, disability, workers compensation, unemployment or similar Taxes payable by the Purchaser resulting therefrom) shall be deducted from the Purchase Price. The Purchaser or one of its Subsidiaries or Affiliates shall assume the Liability with respect to amounts payable to any Retention Agreement Recipients pursuant to the terms of the Retention Agreements. The Purchaser agrees to pay all such amounts payable under the Retention Agreements to each Retention Agreement Recipient at such time as provided in, and in accordance with the terms and conditions of, the applicable Retention Agreement. In the event that the amounts payable under a Retention Agreement are canceled and forfeited pursuant to the terms of such Retention Agreement (e.g., because the Retention Agreement Recipient voluntarily resigned his or her employment or was terminated for Cause before the applicable vesting date as set forth therein), then the Purchaser shall notify the Seller and promptly pay to the Seller any such amounts canceled, forfeited and no longer payable by the Purchaser to such Retention Agreement Recipient.
o.In consideration of the Purchaser’s agreement to pay or cause to be paid (i) the Accrued Performance Bonuses and the 2021 Bonus Stub Period Performance Bonuses as set forth in Section 5.8(c), and (ii) the amounts payable to the Retention Bonus Recipients under the Retention Agreements as set forth in Section 5.8(n), the Seller hereby agrees to provide the Purchaser with all information requested by the Purchaser for the purposes of implementing and administering these payments and the Retention Agreements, and, for a period of 12 months following the Closing, to make its (and its Affiliates’) employees available to the Purchaser and its Subsidiaries and Affiliates to answer questions and provide such additional data and support as requested by the Purchaser or its Subsidiaries or Affiliates. If, during the 12-month period following the Closing, any representative of the Purchaser contacts the Seller to request assistance or additional information required to implement and administer these payments, and the Seller does not promptly undertake commercially reasonable efforts to provide such data within 45 days following such request, the Purchaser shall no longer be obligated to pay the Accrued Performance Bonuses, the 2021 Bonus Stub Period Performance Bonuses, or the amounts payable under the Retention Agreements, and shall (i) promptly refund to the Seller any unpaid amounts in respect of the Accrued Performance Bonuses or the amounts payable under the Retention Agreements for the Seller to pay or cause to be paid, as appropriate, and (ii) be permitted to determine 2021 Bonus Stub Period Performance Bonuses for the Transferred Employees based upon the metrics with respect to which annual bonuses are determined under the annual cash-based bonus plans or policies of the Purchaser in which similarly situated employees of the Purchaser or its Affiliates are eligible to participate.
Section 5.9Privileged Matters
-80-


. The parties hereto hereby acknowledge that Troutman Pepper Hamilton Sanders LLP has acted as counsel to the Seller in connection with the transactions contemplated herein. The following provisions apply to the attorney-client relationship between  the Seller and Troutman Pepper Hamilton Sanders LLP prior to Closing and  the Seller and Troutman Pepper Hamilton Sanders LLP following Closing. The Purchaser agrees that  it will not seek to disqualify Troutman Pepper Hamilton Sanders LLP from acting and continuing to act as counsel to the Seller either in the event of a dispute hereunder or in the course of the defense or prosecution of any claim relating to the transactions contemplated herein because of their representation of the Seller in connection with the transactions contemplated herein; and  the Seller has a reasonable expectation of privacy with respect to the Seller’s communications (including any e-mail communications using the Seller’s e-mail system) with Troutman Pepper Hamilton Sanders LLP to the extent such communications concern the transactions contemplated by this Agreement or the other Transaction Documents. The parties furthermore agree that for the purposes of the attorney-client privilege, any communications between Troutman Pepper Hamilton Sanders LLP and the Seller that were made in the course of negotiating the transactions contemplated by this Agreement or the other Transaction Documents that relate to the subject matter of this Agreement or that may be relevant to any claims for indemnification under this Agreement or any other dispute arising in connection with the transactions contemplated hereby (“Protected Communications”) shall be deemed privileged communications of the Seller for the purposes of such claims or disputes, and to the extent that they may not be considered as such at law, the parties hereto agree to contractually treat such Protected Communications as if they were privileged communications of the Seller; provided, that, in the event of a dispute after the Closing between the Purchaser, on the one hand, and a Person other than the Seller, on the other hand, the Purchaser may assert the attorney-client privilege to prevent disclosure of Protected Communications by Troutman Pepper Hamilton Sanders LLP to such Person.
Section 5.10Further Action; Third Party Consents.
a.Except as otherwise provided in this Agreement, the parties hereto shall, and shall cause their respective Affiliates to, use commercially reasonable efforts to take, or cause to be taken, all appropriate action, to do, or cause to be done, and to assist and cooperate with the other party hereto in doing, all things necessary, proper or advisable under applicable Law (other than with respect to the matters covered in Section 5.4) to negotiate, execute and deliver the Transaction Documents and such other documents and other papers as may be required to carry out the provisions of this Agreement and to consummate and make effective the transactions contemplated by this Agreement or the other Transaction Documents.
b.From time to time after the Closing, without additional consideration, each party hereto shall, and shall cause its Affiliates to, execute and deliver such further instruments and take such other action as may be necessary or is reasonably requested by the other party hereto to make effective the transactions contemplated by this Agreement or the other Transaction Documents. Without limiting the foregoing, upon reasonable request of a party hereto, the other party shall, and shall cause its Affiliates to, execute, acknowledge and deliver all such further assurances, deeds, assignments, consequences, powers of attorney and other instruments and papers as may be required for the transfer to the Purchaser ownership of the
-81-


Transferred Assets, subject to Permitted Encumbrances, and the assumption by the Purchaser of the Assumed Liabilities, as contemplated by this Agreement or the other Transaction Documents.
c.Prior to the Closing, the Seller shall, and shall cause its Subsidiaries to, use commercially reasonable efforts to obtain all third party consents, waivers or approvals set forth on Section 7.2(g) of the Seller Disclosure Schedule, including paying any fees and expenses associated with obtaining such third party consents, waivers or approvals.
d.Prior to the Closing, the Seller shall, and shall cause its Subsidiaries to, promptly duly execute and deliver to the Purchaser such authorizations to share information as the Purchaser may reasonably request, in each case, in substantially the form set forth on Section 5.10(d) of the Seller Disclosure Schedule.
Section 5.11Misdirected Payments.
a.If the Seller or any of its Affiliates, on the one hand, or the Purchaser or any of its Subsidiaries, on the other hand, after the Closing Date receives any funds properly belonging to the other party or its Affiliates or Subsidiaries, as applicable, including under any Shared Contract, the receiving party will promptly so advise such other party and will promptly deliver such funds to an account or accounts designated in writing by such other party.
b.The Seller will promptly deliver to the Purchaser any mail (including e-mail) or other communication received by the Seller from and after the Closing Date pertaining to the Business, the Transferred Assets or the Assumed Liabilities. The Purchaser will promptly deliver to the Seller any mail (including e-mail) or other communication received by the Purchaser from and after the Closing Date pertaining to the Excluded Assets or the Excluded Liabilities.
c.Following the Closing,  in the event that the Seller, the Purchaser or any of their respective Affiliates discovers an asset that would constitute a Transferred Asset if held by the Seller immediately prior to the Closing is owned by the Seller and was not acquired by the Purchaser hereunder, the Seller shall assign, transfer and convey such asset to the Purchaser for no additional consideration, and shall execute and deliver such further documents and instruments necessary to give effect to and evidence such assignment, transfer and conveyance and  in the event that the Seller, the Purchaser or any of their respective Affiliates discovers an asset that did not constitute a Transferred Asset immediately prior to the Closing was acquired by the Purchaser or its Affiliates hereunder, the Purchaser or its Affiliates shall assign, transfer and convey such asset to the Seller for no additional consideration, and shall execute and deliver such further documents and instruments necessary to give effect to and evidence such assignment, transfer and conveyance. For income Tax purposes, the Purchaser and the Seller shall treat any transfer under this Section 5.11(c) as having occurred at the Closing, except to the extent otherwise required by applicable Law.
d.Notwithstanding anything to the contrary contained in this Agreement, in the event that any Material Contract was not set forth on Section 3.13(a) of the Seller Disclosure Schedule as of the date hereof, the Purchaser shall have ten Business Days from the date the
-82-


Purchaser receives a complete copy of such Contract to review such Contract and determine, in its sole discretion, whether to reject such Contract. If the Purchaser determines to reject such Contract, the Seller shall retain all rights, benefits and obligations pursuant to such Contract, the Purchaser shall have no liability with respect to such Contract and such Contract shall be deemed to be an Excluded Asset for all purposes hereunder.
Section 5.12Title Insurance.
a.No later than 15 Business Days after the date of this Agreement, the Seller shall deliver to Purchaser for the Owned Real Property (i) one or more title commitments (each, a “Title Commitment”) issued by the Title Insurer, naming the Purchaser (or its designee) as the proposed insured, wherein the Title Insurer shall agree to issue an ALTA form of owner’s Title Policy (ii) one or more ALTA/NSPS surveys (each, a “Survey”) certified to the Purchaser (or its designee) and the Title Insurer. If the Purchaser seeks to have any Permitted Encumbrance removed of record (or omitted from the Title Commitment), the Seller shall use commercially reasonable efforts (but excluding making any payments or incurring any costs, liability or other obligations) to cooperate with the Purchaser in curing (or having the Title Insurer insure over) any Permitted Encumbrance which appears on the Title Commitment.
b.On the Closing Date, the Title Insurer shall file or record, or cause to be filed or recorded, the applicable Local Conveyance Documents (and all other necessary documents) in order that the legal and equitable title to the Owned Real Property shall be duly vested in the Purchaser (or its designee) free and clear of all Encumbrances other than Permitted Encumbrances. The Title Insurance costs shall be paid by the Purchaser, Survey costs shall be paid by the Seller, and all escrow closing costs shall be borne equally by the Seller and the Purchaser.
Section 5.13Financing
.

a.The Purchaser shall use, and shall cause its Affiliates to use, its commercially reasonable efforts to take, or cause to be taken, all actions and to do, or cause to be done all things necessary, proper or advisable to arrange and consummate the Debt Financing (or any Alternative Financing) on the terms and conditions described in the Debt Financing Agreements and to cause the conditions precedent described in the Debt Commitment Letter to be satisfied in a timely basis, including using its commercially reasonable efforts to (i) maintain in effect the Debt Financing Agreements (including by complying with so-called “flex” provisions) until the funding of the Debt Financing at or prior to Closing, (ii) satisfy on a timely basis (or obtain a waiver of) all conditions and covenants applicable to the Purchaser to obtaining the Debt Financing at Closing as set forth therein, (iii) negotiate, execute and deliver definitive agreements with respect to such Debt Financing on the terms and conditions (including the “flex” provisions) contemplated by the Debt Financing Agreements (and provide copies thereof to the Seller), (iv) fully pay any and all commitment fees or other fees required by the Debt Financing Agreements and (v) upon satisfaction of the conditions set forth in the Debt Commitment Letter, consummate the Debt Financing at or prior to Closing. In the event that the
-83-


Purchaser becomes aware of any event or circumstance that makes procurement of all or any portion of the Debt Financing unlikely to occur in the manner or from the sources contemplated in, or pursuant to the terms and conditions of, the Debt Commitment Letter and such Debt Financing or portion thereof is reasonably required for the Purchaser to consummate the transactions contemplated by this Agreement, the Purchaser shall reasonably promptly notify the Seller, and the Purchaser shall use its commercially reasonable efforts to obtain, as promptly as practicable following the occurrence of such event or circumstance, replacement financings in the form of commitments (other than amounts that are replaced by other funds available to the Purchaser) from alternate sources (the “Alternative Financing”) on terms and conditions that will enable the Purchaser to consummate the transactions contemplated by this Agreement and that are not materially less favorable in the aggregate to the Purchaser than those contained in the Debt Commitment Letter; provided, however, that such Alternative Financing shall not (i) be subject to any additional or modified conditions or other contingencies to the funding of the Debt Financing than those contained in the Debt Commitment Letter or (ii) otherwise be reasonably likely to impair or materially delay the Closing or the date on which the Debt Financing would be obtained. The Purchaser shall deliver to the Seller complete and correct copies of all material amendments, supplements, other modifications to the Debt Commitment Letter and all agreements pursuant to which any Alternative Financing shall be made available to the Purchaser. For purposes of this Agreement, the term “Debt Financing” shall also be deemed to include any alternate Alternative Financing obtained by the Purchaser and the term “Debt Commitment Letter” shall also be deemed to include any commitment letter (or similar agreement) with respect to such Alternative Financing.
b.Prior to the Closing, the Seller shall use commercially reasonable efforts to provide, and shall cause its Subsidiaries and its and their respective officers, directors and employees, and shall instruct its accountants, consultants, investment bankers, legal counsel, agents and other advisors and representatives to use their respective commercially reasonable efforts to provide, in connection with the arrangement of the Debt Financing, all reasonable cooperation (including with respect to timeliness) requested by the Purchaser that is customary in connection with the arrangement of debt financing for transactions that are substantially similar to the transactions contemplated by this Agreement, including using commercially reasonable efforts to (i) provide financial and other pertinent information, including any Required Information regarding the Seller and its Subsidiaries and the Business as may be reasonably requested in writing by the Purchaser in order to consummate the Debt Financing or as necessary to satisfy the conditions set forth in the Debt Commitment Letter, (ii) participate in a reasonable number of meetings, due diligence and drafting sessions, presentations (including, without limitation, marketing (or similar) presentations, and lender or other investor presentations) and sessions with rating agencies, (iii) assisting in preparing customary documents and materials, including confidential information memoranda, lender and investor presentations, rating agency presentations and similar documents and materials in connection with the Debt Financing (including the execution and delivery by officers of the Seller of customary authorization letters), (iv) reasonably cooperating in satisfying the conditions precedent set forth in the Debt Commitment Letter or any definitive document relating to the Debt Financing (to the extent that such conditions precedent in such definitive documents are materially consistent with the conditions precedent set forth in the Debt Commitment Letter and the satisfaction of such
-84-


condition requires the cooperation of, and is within the control of, the Seller and/or any of its Subsidiaries) and (v) furnishing the Purchaser and the Financing Sources promptly with all documentation and other information which any Financing Source providing or arranging Debt Financing has determined is required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the Patriot Act and the Beneficial Ownership Regulation, it being understood and agreed that information and documents provided by the Seller may be delivered to agents and lenders and other Financing Sources under the Debt Commitment Letter and their representatives (subject to customary arrangements for confidentiality, including the Purchaser providing prior written notice of disclosure to the Seller); provided, however, that neither the Seller nor any of its Subsidiaries shall be required to pay any commitment or other fee or incur any other liability or obligation in connection with the Debt Financing or to take any action that would be prohibited by any applicable Law or cause a default of, or breach under, or otherwise violate any Contract. The Purchaser shall promptly, upon request by the Seller, reimburse the Seller for all out-of-pocket costs and expenses (including attorneys’ fees) incurred by the Seller in connection with the cooperation of the Seller contemplated by this Section 5.13(b) and shall indemnify and hold harmless the Seller and its directors, officers, employees, representatives and Affiliates (collectively, the “Cooperation Indemnitees”) from and against any and all Losses suffered or incurred by any of them in connection with the arrangement of the Debt Financing and any information used in connection therewith, except to the extent suffered or incurred as a result of the willful misconduct or bad faith of the Cooperation Indemnitees.
c.Prior to the Closing without the prior written consent of the Seller, the Purchaser shall not permit any material amendment or modification to be made to, or any waiver of any provision or remedy of, any Debt Financing Agreement, if such amendments, modifications or waiver would impose new or additional conditions or otherwise expand, amend, modify or waive any of the conditions to receipt of the Debt Financing, if such amendment, modification or waiver would reasonably be expected to cause a material delay to receipt of the Debt Financing under any Debt Financing Agreement or if such amendment, modification or waiver would reduce the amount of the Debt Financing below an amount which, when combined with the cash or cash equivalents otherwise available to the Purchaser, would not provide the Purchaser with sufficient funds to consummate the transactions contemplated by this Agreement; provided that for the avoidance of doubt, the Purchaser may replace, modify, supplement or amend the Debt Commitment Letter to add lead arrangers, bookrunners, syndication agents or similar entities which had not executed the Debt Commitment Letters as of the date hereof, and make other amendments, modifications or waivers, as long as such replacement, modification, supplement or amendment does not result in the imposition of new or additional conditions or otherwise expand, amend, modify or waive any of the conditions to the receipt of the Debt Financing in a manner which would reasonably be expected to cause a material delay to the receipt of the Debt Financing or, if applicable, the Alternative Financing.
d.Notwithstanding any other provision of this Agreement, for all purposes of this Agreement, unless the Seller shall have engaged in willful misconduct or bad faith in connection with its obligations under this Section 5.13, the Seller shall not be deemed to be in
-85-


breach of any of its obligations under, and it shall be deemed to have complied with all of its obligations contained in this Section 5.13.
e.The Purchaser acknowledges and agrees that it shall not be a condition to Closing for the Purchaser to obtain the Debt Financing or the Alternative Financing.
Section i26EHS and FDA Regulatory Information.
At the Closing, the Seller and its Subsidiaries shall provide the documents and information set forth Section 1.189 of the Seller Disclosure Schedules in whatever format they currently exist (i.e., in paper and/or electronic format) or in a format mutually agreed upon by the parties, including in IUCLID, or other relevant formats, and in all languages readily available to the Seller or its Subsidiaries in each such format.
Article VI.
TAX MATTERS
Section 6.1Straddle Period Taxes
. For all purposes of this Agreement, any Taxes (other than Transfer Taxes) incurred with respect to the Transferred Assets or the Business for a Straddle Period shall be allocated between the Pre-Closing Tax Period and Post-Closing Tax Period of such Straddle Period as follows:  any such Tax that is based upon or related to income or receipts shall be allocated based on an interim closing of the books as of the close of business on the Closing Date, and  any such Tax not described in clause (a) hereof shall be prorated based on the relative number of days in such Pre-Closing Tax Period and such Post-Closing Tax Period; provided that exemptions, allowances or deductions that are calculated on an annual basis (or on a monthly basis, where required) shall be allocated between the period ending on and including the Closing Date and the period beginning after the Closing Date (or with respect to federal income Taxes in proportion to the number of days in each period).
Section 6.2Tax Cooperation and Exchange of Information
. The Seller and the Purchaser shall provide each other, the Purchaser shall cause each of its Subsidiaries to provide the Seller, and the Seller shall cause each of its Affiliates to provide the Purchaser, with such cooperation and information as either of them reasonably may request of the other in filing any Tax Return, amended Tax Return or claim for refund, determining a liability for Taxes or a right to a refund of Taxes, or participating in or conducting any audit or other proceeding in respect of Taxes relating to the Transferred Assets or the Business. Such cooperation and information shall include providing copies of relevant Tax Returns or portions thereof, together with related work papers and documents relating to rulings or other determinations by Governmental Authorities. The Seller and the Purchaser shall make themselves (and their respective employees) reasonably available on a mutually convenient basis to provide explanations of any documents or information provided under this Section 6.2. Notwithstanding anything to the contrary in Section 5.2, each of the Seller and its Affiliates and the Purchaser and its Subsidiaries shall retain all Tax Returns, work papers and all material
-86-


records or other documents in its possession, including any electronic files, relating to Tax matters relevant to the Transferred Assets or the Business for any taxable period that includes the Closing Date and for all prior taxable periods until the later of  the expiration of the statute of limitations of the taxable periods to which such Tax Returns and other documents relate (including any extensions or waivers to such statute of limitations agreed to in writing with a Governmental Authority), or  six years following the filing date for such Tax Returns. After such time, before the Seller or any of its Affiliates or the Purchaser or any of its Subsidiaries shall dispose of any such documentation in its possession, including electronic files, the other party shall be given an opportunity, after 90 days’ prior written notice, to remove and retain all or any part of such documents as such other party may select (at such other party’s expense). Any information obtained under this Section 6.2 shall be kept confidential, except as may be otherwise necessary in connection with the filing of Tax Returns or claims for refund or in conducting an audit or other proceeding with respect to Taxes.
Section 6.3Transfer Taxes.
Any Transfer Taxes shall be borne and paid 50% by the Purchaser and 50% by the Seller. The party that is required to do so by applicable Law shall prepare and file any Tax Return required to be filed in connection with any Transfer Tax, and shall notify the non-filing party of the non-filing party’s share of such Transfer Tax. Within four Business Days of receiving such notice, the non-filing party shall pay its share of such Transfer Tax to the filing party; provided, however, that the non-filing party shall have no obligation to make such payment more than three Business Days prior to the due date for the filing of such Tax Return. The Purchaser and the Seller agree to  cooperate in the execution and delivery of all instruments and certificates necessary to enable the appropriate party to file any Tax Returns relating to the Transfer Taxes and  cooperate and use commercially reasonable efforts to mitigate any Transfer Taxes.
Section 6.4Bulk Sales.
The Purchaser and the Seller hereby mutually agree to waive compliance with the provisions of any bulk transfer or sales Laws, to the extent applicable to the transactions contemplated hereby.
Section 6.5Tax Treatment.
The Seller, the Purchaser and the SPV acknowledge and agree that for income Tax purposes, (a) the transfer of the Transferred Assets in exchange for the Purchase Price pursuant to the Sale and Purchase shall be treated as a sale and purchase of 52.6% of each of the Transferred Assets (and an assumption of 52.6% of each of the Assumed Liabilities by Purchaser), subject to adjustment to account for any adjustments to Purchase Price hereunder and to account for the Purchaser-Owned IP, in a transaction subject to Section 1001 of the Code, (b) the Contribution and the Preferred Issuance, together, shall be treated as a contribution of 47.4% of each of the Transferred Assets to the SPV (and an assumption of 47.4% of each of the Assumed Liabilities by the SPV), subject to adjustment to account for any adjustments to Purchase Price hereunder and to account for the Purchaser-Owned IP, in an exchange subject to Situation 2 of IRS Revenue Ruling 99-5, 1999-1 C.B. 434 and Section 721 of the Code and (c)
-87-


the transfer of the Purchaser-Owned IP pursuant to the Sale and Purchase shall be treated as a transaction subject to Section 1001 of the Code (clauses (a), (b) and (c), collectively, the “Intended Tax Treatment”). The Seller, the Purchaser and the SPV agree to report consistently with the Intended Tax Treatment on their Tax Returns, and to not take any position for applicable Tax purposes that is inconsistent therewith.
Section 6.6Wage Reporting.
The Seller and the Purchaser agree to utilize, or cause their respective Affiliates to utilize, the standard procedure set forth in Revenue Procedure 2004-53 with respect to wage reporting with respect to any Transferred Employee.
Article VII.
CONDITIONS TO CLOSING
Section 7.1Conditions to Obligations of the Seller
. The obligations of the Seller to consummate the transactions contemplated by this Agreement or the other Transaction Documents shall be subject to the fulfillment or written waiver, at or prior to the Closing, of each of the following conditions:
a.Representations, Warranties and Covenants. (A) The Purchaser Fundamental Representations shall have been true and correct in all respects as of the date of this Agreement and as of the Closing Date as though such representations and warranties had been made as of the Closing Date, except to the extent such representations and warranties are, by their terms, made as of a specific date, in which case such representations and warranties shall be so true and correct as of such date; and (B) the other representations of the Purchaser and the SPV set forth in this Agreement shall have been true and correct in all respects as of the date of this Agreement and as of the Closing Date as though such representations and warranties had been made as of the Closing Date (in each case, without giving effect to any “material” or similar qualifiers set forth therein), except to the extent such representations and warranties are, by their terms, made as of a specific date, in which case such representations and warranties shall be so true and correct as of such date, except where the failure of any such representation or warranty to be so true and correct would not, and would not reasonably be expected to, prevent or materially delay the consummation by the Purchaser and the SPV of the transactions contemplated by this Agreement;  the covenants and agreements contained in this Agreement to be complied with by the Purchaser and the SPV on or prior to the Closing shall have been complied with in all material respects; and the Seller shall have received a certificate of the Purchaser and the SPV duly executed by a duly authorized representative thereof dated as of the Closing Date certifying the matters set forth in clauses (i) and (ii) above;
b.Governmental Approvals. Any waiting period (and any extension thereof) under the HSR Act shall have expired or shall have been terminated and any consents, authorizations, orders, approvals, declarations and filings required under the Antitrust Laws of the jurisdictions identified on Section 7.1(b) of the Seller Disclosure Schedule shall have been made and obtained.
-88-


c.No Order. There shall not be in effect any Governmental Order issued by a Governmental Authority of competent jurisdiction that permanently enjoins, prohibits or renders illegal the consummation of the transactions contemplated by this Agreement or the other Transaction Documents.
d.Closing Deliveries. The Purchaser shall have delivered the items contemplated by Section 2.9.
Section 7.2Conditions to Obligations of the Purchaser and the SPV
. The obligations of the Purchaser and the SPV to consummate the transactions contemplated by this Agreement or the other Transaction Documents shall be subject to the fulfillment or written waiver, at or prior to the Closing, of each of the following conditions:
a.Representations, Warranties and Covenants. The Seller Fundamental Representations shall have been true and correct in all respects as of the date of this Agreement and as of the Closing Date as though such representations and warranties had been made as of the Closing Date; and the other representations and warranties of the Seller contained in this Agreement shall have been true and correct in all respects as of the date of this Agreement and as of the Closing Date as though such representations and warranties had been made as of the Closing Date (in each case, without giving effect to any “material”, “Material Adverse Effect” or similar qualifiers set forth therein), except for such failures to be so true and correct as would not have, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; the covenants and agreements contained in this Agreement to be complied with by the Seller on or prior to the Closing shall have been complied with in all material respects; and the Purchaser and the SPV shall have received a certificate of the Seller duly executed by a duly authorized representative thereof dated as of the Closing Date certifying the matters set forth in clauses (i) and (ii) above and Section 7.2(e) below.
b.Governmental Approvals. Any waiting period (and any extension thereof) under the HSR Act shall have expired or shall have been terminated and any consents, authorizations, orders, approvals, declarations and filings required under the Antitrust Laws of the jurisdictions identified on Section 7.1(b) of the Seller Disclosure Schedule shall have been made and obtained.
c.No Order. There shall not be in effect any Governmental Order issued by a Governmental Authority of competent jurisdiction that permanently enjoins, prohibits or renders illegal the consummation of the transactions contemplated by this Agreement or the other Transaction Documents.
d.Environmental Requirements. The Covered Locations Pollution Liability Policy in the form attached hereto as Exhibit G (the “Pollution Policy”) shall have been issued by Beazley ECLIPSE, the Seller shall have assigned such Pollution Policy to the Purchaser such that the Purchaser is the First Named Insured and the Seller is the additional Named Insured, and such Pollution Policy shall be in full force and effect. The Purchaser and the Seller shall share equally the cost of the policy premium for the Pollution Policy and shall pay, or cause to be paid,
-89-


their respective portions of such cost within thirty (30) days of the date of this Agreement; provided, however, the Purchaser shall bear the cost of any premiums associated with any election by the Purchaser to extend the ten-year term.
e.No Material Adverse Effect. Since the date of this Agreement, there shall have been no event, circumstance, condition, state of facts, change or effect that has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
f.Closing Deliveries. The Seller shall have delivered the items contemplated by Section 2.8.
g.Third-Party Consents. All third-party consents, waivers, approvals, permits or other actions set forth on Section 7.2(g) of the Seller Disclosure Schedule, each in a form reasonably satisfactory to the Purchaser, shall have been obtained and shall be in full force and effect.
Article VIII.
INDEMNIFICATION
Section 8.1Survival of Representations, Warranties and Covenants
. The representations and warranties of the parties hereto contained in this Agreement or in any certificates delivered pursuant to this Agreement shall survive the Closing for a period of 18 months after the Closing, except that  the representations and warranties contained in Section 3.1, Section 3.2, the first sentence and the last sentence of Section 3.17 and Section 3.18 (the “Seller Fundamental Representations”) and Section 4.1, Section 4.2 and Section 4.5 (the “Purchaser Fundamental Representations”) shall survive the Closing indefinitely, the representations and warranties contained in Section 3.14 other than Section 3.14(a)(iii)(A) shall survive the Closing for a period of 36 months after the Closing and the representations and warranties contained in Section 3.14(a)(iii)(A) shall not survive the Closing; and  the representations and warranties contained in Section 3.10 and Section 3.12 shall survive the Closing for the applicable statute of limitations plus 60 days; and none of the covenants or agreements contained in this Agreement to be performed prior to the Closing shall survive the Closing, and those covenants which by their terms contemplate performance after the Closing shall survive the Closing until the expiration of the term of the undertaking set forth in such covenants and agreements or until performed; provided, however, that any claim made with reasonable specificity by the party seeking to be indemnified within the time periods set forth in this Section 8.1 shall survive until such claim is finally resolved (including any appeals).
Section 8.2Indemnification by the Seller
. The Purchaser and its Affiliates and its and their respective, officers, directors, employees, agents, successors and assigns (each a “Purchaser Indemnified Party”) shall from and after the Closing be indemnified and held harmless by the Seller for, from and against all losses, damages, Taxes, claims, costs and expenses, Liabilities, interest, awards, judgments, fines and penalties
-90-


(including, in each case, those arising out of the defense of any Action and any settlement or compromise thereof or judgment relating thereto and reasonable attorneys’ fees and expenses), including costs and expenses incurred in enforcing the provisions of this Article VIII, actually suffered or incurred by them (hereinafter a “Loss”), to the extent arising out of, or resulting from, without duplication the breach of any representation or warranty made by the Seller contained in this Agreement; the breach of any covenant or agreement of the Seller contained in this Agreement; the Excluded Assets; the Excluded Liabilities; or the items set forth on Section 8.2(e) of the Seller Disclosure Schedule; provided, however, that for purposes of determining the amount of Losses and for purposes of determining whether a breach of any representation or warranty has occurred, no effect shall be given to any references to “materiality”, “Material Adverse Effect” or words of similar import.
Section 8.3Indemnification by the Purchaser.
The Seller and its Affiliates and its and their respective officers, directors, employees, agents, successors and assigns (each a “Seller Indemnified Party”) shall from and after the Closing be indemnified and held harmless by the Purchaser for and against any and all Losses, to the extent arising out of, or resulting from, without duplication  the breach of any representation or warranty made by the Purchaser or the SPV contained in this Agreement; the breach of any covenant or agreement of the Purchaser or the SPV contained in this Agreement; or the Assumed Liabilities; provided, however, that for purposes of determining the amount of Losses and for purposes of determining whether a breach of any representation or warranty has occurred, no effect shall be given to any references to “materiality”, “Material Adverse Effect” or words of similar import.
Section 8.4Limitations on Indemnification.
a.No claim for indemnification under Section 8.2 or Section 8.3 may be asserted nor may any Action be commenced against an Indemnifying Party in respect of such claim unless written notice of such claim or Action is received by such Indemnifying Party describing in reasonable detail the facts and circumstances with respect to the subject matter of such claim or Action (taking into account the information then available to the Indemnified Party) on or prior to the date on which the representation, warranty, covenant or agreement on which such claim or Action is based ceases to survive as set forth in Section 8.1.
b.Notwithstanding anything to the contrary contained in this Agreement,  the Seller shall not be liable for any Losses pursuant to Section 8.2(a) and the Purchaser shall not be liable for any Losses pursuant to Section 8.3(a), in each case, unless and until the aggregate amount of indemnifiable Losses which may be recovered from such Indemnifying Party exceeds $8,625,000 (the “Basket”), whereupon the Indemnified Party shall be entitled to indemnification for the amount of such Losses in excess of such amount;  the Seller shall not be liable for any Losses pursuant to Section 8.2(a) and the Purchaser shall not be liable for any Losses pursuant to Section 8.3(a), in each case, relating to an individual claim resulting in Losses in the amount of $15,000 or less (a “De Minimis Claim”), regardless of whether or not aggregate Losses have exceeded the Basket; nor shall the amount of any such De Minimis Claims be taken into account in determining whether the Basket has been reached;  the maximum amount of
-91-


indemnifiable Losses which may be recovered from any Indemnifying Party arising out of, or resulting from, the causes set forth in Section 8.2(a) or Section 8.3(a) shall be an amount equal to $57,500,000; provided that the foregoing limitations set forth in clauses (i), (ii) and (iii) shall not apply to claims in respect of the Seller Fundamental Representations, the Purchaser Fundamental Representations or fraud and provided, further, that the maximum amount of indemnifiable Losses which may be recovered from the Seller under this Agreement shall be the Aggregate Transaction Value; and  the parties hereto acknowledge and agree that no Indemnifying Party shall have any Liability under this Article VIII for any Loss, if a court of competent jurisdiction determines that such Loss is caused solely by (A) any action or inaction of the Indemnified Party or any of its Representatives; (B) any action or inaction of the Indemnifying Party or any of its Representatives at the written request, at the written direction, or with the written consent, of the Indemnified Party or any of its Representatives; or (C) any action, that the Indemnifying Party or any of its Representatives was expressly required to take or not to take pursuant to the terms of this Agreement, any Transaction Document or, that the Indemnifying Party or any of its Representatives was required to take under applicable Law.
c.Notwithstanding anything to the contrary contained in this Agreement, after the Closing, except to the extent (i) arising out of Third-Party Claims or (ii) reasonably foreseeable as a result of a breach or alleged breach of this Agreement or any certificate delivered pursuant to this Agreement or any other mater giving rise to a claim for indemnification under this Article VIII, none of the parties hereto and none of their respective Affiliates shall have any Liability under any provision of this Agreement or any other Transaction Document for any punitive, incidental, consequential, special or indirect damages, loss of future profits, revenue or income, diminution in value or loss of business reputation or opportunity relating to the breach or alleged breach of this Agreement or any other Transaction Document.
d.For all purposes of this Article VIII, “Losses” shall be calculated net of  any recovery or benefit (including insurance and indemnification, but net of all costs and expenses incurred in obtaining such recovery or benefit, including premium increases) actually paid to the Indemnified Party or any of its Affiliates in connection with the facts giving rise to the right of indemnification and, if the Indemnified Party or any of its Affiliates receive such recovery or benefit after receipt of payment from the Indemnifying Party, then the lesser of (x) the amount of such recovery or benefit, net of all costs and expenses incurred in obtaining such recovery or benefit, including premium increases, and (y) the amount previously recovered from the Indemnifying Party shall be paid to the Indemnifying Party. Any Losses shall be determined without duplication of recovery by reason of the state of facts giving rise to such Losses (A) constituting a breach of more than one representation, warranty, covenant or agreement or otherwise being indemnifiable under multiple provisions of this Article VIII or (B) being taken into account in determining any adjustment to the Purchase Price under Section 2.10 or Section 2.11.
e.Each party hereto shall, and shall cause its respective Affiliates to, use commercially reasonable efforts to mitigate its Losses upon and after becoming aware of any event that would reasonably be expected to give rise to any Losses, and indemnification shall not
-92-


be available with respect to any Loss to the extent such Loss is determined by a court of competent jurisdiction to be attributable to a failure by a party to use commercially reasonable efforts to take (or cause its Representatives to take) reasonable steps to mitigate such Loss; provided, that an Indemnified Party shall not be required to seek recovery from an insurance carrier or other Person with respect to any matter that is the subject of a claim for indemnification under this Article VIII. No party hereto shall be entitled to any payment, adjustment or indemnification more than once with respect to the same Loss. Notwithstanding anything to the contrary contained in this Agreement, to the extent that a Loss was taken into account in determining the Aggregate Transaction Value, no Indemnified Party shall be entitled to any indemnification or any other payment for such Loss.
Section 8.5Notice of Loss; Third-Party Claims.
a.An Indemnified Party shall promptly give the Indemnifying Party written notice in reasonable detail of any matter which an Indemnified Party has determined has given, or would reasonably be expected to give, rise to a right of indemnification under this Agreement, stating the amount of the Loss, if known, and method of computation thereof, and containing a reference to the provisions of this Agreement in respect of which such right of indemnification is claimed or arises.
b.If an Indemnified Party shall receive notice of any Action, audit, demand or assessment against it brought by a third party (each, a “Third-Party Claim”), which would reasonably be expected to give rise to a claim for Loss under this Agreement, the Indemnified Party shall promptly give the Indemnifying Party written notice in reasonable detail of such Third-Party Claim, stating the amount of the Loss, if known, and method of computation thereof, and containing a reference to the provisions of this Agreement in respect of which such right of indemnification is claimed or arises, together with copies of all notices and documents served on or received by the Indemnified Party and its Representatives in respect thereof (subject to applicable Law). A failure by the Indemnified Party to give notice in a timely manner pursuant to Section 8.5(a) or this Section 8.5(b) shall not limit the obligation of the Indemnifying Party under this Agreement, except to the extent such Indemnifying Party is prejudiced thereby. The Indemnifying Party shall be entitled to assume and control the defense of such Third-Party Claim at its expense and through counsel of its choice (which counsel shall be reasonably acceptable to the Indemnified Party), if it gives notice of its intention to do so to the Indemnified Party within 30 days of the receipt of such notice from the Indemnified Party; provided, that the Indemnifying Party shall not be entitled to assume and control the defense of any Third-Party Claim if (x) the Indemnified Party has been advised by counsel that a conflict exists between the Indemnified Party and the Indemnifying Party in connection with the defense of such Third-Party Claim, (y) such Third-Party Claim seeks an injunction or other equitable relief, or arises in connection with any criminal proceeding, criminal investigation or indictment, or (z) the Purchaser reasonably believes that the assumption and defense of such Third-Party Claim by the Seller could adversely affect the Business or its relationships with customers, clients, suppliers or other third parties with whom the Business or any of its Affiliates has a material business relationship. If the Indemnifying Party elects to undertake any such defense against a Third-Party Claim, the Indemnifying Party shall conduct the defense of such Third-Party Claim diligently and in good
-93-


faith and shall give the Indemnified Party a reasonable opportunity to participate in such defense at its own expense. The Indemnified Party shall cooperate with the Indemnifying Party in such defense and make available to the Indemnifying Party, at the Indemnifying Party’s expense, all witnesses, pertinent records, materials and information in the Indemnified Party’s possession or under the Indemnified Party’s control relating thereto (or in the possession or control of any of its Representatives) as is reasonably requested by the Indemnifying Party or its counsel, subject to applicable Law. The Indemnified Party shall not admit any liability with respect to, or settle, compromise or discharge any Third-Party Claim without the Indemnifying Party’s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed). If the Indemnifying Party elects to undertake the defense of a Third-Party Claim, the Indemnifying Party shall have the right to settle any Third-Party Claim (i) (A) for which it obtains a full release of the Indemnified Party from all Liabilities, Losses and obligations in respect of such Third-Party Claim, and (B) the settlement of which does not involve any relief other than money damages which will be paid in full by the Indemnifying Party, and which does not involve a finding or admission of any violation of Law or other wrongdoing by the Indemnified Party, or (ii) the settlement of which the Indemnified Party consents to in writing.
Section 8.6Remedies
. Notwithstanding anything to the contrary in this Agreement, each of the parties hereto acknowledges and agrees that following the Closing except with respect to claims for fraud, and other than as provided in Section 10.4(a) or Section 11.12,  the indemnification provisions of Article VI and this Article VIII shall be the sole and exclusive remedies of the parties hereto and the parties to the other Transaction Documents, as applicable, for any breach of the representations and warranties contained in this Agreement, in any certificate delivered pursuant to this Agreement or in any other Transaction Document and for the breach of or any failure to perform and comply with any covenant or agreement in this Agreement or in any other Transaction Document;  none of the parties hereto, their respective Representatives or any other Person may bring a claim under any other Transaction Document; and  any and all claims arising out of, or in connection with, the Transferred Assets, the Assumed Liabilities, the Business or the transactions contemplated in this Agreement must be brought under and in accordance with the terms of this Agreement; and notwithstanding anything herein to the contrary, no breach of any representation, warranty, covenant or agreement contained herein or in any other Transaction Document shall give rise to any right on the part of any party hereto or thereto, after the consummation of the transactions contemplated by this Agreement or the other Transaction Documents, to rescind this Agreement, any other Transaction Document or any of the transactions contemplated hereby or thereby. Subject to Section 11.12 and the indemnification provisions set forth in this Article VIII, and except for any claims for fraud, from and after the Closing Date, (A) the Purchaser acknowledges and agrees that the Purchaser Indemnified Parties may not avoid the limitations on liability and available remedies provided in this Agreement by seeking damages for breach of contract, tort or pursuant to any other theory of liability, all of which are hereby waived, and (B) the Seller acknowledges and agrees that the Seller Indemnified Parties may not avoid the limitations on liability and available remedies provided in this Agreement by seeking damages for breach of contract, tort or pursuant to any other theory of liability, all of which are hereby waived.
-94-


Section 8.7Further Environmental Provisions.
a.The Seller and the Purchaser agree that during the 45-day period commencing on the Closing Date, the Purchaser shall perform and complete a Phase II ESA at the Owned Real Property in South Haven, Michigan as reasonably necessary to obtain liability protection under Mich. Comp. Laws §324.20126(1)(c) and in accordance with the scope set forth on Exhibit F. All costs of conducting the Phase II ESA, including the costs of any independent third-party environmental consultant engaged to perform the Phase II ESA (the “Consultant”), shall be borne solely by the Purchaser. The Seller may request, and upon such request, the Purchaser shall promptly provide the Seller with a copy of all draft Phase II ESA reports prepared by Consultant engaged to perform the Phase II ESA and shall otherwise keep the Seller informed as to the status of the Phase II ESA. Such draft Phase II ESA reports shall be reviewed by both the Purchaser and the Seller and each may provide comments, questions, and input on the documents prepared by the Consultant within seven days of receiving such documents, which the Consultant shall address in its best professional judgment. The Purchaser shall promptly provide the Seller with copies of the final Phase II ESA report (the “Final Phase II Report”).
b.Any Hazardous Materials whose concentrations, as set forth in the Final Phase II Report, are below the applicable Trigger Levels shall not constitute Seller Environmental Liabilities. Any Hazardous Materials whose concentrations, as set forth in the Final Phase II Report, are above the applicable Trigger Levels shall cease being Seller Environmental Liabilities upon receipt by the Seller of a no further action letter from the Michigan Department of Environment, Great Lakes, and Energy regarding such Hazardous Materials and satisfaction of all terms and conditions therein.
c.With respect to any Remedial Action that is necessary to satisfy the Seller’s indemnification obligations under Section 8.2 for any Seller Environmental Liabilities:
i.the Seller shall have the right, but not the obligation, to conduct and control the Remedial Action and related activities; provided, however, that, if the Seller elects to conduct such Remedial Action, the Seller shall (A) do so in a reasonable manner without unreasonably interfering with the Purchaser’s operations or use of the Manufacturing Facilities and Owned Real Property, (B) consult with the Purchaser in all material respects in connection with undertaking the Remedial Action, (C) provide the Purchaser with copies of all correspondence submitted to and received from any Governmental Authority relating to the Remedial Action or to the associated Release of Hazardous Materials, as well as copies of all reports and assessments prepared by the Seller on the Remedial Action, (D) provide the Purchaser with a reasonable opportunity to provide comments to any material submissions to any Governmental Authority with respect thereto, including to any corrective action plans or proposals, and the Seller shall reasonably consider any such comments in connection with such submission in good faith, and (E) provide the Purchaser with reasonable notice of all planned substantive meetings and telephone conferences with the applicable Governmental Authority and the Purchaser shall have the right to attend and participate in such meetings and telephone conferences; further, the Seller shall not settle or compromise any such Remedial Action
-95-


to the extent that it would materially interfere with the Manufacturing Facility or Owned Real Property without the prior written consent of the Purchaser, such specific consent not be the unreasonably withheld or delayed;
ii.the Purchaser shall, and shall cause its Affiliates to, cooperate with the Seller, including by providing access to the subject site, including access to install, maintain, replace and operate wells and remove impacted soil and/or groundwater or undertake other activities related to such Remedial Action; provided, however, that the Seller shall exercise such rights of access in a reasonable manner without interfering with the Purchaser’s operations or use of the Manufacturing Facilities and Owned Real Property;
iii.pursuant to applicable Environmental Laws including, but not limited to, Mich. Comp. Laws §§ 324.20101 to 324.20142 and Act 2, the Seller shall only be liable for its share of the costs incurred to the extent such Remedial Action is conducted in the Most Cost-Effective Manner (as defined below). As used in this Agreement, the “Most Cost-Effective Manner” shall mean conduct appropriate for the facility determined from the perspective of a reasonable business person acting (without regard to the availability of indemnification hereunder) to (A) achieve compliance with applicable Trigger Levels or other applicable Environmental Laws and Environmental Permits or respond to a requirement or order by a Governmental Authority, or (B) minimize liability to third parties, including to obtain liability protection pursuant to Mich. Comp. Laws §§ 324.20101 to 324.20142 and Act 2, and risk to human health, taking into account any interference with the Purchaser’s operations or use of the Manufacturing Facilities and Owned Real Property and incorporating (1) the least stringent clean-up standards that, based upon the use classification as of the Closing Date (industrial, commercial or residential) of the subject site, are allowed under applicable Environmental Law and that are approved or otherwise acceptable to applicable Governmental Authorities; and (2) the least-costly methods that are allowed under applicable Environmental Law and that are approved by or otherwise acceptable to applicable Governmental Authorities to achieve such standards, including the use of engineering and institutional controls to eliminate or minimize actual or potential exposure pathways. With respect to any Remedial Action that is required to satisfy the Seller’s indemnification obligations under Section 8.2 or this Section 8.7, the Purchaser shall be responsible for performing any operation and maintenance with respect to any such institutional or engineering controls subsequent to completion of their initial installation or recording and for payment of any associated costs directly related to the administration of the operation and maintenance of such institutional or engineering controls and such post-installation or recording costs shall not be subject to indemnification;
iv.The Purchaser shall notify the Seller promptly regarding any requirements or orders from any Governmental Authority regarding a Remedial Action and, subject to Section 8.7(c)(v), shall not take any action to commence or accelerate any such Remedial Action without the prior written consent of the Seller; and
-96-


v.If the Seller, after receiving written notice from the Purchaser pursuant to Section 8.7(c)(iv), fails to timely commence, or cause to be timely commenced, or fails to diligently prosecute to completion in a timely manner, any Remedial Action required by a Governmental Authority or subject to an order of a Governmental Authority, then, notwithstanding Section 8.7(c)(iv), the Purchaser shall have the right, but not the obligation, exercisable by written notice to the Seller at any time, to undertake such Remedial Action, and the Seller shall be responsible for payment of any reasonable and associated costs.
d.With respect to any action (other than any such action that is a Remedial Action) to correct a violation of any Environmental Law or Environmental Permit that is required to satisfy the Seller’s obligations under this Section 8.7 or indemnification obligations under Section 8.2 for any breach of the representations and warranties in Section 3.14 or any Seller Environmental Liabilities and, notwithstanding Section 8.5, including any Third-Party Claim seeking Losses for any pre-Closing violation of, or noncompliance with, any Environmental Law or Environmental Permit:
i.pursuant to applicable Environmental Laws, the Purchaser shall control and complete the conduct of such corrective action in the Most Cost-Effective Manner; provided, however, that the Purchaser shall consult with the Seller in all material respects in connection with undertaking the corrective action, shall provide the Seller with copies of all material correspondence submitted to and received from any Governmental Authority relating to the corrective action or to the associated violation or noncompliance, shall provide copies of all reports and assessments prepared by the Purchaser on the activity other than a Remedial Action, shall provide the Seller with reasonable opportunity to provide comments to any material submissions to any Governmental Authority with respect thereto, including to any corrective action plans or proposals, and the Purchaser shall reasonably consider any such comments in connection with such submission;
ii.the Purchaser shall, and shall cause its Affiliates to, provide the Seller with reasonable notice of all planned substantive meetings and telephone conferences with the applicable Governmental Authority, and the Seller and its Representatives shall have the right to attend and participate in such meetings and telephone conferences;
iii.the Seller shall not be obligated to indemnify any Purchaser Indemnified Party for capital costs incurred in connection with the implementation of a corrective action that are (A) not required by a Governmental Authority or (B) not reasonably necessary to achieve compliance with applicable Environmental Laws and Environmental Permits which costs are in excess of the Most Cost-Effective Manner. The parties hereto agree that, with respect to a corrective action required under Section 8.7(d), the Most Cost-Effective Manner shall include, and the Seller shall be obligated to indemnify the Purchaser Indemnified Parties for, reasonable capital costs incurred in order to allow the Purchaser to operate in a manner and at a level of production that is
-97-


consistent with the subject facility’s operations conducted during the 12-month period prior to the assertion of the particular claim;
iv.the Seller shall under no circumstances be responsible for any costs related to compliance with any Environmental Law or Environmental Permit subsequent to the Closing, including any operating costs related to any capital upgrade or improvements made as, or in connection with any, such corrective action or legal or regulatory changes; provided, that, for the avoidance of doubt, the Seller shall be responsible for all costs related to compliance with any applicable Environmental Law or Environmental Permit arising out of acts or omissions of the Seller or the Business prior to the Closing;
v.the Seller shall under no circumstances be responsible for any removal, abatement, encapsulation or maintenance of any Hazardous Materials included in any building material or equipment, including any Hazardous Materials discovered, encountered or disturbed pursuant to any demolition, renovation or construction subsequent to the Closing; and
vi.for the sake of clarity, the parties acknowledge that, notwithstanding Section 8.5, this Section 8.7 does not in any way limit, condition or otherwise affect the Seller’s right to control the defense of any Third-Party Claim or Action, including any Third-Party Claim or Action seeking fines or penalties for any pre-Closing violation of or noncompliance with any Environmental Law or Environmental Permit. If the Seller is controlling the defense of such Third-Party Claims or Actions, then the Purchaser’s obligations set forth above in Section 8.7(d)(i) and (ii) shall apply to the Seller, and the Seller shall not settle or compromise any such Third-Party Claim or Action to the extent that it would materially interfere with the Business, the Manufacturing Facility or Owned Real Property without the prior written consent of the Purchaser, such specific consent not be the unreasonably withheld or delayed.
e.With respect to the Seller’s obligations under this Section 8.7 or indemnification obligations under Section 8.2 for any breach of the representations and warranties in Section 3.14 or any Seller Environmental Liabilities, the Seller shall not be responsible for Losses to the extent they are caused, triggered, increased or have their timing accelerated by  any negligent act by the Purchaser or any of its Representatives subsequent to the Closing, or  any changes in Environmental Law coming into effect subsequent to the Closing.
f.With respect to the Seller’s obligations under this Section 8.7 or indemnification obligations under Section 8.2 for any breach of the representations and warranties in Section 3.14 or any Seller Environmental Liabilities, the Seller shall not be responsible for Losses and any such Losses shall constitute Purchaser Environmental Liabilities and shall not constitute Seller Environmental Liabilities, to the extent they are caused, triggered, increased or have their timing accelerated by  any change in use classification of a subject Owned Real Property, subsequent to the Closing from industrial to commercial or residential or from commercial to residential due to any action by the Purchaser;  any decommissioning, closure or shutdown of a facility or a unit, including a waste management unit; or  any intrusive
-98-


environmental sampling, analysis, investigation, assessment, or testing of soil or groundwater at any Owned Real Property conducted subsequent to the Closing by or on behalf of the Purchaser or one of its Affiliates unless written notice has been provided to the Seller and such sampling, analyses, investigation, assessment, or testing is (A) required to comply with Environmental Law or required by a Governmental Authority, (B) performed in accordance with Section 8.7(a) or (C) performed in connection with Section 8.7(g).
g.Notwithstanding anything to the contrary contained in this Agreement, if a Governmental Authority requires the Seller to complete a Remedial Action arising from or relating to the presence or any Releases of Hazardous Materials prior to the Closing Date at, in, on or from the Manufacturing Facility or Owned Real Property located in South Haven, Michigan, and the Seller’s Liability is caused, triggered, increased or had its timing accelerated by the Purchaser’s demolition, renovation, construction, disturbance, grading, excavation, dredging or removal to, into or underneath the ground, including but not limited to soil, groundwater, sediment, dredge materials, buildings pads/slabs, foundations, buildings, structures, piping, sumps, pits, vaults, underground storage tanks, debris and waste (unless, in each case, any such activity was performed as a part of routine maintenance work planned and performed at regular intervals and based on testing or other evidence indicating the maintenance work is necessary to extend the life or prevent the premature failure of structures or fixtures), then the Purchaser and the Seller shall split the cost of such Losses equally. Notwithstanding Section 8.7(c)(i), the Purchaser shall have the right to control any Remedial Action related to the foregoing Losses in accordance with and subject to Section 8.7(c).
h.The Purchaser acknowledges that its sole and exclusive remedy against the Seller or any Subsidiary of the Seller, and the Seller acknowledges that its sole and exclusive remedy against the Purchaser or any Subsidiary of the Purchaser, for any Losses or Liabilities relating to any applicable Environmental Laws, Environmental Permits or Hazardous Materials, or any environmental, health or safety matter, including natural resources (“Environmental Losses”), is under Section 8.2 or this Section 8.7. In furtherance of the foregoing, from and after the Closing Date, except for any Losses for which the Seller is obligated to indemnify the Purchaser pursuant to Section 8.2 or this Section 8.7, the Purchaser and the Seller each hereby (i) waive, on its behalf and on behalf of its Affiliates, predecessors, successors and assigns, officers, directors, employees, agents and partners, to the fullest extent permitted under applicable Law, any claim or remedy against the Seller Indemnified Parties and the Purchaser Indemnified Parties, respectively, now or hereafter available under any applicable Environmental Law, including the Comprehensive Environmental Response, Compensation and Liability Act or any other Law, whether or not in existence on the date hereof.
i.Notwithstanding anything to the contrary contained in this Agreement, none of the Seller or any of its Subsidiaries shall be liable for any claim under this Section 8.7 or for indemnification under Section 8.2 for any Seller Environmental Liabilities described in Section 1.151(a) or Seller Environmental Liabilities described in Section 1.151(d) (collectively, “Seller Indemnified Remedial Action or Environmental Noncompliance”) made after the fourth anniversary of the Closing Date; provided, however, that any written claim made with reasonable technical and legal specificity by the Purchaser prior to the fourth anniversary of the Closing
-99-


Date shall survive until such claim is finally and fully resolved. No Losses may be claimed under Section 8.2 for any Excluded Liability that is a Seller Indemnified Remedial Action or Environmental Noncompliance unless and until the aggregate amount of indemnifiable Losses relating to Seller Indemnified Remedial Actions or Environmental Noncompliances exceeds $250,000, whereupon Purchaser Indemnified Parties shall be entitled to indemnification for the amount of such Losses in excess of such amount. The maximum amount of indemnifiable Losses which may be recovered from the Seller arising out of or resulting from Seller Indemnified Remedial Actions or Environmental Noncompliances shall be an amount equal to $25 million.
j.Notwithstanding anything in this Agreement to the contrary, the Seller shall have no indemnification obligation or other Liability for any Losses, and such Losses shall not constitute Seller Environmental Liabilities, to the extent arising from or related to  the presence or any Releases of Hazardous Materials at, in, on or from the Manufacturing Facility or Owned Real Property located in Tyrone, Pennsylvania prior to the Closing Date; the presence or any Releases of per- or polyfluoroalkyl compounds identified or described in Michigan Law or dioxane at, in, on or from any the Manufacturing Facility or Owned Real Property located in South Haven, Michigan prior to the Closing Date and any third-party tort or other third-party claims to the extent arising from or relating to the presence or any Releases of Hazardous Materials at, in, on or from the Manufacturing Facility or Owned Real Property located in South Haven, Michigan prior to the Closing Date as described in Section 1.151(a) of the definition of Seller Environmental Liabilities; or  any exposure prior to the Closing Date, other than (A) to any current or former employee of the Seller, to Hazardous Materials in connection with the Seller’s operation of the Business at any Manufacturing Facility or Owned Real Property or (B) to any Hazardous Material included in any product or material manufactured, marketed, sold or distributed prior to the Closing Date, by the Seller from any Manufacturing Facility or Owned Real Property or by the Business as described in Section 1.151(c) of the definition of Seller Environmental Liabilities; provided, however, (A) to the extent the Purchaser is unable to recover under the Pollution Policy for any Losses described in the foregoing clauses (i) or (iii) due to the Seller’s breach of the Pollution Policy, then the Seller shall indemnify the Purchaser for such Losses to the same extent that such Losses would have been covered by the Pollution Policy but for the Seller’s breach; and (B) to the extent the Purchaser breaches the Pollution Policy and the Seller incurs any Losses that otherwise would have been covered by the Pollution Policy but for the Purchaser’s breach, then the Purchaser shall indemnify the Seller for such Losses.
k.Except as with respect to matters relating to any COVID Action, which are addressed elsewhere in this Agreement, any Liabilities arising from noncompliance with Environmental Laws in the operation of the Business that are identified within six months following the Closing Date shall be presumed to have occurred prior to the Closing Date such that such noncompliance constitutes a Seller Environmental Liability, which presumption shall be rebuttable by the Seller based on a preponderance of the evidence.
Section 8.8Subrogation
-100-


. Upon making any payment for Losses of an Indemnified Party under this Article VIII, the Seller, in the case of the Purchaser Indemnified Parties, and the Purchaser, in the case of the Seller Indemnified Parties, will, to the extent of such payment, be subrogated to all rights (if any) of the Indemnified Party against any insurance policy with respect to the Loss for which the payment relates; provided, that, for the avoidance of doubt, in no event shall the Seller be subrogated to any rights that a Purchaser Indemnified Party may have against any customer, client, supplier or other third party with whom the Business, the Seller or any of its Affiliates has a material business relationship. In addition to any other obligation under this Agreement, the Indemnified Party agrees to duly execute and deliver, on behalf of the Seller or the Purchaser, as the case may be, all instruments reasonably necessary to evidence and perfect the subrogation rights granted pursuant to this Section 8.8.
Article IX.
TERMINATION
Section 9.1Termination
. This Agreement may be terminated at any time prior to the Closing:
a.by either the Seller or the Purchaser if the Closing shall not have occurred within one hundred twenty (120) days following the date of this Agreement (the “Termination Date”); provided, that (i) the right to terminate this Agreement under this Section 9.1(a) shall not be available to either such party whose breach of any representation or warranty hereunder or action or failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to such date, and (ii) neither the Seller nor the Purchaser shall have the right to terminate this Agreement under this Section 9.1(a) if the Pre-Closing IT Integration Completion has not yet occurred as of such time, unless the other party has failed to perform its obligations under Section 5.6(d) of this Agreement and such failure is not cured within five (5) Business Days of notice by the non-breaching party;
b.by either the Seller or the Purchaser in the event that any Governmental Authority of competent jurisdiction shall have issued a Governmental Order that permanently enjoins or prohibits or renders illegal the consummation of the transactions contemplated by this Agreement or the other Transaction Documents and such Governmental Order shall have become final and non-appealable; provided, however, that the right to terminate this Agreement under this Section 9.1(b) shall not be available to any party whose breach of any representation or warranty in this Agreement or failure to fulfill any obligation under this Agreement has been the cause of, or has resulted in, the issuance of such Governmental Order or other action;
c.by the Seller if a breach of any representation, warranty, covenant or agreement on the part of the Purchaser set forth in this Agreement (including an obligation to consummate the Closing) shall have occurred that would, if occurring or continuing on the Closing Date, cause the condition set forth in Section 7.1(a) not to be satisfied, and such breach is not cured, or is incapable of being cured, within 30 days (but no later than the Termination Date) of receipt of written notice by the Purchaser from the Seller of such breach; provided, that
-101-


the Seller is not then in breach of this Agreement so as to cause any of the conditions set forth in Section 7.2(a) not to be satisfied;
d.by the Purchaser if a breach of any representation, warranty, covenant or agreement on the part of the Seller set forth in this Agreement (including an obligation to consummate the Closing) shall have occurred that would, if occurring or continuing on the Closing Date, cause the condition set forth in Section 7.2(a) not to be satisfied, and such breach is not cured, or is incapable of being cured, within 30 days (but no later than the Termination Date) of receipt of written notice by the Seller from the Purchaser of such breach; provided, that the Purchaser is not then in breach of this Agreement so as to cause any of the conditions set forth in Section 7.1(a) not to be satisfied; or
e.by the written consent of the Seller and the Purchaser.
Any termination pursuant to this Section 9.1 (other than a termination pursuant to Section 9.1(e) hereof) shall be effected by written notice from the party so terminating to the other party, which notice shall specify the Section hereof pursuant to which this Agreement is being terminated.
Section 9.2Effect of Termination
. In the event of termination of this Agreement as provided in Section 9.1, this Agreement shall forthwith become void and have no effect and there shall be no liability on the part of any party hereto or any of their respective Representatives; provided, that  Section 5.3, this Section 9.2 and Article XI shall survive any termination; and  nothing herein shall relieve any party hereto from liability for any fraud occurring prior to such termination.
Article X.
RESTRICTIVE COVENANTS
Section 10.1Non-Competition
. Other than conducting the business of the Seller as it is conducted as of the date hereof and the Closing Date (other than the Business), the Seller shall not, and shall cause its Affiliates not to,  for a period of three years after the Closing Date anywhere in the European Union, and  for a period of five years after the Closing Date anywhere in the world (other than the European Union), directly or indirectly, as an advisor, manager, consultant, broker, owner or equity holder (other than as an equity holder of less than two percent of the issued and outstanding shares of a publicly traded company) or otherwise, engage anywhere in, operate, be employed by, perform services for, endorse, solicit business for, have any financial interest in or otherwise be affiliated with, any business, activity or enterprise that competes in any way with the Business as conducted as of the Closing Date other than as a consultant of the Purchaser or its Affiliates; provided, that, notwithstanding the foregoing, this Section 10.1 will not restrict the Seller or any Subsidiary thereof from engaging in the activity of researching, developing, manufacturing, producing, having made or produced, marketing, selling (or providing services related thereto), any Excluded Products.
-102-


Section 10.2Non-Solicitation of Employees
. The Seller shall not, and shall cause its Affiliates not to, for a period of one year after the Closing Date, for itself or on behalf of any other individual or entity, directly or indirectly, solicit for employment or employ or retain, including as a consultant or contractor, any Person who is a then-current employee of the Business, or induce or attempt to induce any such Person to leave his or her employment or retention with the Purchaser or such Affiliate; provided, however, that notwithstanding the foregoing, this Section 10.2 shall not restrict the Seller or any Affiliate from employing any such Person whose employment was terminated by the Purchaser or any Affiliates prior to such solicitation by the Seller or its Affiliates or who responds to a general solicitation or advertisement by the Seller or any of its Affiliates that is not targeted specifically at employees of the Business.
Section 10.3Non-Solicitation or Interference with Customers and Suppliers
. The Seller shall not, and shall cause its Affiliates not to, for a period of two years after the Closing Date, directly or indirectly, for itself or on behalf of any other individual or entity, solicit, divert, take away or attempt to take away from the Business on and after the Closing Date any customers or suppliers of the Business as of the date hereof or as of the Closing Date or the business or patronage of any such customers or suppliers of the Business as of the date hereof or as of the Closing Date or in any way interfere with, disrupt or attempt to disrupt any relationships existing as of the date hereof or as of the Closing Date between the Business and any of its customers or suppliers or other individuals or entities.
Section 10.4Acknowledgments; Enforcement.
a.The Seller acknowledges that, in view of the nature of the businesses of the Purchaser and the business objectives of the Purchaser in acquiring the Business, and the consideration paid to the Seller hereunder, the restrictions and covenants contained or referenced in this Article X are reasonable and necessary to protect the legitimate business interests of the Purchaser and that any violation of such restrictions will result in irreparable injury to the Purchaser, its Affiliates and the Business for which damages would not be an adequate remedy. The Purchaser acknowledges that, in view of the nature of the businesses of the Seller and the business objectives of the Seller in selling the Business, the restrictions and covenants contained or referenced in this Article X are reasonable and necessary to protect the legitimate business interests of the Seller and that any violation of such restrictions will result in irreparable injury to the Seller, its Affiliates and their respective businesses for which damages would not be an adequate remedy. The Seller and the Purchaser therefore acknowledge that, if any such restrictions or covenants are violated, the other party shall be entitled to preliminary and injunctive relief against the violating party as well to an equitable accounting of earnings, profits and other benefits arising from such violation without the posting of any bond or deposit with any Governmental Authority.
b.If, at the time of enforcement of any covenant contained in this Article X, a court or other Governmental Authority shall hold that the duration, scope or geographic restrictions stated herein are unreasonable under circumstances then existing, the parties hereto
-103-


agree that the maximum duration, scope or geographic area reasonable under such circumstances shall be substituted for the stated duration, scope or geographic area and that the court or other Governmental Authority shall be allowed and directed to revise the restrictions contained herein to cover the maximum period, scope and geographic area permitted by Law.
Article XI.
GENERAL PROVISIONS
Section 11.1Expenses
. Except as otherwise specified in this Agreement, all costs and expenses, including fees and disbursements of counsel, financial and other advisors and accountants, incurred in connection with this Agreement and the transactions contemplated by this Agreement or the other Transaction Documents shall be borne by the party incurring such costs and expenses, whether or not the Closing shall have occurred.
Section 11.2Seller Disclosure Schedule
. Notwithstanding anything to the contrary contained in the Seller Disclosure Schedule, in this Agreement or in the other Transaction Documents, the information and disclosures contained in any Section of the Seller Disclosure Schedule shall be deemed to be disclosed and incorporated by reference in each other Section of the Seller Disclosure Schedule as though fully set forth in such other Section to the extent the relevance of such information to such other Section is reasonably apparent on the face of such disclosure notwithstanding the omission of a reference or a cross-reference with respect thereto and notwithstanding any reference to a Section of the Seller Disclosure Schedule in this Agreement. Certain items and matters (other than matters required by a particular representation or warranty to be included in the Seller Disclosure Schedule) are listed in the Seller Disclosure Schedule for informational purposes only and may not be required to be listed therein by the terms of this Agreement. In no event shall the listing of items or matters in the Seller Disclosure Schedule be deemed or interpreted to broaden, or otherwise expand the scope of, the representations and warranties or covenants and agreements contained in this Agreement. No reference to, or disclosure of, any item or matter in any Section of this Agreement or any Section of the Seller Disclosure Schedule shall be construed as an admission or indication that such item or matter is material or that such item or matter is required to be referred to or disclosed in this Agreement or in the Seller Disclosure Schedule (other than any matters required by a particular representation or warranty to be included in the Seller Disclosure Schedule). Without limiting the foregoing, no reference to, or disclosure of, a possible breach or violation of any contract or agreement, Law or Governmental Order shall be construed as an admission or indication that a breach or violation exists or has actually occurred.
Section 11.3Notices
. All notices, requests, claims, demands, disclosures and other communications required or permitted by this Agreement shall be in writing and shall be deemed to have been given at the earliest of the date  when delivered personally, by messenger or by overnight delivery service by a recognized commercial carrier to an officer of the other party, when received if mailed by
-104-


registered or certified United States mail, postage prepaid, return receipt requested, or  when received via electronic mail, in all cases addressed to the person for whom it is intended at his address set forth below or to such other address as a party shall have designated by notice in writing to the other party in the manner provided by this Section 11.3:
if to the Seller:
Albemarle Corporation
Suite 900
4250 Congress Street
Charlotte, North Carolina 28209
Attention:    Karen G. Narwold
Email:    karen.narwold@albemarle.com
with copies (which shall not constitute notice) to:
Albemarle Corporation
Suite 900
4250 Congress Street
Charlotte, North Carolina 28209
Attention:    Legal Dept.
Email:    legal_notices@albemarle.com
and
Troutman Pepper Hamilton Sanders LLP
1001 Haxall Point
Richmond, Virginia 23219
Attention:    John Owen Gwathmey
Email:    johnowen.gwathmey@troutman.com
if to the Purchaser or the SPV:
W. R. Grace & Co.–Conn.
7500 Grace Drive
Columbia, Maryland 21044
Attention:    President, Materials Technologies
Email:    GraceMT@grace.com
with copies (which shall not constitute notice) to:
W. R. Grace & Co.-Conn.
7500 Grace Drive
Columbia, Maryland 21044
Attention:    Legal Services Group
Email:    GraceLaw@grace.com
-105-


and
Fried, Frank, Harris, Shriver & Jacobson LLP
One New York Plaza
New York, New York 10004
Attention:    Steven Epstein
Email:    Steven.Epstein@friedfrank.com
Section 11.4Public Announcements
. The initial press release in respect of the transactions contemplated by this Agreement and the other Transaction Documents shall be prepared by the Purchaser (and the Purchaser shall give the Seller a reasonable opportunity to review and comment thereon). None of the parties to this Agreement shall make, or cause to be made, and each of the parties to this Agreement shall cause its Affiliates and Representatives not to make, any press release or public announcement in respect of this Agreement, the other Transaction Documents or the transactions contemplated hereby and thereby or otherwise communicate with any news media regarding this Agreement, the other Transaction Documents or the transactions contemplated hereby and thereby (each, a “Public Announcement”) without the prior written consent of the other party (and shall consult with and give such other party a reasonable opportunity to review and comment thereon), unless such Public Announcement is required by Law or applicable stock exchange regulation, in which case the parties to this Agreement shall, to the extent practicable, consult with each other as to the timing and contents of any such Public Announcement; provided, however, that, notwithstanding the foregoing, the Purchaser, its Affiliates and its Representatives and the Seller, its Affiliates and its Representatives shall be entitled to make any Public Announcement without such consent to the extent such Public Announcement is consistent in all material respects with the initial press release.
Section 11.5Severability
. If any term or other provision of this Agreement is declared invalid, illegal or incapable of being enforced by any Governmental Authority, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect for so long as the economic or legal substance of the transactions contemplated by this Agreement or the other Transaction Documents is not affected in any manner materially adverse to any party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement or the other Transaction Documents are consummated as originally contemplated to the greatest extent possible.
Section 11.6Entire Agreement
. This Agreement, the Disclosure Schedules, the other Transaction Documents and the Confidentiality Agreement constitute the entire agreement of the parties hereto with respect to
-106-


the subject matter hereof and thereof and supersede all prior agreements and undertakings, both written and oral, among the parties hereto with respect to the subject matter hereof and thereof.
Section 11.7No Setoff
. Obligations under this Agreement, including Article VIII, shall not be netted, recouped or set off against any other obligations of the parties, whether arising under this Agreement, under any other agreement between the parties hereto, by operation of Law or otherwise, and no other obligations of the parties shall be netted, recouped or set off against obligations under this Agreement, whether arising under the Agreement, under any other agreement between the parties hereto, by operation of Law or otherwise, and each party hereby waives any such right of setoff, netting or recoupment.
Section 11.8Assignment
. This Agreement and the rights and obligations hereunder may not be assigned by operation of Law or otherwise without the express written consent of the Seller or the Purchaser (which consent may be granted or withheld in the sole discretion of the Seller or the Purchaser), as the case may be, and any attempted assignment that is not in accordance with this Section 11.8 shall be null and void; provided, that the Purchaser may assign its rights and obligations hereunder without such consent to (i) any Affiliate of the Purchaser, (ii) any Subsidiary of the Purchaser or (iii) any lender, including any Financing Sources (or agent or representative thereof) for collateral purposes, which assignment shall not relieve the Purchaser of its obligations hereunder.
Section 11.9Amendment
. This Agreement may not be amended or modified except (a) by an instrument in writing signed by, or on behalf of, the Seller and the Purchaser that expressly references the Section of this Agreement to be amended; or (b) by a waiver in accordance with Section 11.10. Notwithstanding anything in this Agreement to the contrary, Section 5.13(b), Section 11.8, this Section 11.9, Section 11.11, Section 11.12(b), Section 11.13 and Section 11.14 and the definitions of “Debt Financing”, “Debt Financing Agreements” and “Financing Sources” (and any provision of this Agreement to the extent an amendment or modification of such provision would modify the substance of any such Section) may not be amended, modified or waived in a manner that adversely affects any Financing Source without the prior written consent of such Financing Source adversely affected thereby.
Section 11.10Waiver
. Any party to this Agreement may  extend the time for the performance of any of the obligations or other acts of the other party;  waive any inaccuracies in the representations and warranties of the other party contained herein or in any document delivered by the other party pursuant to this Agreement; or  waive compliance with any of the agreements of the other party or conditions to such obligations contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the parties to be bound thereby. Notwithstanding the foregoing, no failure or delay by any party hereto in exercising any right
-107-


hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or future exercise of any other right hereunder. Any waiver of any term or condition hereof shall not be construed as a waiver of any subsequent breach or as a subsequent waiver of the same term or condition, or a waiver of any other term or condition of this Agreement.
Section 11.11No Third-Party Beneficiaries
. This Agreement shall be binding upon and inure solely to the benefit of, and be enforceable by, only the parties hereto and their respective successors and permitted assigns and nothing herein, express or implied, is intended to, or shall confer upon, any other Person any right, benefit or remedy of any nature whatsoever, including any rights of employment for any specified period, under or by reason of this Agreement. Notwithstanding the foregoing, each Financing Source is an express third party beneficiary of Section 5.13(b), Section 11.8, Section 11.9, Section 11.11, Section 11.12(b), Section 11.13 and Section 11.14.
Section 11.12Specific Performance
.
(1)The parties hereto acknowledge and agree that the parties hereto would be irreparably damaged if any of the provisions of this Agreement are not performed in accordance with their specific terms or are otherwise breached and that any non-performance or breach of this Agreement by either party hereto could not be adequately compensated by monetary damages alone and that the parties hereto would not have any adequate remedy at Law. Accordingly, in addition to any other right or remedy to which any party hereto may be entitled, at Law or in equity (including monetary damages), such party shall be entitled to enforce any provision of this Agreement by a decree of specific performance and to temporary, preliminary and permanent injunctive relief to prevent breaches or threatened breaches of any of the provisions of this Agreement, without posting any bond or other undertaking.
(2)Notwithstanding anything herein to the contrary, the Seller (on behalf of itself, each of its Affiliates and Subsidiaries and any of their respective Representatives) hereby waives any rights or claims against the Financing Sources in connection with this Agreement or the Debt Financing, whether at law or equity, in contract, in tort or otherwise and the Seller (on behalf of itself, each of its Affiliates and Subsidiaries and any of their respective Representatives) agrees not to commence (and if commenced, agrees to dismiss or otherwise terminate) any Action against any Financing Source in connection with this Agreement or the transactions contemplated hereby (including any Action relating to the Debt Financing). In furtherance and not in limitation of the foregoing, it is agreed that no Financing Source shall have any liability for any losses to the Seller or any of its Affiliates or Subsidiaries (or any of their respective Representatives or equityholders) in connection with this Agreement or the transactions contemplated hereby. Nothing in this Section 11.12(b) shall in any way expand the circumstances in which the Purchaser may be liable under this Agreement or as a result of the transactions contemplated hereby (including as a result of the Debt Financing).
-108-


Section 11.13Governing Law
. This Agreement and any claim, controversy or dispute arising under or related to this Agreement or the Debt Financing shall be governed by, and construed in accordance with, the laws of the State of New York, including Sections 5-1401 and 5-1402 of the New York General Obligations Law without giving effect to any other principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction. Except as provided in Section 2.11, each party hereto irrevocably agrees that it shall bring any and all Actions or proceedings in respect of any claim arising out of, related to, or in connection with, this Agreement, the Debt Financing or the transactions contemplated hereby, or the relationship between the parties hereto, whether in tort or contract or at law or in equity, exclusively in any New York State court sitting in the Borough of Manhattan (or in the case of claims where the federal courts have and accept jurisdiction, the United States District Court for the Southern District of New York), and in each case, appellate courts therefrom, and consistent with the foregoing, each of the parties hereto hereby (a) submits (and agrees to cause its controlled affiliates to submit) to the exclusive jurisdiction of such court for the purpose of any Action, directly or indirectly, arising out of, relating to, or in connection with this Agreement or the Debt Financing brought by any party hereto; (b) agrees (and agrees to cause its controlled affiliates to submit) that service of process will be validly effected by sending notice in accordance with Section 11.3; (c) irrevocably waives and releases, and agrees not to assert or support (and agrees to cause its controlled affiliates to so waive, release and agree) by way of motion, defense, or otherwise, in or with respect to any such Action, any claim, whether actual or potential, known or unknown, suspected or unsuspected, based upon past or future events, now existing or coming into existence in the future, that (A) such Action is not subject to the personal jurisdiction of such above-named courts; (B) its property is exempt or immune from attachment or execution in the State of New York; (C) such Action is brought in an inconvenient forum; (D) that the venue of such Action is improper; or (E) this Agreement (including the Debt Financing) or the transactions contemplated by this Agreement may not be enforced in or by any of such above-named courts; and (d) agrees not to move to transfer any such Action to a court other than any of the above-named courts. Notwithstanding the foregoing, with respect to the Owned Real Property only, the laws of the state where the Owned Real Property is located shall control in connection with any matters relating to the Owned Real Property without giving effect to any other principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction.
Section 11.14Waiver of Jury Trial
. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES (AND AGREES TO CAUSE ITS CONTROLLED AFFILIATES TO WAIVE) TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION OR LIABILITY, DIRECTLY OR INDIRECTLY, ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH THIS AGREEMENT (INCLUDING THE DEBT FINANCING) OR THE TRANSACTIONS CONTEMPLATED BY this Agreement or the other Transaction Documents. EACH OF THE PARTIES HERETO HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS
-109-


REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY SUCH ACTION OR LIABILITY, SEEK TO ENFORCE THE FOREGOING WAIVER; AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTY HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY this Agreement or the other Transaction Documents, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 11.14.
Section 11.15Counterparts
. This Agreement may be executed and delivered (including by facsimile or other means of electronic transmission, such as by electronic mail in “pdf” form) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement.
Section 11.16Interpretation and Rules of Construction.
(3)In this Agreement, except to the extent otherwise provided or that the context otherwise requires:
(a)when a reference is made in this Agreement to an Article, Section, Exhibit or Schedule, such reference is to an Article or Section of, or an Exhibit or Schedule to, this Agreement;
(b)the table of contents and headings for this Agreement are for reference purposes only and do not affect in any way the meaning or interpretation of this Agreement;
(c)whenever the words “include,” “includes” or “including” are used in this Agreement, they are deemed to be followed by the words “without limitation”;
(d)the words “hereof,” “herein” and “hereunder” and words of similar import, when used in this Agreement, refer to this Agreement as a whole and not to any particular provision of this Agreement;
(e)all terms defined in this Agreement have the defined meanings when used in any certificate or other document delivered or made available pursuant hereto, unless otherwise defined therein;
(f)where used with respect to information, the phrases “delivered” or “made available” shall mean that the information referred to has been physically or electronically delivered to the relevant parties or their respective Representatives, including, in the case of “made available” to the Purchaser, material that has been posted in a “data room” (virtual or otherwise) established by the Seller;
(g)references to “day” or “days” are to calendar days;
-110-


(h)the definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms;
(i)references to a Person are also to its successors and permitted assigns;
(j)the word “or” shall be disjunctive but not exclusive;
(k)when calculating the period of time before which, within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded. If the last day of such period is not a Business Day, the period in question shall end on the next succeeding Business Day; and
(l)references to sums of money are expressed in lawful currency of the United States of America, and “$” refers to U.S. dollars.
[SIGNATURE PAGE FOLLOWS]

-111-


IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as of the date first written above by its respective officers thereunto duly authorized.
ALBEMARLE CORPORATION
By:    /s/ Karen G. Narwold    
Karen G. Narwold
Executive Vice President, Chief Administrative Officer, General Counsel & Corporate Secretary
[Signature Page to Sale, Purchase and Contribution Agreement]


W. R. GRACE & CO.-CONN.
By:    /s/ William Dockman    
Name: William Dockman
Title: SVP, Chief Financial Officer
FINE CHEMICAL MANUFACTURING SERVICES LLC
By:    /s/ William Dockman    
Name: William Dockman
Title: SVP, Chief Financial Officer


[Signature Page to Sale, Purchase and Contribution Agreement]


IMAGE1A.JPG

Elizabeth C. Brown
Senior Vice President and
Chief Human Resources Officer

T +1 410.531.4664
M +1 410.531.4233
elizabeth.brown@grace.com

W. R. Grace & Co.
7500 Grace Drive
Columbia, MD 21044



November 13, 2020

Cherée Johnson


Dear Cherée:

This letter specifies the terms of your employment with W. R. Grace & Co. (the “Company”), as approved by the Board of Directors (the “Board”) of the Company and/or the Compensation Committee of the Board, as applicable. I am very pleased that you have agreed to join the Company and believe that you will make a valuable contribution to the Companys future.

If you accept the terms of this letter, please sign where indicated below and return a copy to me.

Position and Responsibilities
You will join the Company as an employee on January 11, 2021, or another date around that time as agreed by you and the Company. Effective upon joining the Company, you will assume the position of “Senior Vice President, General Counsel and Secretary”, with the responsibility of assisting in the management of all Legal functions at the Company (and of its subsidiary, W. R. Grace & Co.-Conn.) and report directly to Hudson La Force, the Company’s President and Chief Executive Officer. We anticipate that the Board will elect you as an Executive Officer at the January 21, 2021 Board meeting. (As all other Company employees, you will be employed by W. R. Grace & Co.-Conn., a 100% owned subsidiary of the Company, but will be elected an officer of both W. R. Grace & Co. and W. R. Grace & Co.-Conn.). Your office will be located at the Companys headquarters in Columbia, Maryland.
At all times, you will be an employee of the Company “at will” with no definite term of employment, and you will be subject to the same requirements as other salaried employees of the Company, except as provided under this letter.
Compensation
Upon joining the Company, you will be entitled to the following:
Your initial annual base salary will be $400,000. This position is considered a salaried exempt position. You will be paid monthly on the 12th of each month.

1 grace.com
IMAGE_02A.JPG


1.Your base salary will be subject to periodic review at the same intervals applicable to other similarly situated Grace salaried employees, generally every 18 to 24 months. Performance reviews will be conducted annually.

2.Your salary will cease to accrue immediately upon your termination of employment with the Company, regardless of the reason for such termination.

3.You will participate in the Company’s Annual Incentive Compensation Program (the “AICP”) for 2021. For that calendar year, your targeted award under the Program will be 70% of your annual base salary, based on the applicable financial performance of the Company and your individual performance during that year, subject to the terms of the Program. The cash payment you may receive under the AICP for 2021 will be prorated based upon the period of time of your active employment with Grace during the 2020 calendar year.

We also anticipate that your targeted award under future AICP Programs will be no less than 70% of your annual base salary for the applicable calendar year, pending of course any redesign of the Program in the future by the Company’s Board or its Compensation Committee. The design of AICP bonuses will be determined by the Company, and there are no guarantees with respect to how any design changes will affect future AICP bonus payments to you.

4.You will receive a sign-on bonus of $100,000, paid to you within 30 days of your first day of employment, subject to re-payment provisions if you should leave the Company voluntarily within the first year of employment. Your sign on bonus is subject to state and federal taxes where applicable.

5.You will receive a sign-on grant of “restricted stock units” on Grace Stock (“RSUs”) valued at $300,000. The RSUs will vest in equal tranches on the first and second anniversary of the date of grant, provided you are employed by the Company on that date. The actual number of RSUs granted to you under your award will be calculated as follows: the appropriate dollar value of the RSU award divided by the “market price” of a share of Grace’s common stock on the date of grant. In the event of an involuntary termination, any unvested RSUs will vest. You will receive further information in the grant documents that will be provided after your hire.
Long Term Incentive Compensation
You will be eligible to receive a grant under the Company’s Long-Term Incentive Plan in February 2021 (the “2021 LTIP”), with a total targeted award value of $450,000. The design of the Program is still being determined and you will receive this grant at the same time other eligible Company employees receive a 2021 LTIP grant. You will receive further information regarding the terms of the 2021 LTIP in a separate memo.
Future LTIP awards will be based on your performance, the program design, and other factors deemed appropriate by senior management and the Board. The timing and terms of any LTIP award will be the same as the terms governing the awards of the other participants in the Company. All LTIP awards are subject to the approval of the Compensation Committee of the Board of Directors.
2 grace.com
IMAGE_02A.JPG


Stock Ownership Guidelines
In order to ensure· that the long-term financial interests of our directors and key executives are fully aligned with the long-term interests of our stockholders, our Board of Directors has implemented stock ownership guidelines. The stock ownership guideline for your position is 3X base salary and you will have five years from your date of hire to comply with the guideline.
Severance Coverage
Upon joining the Company, you will be covered by the Severance Plan for Leadership Team Officers of Grace. A copy of that Plan is enclosed for your reference.
Executive Severance Arrangement (Change-In-Control)
When, as anticipated, the Board elects you as an executive officer, the Company will enter into a written Executive Severance Agreement, or a so-called “golden parachute”, with you. In general, the terms of that agreement will provide for a severance payment of 3.0 times the sum of your annual base salary plus your targeted annual incentive compensation award (adjusted in accordance with the terms of that agreement), and certain other benefits, in the event your employment terminates under certain conditions following a change-in-control of the Company. The form and provisions of your Executive Severance Agreement will be the same as applicable to other elected officers of the Company. You will be provided with that agreement under separate cover.
Executive Physical
You will also be eligible for an annual “executive physical” performed at Johns Hopkins Hospital in Baltimore, at Company expense. The terms of the physical will be the same as applicable to other elected officers of the Company based in Maryland.
Vacation
You will be eligible for 20 days of paid vacation, in addition to the normal observed holidays and floating holidays. Your vacation will not be prorated for 2021 based on your intended start date.
Other Benefit Programs
You will also be eligible to participate in the benefit plans and programs generally available to similarly situated employees and officers of the Company (subject to the continuation of the plans and programs, and as amended from time to time). I have included a summary of Grace’s benefits plans currently provided to salaried employees.
Pre-employment Requirements
Prior to joining Grace, you will be required to undergo a drug screening test. Please send the following information to Ann Goluboff R.N., in our Medical Department at ann.goluboff@grace.com to schedule an appointment locally in your area: Name, Address, Work Location, Position, Phone Number, Start Date and Email address.
This offer of employment is contingent upon successfully completing the drug screening test, background check, and your provided documentation establishing your eligibility to work in the United
3 grace.com
IMAGE_02A.JPG


States. Upon acceptance of your offer, you will need to schedule and take your drug screen within 5 business days or offer will be null and void.
Acceptance of this offer indicates that you will be an employee “at will” of Grace and commits neither you nor Grace to any duration of employment. You will have the same responsibilities, and be subject to the same requirements, as other similarly situated Grace salaried employees.
New Hire Information
Upon written acceptance of this offer, you will receive a “Welcome to Grace” email from our Onboarding system with instructions on how to access our Global Onboarding and Orientation System. This email will include important information regarding the I-9 process. Please log in as soon as possible to begin your onboarding tasks for this will expedite your onboarding to Grace. We look forward to having you join our organization, and we know that you will be a valuable addition to Grace. Please acknowledge acceptance of this offer below and return a signed copy to my attention along with the signed New Hire Agreement. Should you have any questions, please email Stephanie Wheeler at Stephanie.Wheeler@grace.com.
Confidentiality and Non-Compete
In addition, as a condition of commencing employment, you will be required to sign the Company’s New Hire Officer Agreement, a copy of which is enclosed, and which includes provisions regarding the confidentiality of Company information, and non-competition and other provisions.
Indemnification
The Company shall, to the extent permitted by applicable law, indemnify you and hold you harmless from and against any and all losses and liabilities you may incur as a result of your performance of your duties as an officer or employee of the Company. In addition, the Company shall indemnify and hold you harmless against any and all losses and liabilities that you may incur, directly or indirectly, as a result of any third party claims brought against you (other than by any taxing authority) with respect to the Company’s performance of (or failure to perform) any commitment made to you under this letter. The Company shall obtain such policy or policies of insurance as it reasonably may deem appropriate to effect this indemnification.
Miscellaneous
Cherée, in consideration of your employment by the Company, in the future, effective upon your cessation of employment with the Company or at any other time at the request of the Company, you agree that you will resign as a director, partner, officer and/or any other position of each direct or indirect subsidiary of the Company and/or of any other business entity directly or indirectly controlled by the Company, and to transfer to the Company any stock or other interest in any such subsidiary or business entity (which you may hold as a result of your employment with the Company). Also, at the request of the Company, and at its cost, you agree to execute any statement or document, or take such other action, to effectuate such resignations and transfers. (Note, this provision does not apply to any equity you may hold in the Company, only to direct or indirect subsidiaries of the Company.) You also agree to
4 grace.com
IMAGE_02A.JPG


return all Company property to the Company, effective upon your cessation of employment or at any other time at the request of the Company.
This letter is intended to summarize certain benefits that you will be entitled to under benefit plans and policies of Grace as a result of your employment by Grace in the capacity specified. This summary does not purport to be complete and is qualified in its entirety by reference to the full text of such plans and policies. In the event of any conflict between this letter and such plans and policies, the terms of such plans and policies will control. This letter does not give rise to any legal obligations on the part of Grace beyond those specified in such plans and policies.
Cherée, again, we are very excited about your decision to join Grace and look forward to a productive and rewarding relationship.

Sincerely,

/s/ Elizabeth C. Brown
Elizabeth C. Brown
Senior Vice President and Chief Human Resources Officer

ACCEPTED:
/s/ Cherée Johnson
Date: 11/16/20


Enclosures
cc: H. La Force
5 grace.com
IMAGE_02A.JPG
EXHIBIT 21



W. R. GRACE & CO., a Delaware corporation

U.S. SUBSIDIARIES



SUBSIDIARY NAME

STATE OF INCORPORATION
Alltech Associates, Inc.
IL
Gloucester New Communities Company, Inc.
NJ
Grace Chemical Company of Cuba
IL
Grace Collections, Inc.
DE
Grace Energy Corporation
DE
Grace Management Services, Inc.
DE
Grace PAR Corporation
DE
Grace Technologies, Inc.
DE
Guanica-Caribe Land Development Corporation
DE
Kootenai Development Company
MT
W. R. Grace Capital Corporation
NY
W. R. Grace International LLC
DE
W. R. Grace & Co.-Conn.
CT
W. R. Grace Land Corporation
NY
1


EXHIBIT 21

NON-U.S. SUBSIDIARIES


COUNTRY/
SUBSIDIARY NAME
ABU DHABI FREE ZONE
Grace Refining Technologies Middle East Trading Ltd.
AUSTRALIA
Alltech Associates (Australia) Pty. Ltd.
BRAZIL
W. R. Grace Brasil Indústria e Comércio de Produtos Quimicos Ltda.
CANADA
GEC Divestment Corporation Ltd.
W. R. Grace Canada Corp.
CHINA – PEOPLE’S REPUBLIC OF
Grace Catalysts (Qingdao) Company Limited
Grace Trading (Shanghai) Co. Ltd.
CUBA
Envases Industriales y Comerciales, S.A.
Papelera Camagueyana, S.A.**
FRANCE
Alltech France S.A.R.L.
GERMANY
Alltech Grom GmbH
Grace Germany GmbH (fka Grace Energy GmbH)
Grace Europe Holding GmbH
Grace GmbH (fka Grace GmbH & Co. KG)
Grace GP GmbH
Grace Management GP GmbH
Grace Silica GmbH
Mertus 366. GmbH
HONG KONG
W. R. Grace Trading (Hong Kong) Limited
HUNGARY
Grace Értékesito Kft.
INDIA
Grace Davison Chemicals India Pvt. Ltd.
IRELAND
Grace European Finance (Dublin) Limited
ITALY
Alltech Italia S.R.L.
Grace Italy S.r.l.
JAPAN
W. R. Grace Japan K.K.
KOREA
W. R. Grace Korea Inc.
2


EXHIBIT 21

W. R. Grace Korea Limited
LUXEMBOURG
Grace Luxembourg S.à r.l.
MALAYSIA
W. R. Grace Specialty Chemicals (Malaysia) Sdn. Bhd.
MEXICO
Grace Holdings, S.A. de C.V.
NETHERLANDS
Alltech Applied Science B.V.
Denac Nederland B.V.
Grace Netherlands B.V.
OMAN
Grace Catalysts LLC
PHILIPPINES
Grace Global Operations Center (Philippines) Inc.
RUSSIA
Grace CIS LLC
SINGAPORE
Grace Products (Singapore) Private Limited
SOUTH AFRICA
Grace Products South Africa (Private) Limited
SPAIN
Grace Catalysts & Materials S.L.U.
SWEDEN
Grace Catalyst AB
THAILAND
W. R. Grace Trading (Thailand) Limited
TURKEY
Grace Turkey Kimyevi Madde Hizmetleri Anonim Şirketi (Grace Turkey Chemicals Services Inc.)
UNITED KINGDOM
Alltech Associates Applied Science Limited
3


EXHIBIT 23

Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-224767, 333-194171) of W. R. Grace & Co. of our report dated February 25, 2021 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP
Baltimore, Maryland
February 25, 2021

1

EXHIBIT 24


POWER OF ATTORNEY


The undersigned hereby appoints WILLIAM C. DOCKMAN, CHERÉE H. JOHNSON, and SEAN E. DEMPSEY as his/her true and lawful attorneys-in-fact for the purpose of signing the Annual Report on Form 10-K of W. R. GRACE & CO. for the year ended December 31, 2020, and all amendments thereto, to be filed with the Securities and Exchange Commission. Each of such attorneys-in-fact is appointed with full power to act without the others.



Robert F. Cummings, Jr. /s/ Robert F. Cummings, Jr. Dated: The 6th day of February 2021
Julie Fasone Holder /s/ Julie Fasone Holder Dated: The 5th day of February 2021
Diane H. Gulyas /s/ Diane H. Gulyas Dated: The 5th day of February 2021
Henry R. Slack /s/ Henry R. Slack Dated: The 8th day of February 2021
Christopher J. Steffen /s/ Christopher J. Steffen Dated: The 5th day of February 2021
Mark E. Tomkins /s/ Mark E. Tomkins Dated: The 5th day of February 2021
Shlomo Yanai /s/ Shlomo Yanai Dated: The 7th day of February 2021







EXHIBIT 31(i).1
CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Hudson La Force, certify that:
1.I have reviewed this annual report on Form 10-K of W. R. Grace & Co.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 25, 2021
/s/ HUDSON LA FORCE
Hudson La Force
President and Chief Executive Officer
(Principal Executive Officer)



EXHIBIT 31(i).2
CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, William C. Dockman, certify that:
1.I have reviewed this annual report on Form 10-K of W. R. Grace & Co.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 25, 2021
/s/ WILLIAM C. DOCKMAN
William C. Dockman
Senior Vice President and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)


EXHIBIT 32
CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
        Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), the undersigned certifies that (1) this Annual Report of W. R. Grace & Co. (the "Company") on Form 10-K for the period ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (this "Report"), fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (2) the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ HUDSON LA FORCE
Hudson La Force
President and Chief Executive Officer
(Principal Executive Officer)
 
/s/ WILLIAM C. DOCKMAN
William C. Dockman
Senior Vice President and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
 
Date: February 25, 2021
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



EXHIBIT 95

MINE SAFETY DISCLOSURES

The following table provides information about citations, orders and notices issued from the Mine Safety and Health Administration (the “MSHA”) under the Federal Mine Safety and Health Act of 1977 (the “Mine Act”) during fiscal year 2020.
Mine §104 S&S*
Citations
(#)
§104(b) Orders
(#)
§104(d) Citations and Orders
(#)
§110(b)(2) Violations
(#)
§107(a) Orders
(#)
Total Dollar Value of MSHA Assessments Proposed
($)
Total Number of Mining-Related Fatalities
(#)
Received Written Notice of Pattern of S&S* Violations under §104(e)
(yes/no)
Received Notice of Potential to have Pattern of S&S* Violations under §104(e)
(yes/no)
Clay Mine
Aiken, SC
615 No No
____________________________________________________________________________________________________
*    S&S refers to violations of mandatory health or safety standards that could significantly and substantially contribute to the cause and effect of a coal or other mine safety or health hazard under §104 of the Mine Act.
The following tables provide information about legal actions before the Federal Mine Safety and Health Review Commission (the “FMSHRC”) during fiscal year 2020.
Mine Pending as of
December 31, 2020
(#)
Instituted during fiscal year 2020
(#)
Resolved during fiscal year 2020
(#)
Clay Mine
Aiken, SC
With Respect to Legal Actions Pending as of December 31, 2020
Mine Contests of Citations and Orders per Subpart B*
(#)
Contests of Proposed Penalties per Subpart C*
(#)
Complaints for Compensation per Subpart D*
(#)
Complaints of Discharge, Discrimination or Interference per Subpart E*
(#)
Applications for Temporary Relief per Subpart F*
(#)
Appeals of Judge’s Decisions or Orders to the FMSHRC per Subpart H*
(#)
Clay Mine
Aiken, SC
____________________________________________________________________________________________________
*    29 CFR part 2700.